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Abstract 
The natural product tagetitoxin is a phytotoxin which was first isolated from the bacterium 
Pseudomonas syringae pv. tagetis in 1981. Tagetitoxin is an inhibitor of chloroplast and bacteria 
RNAP and also selectively inhibits RNAP III in eukaryotes. Multiple biological mechanisms of 
inhibition and several structures have been proposed for tagetitoxin. The structural ambiguity 
and potential useful biological activity have driven the desire for a total synthesis of tagetitoxin’s 
proposed structures; none of which of yet have been successful. 
This body of research describes the recent developments our group has contributed towards the 
synthesis of tagetitoxin. The main objective was to synthesize targets 323a and 323b which both 
contain the oxathiobicyclo[3.3.1]nonane ring system found in two of the proposed structures of 
tagetitoxin.  
Our initial strategy focused on four synthetic routes derived from diacetone mannose (DAM). In 
this strategy, the route nearest to obtaining the bicyclic core of 323a and 323b was the dithiane-
reduction route. In this route, the target precursors 389 and 415 (and analogues) were made, but 
attempted thioacetate deprotection and concomitant cyclization of the thiol/thiolate onto a ketone 
or sulfonate ester to yield the oxathiobicyclo[3.3.1]nonane ring system led to either 
decomposition or complex mixtures. This failure was attributed to the presence of isopropylidene 
groups hampering the cyclization by imposing steric constraints on ring closure.   
We then conducted synthetic routes starting from D-galactose in the D-galactose and exo-glycal 
routes (avoiding the use of any isopropylidene groups). Failure to insert a hydroxyl-methylene 
group on the C-1 position by anomeric nitrile anion chemistry or ring-opening an anomeric spiro-
epoxyacetal with TMSCN led us to attempt a hydroboration-oxidation on an exo-galactal 
derivative which was partially successful. Optimization of the hydroboration-oxidation pathway 
in the exo-glycal route is promising for future research.   
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Background 
The natural product tagetitoxin was first isolated in 1981,1 and since then research has mostly 
focused on its interesting inhibitory activity of RNA Polymerase (RNAP), whilst comparatively 
little research has been carried out on its biosynthesis and chemical synthesis. Despite great 
developments in its biological research, tagetitoxin has yet to be isolated in a pure crystalline 
form and therefore no crystal structure of the natural product in its free form has been published. 
As a result, there has been debate about its structure in the literature. From a synthetic 
perspective, a total synthesis of tagetitoxin would provide the best means to confirm its structure.   
Discovery and Isolation  
In 1981, Mitchell and Durbin isolated and purified tagetitoxin from liquid cultures of the plant 
pathogenic bacterium Pseudomonas syringae pv. Tagetis.1 The steps involved in the isolation, 
included multiple methanol precipitations and methanol:chloroform:water (MCW) extractions. 
These steps decreased the amount of unwanted mineral salts and carbohydrates present with the 
toxin, so that the resultant crude mixture could undergo chromatographic purification. 
Subsequent chromatographic steps involving gel filtration, ion-exchange and partition 
chromatography led to the isolation of tagetitoxin as a colourless glassy residue. Mitchell and 
Durbin, also concluded that the natural product contained a phosphate functional group (by 
formation of blue-grey colour upon spraying molybdate reagent on TLC plate spotted with the 
tagetitoxin sample), amino functional group (by ninhydrin staining TLC plate spotted with the 
tagetitoxin sample) and a sulfur atom (by 35S-radioactive labelling).  
Structure 
A difficulty in the structural characterization of tagetitoxin has been the inability to obtain an X-
ray crystal structure due to the natural product’s non-crystalline glassy form. Furthermore, while 
its absolute stereochemical configuration has yet to be determined, several structures of 
tagetitoxin have been proposed. 
Structure 1 
The first structure was proposed by Mitchell and Hart in 1983.2 IR spectroscopic analysis 
indicated the presence of hydroxyl group(s), carbonyl group(s) and phosphate functional 
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group(s) in the molecule. Field Desorption Mass Spectrometry (FDMS) suggested the molecular 
weight of the natural product to be 435 gmol-1. 
In the 31P NMR, the presence of a doublet (J = 11.5 Hz) at 1.0 ppm downfield from a phosphate 
indicated the presence of a phosphate ester of a secondary alcohol function.  
The sulfur atom was deduced to be part of a thiohemiketal functionality. This conclusion was 
reached firstly on the observation that adding strong acid to tagetitoxin did not liberate a sulfate, 
indicating the absence of a sulfate ester. Secondly, there was no red-colour observed when 
reacting tagetitioxin with sodium nitroprusside, suggesting the absence of a thiol in the molecule. 
Pre-treating the natural product with dilute hydrochloric acid, however, then gave a positive 
colour test for thiols; this was rationalized as there being a thiohemiketal which ring-opened in 
dilute acid.  Thirdly, there was only one sulfur atom in the molecule because growing P.s tagetis 
in the presence of radioactively labelled phosphate (32PO4
3-) and sulfate (35SO4
2-) produced 
radiochemically pure tagetitoxin with phosphorous-sulfur ratio of 1:1.   
Key conclusions made from the 13C NMR data indicated eleven carbon environments including 
three carboxyl carbons and five carbons monosubstituted with oxygen.  The functionalities on 
those five carbons were deduced to be an acetate, phosphate and either one hydroxyl and one 
ether group or three hydroxyl groups based from 1H and 13C NMR chemical shift data.  
Further data from the 1H NMR (more specifically the well-defined multiplets) gave much 
structural information about the framework of the natural product.   
Using the MS and NMR data, the molecular formula for tagetitoxin was proposed to be 
C11H18O13SNP. Finally, based on the molecular formula and the absence of any carbon-carbon 
multiple bond signals in the 13C NMR spectrum, tagetitoxin was hypothesized to be a single ring 
structure. Combining all these analyses, structure 1 was proposed (Figure 1).  
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Figure 1: First proposed structure for tagetitoxin.2 
Structures 2 and 3 
In 1989, based on more refined NMR experiments and higher resolution MS measurements, four 
new structures (Figure 2) were proposed by Mitchell et al.3 
 
Figure 2: Revised structures for tagetitoxin.3 
Fast atom bombardment (FAB) mass spectrograms showed the molecular weight to be 416 
leading to the proposition of a new molecular formula, C11H18O11N2SP. The extra nitrogen in the 
molecular formula was concluded to be of an amide moiety from NMR data. The structure of 
tagetitoxin was proposed to be bicyclic based on the number of hydrogens in the molecular 
formula and the absence of any carbon-carbon multiple bond(s) from NMR data. Furthermore, 
from the data, the authors concluded that the oxygen-containing functional groups were a 
carboxylic acid and amide, acetate, phosphate and either two hydroxyl or two ether groups.  
All four structures were strongly supported by nuclear Overhauser effect (nOe) experiments (for 
example the significant nOe experienced between H-C-5 and H-C-6). In addition, nOe 
experiments were critical in disproving structure 1, as the nOe observed between H-C7 and H-C-2 
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would not be expected for structure 1, since these protons have a too distant spatial proximity 
from each other.  
The authors utilized the Karplus relationship from the coupling constants of the protons in the 
four-carbon series (C-5 to C-8), to deduce the dihedral angles between them. They found, while 
this data was in good agreement with structures 2 and 3, it had better supported structures 2. It, 
for example, showed that H-C-6 and H-C-7 should be in a true diaxial relationship, which is 
evident for structures 2 but not for structures 3 because of the constraints the five-membered 
oxathiane ring places on the seven-membered ring. There, however, was not enough evidence to 
completely discredit structures 3.  
COLOC pulse sequences gave further information on the oxathiane ring. For example, a strong 
correlation between the C-4 and the methylene protons on the oxathiane ring further supported 
the presence of a thiohemiketal or thioketal.  
Finally, the authors preferred structures 2a and 3a where the amide moiety is bonded to C-4, due 
to the lower 13C NMR chemical shift of the carboxyl carbon bonded to C-4 than C-1. However, 
since the chemical shift difference between the carboxyl carbons are low, structures 2b and 3b 
were not discounted.   
In 2005, Gronwald et al. isolated tagetitoxin using a slightly different method.4 They used the 
same procedure as Mitchell et al.,1 except that they used partition chromatography instead off the 
initial methanol precipitation and MCW partitioning steps.  
From electrospray ionization (ESI) mass spectrometry, Gronwald et al. concluded that the 
molecular weight of tagetitoxin was 678 rather than 416 as previously reported by Mitchell et al. 
This difference was explained by the presence of an ion at m/z = 679.5216, which they assigned 
as the protonated molecular ion. While they found an ion with m/z = 417.3316, they identified it 
as a fragment of their protonated molecular ion. The ion at m/z = 417.0361 previously identified 
as the protonated molecular ion by Mitchell et al., was suggested by Gronwald et al. to be a 
fragment of minor contaminants.   
The 1H and 13C NMR spectra reported by Mitchell et al. were mostly in agreement with the 
spectra from Gronwald et al., with the only difference seen in the latter being the extra peaks in 
the 1H NMR (1.75ppm and 2.53ppm) and the 13C NMR (23.2ppm and 181.5ppm) spectra.  
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To account for the differences in the MS data despite good agreements with the NMR data, 
Gronwald et al. suggested that the higher molecular weight of 678 may be rationalized by the 
presence of atoms (such as oxygen, nitrogen and sulfur) and exchangeable protons not detected 
by 1D NMR experiments.    
Furthermore, Structure 2 was supported by many 2D NMR experiments carried out by Gronwald 
et al. such as COSY, TOCSY and HMQC spectra, but there were some discrepancies with 
regards to the HMBC spectra. 
Despite these conclusions, Gronwald et al. did not propose a new molecular formula nor a 
revised structure.  
Structure 4 
Later in 2005, Vassylyev et al. published an X-ray crystal structure of the bacterial Thermus 
thermophilus RNAP-tagetitoxin complex, showing tagetitoxin bound to the enzyme’s active 
site.5 Even though the structure of tagetitioxin was not being investigated in this paper, structure 
4 was indirectly proposed (Figure 3).  
 
Figure 3: Structure of tagetitoxin indirectly proposed by Vassylyev et al.5 
Whilst structure 4 has the same framework as structure 2, the relative stereochemistry is 
different, where more specifically the chiral carbon centres bearing the phosphate group and the 
acetate group (C-8 and C-6) have inverted.  
Despite there being good agreement between the theoretical and experimental electron density 
maps of structure 4, it is inconsistent with the previously reported NMR data.2,3 Furthermore, 
whilst a resolution of 2.4 Å is good for studying a protein structure,6 it is not deemed sufficient to 
fully clarify the structure of a small molecule like tagititoxin.7 
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Structure 5 
Finally, in 2016, Aliev et al. further analysed a tagetitoxin sample originally isolated and purified 
by Mitchell.1,2 They published more NMR and MS data which led them to propose a new 
structure (Figure 4) and refute previous structures.8  
 
Figure 4: Structure proposed by Aliev et al.8 
Aliev et al. concluded that the sample isolated by Gronwald et al.,4 was less pure than that from 
Mitchell et al.1,2 This was rationalized by the absence of the extra peaks Gronwald et al. 
observed in the 1H NMR (1.75ppm and 2.53ppm) and 13C NMR (181.5ppm). 
Moreover, on analysing MS data, no species with a molecular weight of 678 was seen, which 
disagreed with Gronwald and co-workers’ proposed molecular weight of tagetitioxin.  
Key disagreements with the previous structures (1, 2, 3 and 4) were found from the HMBC 
spectrum and the long range JCH values. These disagreements were:
 
1. A correlation between C-11 and H-C-8 is seen which is inconsistent with structures 2a, 3a 
and 4 because of the presence of six bonds between these atoms.  
2. The JCH value of 5.0 Hz, between C-10 and H’-C-2 is too large to be a 4JCH correlation. 
This is not consistent with structures 2b and 3b, since the size of the JCH suggests that this 
pair of atoms should be closer together.  
3. The cross peaks observed for C-7 with H-C-2 (JCH = 5 Hz) and with H’-C-2 (JCH = 3 Hz) 
are inconsistent with all structures 1 to 4. This is due to the four-bond separation between 
these aforementioned atoms.  
4. The JCH value of 1.4 Hz for C-4 and H-C-6 is too small to be a JCH correlation for atoms 
that have a ~180ᵒ dihedral angle, which is inconsistent structures 2a and 2b. 
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The key disagreements for previously reported structures were verified with the authors’ 
proposed structure 5: 
1. C-11 and H-C-8 in structure 5 are 3 bonds apart, and therefore correlate.  
2. C-10 and H’-C-2 in structure 5 are 3 bonds apart accounting for the 3JCH value of 5.0 Hz 
between them.  
3. In structure 5, C-7 is 3 bonds apart with H-C-2 and H’C-2 explaining the 3JCH coupling 
observed.  
4. If the 6-membered ring of structure 5 is in a chair confirmation H-C-6 and C-4 will have a 
dihedral angle of ~60ᵒ, which accounts for the low 3JCH value between these.  
The authors also concluded that there was trans stereochemistry at the ring junction due to the 
high coupling constant (3JHH = 12.4Hz) between H-C-6 and H-C-7. Further data from NOESY, 
vicinal 3JHH coupling constants, HMBC and DFT calculations (the latter was used to explain 
unexpected missing HMBC correlations), provided further support for structure 5.   
Biological Activity 
Application of tagetitoxin to the stems of plants in the Asteraceae family such as zinnia (Zinnia 
elegans Jacq) and sunflower (Helianthus annuus) leads to apical chlorosis (bleaching of apical 
green plant tissue due to decreased amount of chlorophyll in that tissue).2 This effect is due to the 
translocation of the toxin to apical regions of the plant where it inhibits chloroplast RNAP, 
suppressing differentiation of proplastids into chloroplasts, preventing new chlorophyll 
accumulation in these regions.9 Two radiolabelling experiments supported this hypothesis.10 
Initially, Matthews and Durbin performed in organello incorporation reactions where tagetitoxin 
was added to isolated, intact chloroplasts and the rate of incorporation of radiolabelled uridine 
into RNA was measured.10 It was observed that tagetitoxin application led to a decrease in the 
rate of incorporation of [3H] uridine into RNA; indeed at tagetitoxin concentrations of 1mM, 
there was negligible [3H] uridine incorporation. Furthermore, the addition of tagetitoxin to in 
vitro transcriptionally active chloroplast protein extracts reduced [32P] UTP incorporation into 
RNA. Both experiments suggest that RNA synthesis in chloroplasts is suppressed due to 
tagetitoxin inhibition of chloroplast RNAP.  
9 
 
Moreover, tagetitoxin inhibits RNAP III in vitro in many eukaryotes such as yeast, insects and 
vertebrates.11 This is in contrast to the other eukaryotic nuclear RNAPs, RNAP I and RNAP II 
which appear to be more resistant to inhibition from the toxin.12 For example tagetitoxin at low 
concentrations (0.3-3.0 μm) inhibit RNAP III directed transcription in various organisms but has 
little effect on RNAP II directed transcription.13  
Finally, inhibition of in vitro RNA synthesis directed by RNAP from Escherichia Coli by 
tagetitoxin at concentrations less than 1μM has also been reported.10,13 
In summary, tagetitoxin inhibits chloroplast and bacterial RNAP. Tagetitoxin is also a selective 
inhibitor of RNAP III compared to the other nuclear RNAPs in a variety of eukaryotes.   
Biological Mechanism of Inhibition  
In 1994, Matthews and Durbin conducted abortive initiation assays to primarily investigate the 
inhibition kinetics of tagetitoxin on E. Coli RNAP.12 They concluded that tagetitoxin acts an 
uncompetitive inhibitor of E. Coli RNAP which indicates that the toxin does not prevent the 
nucleotide triphosphate (NTP) substrate from binding with the enzyme. It was also inferred from 
these studies that tagetitoxin does not affect phosphodiester bond formation between an NTP 
substrate and the nascent RNA chain. The authors suggested that the inhibition may be due to 
tagetitoxin affecting the stability of the binding between the nascent RNA chain and the enzyme-
DNA template complex. Despite advances in the understanding of the inhibitory effect of 
tagetitoxin on a RNAP, it was widely acknowledged that the exact mechanism of the toxin and 
its target site on RNAP were unclear.5 
A breakthrough in the inhibition mechanism by tagetitoxin on RNAP was achieved by Vassylyev 
et al. in 2005, where an X-ray crystal structure of the complex between a bacterial RNAP (from 
Thermus thermophilus) and tagetitoxin was published.5 Analysis of this structure led to a greater 
insight of the binding between tagetitoxin and RNAP. This structural analysis along with 
homology modelling and biochemical analyses allowed the authors to propose a more detailed 
inhibition mechanism.  
The X-ray structure has shown that the RNAP binding site for tagetitoxin is located at the base of 
the RNAP secondary channel, adjacent to its active site. This suggests that tagetitoxin does not 
prevent NTP substrate binding, which is in agreement with the conclusions drawn by Matthews 
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and Durbin.12 Moreover, the binding between tagetitoxin and the RNAP was primarily made up 
of 18 hydrogen bonds between 9 of the 11 oxygen atoms of the toxin with side chains of adjacent 
amino acid residues of the RNAP (Figure 5).  In addition to the expected catalytic magnesium 
ions (cMg1and cMg2) found in a RNAP, a third magnesium ion (tMg) was observed in the 
RNAP/Tagetitoxin complex. The authors suggested that this well-fixed tMg coordinates to the 
phosphate group of tagetitoxin stabilizing the toxin further. The tMg is well-fixed because of its 
coordination to the side chains of two active site amino acid residues of RNAP.  
 
Figure : A schematic diagram of the tagetitoxin binding site on RNAP. 5 
Vassylyev and co-workers postulated a two-step mechanism for tagetitoxin inhibition RNAP 
(Figure 6). They proposed that the mechanism involves the stabilization of an inactive 
transcription intermediate whilst the NTP substrate is loading into the active site. In this 
mechanism, whilst tagetitoxin is being bound to its binding site in the enzyme, the NTP substrate 
enters the pre-insertion site. Due to the coordination of tagetitoxin to tMg, the NTP binds to the 
tMg rather than cMg2; binding to cMg2 would otherwise occur without tagetitoxin. The NTP 
substrate is then loaded into the insertion site by a simple rotation forming the insertion complex. 
In the resulting intermediate, the active site has a more compact conformation leading to tighter 
binding of the tMg-bound substrate and greater stabilization, locking the intermediate in an 
inactive state preventing the dissociation of the NTP substrate and the catalytic reaction. The 
authors also proposed that since the NTP coordinates to the tMg rather the cMg2, the positioning 
of cMg1 and cMg2 change. This change in orientation would decrease the stability of the 
pentavalent transition state formed during phosphodiester formation between the terminal 3’OH 
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of the nascent RNA chain and the α-phosphate functionality of the NTP substrate, further 
lowering the catalytic activity.  
 
Figure 6: Proposed inhibitory mechanism of tagetitoxin on RNAP.5 
This mechanism was contested by Artsimovitch et al. in 2011.14 Based on theoretical modelling 
using molecular dynamics simulations, they suggested that the inhibitory effect of tagetitoxin on 
RNAP arises from the interaction between tagetitoxin and the side chains of two amino acid 
residues of the RNAP trigger loop (a flexible protein domain). During typical transcription, the 
trigger loop folds into a trigger helix; this leads to the catalytic amino acid residues being in an 
active configuration. These amino acid residues, then interact with the NTP substrate facilitating 
phosphodiester bond formation between the NTP and the nascent RNA chain.15  However, due to 
the interaction of tagetitoxin with the trigger loop, instead of folding to a trigger helix, it is 
stabilized and trapped in an inactive state, which lowers catalytic activity. Klyuyev and 
Vassylyev later argued that this mechanism was in poor agreement with practical results in 
favour for theoretical models.16 
Finally, in 2013, based on multiple transcription assays, the trigger loop mechanism was revised 
by Yuzenkova et al.17 The nucleotide addition cycle consists of phosphodiester bond formation 
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(between the NTP substrate and the nascent RNA chain), a translocation of RNAP on the DNA 
template strand and then the binding of the next NTP substrate.17 In between phosphodiester 
bond formation and translocation, the transcription elongation complex (the RNAP containing 
complex that additionally includes the DNA template strand and the nascent RNA chain) is in its 
pre-translocated state.18,19 During the subsequent translocation, the trigger loop unfolds.14 
Yuzenkova and co-workers proposed that tagetitoxin stabilizes the folded conformation of the 
trigger loop when the transcription elongation complex is in its pre-translocated state.17 As a 
result the subsequent translocation is slowed down due to the greater difficulty in unfolding the 
trigger loop; this leads to the overall rate of the RNA chain elongation to decrease.  
Importance of Tagetitoxin 
The importance of tagetitoxin originates from its biological activity. For example, due to the 
toxin’s inhibition on chloroplast RNAP, its use as a plant growth regulator has been 
patented.20  Furthermore, since tagetitoxin inhibits a variety of RNAPs, it can be a useful tool for 
molecular biologists investigating transcription. Finally, a total synthesis of the natural product 
would provide opportunities to synthesize a library of analogues; these analogues could be then 
assessed for herbicidal21 and antibacterial activity.22 
Previous Synthetic Studies of Tagetitoxin 
Since all synthetic studies towards tagetitoxin were conducted prior to 2016, the targets were 
generally 2a and 2b as these were the accepted structures at the time.  
Sammakia et al. 
In 1996, Sammakia et al. published their attempt to synthesize tagetitoxin.23 Their retrosynthetic 
analysis of tagetitoxin involved a precursor 6 that can cyclize to give structures 2a or 2b 
(Scheme 1). Synthesis of precursor 6 was planned to be an enzymatic aldol-catalysed coupling 
of dihydroxy acetone phosphate 7 with aldehyde 8. Aldehyde 8 could be made from oxazolidine 
olefin 9 in three steps: dihydroxylation of the olefin moiety; hydrolysis of the oxazolidine; and 
selective oxidation of the primary alcohol to an aldehyde. 
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Scheme 1: Retrosynthetic analysis of proposed tagetitoxin structures 2a and 2b by Sammakia et 
al. 
A range of oxazolidine olefins 9 (Scheme 2 and Table 1) were prepared in a one-pot synthesis. 
This involved a range of thiolate anions attacking a substituted methyl acrylate phosphonate 10 
in a conjugate addition forming an ylide. The ylide, in turn, condensed with the oxazolidine 
aldehyde 11 to produce the olefins 9a to 9e with varying stereoselectivity. 
 
Scheme 2: One-pot synthesis of oxazolidine olefins 9. 
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 R Ethyl  
9a 
i-Propyl 
9b 
t-Butyl 
9c 
Phenyl 
9d 
Benzyl 
9e 
Z:E 60:40 70:30 100:0 20:80 30:70 
 
Table 1: Effect of the sulfur protecting group on the Z:E ratio of olefins 9a-e 
The authors then attempted a range of dihydroxylation methods on olefins 9 (Scheme 3 and 
Table 2).  
 
Scheme 3: Dihydroxylation attempts of olefins 9. 
Olefin Conditions Recovered 9 (%) Yield of 12 (%) Yield of 13 (%) Yield of 14 (%) 
9a a 54 - 48 - 
b 30 - 70 - 
9b a 56 6 28 - 
b 39 15 44 - 
9c a 86 14 - - 
b 32 55 11 - 
9d a 99 - <1 - 
b 34 27 - 39 
9e a 82 - 10 - 
b 22 6 72 - 
 
Table 2: Yields reported for compounds 12, 13 and 14 from the dihydroxylations of olefins 9 
When using conventional methods of stoichiometric or catalytic amounts of osmium tetroxide, 
only sulfur oxidized products were isolated. This then led them to use AD-mix-β or 
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stoichiometric amounts of osmium tetroxide and potassium ferricyanide. However, for most of 
the olefins 9, starting material and sulfur oxidized products (mainly sulfoxides) were the major 
compounds isolated. The most promising result was the dihydroxylation of the bulky t-butyl 
thioether substrate 9c using stoichiometric osmium tetroxide and potassium ferricyanide. Despite 
this promising result, the synthesis to structures 1 and 2a were not pursued and no research 
related to this synthetic strategy has yet to be reported.  
Dent et al. 
Due to tagetitoxin’s reported biological activity, Dent et al. aimed to synthesize related 
analogues of the natural product for evaluation as herbicides and plant growth regulators.21 
Based on structures 2a and 2b, the authors thought that the acetate, amine and phosphate groups 
were key for the biological activity. They also suggested that the sulfur bridge was important to 
impose the desired stereochemistry on the pyranoid ring. As a result, structures 15 and 16 were 
their synthetic targets (Figure 7). To achieve their main goal of gaining greater knowledge on 
structure-activity relationships of tagetitioxin, Dent et al. would have to make carbohydrate-
based vicinal cis-amino phosphates (where the latter in itself is useful synthetic methodology). 
 
Figure 7: Synthetic targets for Dent et al. 
The authors were able to synthesize structure 15 (X=O) in a twelve-step route starting from 
dialdehyde 17 (Scheme 4), which is readily available from periodate oxidation of levoglucosan. 
The cyclic framework of their synthetic target was achieved by the cyclization of dialdehyde 17 
with nitromethane furnishing 18. After hydrogenolytic reduction of the nitro group to produce 
19, the formed amine was then N-Boc protected to give 20. The authors then exploited the syn-
stereochemistry of the C-2 and C-3 substituents; this would eventually allow them to esterify the 
C-2 and C-4 hydroxyl groups selectively. The N-Boc derivative 20 was then treated with 
bis(tributyltin) oxide in toluene under reflux, followed by addition of tetra-n-butylammonium 
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bromide and benzyl bromide to form the N-benzyloxazolidinone derivative 21. The authors then 
carried out a three-step sequence of protections and deprotections of various groups to afford 24. 
Compound 24 then underwent a phosphitylation using o-xylene-N,N-diethylphosphoramidite and 
1H-tetrazole, which was  followed by an oxidation using m-CPBA yielding phosphate ester 25. 
The authors subsequently deprotected the tetrahydropyranly acetal (THP) and then acetylated the 
C-4 hydroxyl group, which formed compound 27. Hydrogenolysis of the phosphate ester and 
benzyl amine moieties in 27 were performed leading to synthetic target 15. Hydrogenolysis of 
intermediate 26 led to an additional analogue 28 which along with 15 were tested for herbicidal 
activity.  
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Scheme 4: Dent and co-workers’ synthesis of analogues 15 and 28. 
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Biological testing showed compound 15 and its deacylated analogue 28 to have no herbicidal 
activity against a variety of agriculturally important weeds:  
Avena Fatua (wild oat), Setaria viridis (green foxtail), Amaranthus retroflexus (redroot pigweed) and 
Chenopodium album (fat hen).  
A second set of analogues based on structure 15, were then targeted by the authors using 
different synthetic methodology, whereby the insertion of the amino functionality at C-3 would 
be different. This would be achieved by forming a good leaving group at the C-3 position 
followed by a SN2 reaction using a nitrogen-based nucleophile which could later be transformed 
to an amino functional group (e.g. azide nucleophile).  
Their first attempted synthesis following the above methodology started from 1,6-anhydro-D-
galactose 29 and it sulfur analogue 30 (Scheme 5). Acetonide formation of the hydroxyl groups 
on C-3 and C-4 in 29 and 30, allowed subsequent selective phosphate ester formation on the C-2 
position forming 32, 33 and 35. Phosphate ester formation was achieved using either a dialkyl 
chlorophosphate in pyridine or a pyrophosphate with a strong base (only the latter strategy was 
used on the sulfur analogue 34). Subsequent steps (d, e and f) involved successive protections 
and deprotections of various groups in order to reach 38 or 40. The authors began this sequence 
with an acetonide deprotection affording 36 and 37. They, however, could not isolate the 
required diol from acetonide hydrolysis of sulfur species 35 (presumed to be because of the 
sulfur atom participating in reactions involving carbocations generated in these acidic 
conditions). Under a variety of conditions, Dent and co-workers, then unsuccessfully attempted 
to selectively acetylate the C-4 hydroxyl group over the C-3 hydroxyl group in 36 and 37, since 
they only isolated inseparable mixtures of the monoacetates 38 and 39 or 40 and 41 respectively. 
The origin of this poor selectivity was attributed to either an inherent unselective reaction or 
ester migration occurring during the reaction.  
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Scheme 5: Dent and co-workers’ second route to analogues based on structure 15. 
As a result, the authors changed their approach in an attempt to isolate 40 (Scheme 6). This 
involved forming a cyclic brominated orthoacetate 42 (from 37) and then subjecting this to mild 
acidic hydrolysis. This methodology was hypothesized to lead to bromoacetate 43. Compound 43 
could then be acetylated on the C-4 position, then deprotection of the C-3 bromoacetate in the 
presence of the C-4 acetate would lead to the desired 40. Although brominated orthoacetate 42 
was successfully synthesized, when subjected to mild hydrolysis an inseparable mixture of 
bromoacetates 43 and 44 were formed causing the authors to abandon this methodology.  
Scheme 6: Dent and co-workers’ alternative route to structure 40. 
Dent and co-workers’ second attempted route in selectively functionalizing 29 and 30 exploited 
the regioselective reductive cleavage of a methoxybenzylidene acetal (Scheme 7). After forming 
a methoxybenzylidene acetal on the C-3 and C-4 position and successively silyl protecting the C-2 
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hydroxyl group to form 47 and 48 respectively, treatment with LiAlH4-AlCl3 produced only the 
3-O-p-methoxybenzyl ethers 49 and 50. Subsequently via a series of protections and 
deprotections, compounds 53 and 54 were made where the hydroxyl group on C-3 was 
unprotected. This therefore allowed introduction of a good leaving group on the C-3 position 
(triflate, tosylate and mesylate) and displacement of that leaving group with an azide 
nucleophile. However, despite successfully synthesizing sulfonate esters 55 – 60, treatment with 
sodium azide in DMF, HMPA or DMSO failed to yield compounds 61 and 62 as only starting 
material or decomposition was seen. The rationale for these observations was steric hindrance 
from the adjacent bulky silyl ether.  
 
Scheme 7: Attempted synthesis of compounds 61 and 62 by Dent et al. 
Dent et al. then focused on synthesizing compounds based on structure 16 starting from 
pentaprotected carbohydrates. Their strategy involved a one carbon chain extension at the C-1 
position of a D-galactopyranose derivative, followed by ring closure linking this new carbon 
atom with the C-6 by a sulfur or oxygen atom. Following this, phosphorylation, acetylation and 
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introduction of the amino functionality (latter by SN2 chemistry) would then yield 16 (Scheme 
8).  
 
Scheme 8: Dent and co-workers’ methodology to synthesize analogue 16. 
In this strategy, the authors started with the bromination of D-galactose pentaacetate 63 to give 
the α-glycosyl bromide, which was then treated with mercuric cyanide in nitromethane to furnish 
the β-nitrile 64 (Scheme 9). Two approaches to synthesize 66 from 64 were successfully 
achieved. The first approach involved a reductive hydrolysis of a nitrile to an aldehyde using 
Raney nickel with the hydrogen source sodium hypophosphite in aqueous acetic acid and 
pyridine, followed by the in-situ trapping of that aldehyde with a diamine to form imidazolidine 
65. The success of this reaction was variable due to the occurrence of undesired side-reactions. 
The aldehyde was then regenerated by hydrolysis of the imidazolidine and then reduced using 
sodium borohydride. The resultant crude product was then acetylated to form 66. The second 
approach involved deacylation of 64, basic nitrile hydrolysis and then acetylation of the crude 
hydrolysis product which gave a mixture of γ-lactone 67 and hydroxy carboxylic acid 68. 
However, under strong acetylation conditions, 68 was cleanly reconverted into γ-lactone 67. 
Lithium aluminium hydride (LAH) reduction of the lactone and subsequent peracetylation gave 
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66. After compound 69 was formed from deacetylation of 66, selective tosylation on the 
methylene alcohols produced compounds 70 and the undesired tri-tosylate 71. Acetonide 
formation on ditosylate 70, led to the bicyclic precursor 72. Attempts at ring closure in 72 using 
sulfide nucleophiles (lithium or sodium sulfide) in DMF failed to produce the bicyclic structure 
73. However, thiol 74 was isolated where only one of the tosylates was displaced by the sulfide 
nucleophile. The authors attributed this result to the isopropylidene groups placing steric 
constraints on the ring closure.  
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Scheme 9: Dent and co-workers’ attempted synthesis of bicyclic structure 73. 
As the synthesis of 73 was unsuccessful, Dent et al. decided to replace the isopropylidene group 
with benzyl groups when forming further precursors for target 16 (X=O). Hence, starting from 
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compound 65, they performed a sequence of deprotections and protections of various groups to 
reach the tri-benzylated compound 76 (Scheme 10). After unmasking the aldehyde in 76, sodium 
borohydride reduction and trityl deprotection, diol 77 was isolated. Two different methods on 77 
were undertaken in an attempt to isolate the desired cyclic ether 78:  
1. An acidic cyclodehydration in toluene under reflux. 
2. Treatment with triphenylphosphine and diethyl azodicarboxylate (DEAD).  
In both methods, however, starting material was only recovered. The authors then tried a mono-
tosylation on diol 77 but this led to a mixture of the regiomeric mono-tosylates 79 and 80 in 
addition to di-tosylate 81. Nevertheless, since they were able to isolate 79, they attempted the 
cyclization using sodium hydride, but this gave a complex mixture.   
 
Scheme 10: Dent and co-workers’ attempted synthesis of bicyclic structure 78. 
Finally, Dent et al. wanted to introduce a nitrogen functional group attached to the C-3 position 
prior to the ring closure to assess whether the substituent on this position in the previous routes 
sterically hindered the cyclization. They, therefore synthesized the di-benzylidene acetal 82 from 
69 (Scheme 11). This allowed subsequent transformation of the C-3 hydroxyl group in 82 to a 
variety of sulfonate esters (compounds 83-86). However, nucleophilic displacement of these 
sulfonate esters with an azide nucleophile under a range of conditions led to either no reaction or 
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decomposition of the starting material, except for tosylate 85 which furnished azide 87 but at 
only 10% yield. Due to the low yield, the synthesis was abandoned at this stage.  
 
Scheme 11: Synthesis of azide 87 by Dent et al. 
In summary, Dent et al. were successful in making the analogue 15 (Scheme 4) but only with an 
oxygen bridge rather than a sulfur bridge. They were also unsuccessful in the synthesis of 
analogue 17, which is more closely related to tagetitoxin structures 2a and 2b.  
Porter and Plet 2006 
In 2006, Porter and Plet published the first synthesis of the bicyclic core of tagetitoxin from a 
carbohydrate precursor.24 
Their first strategy, was based on a carbene-mediated ring expansion of a 1,3-oxathiolane moiety 
(Scheme 12). In this approach a metallocarbene would be generated from a transition metal 
catalysed decomposition of a diazo derivative. The nucleophilic sulfur atom would then attack 
the electrophilic carbon of the metallocarbene forming a sulfur ylide. This would cause the 1,3-
oxathiolane moiety to ring open followed by a ring closure to form a 1,4-oxathiane moiety in a 
Stevens rearrangement.   
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Scheme 12: Carbene mediated ring expansion strategy of 1,3-oxathiolones to form the 
tagetitoxin bicyclic structure envisaged by Porter and Plet. 
In order to test their ring expansion strategy towards the synthesis of the bicyclic core of 
tagetitoxin, the investigators firstly synthesized compound 88 (Scheme 13). Compound 88 was 
synthesized from D-glucose by selective tosylation on the C-6 hydroxyl group, peracetylation, 
bromination on the anomeric position and substitution of the two leaving groups using a xanthate 
species. They then attempted the ring expansion of 88 using ethyl diazo(triethylsilyl)acetate and 
catalytic rhodium(II)acetate, but only glycal 91 was formed rather than the intended sulfur 
bridged bicyclic structure. The authors explained this result from the behaviour of the zwitterion 
intermediate 90; instead of 90 undergoing the desired C-C bond formation, it ring-flipped to the 
more stable conformer which was followed by a proton transfer affording 91. Thus, Porter et al. 
synthesized the more constrained precursor 92, in five steps from 3-methyl-D-glucose for the 
ring expansion, because the consequent zwitterion (analogous to 90) would have a locked 
conformation preventing any ring flipping. Yet, when subjecting 92 to ethyl 
diazo(triethylsilyl)acetate and rhodium(II) heptafluorobutyrate, only alcohol 94 at low yield was 
isolated. This probably occurred because of nucleophilic ring opening of ylide 93 with a water 
molecule followed by a proton transfer. 
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Scheme 13: Porter and Plet’s attempt to synthesize the bicyclic core of tagetitoxin using their 
ring expansion strategy.  
As a result, to synthesize the 1,4-oxathiane ring of tagetitoxin, the investigators altered their 
approach from a ring expansion strategy to cyclization of a thiol onto an electrophilic ketone. 
The key methodology for this approach, involved the insertion of a bromoalkyne (masks an α-
ketoester) and a thioacetate moiety (masks a thiol) onto a carbohydrate derivative, followed by 
the unmasking of these groups leading to cyclization.  
Starting from the β-thioglycoside 95, selective silyl protection of the primary alcohol and 
subsequent perbenzylation furnished 96 (Scheme 14). Compound 96 was then transformed into 
δ-lactone 97 by hydrolysis of the thioglycosidic linkage using N-bromosuccinimide (NBS), 
followed by oxidation when treated with Dess-Martin periodinane (DMP).  Silyl alkyne 98 was 
then formed after cerium-mediated addition of trimethylsilylacetylene onto the lactone and 
sequent hydrosilane reduction on the C-1 position. The silyl alkyne moiety was then transformed 
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into a bromoalkyne by protodesilylation and bromination of the terminal alkyne. Oxidation of the 
bromoalkyne to an α-ketoester was achieved using potassium permanganate in aqueous methanol 
yielding 101. Deprotection of the primary silyl ether in 101, would then allow activation of the 
primary alcohol into a good leaving group and its displacement with a thioacetate nucleophile. 
However, when attempting to cleave the silyl ether with tetra-n-butylammonium fluoride 
(TBAF), elimination of the 2-benzyloxy group occurred forming glycal 102 in most likely an 
E1cb reaction. The authors therefore changed the conditions and used hydrogen fluoride – 
pyridine complex, but instead tricyclic ketal 103 was formed. To reach 103, the silyl ether and 
the benzyl ethers on the C-3 and the C-4 in 101 must have been cleaved, which was followed by a 
ketal formation between the ketone and the liberated hydroxyl groups on the C-3 and C-6 centres.  
 
Scheme 14: Synthesis of intermediate 101 by Porter and Plet. 
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To overcome the difficulty in deprotecting the silyl ether on the C-6 position in the presence of 
the α-ketoester, the authors altered the sequence of the route; specifically, they planned to 
incorporate the sulfur functionality before the α-ketoester synthesis. Starting from 98, double 
desilylation of the silyl alkyne and silyl ether occurred forming 104 (Scheme 15). The hydroxyl 
group on the C-6 centre transformed into a mesylate and was subsequently displaced with a 
potassium thioacetate nucleophile in DMF.  Using the same previous methods, bromination of 
the alkyne and subsequent oxidation with potassium permanganate gave the α-ketoester bicyclic 
precursor 106. Thioacetate deprotection and in-situ cyclization of the thiolate onto the ketone led 
to bicyclic thiohemiketal 107.  
 
Scheme 15: Porter and Plet’s synthesis of the bicyclic core of tagetitoxin (107). 
In summary Porter and Plet attempted two strategies to synthesize the bicyclic core of 
tagetitioxin. Although the carbene-mediated ring expansion approach failed, they were 
successful in their methodology involving a thiolate cyclizing onto an electrophilic ketone. This 
was only achieved with inserting the thioacetate moiety before forming the α-ketoester, 
illustrating the importance in the order of the steps in the route. However, a carboxylic acid 
derivative on the anomeric position on the bicyclic core was still missing.  
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Porter et al. 2008 
In 2008, Porter and co-workers again synthesized the core structure of tagetitoxin.25 This was 
achieved by building on their previous work regarding the carbene-mediated ring expansion of a 
1,3-oxathiolane moiety to a 1,4-oxathiane moiety.24 The authors concluded, that their previous 
ring expansion attempts did not work because of the conformational flexibility of the zwitterion 
90 leading to the undesired glycal 91.24 However, even when they incorporated a di-tert-
butylsilane bridge on the C-2 and C-4 hydroxyl groups to form the more constrained precursor 92, 
no ring expansion products were still observed (Scheme 13).24 Nevertheless, Porter et al. still 
postulated that the conformational flexibility rationale was the cause for the ring expansion 
failure. They therefore aimed to synthesize the ylide in an intramolecular reaction (rather than 
intermolecular fashion as previously).24 This would lead to a more constrained ylide and 
subsequent zwitterion intermediate, which would favour the desired C-C bond formation.    
To test their postulate, the authors made thioanhydroglucose 108 in a four-step route according 
to the literature.26,27 They then devised a synthetic route to tetracyclic structure 109 from 
thioanhydroglucose 108 (Scheme 16). Selective protection of the C-2 and C-4 hydroxyl groups 
with a di-tert-butylsilane bridge furnished 110. This was followed by acetoacetylation and 
subsequent diazo transfer yielding 111. Treatment of 111 with rhodium(II) acetate dimer formed 
isolable tetracyclic ylide 112 (further confirmed with X-ray crystallography).  However, despite 
heating 112 in an array of solvents of different polarities such as xylene, methanol and DMSO, 
only starting material or decomposition (latter only observed at extended reaction times) were 
seen. 
31 
 
 
Scheme 16: Attempted synthesis of tetracyclic 109 by a thermal promoted Stevens 
rearrangement by Porter et al. 
Porter et al. proposed two mechanisms for the thermally promoted Stevens rearrangement 
(Scheme 17). The homolysis mechanism a, is the general favoured mechanism for the Stevens 
rearrangement.28,29 However, to account for the isolation of glycal 91 from their  previous 
attempted ring expansion on 88,24 they suggested that heterolytic mechanism b would be 
favoured for these substrates under thermal conditions. Thus, they found it surprising when the 
ylide was generally stable under these conditions (dependent on reaction times). They also 
thought pathway b would be more favoured with acidic conditions (due to increased polarization 
of the C-S bond). Therefore, protic acids (such as trifluoroacetic acid and triflic acid) and Lewis 
acids (such as [Cu(acac)2]) were then added to ylide 112 but these failed to induce the desired 
Stevens rearrangement.  
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Scheme 17: Porter and co-workers’ proposed mechanisms for the thermally promoted Stevens 
rearrangement. 
Since, a Stevens rearrangement did not occur on ylide 112 under acidic or thermal conditions, 
Porter et al. attempted a photochemical variant of the Stevens rearrangement. They subjected 
ylide 112 to photolysis in acetonitrile, affording the tetracycle target 109 (Scheme 18). 
 
Scheme 18: Porter and co-workers’ synthesis of target 109 by a photo-Stevens reaction of 112 
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Having made the tetracyclic structure 109, the authors explored the scope of their methodology. 
More specifically, they synthesized further substrates to assess which structural features were 
important for ylide formation and the photo-Stevens rearrangement.  
The first structural feature investigated was the effect the di-tert-butylsilylene protecting group 
(on the C-2 and C-4 hydroxyl groups) had on ylide formation or the photo-Stevens rearrangement. 
Hence, via a sequential deprotection-protection, the authors formed 114 from 113 where the 
bridged silyl ether on the C-2 and C-4 was replaced with two triethylsilyl (TES) ethers (Scheme 
19). A Diazo transfer and subsequent rhodium-catalysed diazodecomposition led to ylide 116 
(analogous to ylide 112 except with the non-bridged silyl ether protecting group). Photolysis of 
116 yielded the tricyclic product 117 (with similar rates and yields to the previous example 109).  
 
Scheme 19: Porter and co-workers’ synthesis of tricyclic structure 117. 
Finally, the authors wanted to examine whether the acetyl group alpha to the carbon centre of the 
ylide was important in this methodology. Diazoacetate 120 was therefore made in three steps 
from alcohol 110, via acetylation, acetoacetylation and a diazo transfer (Scheme 20). Attempted 
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ylide formation using rhodium(II)acetate dimer in benzene failed and instead furnished 121; this 
compound must have been produced from the formed rhodium carbenoid reacting with the 
benzene solvent.30 As a result, the authors changed the solvent to dichloromethane which gave 
the desired ylide 122. Since, 122 was unstable to column chromatography, the crude reaction 
mixture was directly subjected to photolysis yielding target compound 123.  
 
Scheme 20: Porter and co-workers’ synthesis of tetracyclic 123. 
To summarize, Porter et al. developed another route to make the core structure of tagetitoxin. 
The key steps in this route were the intramolecular ylide formation, between the sulfur atom and 
an in-situ formed metallocarbenoid, followed by a photo-Stevens rearrangement. They 
additionally inferred that the silyl bridge tether between the oxygens on the C-2 and C-4 position 
as well as the acetyl group alpha to the nucleophilic carbon on the ylide were not important 
factors for this methodology to be successful. This strategy, however, would need to be explored 
further and adapted to achieve a total synthesis of tagetitoxin.   
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Porter et al. 2009 
In 2009, Porter et al. adapted their previous strategy of forming the tagetitoxin bicyclic core 
(from a thiol/thiolate cyclizing onto an electrophilic ketone),24 to attempt a total synthesis of 
tagetitoxin 124 and decarboxytagetitoxin 125 (Figure 8).31  
 
Figure 8: Synthetic targets for Porter et al. 
Their initial target was decarboxytagetitoxin 125, starting from D-glucose. The key methodology 
of this route was to invert the stereogenic centres at the C-2 and the C-3 positions with the 
incorporation of a nitrogen functionality at the C-3, via the formation and subsequent trans-
diaxial ring opening of a 2,3-β-epoxide with an azide nucleophile.  
The diol 126 was prepared from D-glucose in two steps according to the literature (Scheme 
21).32 Diol 126 was doubly deprotonated using sodium hydride and then underwent selective 
tosylation at the O-2 position, which triggered the O-3 alkoxide to intramolecularly displace the 
tosylate to form the 2,3-β-epoxide. The epoxide was then ring-opened with sodium azide to form 
127. After silyl protection of the hydroxyl group on the C-2, the anomeric allyl ether was 
deprotected to form a lactol, which in turn underwent a DMP oxidation yielding lactone 128. 
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Scheme 21: Attempted synthesis of compound 129 by Porter et al. 
Treatment of lactone 128 with an in-situ generated cerium-acetylide did not lead to the desired 
addition product; this was surprising, given the success when subjecting the related lactone 97 to 
these conditions in their previous work.24 Instead the only compound isolated was the double 
addition product 130. The authors hypothesized that after the desired nucleophilic attack of the 
cerium-acetylide onto the lactone, a ring opening to a ketone occurred, which then underwent a 
second organometallic addition. This was followed by a silyl migration from the O-2 position to 
the formed tertiary alkoxide producing 130. As a result, Porter and co-workers carried out the 
reaction with ytterbium triflate instead of cerium chloride, so that an organoytterbium instead of 
an organocerium species would react with lactone 128. Compound 131, however, was formed 
instead of 129. Porter and co-workers proposed a mechanism for this transformation (Scheme 
22). Initially the ytterbium acetylide attacks the lactone to form 132 which ring opens to 133. 
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Subsequently a transannular hydride shift occurs forming 134 which then cyclized to 131 upon 
workup.  
 
Scheme 22: Porter and co-workers’ proposed mechanism for the formation of 131. 
To overcome problems arising from the introduction of the acetylene moiety at the anomeric 
position on 128, the authors decided changed the order of the route. Specifically, they planned to 
incorporate the alkyne moiety prior to the inversion of the C-2 and C-3 chiral centres (i.e. to insert 
the alkyne moiety before they form the 2,3-β-epoxide). They rationalized that by carrying out the 
synthesis in this order, the acetylide would add to a glucose configured substrate (rather than an 
altrose configured substrate) which is more similar to the lactone 97 used for this analogous 
reaction in their previous successful strategy (Scheme 14).24  
Porter et al. synthesized 1,6-anhydroglucose 135 from D-glucose in four steps from the 
literature.33 Following selective silyl protection of the O-2 and O-4 to form 136, the authors 
introduced an alkyne moiety on the anomeric position using Vasella’s method (Scheme 23).34 
This method involved the reaction between a lithium acetylide and aluminium trichloride to form 
a Al(C≡CTMS)3 species which upon treatment with 136, led to 137. Formation of 138 was then 
achieved by deprotection of the silyl ethers and sequent protection of the O-5 and O-6 in the 
form of a p-methoxybenzylidene acetal. Synthesis of epoxide 139 was, however, not achieved 
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using their previous strategy. This is because despite trying a range of conditions (TsCl, Ts-
imidazole, Ts2O and MsCl with either pyridine or sodium hydride as base) no regioselectivity 
was accomplished for the sulfonylation of one of the hydroxyl groups on C-2 or C-3 centres over 
the other (since only inseparable 1:1 mixtures of the respective mono-sulfonates were obtained).  
 
Scheme 23: Attempted synthesis of epoxide 139 by Porter et al. 
To solve this regioselective problem, the route was altered to make a substrate analogous to 138 
with the exception of O-3 being protected (Scheme 24). Acetate 140 was therefore synthesized 
from 137 by a selective silyl protection on O-6 and sequent acetyl protection on O-3. Silyl ether 
cleavage and acetal formation then followed yielding 141. Tosylation of the free hydroxyl group 
on C-2 was accomplished and then epoxide formation was attempted. Under basic conditions, 
deacetylation of O-3 and concomitant displacement of the tosylate as well as removal of the silyl 
group on the alkyne led to the epoxide 142 being formed. Yet, when attempting to ring open the 
epoxide with an azide nucleophile in acidic conditions, only partial hydrolysis of the acetal was 
seen. Thus, the authors tried non-acidic conditions such as heating the epoxide with sodium azide 
in DMF, but only elimination product 143 was observed. Trans-diaxial ring opening of epoxide 
142 to azide 144 was eventually achieved using Yamamoto’s procedure.35 In this procedure, 
ytterbium triisopropoxide (formed in-situ from ytterbium triflate and lithium isopropoxide) 
activates the epoxide for nucleophilic attack from the azide.  
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The next target was to install the thioacetate on the C-6 position. To achieve this, they protected 
the 2-O with an acetyl group, hydrolysed the acetal and then performed a selective tosylation on 
the primary alcohol. This was followed by a displacement of the tosylate with a thioacetate 
nucleophile furnishing 145. After silylation of the O-4, bromination of the terminal alkyne was 
achieved using NBS and catalytic AgNO3. However, oxidation of the bromoalkyne moiety in 
146 to an α-ketoester using potassium permanganate in methanol (as similarly carried out in the 
synthesis of 106 in their earlier work)24 failed for this substrate as only decomposition was 
observed; this prevented the synthesis of decarboxytagetitoxin 2 being achieved.   
 
Scheme 24: Attempted synthesis of bicyclic precursor 147 by Porter et al. 
Porter et al. also focused on the total synthesis of tagetitoxin 124. They adapted their previous 
strategy (shown in Scheme 23) to include the installation of a vinyl group on the C-5 of the 
glucose configured backbone, envisaging later oxidation of this group to a carboxylic acid 
derivative. Incorporation of the vinyl group, was based on an strategy described by Rao et al.,36 
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with the key step being stereoselective addition of a vinyl Grignard reagent to a 5-keto derivative 
of glucose.  
Porter and co-workers synthesized a similar 5-keto derivative of glucose 149 to Rao et al. (the 
only difference being the protecting group on the O-3).36 This was accomplished in four steps 
from compound 148 (Scheme 25): protection of the 3-O with a PMB group; hydrolysis of the 
5,6-acetonide; selective silyl protection of the O-6; and finally a Swern oxidation of the 
remaining free hydroxyl group on the C-5 position. Subsequent stereoselective Grignard addition 
afforded 150. Upon heating 150 in a mixture of acetic and trifluoracetic acid, global deprotection 
and concomitant cyclization occurred to give the desired 1,6-anhydroglucose derivative; it was 
also vital to have a thioanisole cation scavenger in the reaction mixture as it prevented unwanted 
side reactions. Due to the nature of the conditions (heat and acid),  Fischer esterification side 
products were formed in addition. Thus, the investigators subjected the crude mixture to sodium 
methoxide in methanol to deacetylate the mixture of acetates producing 151 in high yield. Via 
the same methodology in their previous synthetic studies towards decarboxytagetitoxin 
(synthesis of 137 from 135 shown in Scheme 23), the authors performed two further steps to 
yield 152. No further work on this route, however, has been published.  
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Scheme 25: Synthesis of compound 152 by Porter et al. 
In summary, whilst Porter et al. have previously developed a successful synthetic route to the 
bicyclic core of tagetitoxin from thiol/thiolate cyclizing onto a ketone,24 applying and adapting 
this methodology towards a total synthesis of the natural product and its non-natural decarboxy 
analogue have proved difficult despite isolating promising intermediates 146 and 152.31 In fact, 
since this paper, no further research related to this synthetic approach has yet to be reported.  
Porter et al. 2012 
In 2012, Porter and co-workers published another paper building on their earlier research 
concerning ring expansions of a 1,3-oxathiolane moiety in thioanhydrosugars to a 1,4-oxathiane 
moiety and its application towards tagetitoxin synthesis.24,25,37 Although Porter and co-workers 
were previously successful in forming a sulfonium ylide from the reaction of a sulfur atom of a 
thioanhydrosugar with a metallaocarbenoid (generated in situ from a transition metal complex 
and α-diazoester),24,25 they explored methods of forming the ylide without the use of a transition 
metal complex.37 Furthermore, the authors aimed to adapt their previous successful ring 
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expansion methodology in synthesizing the tagetitioxin bicyclic core (based on a carbene-
mediated intramolecular sulfonium ylide formation followed by a photochemical 1,2-Stevens 
rearrangement) to a closer related analogue of decarboxytagetitoxin.   
Using compound 92 (made in their earlier studies),24 Porter et al. planned to carry out an S-
alkylation to form a sulfonium bromide salt 153 followed by a deprotonation to form the ylide 
154  (Scheme 26).  
 
Scheme 26: Porter and co-workers’ retrosynthetic analysis of ylide 154. 
Reaction of 92 with ethyl bromoacetate produced no trace of sulfonium salt 153, instead only 
compound 155 was isolated (Scheme 27); this was formed from nucleophilic attack of the 
bromide ion on the formed sulfonium ion. To prevent this undesired reaction, the authors added 
either silver salts (to form insoluble silver bromide removing the bromide nucleophile) or 
replaced the bromide leaving group on the alkylating agent with a non-nucleophilic group (such 
as a triflate). However, neither of these attempts yielded 153.   
 
Scheme 27: Synthesis of compound 155 by Porter et al. 
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The authors considered another method of generating an ylide considered by forming a free 
carbene (rather than a metallocarbene) from diazo compound 111 under photolytic conditions 
(Scheme 28). If successful, ylide formation and the subsequent photochemical 1,2-Stevens 
rearrangement could be done in one-pot. However, irradiation of 111 with UV light in 
acetonitrile only formed compounds 156 and 157. Compound 156 was most likely formed by a 
Wolf rearrangement of the generated free carbene, followed by hydrolysis on the formed ketene 
intermediate. Whilst oxazole 157 was most likely produced by the reaction between the free 
carbene and acetonitrile. On changing the solvent to dichloromethane or chloroform, the major 
product malonate 156. 
 
Scheme 28: Synthesis of compounds 156 and 157 from 111 by Porter et al. 
To further expand the scope of their methodology, the authors wanted to make 158 (Scheme 29); 
this is an analogue of compound 109 which they had successfully synthesized in their previous 
study.25 The key difference between these congeners is the presence sulfoxide functionality in 
158 rather than a thioether. The oxosulfonium ylide 161 was synthesized from compound 113 
(made in their previous studies)25 in three steps: controlled thioether oxidation; diazo transfer; 
and diazodecomposition using rhodium acetate. Only decomposition, however, was observed 
when irradiating tetracyclic ylide 161 with UV light.  
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Scheme 29: Attempted synthesis of tetracyclic sulfoxide 158 by Porter et al. 
Finally, Porter et al. tried to make a closely related analogue of decarboxytagetitoxin using their 
methodology on a photochemical 1,2-Stevens rearrangement of a sulfonium ylide. To achieve 
this, Porter and co-workers made key changes to their previously successful routes in 
synthesizing the tagetitoxin bicyclic core (Schemes 18, 19 and 20).25 One modification was to 
tether the diazo functionality through an equatorial oxygen at the C-2 position rather than the 
axial position at C-3. This would affect the intramolecular ylide formation which would now 
occur between the sulfur atom of the 1,3-oxathiolane with the diazo functionality on the C-2 
position instead of the C-3 position.  This modification would allow the installation of a nitrogen 
functionality at the C-3 position as is the case with decarboxytagetitoxin. 
The authors started the synthesis by making a 2,3-β-epoxy derivative in two steps from 
compound 162, which was then ring opened with sodium azide to yield 163 (Scheme 30). 
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Subsequently, a Hanessian-Hullar oxidative ring opening of the benzylidene acetal moiety led to 
164.38,39 A SN2 displacement of the bromide with a thioacetate nucleophile followed to afford 
thioester 165. Under strong acidic acetylation conditions, acetylation of the 2-OH, thioacetate 
cleavage and concomitant cyclization (where the formed thiol displaced the 1-OMe in a 5-exo-tet 
reaction) were all accomplished in one step, yielding 166.  
 
Scheme 30: Synthesis of 166 by Porter et al. 
The next goal for the authors, was to trifluoraceteylate the 2-OAc in 166 and to subsequently 
perform a detrifluoroacetylating diazo transfer to form 170 (Scheme 31). The trifluoroacetylation 
of 166 using LDA and trifluoroethyl trifluoroacetate, however, proved troublesome, because the 
only products observed were alcohol 167 and acetoacetate 168. Since, only these products were 
seen without even adding the electrophile, the authors postulated that after the deprotonation of 
166 by LDA, a Claisen condensation followed by an elimination took place to form a ketene and 
167 (in its alkoxide form). The ketene then reacted with the ester enolate species forming 168. 
Despite varying the base and temperature, compound 169 was not seen. The authors therefore 
attempted an alternative route whereby they deacetylated 166 to form 167, which was then 
subjected to the 2-fluoroacetylderiative of Meldrum’s acid under reflux furnishing 169.  
Compound 169 then underwent a detrifluoroacetylating diazo transfer to form 170. 
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Diazodecomposition and consequent intramolecular ylide formation from 170 was unsuccessful 
despite performing a range of conditions with various catalysts [Rh2(OAc)4, CuPF6(MeCN)4, 
AgOTf, Cu(acac)2].  
 
Scheme 31: Attempted synthesis of ylide 171 by Porter et al. 
As a result, the authors changed their strategy for the synthesis of ylide 171 from a transition 
metal catalysed diazodecomposition to an intramolecular S-alkylation followed by 
deprotonation. Hence, 172 was made by acylation of the 2-OH in 167 with bromoacetyl bromide 
(Scheme 32). However, intramolecular displacement of the bromide by the sulfur atom to form 
sulfonium salt 173 was not observed with or without the presence of silver salts.   
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Scheme 32: Attempted synthesis of sulfonium salt 173 by Porter et al. 
As the authors previously made the thermally stable acetyl-substituted ylides 112 and 116,25 they 
aimed to synthesize ylide 175 (Scheme 33). To achieve this, acetoacetylation of 167 was 
performed to give 168, which then underwent a diazo transfer to form 174. Although ylide 175 
was formed from 174 by diazodecomposition, it was impure and in low yield. Furthermore, 
irradiation of impure ylide 174 did not furnish the desired ring expansion product 176.  
 
Scheme 33: Attempted synthesis of tricyclic 176 by Porter et al. 
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In summary, alternative methods to transition metal catalysed diazodecomposition for ylide 
formation such as photolytic conditions or S-alkylation followed by deprotonation failed due to 
undesired side reactions. Moreover, modifying their earlier successful methodology in making 
the tagetitoxin bicyclic core,25 to closer related analogues of tagetitoxin by either sulfoxide 
incorporation instead of a thioether or to tether the diazo functionality through an equatorial 
linkage at the C-2 proved unsuccessful; the latter of which was explained by increased strain in 
the ylide. These results highlight the difficulty in expanding the scope of the ring expansion 
strategy and its applicability to a total synthesis of tagetitoxin. Thus, since this paper, no further 
related work to this strategy has been published.  
Nishikawa et al.  
In 2013, Nishikawa and co-workers synthesized a fully functionalized tagetitoxin core structure.7 
The first step in their synthesis of a tagetitoxin core structure was a Ferrier-type α-selective C-
glycosylation of galactal 177 with tin acetylene and TMSOTf, producing 178 (Scheme 34). The 
yield and the selectivity in these conditions were much higher than using conventional methods, 
such as with bis(trimethylsilyl)acetylene and Lewis acids like SnCl4.
40,41 After cleavage of the 
two acetates and TMS group using methanolic sodium methoxide, the primary alcohol was 
selectively silyl protected forming 179. This allowed selective carbamoylation to then take place 
on the remaining free hydroxyl group via trichlorocetyl carbamoylation and subsequent 
hydrolysis to form 180.  
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Scheme 34: Synthesis of compound 180 by Nishikawa et al. 
The next target in the synthesis was the stereocontrolled installation of a nitrogen functionality at 
the C-3 position and an oxygen functionality at the C-2 position in a stereocontrolled manner. The 
authors envisaged that this could be accomplished by the synthesis of an 2,3-β-aziridine 
derivative and subsequent regioselective opening with an oxygen nucleophile (Scheme 35). 
Treatment of 180 under typical aziridination conditions of catalytic amounts of Rh2(OAc)4 and 
PhI(OAc)2 with magnesium oxide,
42 afforded aziridine 181, albeit in low yield (17%). However, 
upon modification of the conditions, namely using Rh2(OAc)4, PhIO and 4Å molecular sieves, 
the reaction was optimized to 70% yield. Aziridine 181 was then ring-opened regioselectively 
with an acetate nucleophile to furnish 182. The carbamate was then benzylated under typical 
conditions, which was then followed by a silyl ether deprotection to afford 183. 
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Scheme 35: Synthesis of compound 183 by Nishikawa et al. 
The investigators then aimed to incorporate a carboxylic acid derivative on the C-5 position. To 
achieve this, the authors planned to make an exo-glycal, carry out an epoxidation on it and finally 
ring open the spiro-epoxyacetal with a cyanide-based nucleophile in a regioselective and 
stereoselective fashion. The authors firstly activated the primary hydroxyl group as a triflate and 
displaced it with lithium phenylselenide (generated from diphenyldiselenide and n-BuLi) to 
produce selenide 185 (Scheme 36). Using mCPBA, 185 was then oxidized to give the selenoxide 
which then underwent a selenoxide elimination to give exo-glycal 186. Electrophilic epoxidation 
was then successfully carried out on 186 to yield spiro-epoxyacetal 187. When attempting to ring 
open the epoxide using TMSCN and a range of Lewis acids, the desired nitrile 188 was not 
observed. Treatment, however, with Et2AlCN did produce 188 as a single diastereomer but only 
in an 8% yield. Eventually the authors found optimal conditions for this reaction using TMSCN 
and molecular iodine in toluene and hexane at 0 oC; this led to the isolation of 188 in sufficient 
yield (44%) after acidic hydrolysis of the TMS ether.  
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Scheme 36: Synthesis of nitrile 188 by Nishikawa et al. 
Having succeeded in making a fully functionalized pyranoid framework of tagetitoxin (188), the 
authors then aimed to construct the 1,4-oxathiane moiety of the natural product. In order to 
achieve this, they firstly incorporated a sulfur functionality into the structure in the form of a 
thioacetyl group, using similar methodology to Porter et al.,24 whereby the primary alcohol of  
188 was transformed into a triflate and then displaced with a thioacetate nucleophile to afford 
189 (Scheme 37).  The authors then planned to deprotect the thioacetate group to release the 
thiolate which would then undergo a concomitant 6-exo-dig cyclization. Although treatment of 
189 with LiSMe did cause the intended thioacetyl deprotection, only the undesired 7-endo-dig 
cyclization from the generated thiolate occurred. Therefore, Nishikawa and co-workers planned 
to modify their cyclization strategy; instead of an in-situ generated thiolate undergoing a 6-exo-
dig cyclization, they envisaged that it would undergo a conjugate addition on an α,β-unsaturated 
sulfoxide in a 6-exo-trig cyclization. Thus, the authors synthesized the α,β-unsaturated sulfoxide 
190 in two steps from 189 by a radical addition of thiophenol to the alkyne moiety and 
subsequent oxidation of the vinyl thioether with mCPBA. Treatment of 190 with lithium hydride 
in methanol led to initial thioester cleavage and an in-situ conjugate addition of the formed 
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thiolate on the vinyl sulfoxide, but deacetylation and nitrile transformation into an imidate were 
additionally observed leading to 191 forming. Subsequent acidic hydrolysis on the imidate was 
then carried out to give methyl ester 192, which in turn was acetylated to form 193.  
 
Scheme 37: Synthesis of compound 193 by Nishikawa et al. 
Transformation of the sulfoxide moiety of 193 into an aldehyde via the Pummerer rearrangement 
to form 194 was attempted (Scheme 38). However, the use of conventional conditions such as 
acetic anhydride and sodium acetate only led to unreacted starting material. This prompted the 
authors to use the more electrophilic trifluoracetic anhydride instead. This led to starting material 
being recovered, although, epimerization of the chiral sulfoxide was observed (diastereomeric 
ratio changed from 1:7 to 2:1); this indicates that the sulfoxide must have been 
trifluoroacetylated initially but then underwent an intermolecular displacement with a 
trifluoroacetate nucleophile. In order to solve the aforementioned difficulties encountered in this 
transformation, a strong electrophilic activating agent with a poor nucleophilic leaving group 
(TMSOTf) and a non-nucleophilic base (Et3N) were used; the former led to successful sulfoxide 
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activation and the latter led to successful elimination of the generated silylated sulfoxide to the 
thonium ion, which in turn underwent hydrolysis to form aldehyde 194.  
 
Scheme 38: Synthesis of compound 194 by Nishikawa et al. 
The final objectives to synthesize the core structure of tagetitoxin was the conversion of the 
aldehyde into an amide and formation of a thioketal functionality. Surprisingly, the authors 
accomplished both these goals in one step (Scheme 39). Oxidative amidation of aldehyde 194 
with benzylamine and iodine in methanol produced thioketal 195 rather than the expected 
compound 196. It was postulated, that during the reaction, 196 was produced but then underwent 
acetate cleavage. Additionally, under these conditions, the sulfide was activated with iodine to 
form a sulfonium ion which was then trapped by a methanol molecule furnishing 195. 
Acetylation of 195 gave the tagetitoxin core structure 197. 
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Scheme 39: Synthesis of the core structure of tagetitoxin (197) by Nishikawa et al. 
In summary, Nishikawa et al. synthesized the first fully functionalized tagetitoxin core. Their 
key methodology in constructing the bicyclic ring system involved the deprotection of a 
thioacetate and concomitant intramolecular conjugate addition of the free thiolate on a vinyl 
sulfoxide. Moreover, compared to previously synthesized tagetitoxin core structures,24,31 
compound 197 is the only one which has a carboxylic derivative on the pyranoid core of the 
natural product (which was accomplished by the synthesis and subsequent ring opening of a 
spiro-epoxyacetal).  
Previous Work in The Page Group  
The targets in all previous studies in the Page group towards the synthesis of tagetitoxin have 
been structures 2a and 2b.43–45 There have been several routes attempted by the Page group to 
make the bicyclic core of structures 2a and 2b. In all routes, the planned synthesis of the 1,4-
oxathiane moiety in the bicyclic core has been based upon Porter and co-workers’ methodology 
where a thioacetyl functionality is deprotected leading to an in-situ cyclization of a free thiol or 
thiolate onto a ketone.24  
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Roy 
Early studies in the Page group towards the synthesis of tagetitoxin were carried out by Claud-
Éric Roy.43 Their synthetic pathways generally started from non-cyclic materials (such as mucic 
acid or meso-tartaric acid) before moving on to cyclic starting materials such as D-mannose.  
Mucic Acid Route 
The first strategy of the group began from a non-cyclic starting materiel mucic acid (Scheme 
40).  
 
Scheme 40: Retrosynthesis of the target bicyclic structure 198 from mucic acid. 
In this strategy, bicyclic precursor 199 could be derived from 200 by activating the hydroxyl into 
a good leaving group and then displacing it with a thioacetate nucleophile. The fully 
functionalized pyranoid core 200, could be made from cyclization in terminal epoxide 201. This 
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epoxide intermediate 201 could be synthesized from di-ketoester 202 via a Wittig or Tebbe 
olefination-epoxidation sequence or a Corey-Chaykovsky reaction on one of the ketones.46–48 
Compound 202 could be formed by a Krapcho decarboxylation of the two esters, other than the 
two α-ketoesters in 203. Enolization of both esters in 204, which then undergo nucleophilic 
attack on an esterified derivative of oxalic acid could then lead to the installation of the two α-
ketoester moieties seen in 203. Finally, 204 could be synthesized from readily available mucic 
acid 205 by esterification of the two carboxylic acid moieties followed by relevant hydroxyl 
group protection.  
Roy began the route by synthesizing compound 207 in two steps from mucic acid 205 (Scheme 
41) as described by Hirsch et al.49 These steps were a Fischer esterification to form bis-methyl 
ester 206 which was then treated with acid in acetone to furnish bis-acetonide 207. However, 
only low yields (17-25%) of 207 were obtained; changing the acid catalyst led to either lower 
yields or decomposition.    
 
Scheme 41: Two-step synthesis of 207 from mucic acid 205. 
The next planned step in the synthesis was the insertion of the two α-ketoester moieties to give 
208 (Scheme 42 and Table 3).  
 
Scheme 42: Acylation attempts of 207. 
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Entry Base Solvent  Temperature/oC Result 
150 EtONa EtOH rt SM 
2 NaH THF 0 SM 
3 LDA THF -78 SM 
4 LDA THF -78 SM 
 
Table 3: Conditions reported for the acylation attempts of compound 166 
This was initially attempted using Kagan’s conditions,50 where sodium ethoxide was used as a 
base (to form the ester enolates), and diethyl oxalate used as the electrophile. Under these 
conditions, however, only starting material was recovered (entry 1). Consequently, the group 
used stronger bases such as sodium hydride and lithium diisopropylamide (LDA) but this 
similarly led to full starting material recovery (entries 2 to 4).   
To investigate the failure of this reaction, the group attempted to alkylate 207 to assess the 
reactivity of the carbon being deprotonated. Only starting material, however, was observed when 
using ethyl iodide as the alkylating agent with the same bases used in the attempted acylation 
(LDA and sodium hydride). This unexpectedly suggests that under these conditions, the ester 
enolate of 207 is not generated or not reactive enough to attack the diethyl oxalate in a 
nucleophilic manner.  
This route was therefore abandoned due to the low yields obtained with bis-acetonide 207 as 
well as the failure in producing bis-ketoester 208.  
Tartaric Acid Route 
The group then moved onto a different strategy starting from meso-tartaric acid (Scheme 43). 
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Scheme 43: Retrosynthesis of the target bicyclic structure 198 from meso-tartaric acid. 
In this route, bicyclic precursor 199 could be formed from 209 by deprotection of the exo-cyclic 
secondary hydroxyl group and then subsequent oxidation of the α-hydroxyester to an α-ketoester. 
Similarly to the retrosynthetic analysis in the mucic acid route, the thioacetate moiety could be 
incorporated into the structure 210 by displacement chemistry. Intermediate 210 could be 
derived by reaction between the anomeric ester enolate of 211 with formaldehyde. The 
functionalized pyranoid core 211 could be made by a 6-exo-tet cyclization from attack of a 
nucleophilic hydroxyl onto an activated hydroxyl group (e.g. sulfonate ester) in the cyclic 
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precursor 212, which in turn could be made by the bis-dihydroxylation of 213. The bis-
alkenylcarboxylic ester 213 could be synthesized by a Wittig olefination on both aldehydes of 
214. Finally, esterification and relevant hydroxyl group protection on meso-tartaric acid followed 
by ester reduction would furnish dialdehyde intermediate 214. 
It was planned that the synthesis would be first attempted with racemic tartaric acid and then the 
optimized conditions would be applied to meso-tartaric acid (due to the high cost of the latter).  
Using Carmack’s procedure,51,52 Roy synthesized intermediate (+)-218 from racemic tartaric acid 
217 (Scheme 44). In this one-pot reaction, under acidic conditions (p-toluenesulfonic acid) in 
methanol and 2,2-dimethoxypropane under reflux, both carboxylic acids underwent a Fischer 
esterification in addition to the ketalization of the diol functionality. Although it was 
advantageous to have both the esterification and ketalization in one pot, the reaction was 
capricious, since results varied from quantitative yields of (+)-218 to complex mixtures with 
undesired side products such as acid (+)-219 and (+)-220.   
 
Scheme 44: Synthesis of (+)-218 from racemic tartaric acid (+)-217. 
The next target in this strategy, was the synthesis of dialkene (+)-222 from (+)-218 by a one-pot 
bis-[ester reduction/Wittig olefination] (Scheme 45). In this step, the diester was reduced to the 
dialdehyde (+)-221 using diisobutylaluminium hydride (DIBAL) which was followed by a 
Wittig olefination of the formed aldehydes. It was observed that for the reduction, the addition 
rate of the hydride and reaction time were significant variables that required optimization to 
avoid starting material decomposition or full reduction of the esters to alcohol moieties. After 3 
hours at -78 oC, the Wittig ylide was then added to the reaction mixture, which led to an 
inseparable mixture of the (E,E)-dialkene (+)-222 and its geometric isomer (Z,Z)-dialkene (+)-
223. Since, however, it was important to perform the next steps with only one isomer (to help 
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with the potential isolation of cyclized compound 211 later on in the synthesis), this mixture was 
not used further in the synthesis.   
 
Scheme 45: One-pot bis-[ester reduction/Wittig olefination] of intermediate (+)-218 
With the goal being to isolate only one geometric isomer of the dialkene, Roy planned to adapt a 
synthesis carried out by Saito et al.,53 since they succeeded in making the (E,E)-dialkene (+)-222 
from a one-pot bis-[ester reduction/Horner Wadsworth-Emmons olefination] on (+)-224 
(Scheme 46). Saito et al. conclude that this type of diester starting material (with acetonide 
protecting group and isopropylic esters) in a toluene-hexane solvent system with 
diisopropylphosphonate as the Horner Wadsworth-Emmons (HWE) olefination reagent were key 
features for the success of the reaction.53  
 
Scheme 46: Saito and co-workers’ synthesis of dialkene 222 from compound 224.53 
However, Roy intended to perform this bis-[ester reduction/HWE] on isopropylic diester 225 
rather than (+)-224. The synthesis would, therefore, be started from meso- rather than rac-tartaric 
acid (despite the high cost of the former). Thus, isopropylic diester 226 was synthesized in two 
steps from meso-tartaric acid 216 by a Fischer esterification and subsequent ketalization.  
(Scheme 47). 
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Scheme 47: Two-step synthesis of 226 from meso-tartaric acid 216. 
Roy then attempted the bis-[ester reduction/HWE] on 225 using conditions reported from Saito 
et al. (Scheme 48).53 However, only low yields (13-15%) of dialkene 227 were obtained. 
Changing reaction times, rate of addition of reagents as well as the base that deprotonates the 
phosphonate from n-BuLi to non-nucleophilic LDA led to no improvement in yield. 
 
Scheme 48: One-pot bis-[ester reduction/HWE olefination] of 226. 
Despite the poor yields for dialkene 227, the bis-dihydroxylation using AD mix-β was attempted 
(Scheme 49). The crude 1H NMR spectrum, however, showed a resultant complex mixture. 
Purification attempts by chromatography on silica gel or alumina proved futile because the 
mixture was lost with no recovery possibly due to its polarity.   
 
Scheme 49: Failed synthesis of 228 by bis-dihydroxylation of 227. 
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The low yields of the dialkene 227 in addition to no single isolable product from the bis-
dihydroxylation, led the group to focus on a different strategy.   
Darzens Route 
Roy then moved onto a strategy with the cyclic starting material D-mannose (Scheme 50).  
 
Scheme 50: Retrosynthesis of target structure 229 from D-mannose 235 in the Darzens route. 
In this strategy, structure 229 is the synthetic target. If 229 were successfully made, the strategy 
would then be modified to install an ester on the thiohemiketal centre. The target precursor 230 
could be synthesized from 231 in three-steps: selective acetonide hydrolysis; primary hydroxyl 
protection; and oxidation of the secondary alcohol. The insertion of the thioacetyl-methylene 
moiety on 232 to afford 231 is identical to the aforementioned methodology in the meso-tartaric 
acid route. The synthesis of the pyranoid core in 232 could be achieved by a 6-endo-tet 
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cyclization in glycidic ester 233 followed by a protection of the OH on C-2. This glycidic ester 
233 could form from a Darzens reaction between an α-haloester and diacetone mannose (DAM) 
234. Finally, DAM 234 could be synthesized from D-mannose 235 using acid catalysis in an 
acetone solvent.   
The key feature in this route is the proposed Darzens condensation reaction involving a 
nucleophilic addition of an α-haloester (using enolate chemistry) on the acyclic hydroxy-
aldehyde form of DAM 234 followed by a 3-exo-tet cyclization to give epoxide 233 (Scheme 
51). This reaction exploits the aldehyde chemical properties that most cyclic carbohydrate 
derivatives have, arising from the equilibrium between the ‘closed’ lactol form and the ‘open’ 
hydroxy-aldehyde form. Furthermore, in intermediate 236, competing with the 3-exo-tet 
cyclization for epoxide formation, a 6-exo-tet cyclization could occur to give the desired 
glycoside 237. Alternatively, even if epoxide formation occurs in the reaction, the formed 
epoxide intermediate could undergo a concomitant 6-endo-tet cyclization (although in 
competition with the more favourable undesired 5-exo-tet cyclization) to give the C-glycosyl 
ester 237.  
 
Scheme 51: Proposed mechanism for the Darzens reaction on DAM 234. 
For the first step of the route, Roy synthesized DAM from D-mannose using a literature 
procedure from Schmidt et al. (Scheme 52).54 The reaction occurred by the protection of the cis-
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hydroxyl groups in the furanose form of D-Mannose with isopropylidene groups. It was observed 
that neutralization of the crude reaction mixture prior to second stage of the reaction was critical, 
since without doing this only decomposition was observed.   
 
Scheme 52: Synthesis of DAM 234 from D-mannose 235. 
Subsequently the Darzens reaction on DAM was attempted (Scheme 53). However, only starting 
material was observed in the reaction, despite trying different deprotonation conditions for the 
addition of the α-haloester.  
 
Scheme 53: Attempted Darzens reaction on DAM 234. 
As a result, the group modified their strategy (Scheme 54). In this approach, the Darzens 
reaction would occur on a protected derivative of the ‘open’ form of DAM. Then basic 
deprotection and concomitant 6-endo-tet cyclization would then eventually lead to glycoside 
237.  
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Scheme 54: Proposed synthetic approach to pyranoid 237. 
To make this protected derivative, Roy followed a synthesis performed by Hashimoto et al. 
(Scheme 55).55 In this synthesis diol 241, was synthesized by the total reduction of the lactol 
functionality in DAM 234 using LAH. A selective benzoylation on the primary hydroxyl group 
and subsequent silylation on the secondary alcohol then afforded 243. Deprotection of the 
benzoyl group and subsequent oxidation of the resulting primary alcohol furnished aldehyde 245.  
 
Scheme 55: Hashimoto and co-workers’ five-step synthesis of aldehyde 245 from DAM 234. 55 
Although benzoyl 242 was reached easily by Roy using Hashimoto and co-workers’ conditions, 
difficulties were encountered in the ensuing silylation of the secondary alcohol. The use of 
TBSCl was concluded to be ineffective under the conditions reported by Hashimoto et al.,55 as 
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only decomposition was observed. The use of the more electrophilic silylating agent TBSOTf, 
with N,N-Diisopropylethylamine (DIPEA) in Et2O, however, did furnish compound 243 but in 
low yield (37%). After Roy successfully isolated alcohol 244 in quantitative yield from the 
saponification of the benzoyl functionality in 243, the oxidation to the target aldehyde 245 was 
then attempted. Surprisingly when using Moffatt-Pfitzner methodology as reported in Hashimoto 
and co-workers’ synthesis,55 only a mixture of starting material and decomposition was seen. 
Even applying range of other oxidations (Parikh-Doering, Swern and hypervalent iodine 
mediated oxidations) were similarly unsuccessful.  
As a result, Roy planned to follow a synthesis towards an alternate protected aldehyde species 
with an acetyl protected secondary hydroxyl group published by Lopéz-Herrera et al. (Scheme 
56).56 The route consisted of a Wittig olefination of DAM forming terminal alkene 246, then 
acetyl protection followed by ozonolysis yielding aldehyde 248. An advantage of  this synthesis 
was fewer steps compared to the synthesis of aldehyde 245 reported by Hashimoto and co-
workers.55  
 
Scheme 56: Lopéz-Herrera and co-workers’ three-step synthesis of aldehyde 248 from DAM 
234.56 
The Wittig olefination on DAM 234 carried out by Roy, appeared capricious as terminal alkene 
246 was formed in yields varying from 47% to 76%. Acetylation (84-97% yield) and sequent 
ozonolysis (up to 100% yield), however, proceeded smoothly to afford the desired aldehyde 248.   
The next step in the synthesis was the Darzens condensation on aldehyde 248 (Scheme 57). In 
both conditions attempted, glycidic ester 249 was not isolated. When the reaction was performed 
with LDA, only DAM was recovered. When using the milder base t-BuOK, mainly starting 
material and a small amount of DAM was isolated. The formation of DAM in both conditions 
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could be explained by an in-situ deprotection of the acetate by the deprotonated bromoacetate 
nucleophile liberating an anionic oxygen which could attack the aldehyde yielding DAM.  
 
Scheme 57: Failed Darzens reactions of aldehyde 248. 
This route was abandoned due to the inability to isolate glycidic ester 249. 
Pearce 
Continuing the work of Claude-Eric Roy, Pearce undertook a variety of routes starting from 
DAM 234.44 
Dithioacetal Route 
The first route attempted by Pearce involved the nucleophilic addition of a masked α-ketoester 
onto DAM 234 (Scheme 58). 
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Scheme 58: Retrosynthesis of target structure 229 from DAM 234 in the dithioacetal route. 
The synthetic target 229 could be derived from intermediate 232 by the same methodology 
mentioned in the Darzens route.43 Pearce proposed that pyranose 250 could lead to 232 in a 
three-step sequence involving selective protection of the C-2 hydroxyl group, activation of the 
anomeric alcohol into a good leaving group and displacement of the latter with a hydride source. 
Pyranose 250 could be obtained by dethioketalization of 251, which in turn, would trigger a 6-
exo-trig cyclization. The nucleophilic addition of a deprotonated 1,3-dithiane-2-carboxylate ester 
derivative on DAM 234 would yield intermediate 251. Finally DAM 234 would be made from 
D-mannose 235 in identical fashion to previous work in the group.43 
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This route was largely inspired by the synthesis of intermediate 253 from DAM 234 reported by 
Reiner and Schmidt (Scheme 59).57 Pearce planned to reproduce this synthesis except but 
without performing the transesterification after the dethioketalization.  
 
Scheme 59: Reiner and Schmidt’s two-step synthesis of pyranose 253 from DAM 234. 
After synthesizing DAM 234 from D-mannose 235, Pearce then attempted the nucleophilic 
addition of ethyl 1,3-dithiane-2-carboxylate onto DAM with the goal of making 252. The group 
decided to modify Reiner and Schmidt’s procedure by not using MgBr2 (for practicality reasons); 
therefore DAM 234 was added to a lithiated 1,3-dithiane derivative rather than a Grignard 
reagent 1,3-dithiane derivative, but only DAM was recovered. The group rationalized this 
observation by suggesting that the lithiated dithiane acted as a base rather than a nucleophile on 
the open hydroxy-aldehyde form of DAM to reform the closed lactol form. When repeating the 
conditions from the literature,57 high yields of up to 98% of 252 were obtained, though the yields 
did decrease on a scale less than 10g of DAM. 
The next step in this strategy involved the dethioketalization and in-situ cyclization of the 
hydroxyl group onto the formed ketone (Scheme 60 and Table 4).  
 
Scheme 60: Dethioketalization attempts of 252. 
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Table 4: Conditions and results reported for dethioketalization attempts of compound 252. 
When using NBS in aqueous acetone (entry 1) as reported by Reiner and Schmidt,57 pyranose 
254 was isolated albeit in low yields (up to 40%). In addition to poor yields, there were 
scalability issues, where masses greater than ~200 mg of 252 led to little or no product and 
purification issues, due to the production of vast impurities in comparison to small yields of 254. 
The stereochemistry of the resulting pyranose was confirmed by X-ray crystallography. To 
improve the yields, a variety of other dethioketalization procedures were attempted, such as the 
use of different halide donors (entries 2-4), mercury reagents (entries 5-6),58,59 oxidants (entries 
8-10)60–62 and the use of methyl iodide (entry 11). None of these methods, however, led to any 
improvements; the only one with comparable success to NBS (entry 1) were the use of NIS 
(entry 2) and DBDMH (entry 4), presumably because of the dithiane deprotection mechanism of 
all three reagents being identical.  
It was noticeable that in many dethioketalization conditions, DAM 234 was isolated which led 
the group to propose a mechanism for this (Scheme 61).  
Entry Reagents and Conditions Result 
157 NBS, 97% aqueous acetone, 0 oC, 3 min 40% 254 
2 NIS, Acetone, 0 °C, 3 min  40% 254 
3 NCS, Acetone, 0 °C, 3 min  10% 254 
4 DBDMH, Acetone, 0 °C, 3 min  40% 254 
558 HgCl2, (MeOH/H2O 9:1) reflux, 18 h DAM 234 
659 HgO, (MeOH/H2O 9:1) reflux, 18 h  DAM 234 
860 H2O2 (MeOH/H2O 5:1) 6 h  DAM 234 
961 mCPBA, DCM, RT, 4 h  DAM 234 
1062 Oxone® DCM, RT, 4 h  DAM 234 
11 MeI, DCM, reflux, 2 h  SM 
71 
 
 
Scheme 61: Proposed mechanism for DAM 234 production in the dethioketalization attempts of 
252. 
Despite the low yields of the dethioketalization, Pearce decided to continue the route with the 
next step being the selective protection of the hydroxyl group on the C-2 position in 254. 
Attempts to protect the hydroxyl group as a TBDPS ether failed even after refluxing for several 
days; this failure was attributed to a steric rationale. Nevertheless, TBS and TIPS protection of 
the C-2 hydroxyl were achieved (Scheme 62), though only at low yields for the former. 
 
Scheme 62: Synthesis of silyl ethers 255 and 256. 
Pearce then attempted to activate the anomeric hydroxyl group. Initially, the hydroxyl group was 
methylated (Scheme 63), since there was literature precedent for the reductive cleavage of 
anomeric methoxy groups using triethylsilane and TMSOTf from Gray et al.63 The group also 
mesylated and acetylated the anomeric alcohol as they thought the reduction of the mesylated 
compound would be easier to achieve due to better leaving group ability of the mesylate and acyl 
groups compared to the methoxy group.  
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Scheme 63: Activation of anomeric hydroxyl group in 255 and 256. 
The reduction of the methylated, acetylated and mesylated products (257-260) using Et3SiH and 
TMSOTf according to the literature63 was unsuccessful (Scheme 64). Consequently, the group 
tried a range of combinations of Lewis acids (BF3.Et2O, AlCl3 and TiCl4) and hydride reductants 
(Et3SiH and NaBH3CN) but only starting material was recovered.  
 
Scheme 64: Failed reductions of anomeric centre in compounds 257 – 260. 
Due to the low yields obtained in the dethioketalization and the failure of the reductions, the 
group decided to develop a new route.  
Reduction Route 
In order to synthesize target 229, Pearce persevered with the dethioketalization strategy but 
aimed to reduce and thereby effectively remove the ester moiety. This would lead to the 
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dethioketalization and removal of the anomeric hydroxyl group being attempted on different 
substrates, as compared to the dithioacetal route (Scheme 65).  
 
Scheme 65: Retrosynthesis of target structure 229 from DAM 234 in the Reduction route. 
The retrosynthetic analysis for target 229 from intermediate 232 is identical to previous routes 
(i.e. the dithioacetal and Darzens routes). Structure 232 could derive from 261 in three steps: a 
selective deprotection of the methylene alcohol; primary alcohol oxidation to the carboxylic acid; 
followed by esterification. Activation and subsequent removal of the anomeric hydroxyl group in 
pyranose 262 could form intermediate 261. Pyranose 262 could be formed from 
dethioketalization of intermediate 263, which in turn could be made by the reduction of the ester 
moiety in 251 and then protection of the primary alcohol.  Structure 251 could be synthesized 
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from D-mannose in 2 steps as previously achieved by Pearce in the dithioacetal route (where 
ester 252 was made). 
Starting from compound 252, the group successfully reduced the ethyl ester moiety using LAH 
to afford triol 264 (Scheme 66). Selective protection of the primary alcohol in 264 with an acetyl 
group proved challenging in any conditions using DMAP, since only the tri-acetylated 
compound 265 and starting material were recovered. Standard acetylation conditions without 
DMAP, however, afforded compound 266 in good yield. Pearce also formed the tert-
butyldiphenylsilyl (TBDPS) ether of primary hydroxyl group albeit in low yield (18%).  
 
Scheme 66: Synthesis of compounds 266 and 267. 
Compounds 266 and 267 were then subjected to the dethioketalization reaction (Scheme 67). 
Treatment with NBS in aqueous acetone led to no desired product, although replacing NBS with 
DBDMH gave pyranoses 268 and 269 in good yield.  
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Scheme 67: Dethioketalization of compounds 266 and 267. 
The next step of the route was the reduction of the anomeric position in 268 and 269 using 
Gray’s conditions (Scheme 68).63 Unfortunately, under these conditions only decomposition of 
268 and 269 observed.   
 
Scheme 68: Failed reductions of anomeric centre using Gray’s conditions.63 
As a result, the group opted to methylate the anomeric and C-2 hydroxyl groups in 268 and 269 in 
anticipation that this would aid removal of the anomeric hydroxyl group in the later reduction. 
However attempted methylations on 268 and 269 only led to decomposition (Scheme 69). 
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Scheme 69: Failed methylation of compounds 268 and 269. 
The unsuccessful attempted reductions of the anomeric centre and dimethylations steered the 
group away from the dethioketalization strategy in developing a new route.  
Wittig Route 
Pearce then opted for a different approach to reach target 229; this involved a Wittig reaction on 
DAM to introduce the ester moiety instead of the nucleophilic addition of a deprotonated 
functionalized dithiane in his previous routes (Scheme 70).  
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Scheme 70: Retrosynthesis of target structure 229 from DAM 234 in the Wittig route. 
As explained in previous routes, target 229 could be derived from 232. Similarly to the Darzens 
route performed by Roy,43 the pyranoid core of 232 could be made by the deprotection of the 
secondary alcohol in glycidic ester 240 and concomitant 6-endo-tet cyclization. Glycidic ester 
240 could originate from epoxidation of alkene 274, which in turn could be made from a Wittig 
olefination of DAM 234 using an ester-stabilized ylide.  
After synthesizing, the ethyl ester-stabilized ylide (from refluxing ethyl bromoacetate and 
triphenylphosphine in toluene followed by a NaOH wash), the Wittig olefination on DAM was 
attempted using previously published conditions (Scheme 71).64 Under these conditions, the 
major E-alkene 275 and minor Z-alkene 276 products were isolated. The minor Z-alkene 276 was 
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discarded, presumably due to the low yields of the latter (10–20%). Hence, Pearce proceeded to 
the next step only with E-alkene 275.  
 
Scheme 71: Wittig olefination of DAM 234. 
Acetylation of the secondary alcohol in E-alkene 275 was then achieved to afford compound 277 
(Scheme 72).   
 
Scheme 72: Acetylation of compound 275. 
The group then aimed to synthesize glycidic ester 278 (Scheme 73). However, despite trying a 
range of epoxidation conditions, the glycidic ester was not isolated nor even observed.  
 
Scheme 73: Failed epoxidations of alkene 277. 
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The disappointing epoxidation results, led the group to slightly modify their methodology by 
devising other cyclization methods (Scheme 74). In this new strategy, a bromination on the 
unprotected E-alkene 275 would be performed; this could cause a 6-endo-tet cyclization (albeit 
in competition with the more favourable 5-exo-tet cyclization) of the secondary alcohol onto the 
bromonium ion to afford 279. Subsequent displacement of the bromine on the C-2 with an 
oxygen nucleophile could afford pyranoid 280.     
 
Scheme 74: Proposed synthetic approach to pyranoid 280. 
Regrettably, the attempted bromination involving the addition of neat bromine to a solution of 
275 in DCM at 0 oC led to a complex mixture, from which neither pyranoid 279 nor the 1,2-
dibrominated compound were isolated.  
Finally, Pearce planned one last strategy starting from the acetyl-protected alkene 277, whereby 
instead of functionalizing the alkene, a reduction would be attempted (Scheme 75).  
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Scheme 75: Retrosynthesis of target structure 281 from alkene 277. 
The only disadvantage of this strategy was the absence of a functionality on the C-2 position. If, 
however, synthetic target 281 was successfully made, however, methods to functionalize the C-2 
position would be revisited. The retrosynthetic analysis for target 281 from 284 is identical in 
methodology to the previous target 229 from compound 232 (as mentioned in earlier routes). 
Compound 284 could be made from alkene 277 in three steps. Alkene 277 could firstly be 
reduced by a hydrogenation to give compound 286. Then the ester in 286 could undergo an α-
halogenation to form 285, offering a good leaving group alpha to the ester and thus subsequent 
cleavage of the acetate group could trigger a 6-exo-tet cyclization to afford C-glycoside 284.  
81 
 
Pearce successfully reduced alkene 277 with hydrogen gas over palladium on carbon to yield 
286. The following α-halogenation of the ester, however, proved difficult (Scheme 76 and Table 
5).  
 
Scheme 76: α-Halogenations of ester 286. 
 
 
 
 
 
 
Table 5: Conditions and results reported for ester α-halogenation attempts of 286. 
Initially the group used Rathke’s conditions which involved the use of LDA and iodine as the 
halogen donor but only starting material was isolated from the reaction (entry 1).65 The group 
then tested a variety of other bases and halogen donors (entries 2 to 6), though again only starting 
material was recovered. 
To identify the failure of these ester α-halogenation reactions, the group tried to alkylate 286 
with methyl iodide using LDA as the base (Scheme 77). This would establish whether the 
lithium ester enolate of 286 is generated prior to the addition of the halogen donor. Surprisingly, 
no trace of compound 287 was observed suggesting the lithium ester enolate was not formed.  
Entry Reagents and Conditions Result 
165 I2, LDA, THF, -78 °C to rt SM 
2 Br2, LDA, THF, -20 °C to rt  SM 
3 Br2, t-BuLi, HMPA, THF, -78 °C to rt  SM 
4 I2, DBU, DCM, rt  SM 
5 NBS, NEt3, DCM, rt  SM 
6 NCS, LDA, THF, -78 °C to rt SM 
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Scheme 77: Attempted alkylation of ester 286. 
The lack of success in functionalizing alkenes 275 and 277 and incorporating a halide leaving 
group alpha to the ester in 286, led to the abandonment of this route. 
Mahoney 
Following Pearce, Mahoney generally attempted a range of strategies to optimise the dithioacetal 
route (previously established by Pearce), to improve the route’s feasibility and to progress further 
in the synthesis of the target 229.45  
Samarium Diiodide Route 
This first route carried out by Mahoney, specifically targeted the main problems encountered by 
Pearce in the dithioacetal route. These were poor yields, scalability and purification issues in the 
dethioketalization of compound 252 and the inability to remove the anomeric hydroxyl group 
from 255 and 256.44 It was hoped that in the samarium diiodide route would overcome these 
problems (Scheme 78). This is because the dethioketalization would be attempted on a different 
compound as compared to the dithioacetal route. Additionally, instead of the reductive cleavage 
of a methoxy or mesylate group on the anomeric position using a hydride or hydrosilane 
reductant endeavoured in the dithioacetal route, a samarium diiodide promoted coupling between 
the anomeric acetate 289 and formaldehyde would be attempted. If this coupling reaction were 
successful, then the removal of the anomeric oxygen functionality and the introduction of a 
methylene alcohol group could be achieved in one step.  
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Scheme 78: Retrosynthesis of target 229 from DAM 234 in the samarium diiodide route. 
The retrosynthesis for target 229 from intermediate 231 is identical to previous routes undertaken 
in the group, for example the Darzens and dithioacetal routes. Intermediate 231 could form by 
activation of the primary alcohol in 288 followed by a displacement with a thioacetate 
nucleophile. Using samarium diiodide and a formaldehyde electrophile, alcohol 288 could be 
made from anomeric acetate 289, which could be obtained from acetylation of pyranose 290. The 
selective deprotection of OR’ in the α-ketoester 291 should trigger a 6-exo-trig cyclization 
affording pyranose 290. The dethioketalization in this route would be attempted on dithioketal 
292 to yield compound 291. Moreover, compound 292 could be formed from the nucleophilic 
addition of a deprotonated derivative of ethyl 1,3-dithiane-2-carboxylate onto aldehyde 239 
followed by the protection of the formed secondary alcohol. The synthesis of aldehyde 239 could 
be achieved by a sequence of protections and deprotections on diol 241 followed by an oxidation 
of the primary alcohol. The LAH reduction of DAM using previous conditions in the group,43 
would furnish diol 241.  
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The key feature of this route is the samarium diiodide mediated coupling reaction between 
formaldehyde and compound 289. This was inspired by Malapelle et al. who succeeded in the 
transformation of the anomeric acetate in their N-acetylneuraminic acid derivative to the 
corresponding alcohol using samarium diiodide and a range of aldehydes and ketones (Scheme 
79).66 Malapelle and co-workers proposed that a samarium ester enolate was formed on the 
anomeric position which then reacted with an aldehyde or ketone electrophile to eventually 
furnish the resultant alcohols 294.66 Mahoney planned to apply this methodology to anomeric 
acetate 289 with a formaldehyde electrophile.  
 
Scheme 79: Malapelle and co-workers’ synthesis of compounds 294 from 293 using samarium 
diiodide and a range of aldehydes and ketones.66 
The synthesis began, with the LAH reduction of DAM using previous conditions employed by 
the group (Scheme 80).43 The following steps comprised of successive selective protections and 
deprotections of both alcohols to ultimately reach alcohol 297.  
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Scheme 80: Four-step synthesis of compound 297 from DAM 234. 
Mahoney, then attempted a Swern oxidation on 297 followed by a nucleophilic addition of the 
functionalized dithiane derivative (Scheme 81), but in the latter step only DAM 234 was 
isolated. To explain this result, Mahoney proposed that the MOM ether was surprisingly 
deprotected in these conditions, producing the alkoxide form of the hydroxy aldehyde, which is 
in equilibrium with DAM 234.  
 
Scheme 81: Failed synthesis of 298 from 297. 
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Due to this setback, Mahoney decided to form pyranose 254 from DAM 234 in two steps using 
the same synthesis previously completed by Pearce in the dithioacetal route (Scheme 59). Then 
after acetylating both hydroxyl groups in 254 (Scheme 82), Mahoney planned to apply the 
samarium diiodide methodology on the anomeric acetate 299. Despite numerous attempts, the 
group failed to isolate 300 in the presence of samarium diiodide and paraformaldehyde. They 
attributed this failure to possible poor quality of the commercially available samarium diiodide 
solution in THF (since they noticed significant degradation over time). Attempts to synthesize 
their own samarium diiodide solution, however, were unsuccessful. 
 
Scheme 82: Attempted synthesis of 300. 
The failure to couple formaldehyde with 299 using samarium diiodide led Mahoney to 
investigate alternate strategies to synthesize the tagetitoxin bicyclic core 229.  
Nitrile-Dithiane and Methyl Ester-Dithiane Route  
Mahoney’s next route was identical to the dithioacetal route performed by Pearce with the 
exception of having a nitrile or methyl ester instead of an ethyl ester moiety (Scheme 83). It was 
hoped, that this change could improve the yields of the dethioketalization and aid in the removal 
of the anomeric hydroxyl group in 305.   
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Scheme 83: Retrosynthesis of target 301 from DAM 234 in the nitrile-dithiane and methyl ester- 
dithiane route. 
The retrosynthetic analysis for 301 from DAM 234 is identical in methodology to the 
retrosynthesis of 229 in the dithioacetal route (the only difference being the nature of the 
carboxylic acid derivative on the C-1 position).   
In order to incorporate the nitrile or methyl ester functionality in the target 301, the 
functionalized dithiane derivative undergoing nucleophilic addition on DAM would have a 
nitrile or methyl ester moiety instead of an ethyl ester moiety.  Since these particular dithiane 
derivatives are not commercially available (unlike ethyl 1,3-dithiane-2-carboxylate), the first 
goal of the route was to synthesize these derivatives.  
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Using conditions previously published by the Page group in the literature,67 the synthesis of 2-
cyano-1,3-dithiane 309 was accomplished in two steps from 1,3-dithiane 307 (Scheme 84). The 
first step involved a hydride abstraction of 1,3-dithiane 307 when treated with 
triphenylcarbenium tetrafluoroborate in DCM under reflux to furnish salt 308. Addition of 
TMSCN to the salt 308 afforded the desired functionalized dithiane 309.    
 
Scheme 84: Two-step synthesis of 2-cyano-1,3-dithiane 309 from 1,3-dithiane 307 
The synthesis of methyl 1,3-dithiane-2-carboxylate 311 was also achieved in two steps from 1,3-
dithiane 307 (Scheme 85). This synthesis involved the lithiation of the 1,3-dithiane and ensuing 
nucleophilic addition onto solid carbon dioxide to furnish carboxylic acid 310 after acidic work-
up. This was followed by a Fischer esterification to yield 311.  
 
Scheme 85: Two-step synthesis of ethyl 1,3-dithiane-2-carboxylate 311 from 1,3-dithiane 307 
The next aim of the group was to perform the nucleophilic addition of these functionalized 
dithiane derivatives 309 and 311 on DAM 234 (Scheme 86). Regrettably, under the same 
conditions used previously to synthesize 252 in the dithioacetal route, compounds 306 were not 
formed.  
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Scheme 86: Attempted synthesis of compounds 306. 
These unsuccessful results led Mahoney to devise a new synthetic route away from the dithiane 
strategy.  
KDO Route  
The group devised a new synthesis to target 312 from DAM 234; although, there would be and 
absent functionality on the C-2 position (Scheme 87). If successful, however, this methodology 
would be revised to install an oxygen functionality on this position.  
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Scheme 87: Retrosynthesis of target 312 from DAM 234 in the KDO route. 
The target bicyclic core 312 could be derived from 315 by the same methodology mentioned in 
aforementioned earlier routes for 229 from 232. The pyranoid core 315 could be constructed by 
the formation of an ester enolate of 316, which could consequently displace a leaving group in a 
cyclization reaction. Deprotection of the primary alcohol in 317 and subsequent transformation 
into a good leaving group (e.g. halide or sulfonate ester) would furnish 316. The ester moiety 
would be introduced into the structure by selective protection of the primary alcohol in diol 241 
followed by alkylation of the secondary alcohol with an α-halo ester. As already synthesized in 
the samarium diiodide route and Darzens route, diol 241 would be formed by the LAH reduction 
of DAM 234 (e.g. Scheme 80).  
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This route was largely inspired by the production of intermediate 322 part of Ohrui and co-
workers’ synthetic route towards 3-deoxy-D-manno-oct-2-ulosonic acid (KDO).68 In this route, 
Ohrui et al. made pyranoid 322 from diol 241 in 5 steps using the methodology outlined in the 
above retrosynthetic analysis (Scheme 88).  
 
Scheme 88: Ohrui and co-workers’ five step synthesis of pyranoid 322 from diol 241.68 
Mahoney intended, therefore, to replicate this synthesis to reach pyranoid 322. Initially, 
Mahoney was successful in benzylating the primary alcohol in 241 to afford 318 in 90% yield. 
However, after numerous efforts, the ensuing alkylation with ethyl bromoacetate under Ohrui 
and co-workers’ conditions failed to furnish compound 319. Attempts to modify the conditions 
such as varying the amounts of sodium hydride or ethyl bromoacetate proved unsuccessful.   
The failure to synthesize ester 319 led Mahoney to discard this route.  
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Overall, work by the Page Group on the synthesis towards tagetitoxin led to a number of 
noteworthy intermediates via a range of strategies, and some of these routes will be explored 
further (described later within this thesis).   
Project  
Synthetic Target 
Despite Aliev et al. contesting the proposed tagetitoxin structures 1 – 4 due to inconsistencies 
with NMR and MS data,8 the aim of this project was to complete a total synthesis of structures 
2a and 2b (Figure 9).  
 
Figure 9: Proposed tagetitoxin structures 2a and 2b. 
The two significant reasons for synthesizing structures 2a and 2b are: 
1) Contributing to the debate surrounding the structure of the natural product. There are no 
published total syntheses of any of the proposed tagetitoxin structures 1 – 5, and if we 
were to chemically synthesize structures 2a and 2b, their characterization data would be 
compared with the data collated from Aliev et al. This would provide evidence to 
support or refute the conclusions made in the literature regarding the structure of 
tagetitoxin.8 
2) From a synthetic perspective, the large number of complex functionalities in 2a and 2b, 
make these structures interesting and challenging targets.  
Complex Functionalities 
The primary aim of this project was to firstly synthesize intermediates 323a and/or 323b (Figure 
10).  
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Figure 10: Ultimate bicyclic targets 323a and 323b in project. 
Intermediates 323a and 323b each contain the bicyclic core of structures 2a and 2b as well as 
key functionalities such as the thiohemiketal and carboxylic acid derivatives. We then envisaged 
phosphate, amino and acetate functionalities could be incorporated into the bicyclic structures 
323a and 323b to achieve a total synthesis (Scheme 89). 
 
Scheme 89: Retrosynthetic analysis of the functional groups on pyranoid core in structures 2a 
and 2b. 
The easiest functionality to install in the structure would be the acetate group by simple 
esterification of a free hydroxyl group on the C-4 centre with a range of acetylating agents (e.g. 
AcCl and Ac2O) under various conditions.  
Incorporation of the amino group would be more challenging since, in addition, the 
stereochemical configuration of the C-3 position has to be inverted. This could be achieved using 
displacement chemistry; the C-3 hydroxyl group could be activated into a good leaving group 
which could be substituted by an azide nucleophile in SN2 fashion. The azide moiety could then 
be reduced into an amino group by a Staudinger reaction or hydrogenation. 
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The phosphorylation of the C-2 hydroxyl group could be achieved by numerous methods with the 
most common being: 
1) Esterification using activated phosphonates (e.g. phosphoric acid chlorides or 
anhydrides). 
2) Esterification using phosphoric acid or a derivative with activating agents such as DCC, 
trichloroacetonitrile or arylsulfonyl chlorides.  
3) Phosphitylation using a phosphoramidite followed by oxidation with a peracid or a 
peroxide (e.g. mCPBA or H2O2).  
The order and the methods in which these three functionalities would be selectively installed 
onto the structure would depend on the type of the protecting groups present on bicyclic 
structures 323a and 323b, in addition to the exact nature of the synthetic route from these 
compounds to structures 2a or 2b. The exact synthetic route would be determined once bicyclic 
323a and/or 323b was synthesized.  
Bicyclic Skeleton  
To reach our ultimate bicyclic targets 323a and 323b (Figure 10), we attempted a variety of 
routes starting from readily available cyclic sugars such as D-mannose and D-galactose.   
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Nitrile-Wittig Route 
Our first synthetic route was similar to the Wittig route previously performed by Pearce,1 with 
the main difference being the presence of a nitrile instead of an ethyl ester functionality (Scheme 
90).  
 
Scheme 90: Retrosynthesis of target structure 324 from D-mannose in the nitrile-Wittig route. 
If this route to target 324 were successful, then this strategy would be adapted to incorporate a 
carboxylic acid derivative alpha to the thiohemiketal centre in order to reach our ultimate 
bicyclic targets 323a and 323b. 
As planned in all previous routes from the Page group,1–3 the synthesis of the 1,4-oxathiane 
moiety in target 324 is based on the strategy established by Porter and co-workers,4 involving the 
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deprotection of the thioacetate moiety in 325 followed by an in-situ cyclization of the free 
thiol/thiolate onto the ketone. Intermediate 325 could be made from the selective hydrolysis of 
the exo-cyclic isopropylidene group in 326, followed by protection of the primary alcohol and 
oxidation of the secondary alcohol.  The installation of the thioacetyl-methylene moiety in 326 
could be achieved in three steps: condensation between the anomeric nitrile anion of 327 with a 
formaldehyde electrophile would introduce the hydroxyl methylene functional group; activation 
of the aforementioned hydroxyl into a good leaving group (e.g. halide or sulfonate ester); and 
displacement of the leaving group with a thioacetate nucleophile. A 6-endo-tet cyclization of the 
hydroxyl group on the epoxide in glycidic nitrile 328 would construct the pyranoid core in 327. 
Glycidic nitrile 328 could be formed by an epoxidation of alkene 329, which in turn could be 
derived from a Wittig olefination on DAM 234 with a nitrile stabilized ylide. As previously 
achieved in the Page group, DAM 234 could be synthesized from D-mannose 235 in acetone 
under acidic catalysis.1–3  
The key feature of this route is the epoxidation of alkene 327. Since the alcohol in alkene 327 is 
not protected, we were hopeful that during the epoxidation step, the intramolecular 6-endo-tet 
cyclization (although in competition with the faster 5-exo-tet cyclization) in glycidic nitrile 328 
would occur to form pyranoid 329. If successful, pyranoid 329 could be reached potentially in at 
least two steps less than if we protected the hydroxyl group prior to the epoxidation, as carried 
out previously by Pearce in the Wittig route.1 
The project began with the synthesis of DAM 234 from D-mannose 235 in 92% yield using 
conditions established from earlier work in the Page group (Scheme 91).1–3 As discovered 
previously, this procedure did not afford 100% of a single anomer; though this was not important 
since the subsequent Wittig reaction only involves the ‘open’ hydroxy-aldehyde form of DAM 
234 (thus negating the stereochemistry on the anomeric position).  
103 
 
 
Scheme 91: Synthesis of DAM 234 from D-mannose 235. 
Before the Wittig reaction could be attempted, the nitrile stabilized ylide 332 had to be 
synthesized in two steps from triphenylphosphine 330; this was achieved using conditions from 
Aitken et al.5 Firstly, the phosphonium chloride salt 331 was synthesized in 91% yield via 
displacement chemistry using triphenylphosphine and chloroacetonitrile in ethyl acetate under 
reflux (Scheme 92). The ylide 332 was then isolated in 74% yield by deprotonation of the 
phosphonium ion with a triethylamine base. 
 
Scheme 92: Two-step synthesis of ylide 332 from triphenylphosphine. 
The Wittig reaction between stabilized ylide 332 and DAM 234 was then carried out (Scheme 93 
and Table 6).  
 
Scheme 93: Wittig olefination attempts on DAM 234. 
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Entry Solvent Result a 
1 THF 77% SM, 18% 333 (β:α, 63:37) 
2 MeCN 46% SM, 45%  333  (β:α, 2:1) 
3 Toluene 26% SM, 66%  333  (β:α, 2:1) 
a The number of moles of recovered DAM 234 and C-glycosides 333 in the 
inseparable mixture were calculated from molar ratios observed in the 1H NMR 
spectrum.  
Table 6: Conditions and results reported for the attempted Wittig olefinations of DAM 234. 
We initially tried standard conditions, whereby DAM 234 and the ylide 332 were heated under 
reflux in THF, MeCN or toluene for 24 h (entries 1 to 3). In each case, TLC appeared to indicate 
no change during the reaction. After work-up and purification by column chromatography, an 
inseparable mixture of starting material DAM 234 and C-glycosides α- and β-333 was isolated 
(explaining why no change appeared on TLC).   
The formation of C-glycosides 333 does at least indicate that the Wittig reaction was successful 
in synthesizing alkenes 329. This is because compounds 333 were probably formed from a 5-
exo-trig conjugate addition in alkenes 329 (Scheme 94). 
 
Scheme 94: Proposed mechanism for the synthesis of C-glycosides 333. 
The conversion of DAM 234 was fairly poor in all the Wittig attempts, but it did increase upon 
changing solvent from THF to MeCN to toluene (possibly due to the higher temperatures at 
which these solvents reflux at). Longer reaction times, though, made no significant difference in 
conversion.  
As a result, alternative methods were sought to synthesize alkenes 329. We envisaged the use of 
the Horner-Wadsworth-Emmons olefination (HWE) on DAM 234, though the more basic 
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conditions in this reaction would even more likely promote the conjugate addition. Nevertheless, 
an HWE reaction with diethyl cyanomethylphosphonate was attempted (Scheme 95 and Table 
7).  
 
Scheme 95: HWE olefination attempts on DAM 234. 
Entry Reagents and Conditions Result 
1 Diethyl cyanomethylphosphonate, t-BuOK (1.5 
equiv.), THF, 0 oC, 30 mins, then DAM 234, 0 oC to 
rt, overnight 
98% 333 
(β:α, 3:1) 
2a Diethyl cyanomethylphosphonate, K2CO3 (1 equiv.), 
THF, rt 30 mins, then DAM 234, overnight 
81% SM, 
11% 333 
(β:α, 66:34) 
a The number of moles of recovered DAM 234 and C-glycosides 333 in the inseparable 
mixture were calculated from molar ratios observed in the 1H NMR spectrum.  
Table 7: Conditions and results reported for the attempted HWE olefinations of DAM 234. 
Unsurprisingly, when using common conditions (entry 1) only C-glycosides 333 were observed. 
With the goal of making the conditions less basic to suppress any conjugate additions, we 
replaced potassium tert-butoxide with the weaker base potassium carbonate (entry 2). These 
milder conditions, however, only caused a decrease in yield of the C-glycosides 333 (because of 
a lower conversion of DAM 234).  
The C-1 stereochemistry in C-glycosides α-333 and β-333 were assigned from NMR analysis. 
For example, the lower 13C chemical shift of C-1 in β-333 (76.9 ppm) compared to α-333 (80.3 
ppm) signifies a cis relationship between the substituents on the C-1 and C-2 positions.
6,7 
106 
 
Furthermore, the small vicinal coupling constant between the H-C-1 and H-C-2 (
3J1,2) in α-333  
(1.3 Hz) suggests that these protons have a trans relationship.8 Finally from the NOESY spectra, 
there was a significant nOe between H-C-1 and H-C-4 in β-333, suggesting a cis relationship. This 
was unlike α-333 where such a nOe was not observed (Figure 11). Additionally, in contrast to β-
333, a nOe was observed between the methylene protons of the CH2CN moiety and H-C-4 in α-
333, which suggests a cis relationship.   
 
Figure 11: NOESY analysis to assign stereochemistry at the C-1 position in β-333 and α-333. 
The failure of the Wittig and HWE olefinations, led us to investigate alternative strategies to 
synthesize alkene 329. This led us to attempt a retro-Michael reaction of the C-glycosides 333, 
which was inspired by the research conducted by Fleming et al.9 In this work, Fleming and co-
workers performed a retro-Michael reaction (i.e. a β-elimination of the ring oxygen) on a variety 
of compounds including 334 (Scheme 96).   
 
Scheme 96: Retro-Michael reaction on 334 by Fleming et al.9 
The authors attributed the success of the reaction to three specific features of the conditions: 
1. Use of a strong lithium base (i.e. LDA). 
2. Low concentrations of 334 in THF (0.0018 M). 
3. Shortest possible reaction time. 
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Using a lithium base will lead to the formation of a lithium alkoxide intermediate. The authors 
stated that the interaction between the lithium and the oxygen in this intermediate is strong 
enough to suppress unwanted intramolecular and intermolecular conjugate additions to the nitrile 
functionality, which could otherwise trigger an unwanted polymerization.9 The low 
concentration and short reaction time would additionally help to suppress conjugate additions 
and thus polymerizations.   
We therefore applied this retro-Michael methodology to C-glycosides 333 (Scheme 97).  
 
Scheme 97: Synthesis of alkene E-329 by a retro-Michael reaction on 333. 
To our delight, the reaction did afford alkene E-329 in yields of up to 56% after optimization. 
The high vicinal coupling constant between the alkene protons (16.2 Hz) indicated the E-
stereochemistry of the formed double bond. The Z-alkene was also formed in the reaction but 
could not be isolated pure from column chromatography as it co-eluted with a number of other 
compounds and was thus discarded. The reaction was stereoselective towards the E-alkene, since 
analysis from the 1H NMR spectrum of the crude material showed that the E:Z ratio always 
varied from 68:32 to 76:24.  
The required low concentrations of 333 in THF provided practical and scalability issues. 
Increasing the concentration to 0.02 M had no effect on yield, though any further increase led to 
a 0% yield of E-329 possibly due to decomposition or polymerization.  
With alkene E-329 in hand, we proceeded with the epoxidations using a range of conditions from 
the literature (Scheme 98 and Table 8).  
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Scheme 98: Epoxidation attempts on alkene 329. 
Entry Reagents and Conditions Product(s) 
110 H2O2 (35% wt. in H2O), NaOH (6M/H2O, 0.83 equiv.), 0 
oC to rt, 
MeOH, 3 h 
333 
2 H2O2 (35% wt. in H2O), NaOH (2M/H2O, 0.83 equiv.), 0 
oC to rt, 
MeOH, 3 h 
333 
311 NaOCl (from bleach), MeCN, rt, 2 h 333 
412 mCPBA, K2CO3, DCM, rt, 48 h SM 
513 H2O2 (35% wt. in H2O), MeCN, 0 
oC to rt, overnight  SM 
614  Oxone, NaHCO3, 10:1 MeCN:H2O, 0 
oC, 48 h SM 
7 Oxone, NaHCO3, 10:1 MeCN:H2O, 0 
oC  to rt, 48 h SM, 333 
 
Table 8: Conditions and results reported for the attempted epoxidations of alkene 329. 
We initially tried a standard nucleophilic epoxidation with hydrogen peroxide and sodium 
hydroxide in methanol, but only C-glycosides 333 were observed (entry 1). This suggests that, 
under these oxidizing conditions, deprotonation and intramolecular conjugate addition of the 
hydroxyl group in 329 were favoured compared to the desired nucleophilic attack of the 
perhydroxyl anion onto the alkene. Consequently, our next epoxidation attempt was carried out 
under less basic conditions, by repeating our initial entry with the exception of using the more 
dilute 2 M aqueous NaOH instead of 6 M (entry 2); we hoped that under these less basic 
conditions, the epoxidation would be preferred to the intramolecular conjugate addition. Once 
again, however, only compounds 333 were recovered. The same result occurring in an alternative 
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nucleophilic epoxidation using sodium hypochlorite (entry 3), prompted us to try electrophilic 
epoxidations.  
Epoxidation using mCPBA only led to recovery of starting material (entry 4), possibly because 
of the alkene not being reactive enough as it too electron-deficient. We therefore next tested a 
more powerful electrophilic oxygen transfer reagent by using hydrogen peroxide in acetonitrile 
(entry 5), which should trigger the formation of the more reactive peroxyimidic species,15 but 
again only starting material was observed.  
Finally, using a slightly modified procedure from the literature,14 we tried epoxidations using 
oxone. Although this initially led to only starting material being recovered (entry 6). Upon 
increasing the temperature from 0 oC to rt, however, starting material and compound 333 were 
isolated (entry 7). This suggests that the electron-deficient nature of the alkene in 329 makes it 
too unreactive with the peroxymonosulfate anion of oxone, leading to the base promoted 
conjugate addition being more favoured over the epoxidation.   
We concluded that no nucleophilic epoxidations under basic conditions could occur without 
triggering the intramolecular conjugate addition, while all electrophilic epoxidations failed, 
presumably to do with the poor nucleophilicity of the electron-deficient alkene.  
As a result, we planned to protect the hydroxyl group in 329 and only then perform the 
nucleophilic epoxidation, since this would prevent the intramolecular conjugate addition 
happening under basic oxidizing conditions. This strategy would differ from that first envisaged, 
since the epoxidation step would now lead to the O-protected epoxide 338 (Scheme 99). The 
removal of the protecting group under basic conditions would hopefully cause a concomitant 6-
endo-tet cyclization to give pyranoid 336.  
 
Scheme 99: Proposed synthetic approach to pyranoid 336 from alkene 329. 
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We opted to protect the free hydroxyl group in 329 with a silyl and benzoyl group. Surprisingly, 
this protection step proved much more challenging than initially anticipated (Scheme 100 and 
Table 9).   
 
Scheme 100: Protection of alkene 329. 
Entry R Reagents and Conditionsa Products 
116 TIPS Alkene 329, DCM, Imidazole (2 equiv.), TIPSCl (2 
equiv.), DMAP (0.2 equiv.), 72 h  
SM 
2 TBS Alkene 329, DCM, Imidazole (2 equiv.), TBSCl (2 
equiv.), DMAP (0.2 equiv.), 72 h 
SM 
3 TBS Alkene 329, DCM, 2,6 – lutidine (3 equiv.), 
TBSOTf (2.5 equiv.), 72 h 
SM 
4 IPDMS Alkene 329, DCM, Imidazole (2 equiv.), IPDMSCl 
(2 equiv.), DCM, 24 h 
82% 339 
517 Bz Alkene 329, DCM, Et3N (2 equiv.), BzCl (2 equiv.), 
DMAP (0.2 equiv.), 24 h  
81% 333 
6 Bz DCM, BzCl (2 equiv.), Et3N (2 equiv.), DMAP (0.2 
equiv.), Alkene 329, 24 h 
52% 340, 21% SM, 
17% 333 
7 Bz DCM, BzCl (3.3 equiv.), Et3N (4.4 equiv.), DMAP 
(0.2 equiv.), Alkene 329, 24 h 
quant. 340 
aAddition order as reported, temperature: 0 oC to rt.  
Table 9: Conditions and results reported for the attempted silyl ether- and benzoyl- protections 
of alkene 329. 
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Using a slightly modified procedure from Trost,16 we failed to protect the alcohol with a TIPS 
group, only starting material was recovered despite the long reaction time and the presence of the 
nucleophilic catalyst DMAP (entry 1). Given that the alcohol in 329 is secondary and surrounded 
by fairly bulky substituents, we attributed this failure to steric factors. We therefore tried to 
protect the alcohol with the smaller TBS group (entries 2 and 3). Yet, using TBSCl (entry 2) or 
even the more electrophilic TBSOTf (entry 3) did not make any difference. We were, however, 
successful in protecting the alcohol with the less bulky IPDMS group affording alkene 340 in 
81% yield (entry 4). The success of the IPDMS protection provides further support to steric 
factors accounting for the failure of the TBS and TIPS protections.  
Furthermore, we found that the order of addition of reagents was vital for the benzoylations. For 
example, under typical conditions from the literature,17 when the triethylamine base was added 
to alkene 329 before benzoyl chloride and DMAP, only the cyclization products 333 were 
isolated (entry 5). However, when modifying the addition order (by adding alkene 329 to a 
solution of triethylamine, benzoyl chloride and DMAP), the desired benzoyl-protected alkene 
340 was produced in various yields (entries 6 and 7) and the conjugate addition side-reaction 
reduced. In entry 5, the alkene was in a basic solution prior to the addition of the electrophile 
and nucleophilic catalyst. This meant that the conjugate addition was probably already triggered 
before the electrophile and nucleophile catalyst were even added. This was not the case in 
entries 6 and 7 because the alkene was never in a basic solution in the absence of the 
electrophile and DMAP catalyst. Once finding optimal conditions (e.g. addition order as well as 
equivalents of triethylamine and benzoyl chloride) this reaction did proceed smoothly in high 
yields of up to 85% of 340 with no sign of the unwanted intramolecular conjugate addition 
(entry 7). 
Interestingly, in contrast to the benzoylations, the order of addition of reagents was not 
significant in the silyl ether protections. A possible reason for this could be due to imidazole and 
2,6-lutidine being weaker bases than triethylamine; alkene 329 would thus be more likely to 
undergo a base-promoted intramolecular conjugate addition in the presence of triethylamine 
rather than 2,6-lutidine or imidazole.  
Having successfully obtained protected derivatives 339 and 340, our next goal was to form 
epoxides 341 and/or 342 (Scheme 101 and Table 10). 
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Scheme 101: Epoxidation attempts on alkenes 339 and 340. 
Method R Reagents and Conditions a Product 
110 IPDMS, Bz H2O2 (35% wt. in H2O), 6M NaOH (0.83eq), MeOH, 
48 h 
SM 
2 IPDMS, Bz t-BuOOH (70% wt. in H2O), 6M NaOH (0.83eq), 
MeOH, 48 h 
SM 
3 IPDMS H2O2 (35% wt. in H2O), 6M NaOH (1eq), MeOH, 72 h SM 
4 IPDMS t-BuOOH (70% wt. in H2O), 6M NaOH (1eq), MeOH, 
72 h  
SM 
5 Bz H2O2 (35% wt. in H2O), 6M NaOH (1eq), MeOH, 72 h
  329 
6 Bz t-BuOOH (70% wt. in H2O), 6M NaOH (1eq), MeOH, 
72 h  
329 
711 IPDMS, Bz NaOCl (from bleach), MeCN, 72 h b SM 
a temperature: 0 oC to rt; b room temperature. 
Table 10: Conditions and results reported for the attempted epoxidations of alkene 339 and 340. 
We first attempted standard nucleophilic epoxidation conditions on the benzoyl- and IPDMS-
protected alkenes with hydrogen peroxide and tert-butylperoxide (methods 1 and 2). Regrettably, 
neither set of conditions with each alkene furnished the desired epoxides, as only starting 
material was recovered. This influenced us to use more basic conditions by increasing the 
number of equivalents of sodium hydroxide (methods 3 – 6). While only starting material was 
recovered for the IPDMS-protected alkene 339 (methods 3 and 4), these stronger basic 
conditions did lead to the benzoyl ester being cleaved, yielding the unprotected alkene 329 
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(methods 5 and 6).  Further attempts were made using sodium hypochlorite (entry 7), though for 
each alkene 339 and 340 only starting material was recovered. 
Confronted with these disappointing epoxidation results, we devised an alternative strategy to 
pyranoid 327. In this strategy, we would directly brominate alkene 329 to form a bromonium ion 
intermediate 343 which could then undergo an intramolecular 6-endo-tet cyclization (but 
competing with an undesired faster 5-exo-tet cyclization) to afford compound 344 (Scheme 102). 
Displacement of the bromine with a nucleophilic oxygen species would then form pyranoid 327. 
This methodology was identical to the approach followed by Pearce in the Wittig route (Scheme 
72) with the only difference being the presence of a nitrile rather than an ethyl ester.1 
 
Scheme 102: Proposed bromination strategy to pyranoid 327. 
Unfortunately, when subjected to standard bromination conditions, neither pyranoid 344 nor 
even the 1,2-dibrominated compound 345 were detected; only decomposition of the starting 
materials was observed (Scheme 103).  
 
Scheme 103: Attempted bromination on alkene 327. 
After having no success in our bromination strategy, we decided to try another alternative 
synthetic approach to pyranoid 307 (Scheme 104). In this approach, an oxymercuration-
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demercuration would be attempted on the IPDMS- and benzoyl-protected alkene derivatives 339 
and 340. Then, following a protection of the product alcohol (e.g. benzyl or trityl protection), 
halogenation alpha to the nitrile would be performed; this would install a good leaving group 
alpha to the nitrile. Finally, selective deprotection of the IPDMS or benzoyl protecting group in 
350 or 351 would liberate the nucleophilic oxygen (in the form of an alcohol or alkoxide 
depending on the deprotection conditions), which in turn could displace the halide in a 6-exo-tet 
cyclization to afford pyranoid 327.  
 
Scheme 104: Proposed synthetic approach to pyranoid 327 from alkenes 339 and 340. 
In this oxymercuration-demercuration strategy, there are more steps required to synthesize 
pyranoid 327 as compared to the epoxidation or bromination pathways. However, in contrast to 
the previous pathways, there would be no regioselective issues in the cyclization. This is because 
in this pathway, the 5-exo-tet cyclization would be much slower and unfavourable compared to 
the 6-exo-tet cyclization since the former process requires an alkoxide leaving group instead of a 
good halide leaving group as in the latter.  
Consequently, the protected derivatives 339 and 340 were subjected to a range of 
oxymercuration-demercuration conditions (Scheme 105 and Table 11).  
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Scheme 105: Oxymercuration-demercuration attempts on compounds 339 and 340. 
Entry Mercuric Reagent Catalyst Solvent Product 
118 Hg(OAc)2 None 1:1, THF:Water SM 
2 Hg(OAc)2 70 % HClO4 (aq) (0.2 equiv.) 1:1, THF:Water SM 
3 Hg(TFA)2 None 1:1, THF:Water SM 
4 Hg(TFA)2 70 % HClO4 (aq) (0.2 equiv.) 1:1, THF:Water SM 
5 Hg(OAc)2 None 1:1, Acetone:Water SM 
 
Table 11: Conditions and results reported for oxymercuration-demercuration attempts of 
compounds 339 and 340. 
When applying standard literature conditions on 339 and 340 (entry 1),18 only starting material 
was isolated. This prompted us to use more powerful conditions by also adding 70% perchloric 
acid (entry 2); the presence of perchloric acid should trigger the formation of the more 
electrophilic acetoxymercuric cation (part of the acetoxymercury perchlorate ion pair).19,20 
Unfortunately these powerful conditions still made no difference to the result.  Attempts using 
the more electrophilic mercuric trifluoroacetate with or without perchloric acid were also 
unsuccessful (entries 3 and 4). Finally, in one last attempt the solvent system was modified 
whereby THF was replaced with acetone, but as expected this again made no difference (entry 
5).  
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As with the attempted bromination and electrophilic epoxidations on alkene 327, the probable 
reason for the failure of these oxymercuration-demercurations on 339 and 340 is the poor 
nucleophilicity of the electron-deficient alkene.    
Considering the failures of the epoxidations, bromination and oxymercuration-demercurations 
we abandoned this route.  
Vinyl-Transetherification Route 
Following on from the disappointments of the nitrile-Wittig Route, in order to reach target 324, 
we proposed an alternative strategy to synthesize intermediate pyranoid 327 (Scheme 106).  
 
Scheme 106: Retrosynthesis of target structure 324 from DAM 234 in the vinyl-
transetherification route. 
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The retrosynthesis of target 324 from 327 is identical to the nitrile-Wittig Route. In this route, 
pyranoid 327 could be made from diol 352 in a two-step sequence involving esterification of 
both hydroxyl groups (e.g. acetylation or benzoylation) followed by a C-glycosylation reaction 
with TMSCN. The esterification of the anomeric hydroxyl group will incorporate a good leaving 
group on the anomeric centre which would help to activate the molecule for the subsequent C-
glycosylation reaction. Furthermore, esterification of the neighbouring C-2 hydroxyl group 
should additionally activate the molecule for the C-glycosylation due to its role in anchimeric 
assistance.21 Diol 352 could derive from the dihydroxylation of glycal 353. A mercuric acetate 
catalysed intramolecular vinyl-transetherification of enol ether 354 would construct the pyranoid 
framework in glycal 353. Finally, enol ether 354 could be made by a Wittig olefination of DAM 
234 with an ylide derived from (methoxylmethyl)triphenylphosphonium chloride.   
The pivotal steps of this route were the Wittig olefination of DAM 234 and subsequent 
intramolecular vinyl-transetherifcation to afford glycal 353. This exact synthesis has already 
been achieved by Wardrop et al. in 58% yield (over both steps) during their synthesis of KDO 
(Scheme 107); though characterization data for enol ether 354 and glycal 353 were not 
reported.22 
 
Scheme 107: Two-step synthesis of glycal 353 from DAM 234 by Wardrop et al.22 
The route started with the attempted Wittig olefination of DAM 234 (Scheme 108 and Table 
12). 
118 
 
 
Scheme 108: Wittig olefination attempts on DAM 234. 
Entry Base Reaction Temperature Product(s) 
122 t-BuOK Reflux SM 
2 n-BuLi  rt 9-36% 354 (E:Z, 7:3), 0-17% 355 
3 NaHMDS rt 11% 354 (E:Z, varied from 1:0 to 4:1), 30% SM 
4 LDA rt 19% 354 (E:Z, 9:1), 61% SM 
5 LDA reflux 57% (E:Z, varied from 5:1 to 3:2) 
 
Table 12: Conditions and results reported for the Wittig olefination attempts on DAM 234. 
Surprisingly, when using conditions from Wardrop et al.,22 no reaction seemingly occurred as 
only starting material was recovered (entry 1). This happened despite the mixture even being 
heated under reflux for very long reaction times (~72 h). 
We therefore aimed to apply more powerful conditions and replaced the potassium tert-butoxide 
base with n-BuLi (entry 2). This change did considerably improve the conversion (no trace of 
starting material observed in the crude mixture) but a complex mixture was formed (hinting at 
many undesired side reactions) with the only products isolated after purification being the 
desired enol ether 354 (38% yield) and the side product 355 (17%). Compound 355 was probably 
formed from the nucleophilic addition of n-BuLi to the ‘open’ hydroxy aldehyde form of DAM 
234, followed by a dehydration of the formed alcohol. We also found, that when using n-BuLi, 
the reaction had scalability issues; for example, scaling up the reaction beyond 1 g of DAM 234 
led to yields of 354 as low as 9%. The capricious nature of this reaction influenced us to change 
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the base to strong non-nucleophilic bases like NaHMDS (entry 3) or LDA (entry 4), but in these 
cases only low yields of enol ether 354 were obtained due to the occurrence of many side 
reactions (inferred from the presence of crude complex mixtures) and poor conversion of DAM 
234. When using LDA as the base, however, satisfactory yields of enol ether 354 (up to 57%) 
were obtained when increasing the reaction temperature (entry 5) due to a greater conversion of 
DAM 234 (inferred from no trace of DAM 234 being seen in crude mixture). 
The next step involved the intramolecular vinyl-transetherification of 354 (Scheme 109). This 
was accomplished by subjecting enol ether 354 to catalytic mercuric acetate at 110 oC under 
reduced pressure using Kugelrohr distillation apparatus, which furnished glycal 353 in yields up 
to 57%.22,23 
 
Scheme 109: Synthesis of glycal 353 from enol ether 354. 
The dihydroxylation of glycal 353 was then attempted (Scheme 110 and Table 13).  
 
Scheme 110: Dihydroxylation attempts on glycal 353. 
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Entry Reagents and Conditions Product 
124 AD-Mix-α, 1:1 t-BuOH:H2O SM 
224 AD-Mix-β, 1:1 t-BuOH:H2O SM 
3 OsCl3, NMO, 1:1 THF:H2O, overnight 64% 352 (α:β, 14:1) 
 
Table 13: Conditions and results reported for the dihydroxylation attempts on glycal 353. 
Our first attempts were Sharpless asymmetric dihydroxylations using AD-mix-α (entry 1) and 
AD-mix-β (entry 2) since these had the easiest osmium reagent (potassium osmate) to handle 
(i.e. least volatile).24,25 We initially tried both AD-mixes, because it was difficult to predict which 
face of the alkene in 353 would preferentially be dihydroxylated by each AD-mix. This was due 
to the similar steric environment on both sides of the alkene moiety in 353 as well as the 
presence of four stereogenic centres in 353 that could also influence the stereoselectivity. Despite 
long reaction times (7 days) only starting material was observed for each AD-mix reaction. A 
possible reason for these results could arise from the bulky osmium-ligand complex formed in 
these conditions being sterically demanding in addition to glycal 353 being fairly bulky; this 
would cause the 1,3-dipolar cycloaddition between these species to be too slow because of the 
sterically congested transition state for this step.26 
We then performed the dihydroxylation using osmium trichloride (entry 3). Under these 
conditions, we successfully isolated diols 352 (14:1, α:β). These anomers were inseparable in 
flash column chromatography. Consequently, several recrystallizations were attempted to 
separate the anomers, without success.    
Theoretically from the dihydroxylation of glycal 353, there are four possible stereoisomers that 
could be formed (Figure 12).  
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Figure 12: Every possible product from the dihydroxylation of glycal 353. 
From NMR analysis (see below), we assigned the stereochemical configuration on the C-1 and  
C-2 and deduced that the major stereoisomer isolated was diol α-352. We also suggest that the 
minor product, which co-eluted with diol α-352 from column chromatography, was its anomer β-
352.  
From a range of similar compounds in the literature whose conformations have been determined 
from NMR and/or X-ray analysis, the most likely conformation(s) adopted by diols 352 and 356 
is a hybrid between a twist-boat (oS2) and boat conformation (B2,5),
27–30 ideal oS2 or B2,5 
conformations,31–34 or a slightly flattened chair conformation (Figure 13).34 The reason that the 
usual chair conformer is generally not the preferred conformation of the galactose ring originates 
from constraints imposed by the 3,4-O-isopropylidene group.32 
 
Figure 13: Proposed conformations of diol α-352. 
From the NOESY spectrum, for the major product, a strong nOe was observed between one of 
the methyl groups on the 3,4-O-isopropylidene group with both H-C-1 and H-C-2 of the major 
product, implying that these are close in space. No matter what conformation is adopted, it is 
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very unlikely for these atoms to be close in space in diastereomers β-352, α-356 or β-356, 
supporting the suggestion that the major product is diol α-352.   
Furthermore, for the major product there were no nOes observed that would be expected for the 
diastereomers β-352, α-356 or β-356.  For example, if either diol α-356 or β-356 were the major 
products, a nOe between H-C-2 and H-C-5 should be observed if the 
oS2, B2,5, or a hybrid between 
these conformations, were adopted. Moreover, if diol β-352 or β-356 were the major products, a 
nOe should be observed between H-C-1 and H-C-5 if a chair, flattened chair, B2,5, 
oS2, or hybrid 
between these conformations, were adopted. Likewise, for β-352 or β-356, a nOe should be 
observed between H-C-1 and H-C-3 if a chair or flattened chair conformation were adopted. As a 
result, since all these aforementioned nOes were absent, there is greater support that diol α-352 is 
the major product.   
With regards to the minor product, from the NOESY spectrum, there was an observed nOe 
between H-C-1 and H-C-5. Also, there was no nOe observed between H-C-1 and the methyl group 
on the 3,4-O-isopropylidene. These nOe results suggest that H-C-1 is cis to H-C-5 and trans to the 
3,4-O-isopropylidene group, which means that there is a β stereochemical configuration on the 
anomeric C-1 position. Hence, these observations from the NOESY spectrum indicate the minor 
product is β-352 or β-356.  
Additionally, in both the minor and the major product (to a lesser extent in the major product) the 
stereochemical configuration on C-2 can be assigned from the magnitude of the vicinal coupling 
constant between H-C-2 and H-C-3 (
3J2,3) using the Karplus relationship.
35 The 3J2,3 values for the 
minor (7.9 Hz) and the major (6.4 Hz) products seem too high for the H-C-2 being cis with H-C-3 
(no matter which of the previously mentioned conformations are adopted). This indicates that H-
C-2 is trans to H-C-3 and gives further evidence that the major product is α-352 and minor 
product is β-352.   
Finally, the vicinal coupling constant between H-C-1 and H-C-2 (
3J1,2) in the major product is 
only 3.4 Hz whereas in the minor product it is 7.8 Hz. The larger 
3J1,2 for the latter suggests a 
trans relationship between H-C-1 and H-C-2 (providing further evidence that the minor product is 
356) while the former indicates a cis relationship between H-C-1 and H-C-2 (giving further 
indication that the major product is α-352).     
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From observing the stereochemistry of the major product α-352, it appears that the 1,3-dipolar 
cycloaddition with the osmium tetroxide occurs preferentially on the bottom face of glycal 353. 
To rationalize the stereoselectivity of the dihydroxylation, the conformation of glycal 353 must 
be considered. The most likely conformations adopted are the half chair conformations 5H4 and 
4H5 (with the former being less stable due to the significant destabilizing 1,3-pseudo axial – axial 
interaction between the axial substituent on C-5 and the pseudo-axial substituent on C-3).
36,37 
Attack on the bottom face by the osmium species in both conformations are each less sterically 
hindered compared to top face attack (Figure 14). Hence, the 1,3-dipolar cycloaddition on the 
bottom face is faster as it leads to a less sterically congested and thus more stable transition state. 
 
Figure 14: Rationale for stereoselectivity of dihydroxylation on glycal 353. The osmium 
tetroxide species is denoted as Os*. 
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The minor product β-352 was probably formed by the major product α-352 undergoing 
mutarotation during the reaction.   
Using a slightly modified procedure from the literature,38 the diol was then diacetylated to afford 
357 (Scheme 111). 
 
Scheme 111: Synthesis of compounds 357. 
The diacetate 357 was isolated as an anomeric mixture because of the isomers being inseparable 
after column chromatography. The stereochemical configuration of the major product α-357 was 
deduced to be identical to diol α-352 because of the great similarities of the NOESY spectra and 
vicinal coupling constants (around the pyranoid ring) between these compounds.  
We then aimed to perform the C-glycosylation of diacetate 357 with TMSCN to introduce the 
nitrile functionality onto the anomeric position (Scheme 112 and Table 14). 
 
Scheme 112: Attempted C-glycosylation of 357 with TMSCN. 
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Entry Conditions Result 
139 TMSCN, BF3.OEt2, NO2Me Decomposition  
240 TMSCN, BF3.OEt2, MeCN Decomposition  
341,42 TMSCN, SnCl4, MeCN Decomposition  
4 TMSCN, SnCl4, NO2Me
  Decomposition  
543 TMSCN, SnCl4, DCM
 a Decomposition  
644 TMSCN, HgBr2, NO2Me
 Complex mixture 
739 TMSCN, TMSOTf, NO2Me Complex mixture 
8 TMSCN, MeCN SM 
9 TMSCN, MeCN, Reflux SM 
a The reaction was performed at rt rather than at reflux as reported in the 
literature.43 
Table 14: Conditions and results reported for the attempted C-glycosylation of 357 with 
TMSCN. 
Unfortunately, under common literature conditions involving TMSCN with a Lewis acid in a 
polar aprotic solvent (entries 1 to 7), no trace of the desired glycosyl nitrile 358 was detected. 
Instead only decomposition or the formation of complex mixtures were observed.  
These poor results led us to try milder conditions by performing the reaction in the absence of 
any Lewis acid (entry 8); while this did not lead to any decomposition or complex mixtures, the 
conditions were unsurprisingly too mild for any reaction to occur, as only starting material was 
recovered. Repeating the reaction under these neutral conditions at higher temperatures (entry 9) 
for longer reaction times (72 h) was also not sufficient to trigger the reaction.  
Since glycosyl nitrile 358 was not obtained, we decided to try the C-glycosylation with benzoyl 
ester groups on C-1 and C-2 instead of acetates, to see if this could influence the reaction. 
Therefore, from a modified procedure in the literature,45 the diol was esterified using an excess 
of benzoyl chloride in a pyridine solvent (Scheme 113).  
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Scheme 113: Synthesis of compound 359. 
Attempts to grow a crystal of 359 for X-ray analysis failed. However, since the NMR data (i.e. 
vicinal coupling constants and NOESY spectra) were very similar to those of α-357 and the diol 
α-352, the stereochemistry of the dibenzoylated compound 359 was inferred to be identical with 
these respective compounds.  
We then moved onto the C-glycosylation reactions of the dibenzoylated compound 359 with 
TMSCN (Scheme 114 and Table 15). Unfortunately, when subjecting dibenzoyl 359 to the same 
conditions as diacetyl 359, the results were effectively identical, with no trace of desired nitrile 
360 being observed. 
 
Scheme 114: Attempted C-glycosylation of 359 with TMSCN. 
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Entry Conditions Result 
139 TMSCN, BF3.OEt2, NO2Me Decomposition  
240 TMSCN, BF3.OEt2, MeCN Decomposition  
341,42 TMSCN, SnCl4, MeCN Decomposition  
4 TMSCN, SnCl4, NO2Me
  Decomposition  
543 TMSCN, SnCl4, DCM
 a Decomposition  
644 TMSCN, HgBr2, NO2Me
 Complex mixture 
739 TMSCN, TMSOTf, NO2Me Complex mixture 
8 TMSCN, MeCN SM 
9 TMSCN, MeCN, Reflux SM 
a The reaction was performed at rt rather than at reflux as reported in the 
literature.43 
Table 15: Conditions and results reported for the C-glycosylation attempts of 359 with TMSCN. 
Due to the inability to synthesize glycosyl nitriles 358 and 360, we abandoned this route. 
Silyl Enol Ether Route 
In our next approach, we planned to synthesize a silyl enol ether from DAM 234 (Scheme 115). 
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Scheme 115: Retrosynthesis of target 229 from DAM 234 in the Silyl Enol Ether Route. 
If target 229 were successfully prepared, this strategy would be tailored to synthesize our 
ultimate bicyclic targets 323a and 323b. 
Target 229 could derive from compound 232, using the same retrosynthetic analysis described 
above for the previous target 324 from 327 (in the nitrile-Wittig and vinyl-transetherification 
routes) with the only difference being the presence of an ester instead of a nitrile functionality on 
the C-1 position. Pyranoid 232 could be synthesized by the regioselective hydration of glycal 361 
and subsequent protection of the formed alcohol. Glycal 361 could be synthesized by the 
dehydration of pyranose 362. The deprotection of the silyl enol ether in 363 should trigger an 
intramolecular 6-exo-trig cyclization of the hydroxyl group on the formed α-ketoester to furnish 
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pyranose 362. Silyl enol ether 363 could be synthesized from DAM 234 by a Wittig or HWE 
olefination with an appropriate ylide or phosphonate anion.  
This route was inspired by the successful three-step synthesis of glycal 366 from DAM 234 
executed by Chai et al. (Scheme 116).46  
 
Scheme 116: Three-step synthesis of glycal 366 from DAM 234 by Chai et al.46 
In this synthesis, the authors performed an HWE reaction between phosphonate 367 and DAM 
234 to afford a mixture of E and Z silyl enol ethers E-364 and Z-364. Subsequent treatment of 
the silyl enol ethers with TBAF and 20% AcOH led to desilylation and an in-situ 6-exo-trig 
cyclization to form an anomeric mixture of pyranoses 365. Finally, glycal 366 was formed by 
dehydration of anomers 365; this was achieved by mesylation of the anomeric hydroxyl group in 
365 and subsequent elimination using MsCl and Et3N.   
Phosphonate 367, however, had to be synthesized as it is not commercially available. Chai and 
co-workers synthesized 367 in two steps from ethyl glyoxylate hydrate 368 and dimethyl 
phosphite (Scheme 117).46 
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Scheme 117: Synthesis of phosphonate 367 by Chai et al.46 
We therefore decided to replicate their synthesis to obtain glycal 366.  
Our first task in this route was to synthesize the TBS-protected phosphonate 367. In order to 
achieve this feat, we had to first synthesize ethyl glyoxylate hydrate 368. We aimed to do this by 
using Bailey and co-workers’ conditions, where a periodate oxidative cleavage of the 1,2-diol in 
L-diethyl tartrate 369 was carried out (Scheme 118).47  
 
Scheme 118: Synthesis of ethyl glyoxylate hydrate 368 by Bailey et al.47 
However, our attempts at applying these conditions, were of limited success. The 1H NMR 
spectrum of the crude material, showed a mixture of multiple compounds. Due to the complexity 
of the 1H NMR spectrum, we were unable to confirm the presence of the hydrate 368, although 
the presence of the ethyl glyoxylate as a free aldehyde was observed. Attempts to isolate the 
aldehyde or the hydrate (if latter was even formed) using column chromatography proved futile. 
Hence, the crude mixture was used directly for the next step.  
We carried out the nucleophilic addition of dimethyl phosphite to our impure sample of the ethyl 
glyoxylate aldehyde using Chai and co-workers’ conditions (Scheme 119).46 
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Scheme 119: Two-step synthesis of α-hydroxyphosphonate 370 from L-diethyl tartrate 369. 
We were able to isolate the α-hydroxyphosphonate 370, albeit in poor yield (41% over two 
steps). The mediocre yield is probably the result of the use of an impure sample of the ethyl 
glyoxylate aldehyde as well as the production of the undesired organophosphate side-product 
371 (31% yield over 2 steps). This compound was probably formed by a base-catalysed phospha-
Brook rearrangement of α-hydroxyphosphonate 370 occurring during the reaction (Scheme 120).  
 
Scheme 120: Proposed mechanism to account for the production of organophosphate 371. 
Finally, protection of the hydroxyl group in 370 with a TBS group under standard conditions 
gave phosphonate 367 in 91% yield (Scheme 121).  
 
Scheme 121: Silyl protection of α-hydroxyphosphonate 367. 
132 
 
The following step in the route involved the HWE condensation of DAM 234 with phosphonate 
367 (Scheme 122 and Table 16). Despite this reaction being carried out by Chai et al.,46 this 
HWE olefination proved troublesome.   
 
Scheme 122: HWE olefination attempts between DAM 234 and phosphonate 367. 
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Entry Base Deprotonation 
Temperature/ OC 
Reaction 
Temperature/ OC 
Products a 
1 t-BuOK rt 50  SM 
246 t-BuOLi rt 50 SM 
3 b t-BuOLi rt Reflux SM 
4 t-BuOLi 50  50 2% Z-364, 8% E-364, 2% 372, 
60% SM 
5 t-BuOLi 50 Reflux  3% Z-364, 15% E-364, 7% 372, 
51% SM 
6 n-BuLi 0 50 Complex mixture 
7 LDA 0 50 15% Z-364, 7% E-364, 24% 372 
8 LDA 0 rt 3% Z-364, 12% E-364, 3% 372, 
40% SM  
9 NaH 0 50 17% Z-364, 28% E-364, 1% 
372, 11% SM  
10 c NaH 0 50 18% Z-364, 36% E-364, trace 
372  
a Compounds E-364 and 372 were inseparable in column chromatography. The number of moles 
of E-364 and 372 in the inseparable mixture were calculated from molar ratios observed in the 
1H NMR spectrum. Since the yield of the E-364 is based on the number of moles of E-364 in the 
inseparable mixture, the yield of E-364 derives from the aforementioned molar ratios seen in the 
1H NMR spectrum (same applies to 372); b Reaction time: 72 h; c 1.5 equiv. of base and 367 were 
added.  
Table 16: Conditions and results reported for HWE olefination attempts between DAM 234 and 
phosphonate 367. 
Unexpectedly, when using the conditions from Chai et al.,46 with the exception of using t-BuOK 
instead of t-BuOLi (entry 1), only starting material was observed. Though we did not expect any 
difference, we decided to copy fully the conditions in the literature,46 and hence changed the base 
to t-BuOLi (entry 2), but again only starting material was seen. Therefore, the HWE 
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condensation was carried out under more forceful conditions by firstly refluxing the reaction 
mixture and allowing longer reaction times (entry 3), but this made no difference.  
Since we have already tried using more forceful reaction conditions, we attempted to use more 
powerful deprotonation conditions. Therefore prior to DAM 234 addition, the t-BuOLi base and 
the phosphonate 364 were heated at 50 oC for 1 h (entry 4). After work-up, this led to a messy 
crude mixture with the only isolable products after column chromatography being starting 
material 234 (60%), Z-364 (2%) and an inseparable mixture of the E-364 (8%) and an unknown 
side product which we later identified as 372 (2%). The yields of the silyl enol ethers Z-364 and 
E-364 were still very low (10%) due to the large amount of unreacted starting material. We 
therefore repeated this more vigorous deprotonation in addition to subsequently heating the 
HWE reaction mixture at a higher temperature (entry 5). While this slightly improved the 
conversion and the yields of silyl enol ethers Z-364 and E-364, this also caused the yield of the 
unwanted side product 372 to increase as well; there was also still a great amount of unreacted 
starting material (51%). 
At this time, we attributed the low yields of the silyl enol ethers Z-364 and E-364 to the presence 
of large amounts of unreacted starting material. We postulated that there could be three possible 
reasons to explain the high amounts of unreacted starting material: 
1. Issues regarding the deprotonation step of the phosphonate 367 by the tert-butoxide base. 
2. Issues regarding the betaine-forming step involving the hydroxy-aldehyde form of DAM 
and the phosphonate ion of 367; 
3. Occurrence of unwanted side reactions of the phosphonate 367 and/or DAM 234 under 
the applied conditions (such as the one that leads to the undesired side product 372).  
However, considering the success of this HWE reaction by Chai et al.,46 each of these rationales 
appear surprising and unlikely. Nevertheless, since there was an improvement in conversion 
when using more powerful deprotonating conditions (entries 3 to 5) we therefore decided to use 
stronger bases than the tert-butoxide anion.   
The first strong base that we used was n-BuLi (entry 6), but only a complex mixture was 
observed with no isolable products, suggesting many unwanted side reactions occurred which 
most likely have arisen from the nucleophilic character of n-BuLi.   
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This led us to use the strong non-nucleophilic base LDA (entry 7). This gave a complex crude 
mixture, with the only isolable products after purification being the silyl enol ethers Z-364 and 
E-364 as well as the side product 372. While there was no trace of starting material seen in the 
1H NMR spectrum of the crude mixture (indicating an improved conversion), the yield of the 
silyl enol ethers 364 (22%) was still low (albeit higher than previous entries), and the yield of the 
undesired side product 372 increased to 24%. In order to reduce the number of unwanted side 
reactions, we repeated the HWE olefination with LDA, except under milder conditions, by 
lowering the reaction temperature from 50 oC to rt (entry 8). However, the only significant effect 
this had was a decrease in the conversion of the starting material and yields of the silyl enol 
ethers Z-364 and E-364.   
When using NaH as the base (entry 9), much higher yields of the silyl enol ethers Z-364 and E-
364 (46%) were obtained and there were only trace amounts of the unwanted side-product 372. 
Additionally, increasing the equivalents of NaH and the phosphonate 367 to 1.5 equiv. (entry 10) 
gave greater yields of the silyl enol ethers Z-364 and E-364 (probably due to a greater 
conversion of starting material). We generally found that, as in entries 9 and 10, the 1H NMR 
spectra for the crude material were cleaner, hinting that there were fewer unwanted side reactions 
(including the side reaction that produces 372).  
The most likely mechanism to account for the formation of the 372 would involve a silyl 
migration between the phosphonate 367 and DAM 234 (Scheme 123). A possible reason for this 
undesired reaction could arise from phosphonate 367 being bulky, and rather than attacking the 
hydroxy-aldehyde form of DAM in nucleophilic fashion to make the betaine intermediate, it acts 
as a base, deprotonating DAM, as there is greater steric hindrance in the former process. 
However, considering the success of this HWE reaction reported by Chai et al.,46 this 
explanation seems unlikely. Furthermore, it is unclear why the yield of 372 varies considerably 
when different bases are used. 
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Scheme 123: Proposed mechanism to account for the formation of by-product 372. 
As mentioned above, when performing these HWE reactions, we did not know that the side-
product inseparable from E-364 was compound 372. We were only able to identify compound 
372 when performing the subsequent TBAF-based silyl ether and silyl enol ether deprotection 
step on the inseparable mixture containing E-364 and 372 (Scheme 124).  
 
Scheme 124: Treatment of the inseparable mixture of E-364 and 372 with TBAF. 
We found that the silyl enol ether E-364 was UV active whereas 372 was not. We also 
discovered that E-364 was desilylated faster than 372. Hence, we ceased/quenched the reaction 
once E-364 was consumed as shown by TLC (by UV visualization). As a result, after 
purification, compound 372, DAM 234, and the desired pyranoses 365 were isolated. This 
allowed us to fully characterize compound 372. Furthermore, the production of DAM 234 from 
this silyl ether deprotection step provided further evidence of the presence of 372 in the starting 
inseparable mixture.  
The next task in the route was deprotection of the silyl enol ethers to trigger the concomitant 6-
exo-trig intramolecular cyclization to produce pyranoses 362. Using Chai and co-workers’ 
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conditions,46 the silyl enol ethers Z-364 and E-364 were successfully transformed into pyranoses 
362 (α:β varying from, 5:1 to 4:1) in yields of  up to 79% (Scheme 125). As indicated above, 
due to E-364 being inseparable from 372, this additionally led to the production of DAM 234 in 
the reaction.  
 
Scheme 125: Synthesis of pyranoses 365 from the deprotection of silyl enol ethers Z-364 and E-
364. 
In order to synthesize glycal 366, we next attempted the dehydration of pyranoses 365 (Scheme 
126 and Table 17).  
 
Scheme 126: Attempted dehydration of pyranoses 366. 
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Entry Reagents and Conditions a Yield of Glycal 366/% 
146 Et3N (3 equiv.), MsCl (1.5 equiv.), DCM, 0 
oC, overnight 
8 
2 Et3N (5 equiv.), MsCl (1.5 equiv.), DCM, 0 
oC, overnight 
26 
348 Et3N (3.4 equiv.), MsCl (3 equiv.), DCM, 0
 
oC to rt, 3 h, then DBU (3 equiv.), overnight 
64 - 71 
 
Table 17: Conditions and results reported for the dehydration attempts of pyranoses 365. 
We initially used Chai and co-workers’ conditions, where an excess of base (3 equiv.) was used  
to trigger mesylation of the anomeric hydroxyl group in pyranoses 365 in addition to the 
consequent in-situ elimination of the anomeric mesylates 373 (entry 1).46 However, despite 
numerous efforts, we were unable to replicate the yields (80%) reported by Chai et al.,46  as we 
only could isolate glycal 366 in low yields of up to 8%. From the 1H NMR spectrum of the crude 
material, there was a mixture of unknown compounds present alongside glycal 366. 
Interestingly, these unknown compounds appeared to be very polar because they could only be 
isolated from flash column chromatography on silica gel using a very polar solvent system (9:1, 
DCM:methanol). We speculated that the intermediate anomeric mesylates 373 could be in the 
undesired mixture, though considering the high polarity of this mixture it seemed unlikely (the 
complexity of the NMR spectrum for this mixture made it difficult to interpret). As a result, we 
concluded that the production of this polar mixture arises from undesired side-reactions, 
reducing the yield of glycal 366.   
Applying more basic conditions by increasing the equivalents of triethylamine slightly decreased 
production of these polar products (as seen in the 1H NMR spectrum of the crude material), 
which may explain the higher yield of glycal 366 (entry 2); though since the yield was still low, 
further improvement was required.  
To our delight, from an alternative procedure in the literature involving even stronger basic 
conditions using DBU (entry 3),48 there was no trace of the polar unknown mixture in the 1H 
NMR spectrum of the crude material, and provided us higher yields of glycal 366 (up to 71%).  
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Our next goal was the hydration of the alkene in glycal 366. There are three common methods 
for this transformation: an oxymercuration-demercuration; an aqueous acid catalysed hydration; 
and a hydroboration-oxidation reaction.  
In an aqueous acid-catalysed hydration, we anticipated numerous issues such as possible 
unwelcome hydrolysis of the isopropylidene groups and the ethyl ester, and hence we discarded 
this method.  
The choice between an oxymercuration-demercuration or hydroboration-oxidation of glycal 366 
was based upon their predicted regioselectivity. From an electronics rationale, predicting the 
regiochemistry would depend on the ‘victor’ in the competition between the electron-
withdrawing ability (by mesomeric and inductive effect) of the ethyl ester and ring oxygen (by 
inductive effect) against the electron-donating ability of the ring oxygen (by mesomeric effect) in 
glycal 366.  
Yamaguchi et al. performed an oxymercuration-demercuration on a range of compounds with a 
generic structure 374 (Scheme 127).49 These compounds 374 have similar features to glycal 366 
in that they both have an electron-withdrawing group on the C-1 position.  
 
Scheme 127: Yamaguchi and co-workers’ syntheses of compounds 375 by an oxymercuration-
demercuration process.49 
In oxymercurations, the regioselectivity is generally governed by electronic factors, that is by 
nucleophilic attack of a water molecule onto the carbon of the mercurinium ion that can best 
accommodate a partial positive charge;50,51 the regioselectivity observed in Yamaguchi and co-
workers’ example indicates that this carbon in question is C-2. Hence, this observed 
regiochemistry suggests that the electron-withdrawing ability of the ester and ring oxygen is 
more powerful than the electron-donating ability of the ring oxygen.  This literature example 
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therefore indicates that performing an oxymercuration-demercuration on glycal 366 would lead 
to the desired compound 376 as the major regioisomer (Scheme 128).  
 
Scheme 128: Predicted major regioisomer for an oxymercuration-demercuration of glycal 366. 
In contrast, the regioselectivity for hydroborations is based on steric and electronic factors. When 
based on electronic factors, presuming the electron-withdrawing ability of the ester and ring 
oxygen is more powerful than the electron-donating ability of the ring oxygen (as inferred from 
the regiochemistry seen in Scheme 127), the major expected product would be the unwanted 
365. This is because the regioselectivity would be dependent upon the relative stabilities of the 
four-centred transition states in the hydroboration (Figure 15) - since C-2 can stabilize a partial 
positive charge to a greater extent than C-1, transition state 377 (which after oxidation would 
eventually lead to 365) would be more stable than the transition state 378 (which after oxidation 
would eventually lead to the desired 376).52–54  
 
Figure 15: Transition states for the hydroboration of glycal 366. 
However, from a steric rationale, the desired compound 376 would be the major expected 
product since the trisubstituted C-1 position is more sterically hindered than the C-2 position; this 
effect would become more pronounced with bulkier boranes (Scheme 129).55  
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Scheme 129: Predicted major regioisomer for a hydroboration-oxidation (with steric factors or 
electronic factors controlling regioselectivity) on glycal 366. 
As a result, due to a greater predicted regioselectivity for the desired product 376, we chose to 
perform an oxymercuration-demercuration sequence on glycal 366 (Scheme 130 and Table 18).  
 
Scheme 130: Oxymercuration-demercuration attempts on glycal 366. 
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Entry Reagents and Conditions  Product 
118 Hg(OAc)2 (1 equiv.), 1:1, THF:Water, 72 h, then 3M NaOH (aq) and 
NaBH4 (0.5 M in 3M NaOH) 
SM 
2 Hg(OAc)2 (1 equiv.), 70% HClO4 (aq) (0.2 equiv.), 1:1 THF:Water, 
72 h,  then 3M NaOH (aq) and NaBH4 (0.5 M in 3M NaOH) 
SM 
3 Hg(TFA)2 (1 equiv.), 1:1, THF:Water, 72 h, then 3M NaOH (aq) and 
NaBH4 (0.5 M in 3M NaOH) 
SM 
4 Hg(TFA)2 (1 equiv.), 70% HClO4 (aq) (0.2 equiv.), 1:1, THF:Water, 
72 h,  then 3M NaOH (aq) and NaBH4 (0.5 M in 3M NaOH) 
SM 
5 Hg(OAc)2 (1 equiv.), 70% HClO4 (aq) (0.2 equiv.), 1:1, 
acetone:Water, 72 h,  then 3M NaOH (aq) and NaBH4 (0.5 M in 3M 
NaOH) 
SM 
 
Table 18: Conditions and results reported for the oxymercuration-demercuration attempts of 
glycal 366. 
Similarly to the oxymercurations-demercurations processes previously attempted in the nitrile-
Wittig route, we initially applied standard literature conditions to glycal 366 (entry 1).18 
However, even after very large reaction times (72 h), no change was observed by TLC. Although 
it would be unlikely for the organomercury compound and starting material to have the same 
retention factor (Rf) on silica gel, we still attempted the demercuration step, but after work-up, 
1H NMR analysis of the crude material indeed confirmed only starting material 366 was present. 
Even under greater activating conditions, such as the use of catalytic 70% perchloric acid and/or 
use of mercuric trifluoroacetate (entries 2- 4), no change in result occurred. An alternative 
solvent system also made no difference (entry 5).   
These negative results suggest that despite the electron-donating ability of the ring oxygen, the 
alkene of 366 still seems to be too electron-deficient (due to the effects from the electron-
withdrawing ester and ring oxygen) to react with the electrophilic mercuric reagents. However, 
this is perhaps surprising given of Yamaguchi and co-workers’ successful oxymercuration-
demercuration of their glycal 374 (Scheme 127).   
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We ceased further work on this route as our oxymercuration-demercuration reactions were 
unsuccessful, but future work regarding hydroboration-oxidations on glycal 366 was not 
excluded.  
Dithiane-Reduction Route 
The lack of success in the nitrile-Wittig, vinyl-transetherification and silyl enol ether routes 
prompted us to revisit the dithiane strategy established previously by the group (Scheme 131).1,3 
 
Scheme 131: The retrosynthesis of target 379 from DAM 234 in the Dithiane-Reduction route. 
If target 379 were successfully synthesized, this route would be modified to install carboxylic 
acid derivatives on the C-1 and thiohemiketal centres.  
144 
 
As planned in previous routes, thioacetate cleavage of 380 should trigger the thiol/thiolate to 
cyclize onto the ketone to afford target 379. The cyclization precursor 380 could be made by 
selective acetonide hydrolysis of 381 followed by selective protection of the primary alcohol and 
subsequent oxidation of the secondary alcohol. Similar to all previous routes, the thioacetyl 
functionality can be incorporated into the structure from 382 through a sequence involving 
displacement chemistry (i.e. activation of the primary hydroxyl group into a good leaving group 
and substitution of that leaving group with a thioacetate nucleophile in SN2 fashion).  Protection 
of the diol in pyranose 268 followed by deacetylation would afford intermediate 382.  
As already accomplished previously in the Page group, pyranose 268 could be synthesized from 
DAM 234 in four steps (Schemes 64 and 65).1 We therefore planned to copy this four-step 
synthesis to 268. 
The route started with the nucleophilic addition of ethyl 1,3-dithiane-2-carboxylate (in the form 
of a functionalized Grignard reagent) to DAM 234 affording ester 252 in 97% yield (Scheme 
132). Using LAH, the ester was then reduced to a primary alcohol, which in turn was selectively 
acetylated using acetic anhydride and triethylamine in DCM to form compound 266 in yields up 
to 75%.  
 
Scheme 132: Three step synthesis of 266 from DAM 234. 
We then intended to cleave the dithioketal in 266 and trigger the cyclization to form pyranose 
268 using commercially available DBDMH in reagent grade acetone (Scheme 133 and Table 
19).  
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Scheme 133: Dethioketalization attempts on 266 using DBDMH. 
Entry DBDMH equiv.  Products 
1  2.83 10% 383 
2 a 2.83 268 
3 a 1 43% 383 
4 a 2 80-89% 383  
a Sample of DBDMH was recrystallized prior to use. 
Table 19: Conditions and results obtained for the dethioketalization of 266. 
We initially performed the reaction in identical conditions to Pearce’s successful 
dethioketalization of 266 (Scheme 67),1 except for the solvent, where we used reagent grade 
acetone instead of 95% aqueous acetone (entry 1). The 1H NMR spectrum of the crude material 
showed a complex mixture of compounds (indicating many side reactions and/or decomposition 
occurred). After purification, however, the triacetonide 383 was isolated in 7% yield. The 
formation of 383 could be explained by acetonide formation between the C-1 and C-2 hydroxyl 
groups in the intended product 268 (Scheme 134). This was possibly caused by the presence of 
catalytic quantities of HBr (possibly due to impure sample of DBDMH containing trace amounts 
of HBr and/or generated from reaction between DBDMH and water as the reaction was not 
under anhydrous conditions) accompanied by a large excess of acetone.  
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Scheme 134: Possible pathway for the production of triacetonide 383. 
In the retrosynthetic analysis for this route, pyranose 268 was initially planned to be synthesized 
from 266 by a dethioketalization and concomitant cyclization, then in a subsequent step, the C-1 
and C-2 hydroxyl groups were to be protected with suitable groups. Hence, the formation of 
triacetonide 383 is very beneficial because it means the dethioketalization, cyclization and the 
protection of the C-1 and C-2 hydroxyl groups were achieved in one step rather than two. We 
therefore tried to optimize the conditions in order to achieve a high yield of triacetonide 383. 
With the aim of reducing the number of side reactions and/or decomposition, we repeated the 
reaction with purified DBDMH (recrystallized from water prior to use), but only 268 was 
observed in the 1H NMR spectrum of the crude material (entry 2). However, by tailoring the 
equivalents of DBDMH (entries 3 and 4) we eventually produced 383 in yields as high as 89%.  
Our next aim was to deprotect the acetyl group in 383; this would allow us to activate the formed 
primary alcohol into a good leaving group, which would be needed subsequently to install the 
thioacetyl moiety into the structure by displacement chemistry. Deacetylation of 383 was 
achieved in 97% yield using K2CO3 in methanol according to a modified procedure from the 
literature (Scheme 135).56 We planned to activate the primary alcohol as a triflate as these are 
known to be excellent leaving groups. Hence, a triflation of the primary alcohol was carried out 
to furnish 385 in 99% yield. 
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Scheme 135: Two-step synthesis of triflate 385 from 383. 
We proceed to the displacement of the triflate in 385 with a thioacetate nucleophile. Using 
slightly altered conditions to those of Repetto et al. we initially attempted the reaction using 
potassium thioacetate in acetonitrile for 16 h at rt (Scheme 136).57 However, the conversion of 
triflate 385 to 386 was quite low. When repeating the reaction under refluxing conditions for 16 
h, however, 386 was isolated in quantitative yield after work-up and purification.   
 
Scheme 136: Synthesis of 386 from 385. 
The next step involved the regioselective deprotection of the exo-cyclic acetonide. The 
conditions used were reported by Ma et al., who successfully carried out a selective deprotection 
of a primary acetonide on a different substrate using 90% aqueous acetic acid at 40 oC.58 
Subjecting 386 to these conditions led us to obtain diol 387 in 80% yield (Scheme 137).  
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Scheme 137: Selective acetonide hydrolysis of 386.  
After successfully obtaining 387, the next objective was to synthesize the precursor to target 
379/391. In order to do this, we then moved onto the selective protection of the primary alcohol 
in 387; this would allow us subsequently to selectively oxidize the secondary alcohol into a 
ketone. Thus, the primary alcohol was selectively protected with the TBS group using standard 
conditions (Scheme 138). This was followed by a Swern oxidation, which provided the target 
precursor 389 in 86% yield.   
 
Scheme 138: Synthesis of ketone 389. 
We were next tasked with the deprotection of the thioacetate in 389 to provide the thiol/thiolate 
intermediate 390, which was expected to cyclize in-situ to furnish the synthetic target 391 
(Scheme 139 and Table 20).  
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Scheme 139: Thioacetate deprotection attempts of compound 389. 
Entry Reagents and Conditions Result 
159 NaOMe, MeOH Decomposition  
260 NaHCO3, MeOH, reflux Decomposition 
360 NaHCO3, MeOH, rt Decomposition 
461 K2CO3, MeOH Decomposition 
562 NaSMe, MeOH Decomposition 
64,63 N2H4.H2O, MeOH Complex mixture 
764 N2H4, THF  Complex mixture 
865 N2H4.H2O, AcOH, DMF Decomposition  
966 N2H5.OAc, THF Decomposition  
 
Table 20: Conditions and results obtained for the thioacetate deprotections of 389. 
Unfortunately, despite testing a large variety of deprotection procedures from the literature,4,59–65 
including common basic (entries 1 to 4), transthioesterification (entry 5) and hydrazinolysis 
(entries 6 to 9) conditions, only decomposition or complex mixtures were observed.  
Since we were unable to obtain target 390 or even thiol 391, we also used silyl protecting groups 
other than TBS, such as the TIPS and TBDPS groups. Hence, we selectively protected the 
primary alcohol in 387 with TIPS and TBDPS groups under standard conditions (Scheme 140).  
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Scheme 140: TIPS and TBDPS protection of the primary hydroxyl group in 387. 
Swern oxidations of the protected derivatives 392 and 393 were then carried out, allowing us to 
obtain ketones 394 and 395 (Scheme 141).  
 
Scheme 141: Synthesis of ketones 394 and 395. 
Thioacetate deprotections of the TIPS and TBDPS-protected ketones 394 and 395 were then 
attempted. Regrettably, despite trying all the same procedures as previously carried out with the 
TBS ketone 381, only decomposition or complex mixtures were seen (Scheme 142). 
 
Scheme 142: Attempted syntheses of targets 396 and 397. 
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Confronted with these disappointing results, we decided to modify our cyclization strategy. In 
this strategy, instead of oxidizing the secondary alcohol in 388 to a ketone, we planned to 
activate it as a good leaving group such as a sulfonate ester (Scheme 143). The presence of a 
good leaving group in this position should aid the in-situ cyclization during the thioacetate 
deprotection. The major drawback to this strategy is the absence of a thiohemiketal functionality 
in target 400. If 400 were successfully synthesized, however, the route would be revised to install 
a thiohemiketal functionality (for example using Pummerer reaction methodology).  
 
Scheme 143: Proposed synthetic approach to target 400. 
We initially aimed to activate the hydroxyl group in 388 as a tosylate (Scheme 144 and Table 
21).  
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Scheme 144: Attempted tosylation of alcohol 388. 
Entry Reagents and Conditions a Result 
167 Et3N (1.5 equiv.), TsCl (1.1 equiv.), DCM SM 
268 DMAP (1.9 equiv.), TsCl (1.46 equiv.), DCM SM 
369 Et3N (7 equiv.), DMAP (1 equiv.), TsCl (2 equiv.), DCM SM 
470 DMAP (0.1 equiv.), TsCl (2 equiv.), pyridine b SM 
 a reaction time: 72 h, temperature: 0 oC to rt; b 60 oC 
Table 21: Conditions and results obtained for the attempted tosylation of alcohol 388. 
Using methods outlined in the literature (conditions increasing in severity from entries 1 to 4),67–
70 we did not obtain tosylate 401, as only starting material was recovered. A possible reason for 
this failure could be steric hindrance in compound 401. This is because the tosylation requires a 
secondary alcohol (adjacent to a large TBS group and pyranoid ring) to react with a bulky tosyl 
chloride electrophile, leading to a sterically congested transition state.  
The lack of success in the tosylations prompted us to transform the secondary alcohol into a 
triflate (Scheme 145); this was accomplished in 96% yield under the same conditions used 
previously in the route (for the synthesis of 385 – Scheme 135).  
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Scheme 145: Synthesis of the secondary triflate 402. 
We proceeded to the thioacetate deprotection of triflate 402 (Scheme 146 and Table 22). 
Similarly, to the previously attempted thioacetate deprotections of the ketone substrates 389, 394 
and 395, however, the reaction was a failure as neither the thiol 403 or target 400 were isolated, 
only decomposition or complex mixtures were observed.  
 
Scheme 146: Thioacetate deprotection attempts of compound 402. 
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Entry Reagents and Conditions Result 
159 NaOMe, MeOH Complex mixture 
260 NaHCO3, MeOH, rt Complex mixture 
361 K2CO3, MeOH Complex mixture 
462 NaSMe, MeOH Decomposition 
54,63 N2H4.H2O, MeOH Decomposition  
664 N2H4, THF  Decomposition 
765 N2H4.H2O, AcOH, DMF Complex mixture 
866 N2H5.OAc, THF Decomposition  
 
Table 22: Conditions and results obtained for the thioacetate deprotections of 402. 
We next decided to use a mesylate leaving group instead of a triflate to see if this could make 
any difference to the result of the thioacetate deprotections. We successfully synthesized 
mesylate 404 from compound 388 in 66% yield according to the conditions of Hoveyda et al. 
(Scheme 147).71  
 
Scheme 147: Mesylation of 388. 
We attempted the thioacetate deprotection of 404, but once again only decomposition and 
complex mixtures were observed (Scheme 148 and Table 23).  
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Scheme 148: Thioacetate deprotection attempts of compound 404. 
Entry Reagents and Conditions Result 
159 NaOMe, MeOH Decomposition 
260 NaHCO3, MeOH, rt Complex mixture 
361 K2CO3, MeOH Complex mixture 
462 NaSMe, MeOH Decomposition 
54,63 N2H4.H2O, MeOH Decomposition  
664 N2H4, THF  Decomposition 
765 N2H4.H2O, AcOH, DMF Decomposition 
866 N2H5.OAc, THF Decomposition  
 
Table 23: Conditions and results obtained for the thioacetate deprotection of 404. 
With the lack of success using the TBS group in the attempted thioacetate deprotections of 
triflate 402 and mesylate 404, we planned to use the TIPS group instead. As a result, under the 
same conditions used previously (for the synthesis of 402 and 404) we synthesized the TIPS 
triflate 405 and mesylate 406 from 392 in yields of 98% and 64% respectively (Scheme 149).  
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Scheme 149: Triflation and mesylation of 392. 
We then attempted the thioacetate deprotections (under all the same conditions previously tried 
for the TBS triflate 402 and mesylate 404) of 405 and 406. To our disappointment, only 
decomposition occurred.   
The failure of the thioacetate deprotections in all the ketone, triflate and mesylate substrates, led 
us to consider a new route with a different cyclization strategy (Scheme 150).  
 
Scheme 150: Retrosynthetic analysis for target 407 compound 383. 
The 1,4-oxathiane moiety in target 407 could be made from the reaction between the disulfonate 
ester 408 and a sulfide anion (deriving from Li2S or Na2S). Sulfonylation of both hydroxyl 
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groups in 409 would lead to the target precursor 408. Diol 409 could be made from deacetylation 
of compound 410, which in turn could be synthesized from selective protection of the primary 
hydroxyl group in 411. Regioselective isopropylidene hydrolysis of 383 could afford compound 
411. Compound 383 has already been made earlier in the route (in four synthetic steps from 
DAM 234).  
The key step in this strategy is the cyclization to target 407. This step would involve two 
consecutive SN2 reactions: the first being the substitution of the primary sulfonate ester with the 
sulfide ion, forming a thiolate, which in turn would intramolecularly displace the secondary 
sulfonate ester in-situ (Scheme 151).  
 
Scheme 151: Proposed mechanism for the synthesis of target 407 from disulfonate ester 408. 
This route started with a selective acetonide hydrolysis of 383 using aqueous acetic acid 
(Scheme 152). The reaction afforded diol 411 in 90% yield, though a diacetylated side product 
412 was also isolated in low yields (the extra acetylation was probably formed by Fischer 
esterification of the primary alcohol).  
 
Scheme 152: Regioselective isopropylidene hydrolysis of 383. 
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The next step involved the selective protection of the primary alcohol; we chose to use the trityl 
protecting group. Regioselective tritylation of 411 was achieved in 89% yield using conditions 
from Peyrat et al.72 Treatment of the trityl-protected compound 413 with sodium methoxide in 
methanol led to deacetylation, which furnished 414 in 94% yield (Scheme 153).  
 
Scheme 153: Two-step synthesis of 414 from 411. 
We then aimed to activate both hydroxyl groups in 414 as mesylates. The dimesylation was 
carried out under conditions according to the literature,73 which afforded 415 in 70% yield 
(Scheme 154).   
 
Scheme 154: Dimesylation of 414. 
With dimesylate 415 in hand, we then attempted the cyclization to target 416 using an array of 
conditions from the literature (Scheme 155 and Table 24).  
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Scheme 155: Attempted synthesis of target 416 from dimesylate 415. 
Entry Reagents and conditions Result 
174 Li2S, DMF, rt SM 
274 Li2S, DMSO, rt SM 
375  Na2S, DMSO, rt SM 
476 Na2S, DMF, 80 
oC SM 
577 Na2S, DMF, 100 
oC SM 
675 Na2S, DMSO:MeOH (2:1), 60 
oC SM 
778 Na2S, MeOH, reflux SM 
879 Na2S, EtOH, reflux SM 
 
Table 24: Conditions and results obtained for the attempted cyclization of 415. 
When 415 was subjected to conventional conditions such as lithium or sodium sulfide in a polar 
aprotic solvent (entries 1 to 5), only starting material was observed despite long reaction times. 
Repeating entries 1 to 3 at higher temperatures made no difference. Attempting other literature 
conditions (entries 4 to 8) led to the same unwanted outcome. Given the previous success of the 
thioacetate displacement of the triflate in 385, these results were perhaps surprising, since we 
expected that at least the relatively unhindered primary mesylate of 415 would be displaced 
fairly easily by the sulfide anion.  
Due to the lack of reactivity of dimesylate 415 with sulfide anions, we decided to transform both 
hydroxyl groups in 414 to triflates (as these are better leaving groups than mesylates). Hence, 
using a modified procedure from the literature,80 414 was treated with pyridine and triflic 
anhydride, giving ditriflate 417 (Scheme 156).  
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Scheme 156: Ditriflation of 414. 
The cyclization of 417 into target 416 was then attempted under a range of conditions (Scheme 
157 and Table 25). Unfortunately, in each attempt only decomposition or complex mixtures 
were observed. We also attempted the cyclization under milder conditions (entry 8) whereby the 
reaction was carried out at 0 oC, but a complex mixture still resulted.  
 
Scheme 157: Attempted synthesis of target 416 from ditriflate 417. 
Entry Reagents and conditions Result 
174 Li2S, DMF, rt Decomposition 
274 Li2S, DMSO, rt Decomposition 
375 Na2S, DMSO, rt Decomposition 
476 Na2S, DMF, 80 
oC Complex mixture 
575 Na2S, DMSO:MeOH (2:1), 60 
oC Decomposition 
678 Na2S, MeOH, reflux Complex mixture 
779 Na2S, EtOH, reflux Decomposition 
8  Na2S, DMF, 0 
oC Complex mixture 
 
Table 25: Conditions and results obtained for the attempted cyclization of 417.  
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We considered that one possible reason for the failures of the cyclizations to target 416 from 
dimesylate 415 and ditriflate 417 could be due to the large trityl group sterically hindering the 
secondary sulfonate ester. As a result, we decided to use a slightly less bulky TIPS group to 
protect the primary alcohol in 411 instead; this was accomplished in 89% yield (Scheme 158) 
under the same conditions previously used for the TIPS-protection of 387.  
 
Scheme 158: Regioselective TIPS protection of the primary hydroxyl group in 411. 
The next step involved the deacetylation of 418 (Scheme 159 and Table 26). Surprisingly, this 
deacetylation step appeared more problematic than initially envisaged.  
 
Scheme 159: Deacetylation attempts of 418. 
Entry Reagents and conditions a Results 
1 NaOMe, MeOH, 3 h 77% A, 18% B 
2 K2CO3, MeOH, 4 h 77% A, 13% B 
3 DIBAL, THF 69% A 
a room temperature 
Table 26: Conditions and results reported for the attempted deacetylations of 418 
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We initially attempted the deacetylation using sodium methoxide in methanol (entry 1). 
However, we isolated two isomeric products; a major product A and a minor product B. From 
NMR, IR and MS analysis we concluded that either of these products could be the desired 
compound 419. When performing another base-promoted deacetylation using K2CO3 in 
methanol (entry 2), the same two isomeric products were isolated in similar yields to entry 1.  
In order to diagnose whether product A or B is the desired compound 419, we planned to mono-
acetylate A and B respectively; If A is 419, then mono-acetylation of A should lead to 418 (418 
has previously been made earlier in the route) and mono-acetylation of B will not lead to 418 (or 
vice versa). We found that in contrast to B, mono-acetylation of A produced 418 (Scheme 160); 
thus, we concluded that A is the desired product 419.  
 
Scheme 160: Mono-acetylation of products A and B. 
When performing the deacetylation under reductive rather than basic conditions (entry 3), only 
419 (i.e. product A) was isolated. This indicates that the side reaction leading to the production 
of B requires basic conditions. Therefore, we speculate that B is formed from a base-promoted 
1,4-intramolecular migration of the TIPS group in 419 (though more experiments would be 
required to confirm this).  
Using the same conditions previously carried out (for 415), both hydroxyl groups in 419 were 
then transformed into mesylates (Scheme 161).   
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Scheme 161: Dimesylation of 419. 
We then attempted the cyclization of 420 to give target 421 under a range of conditions (Scheme 
162 and Table 27). Yet, as with the attempted cyclizations with the trityl protected dimesylate 
415, only starting material was recovered with no trace of target 421 seen.   
 
Scheme 162: Attempted synthesis of target 421 from dimesylate 420. 
Entry Reagents and conditions Result 
174 Li2S, DMF, rt SM 
274 Li2S, DMSO, rt SM 
375  Na2S, DMSO, rt SM 
476 Na2S, DMF, 80 
oC SM 
577 Na2S, DMF, 100 
oC SM 
675 Na2S, DMSO:MeOH (2:1), 60 
oC SM 
778 Na2S, MeOH, reflux SM 
879 Na2S, EtOH, reflux SM 
 
Table 27: Conditions and results obtained for the attempted cyclization of 420. 
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Due to the failure of the cyclizations with the TIPS-protected dimesylate 420, we planned to 
attempt the cyclizations with a ditriflate instead. Consequently, a ditriflation on 419 was 
completed, affording 422 in near quantitative yield (Scheme 163).  
 
Scheme 163: Ditriflation of 419. 
With ditriflate 422 in hand we attempted the cyclizations with the sulfide anion, again under a 
range of conditions (Scheme 164 and Table 28). 
 
Scheme 164: Attempted synthesis of target 421 from ditriflate 422. 
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Entry Reagents and conditions Result 
174 Li2S, DMF, rt Trace unknown 
product 
274 Li2S, DMSO, rt Unknown product 
375 Na2S, DMSO, rt Trace unknown 
product 
476 Na2S, DMF, 80 
oC Decomposition 
575 Na2S, DMSO:MeOH (2:1), 60 
oC Decomposition 
678 Na2S, MeOH, reflux Decomposition 
779 Na2S, EtOH, reflux Complex mixture 
8  Na2S, DMF, 0 
oC Decomposition 
 
Table 28: Conditions and results obtained for the attempted cyclization of 422. 
Interestingly, in three sets of conditions (entries 1 to 3), the same unknown product was isolated 
in variable yields; thorough NMR and MS analysis ruled out this product from being target 421 
or an intermediate thiol. Decomposition and complex mixtures were observed in the rest of the 
attempts (entries 4 to 8).  
We concluded any future work with this cyclization strategy due to the failure of the cyclizations 
with the trityl-protected and TIPS-protected sulfonate esters 415, 417, 420 and 422. 
In the dithiane-reduction route, three cyclization strategies were attempted on numerous 
substrates: 
1. Thioacetate deprotection and in-situ cyclization of the liberated thiol/thiolate onto a 
ketone.  
2. Thioacetate deprotection and in-situ cyclization of the liberated thiol/thiolate onto a 
sulfonate ester.  
3. Displacement of two sulfonate esters using a sulfide anion.  
A common trait that all the substrates for these cyclization strategies have, are the two cyclic 
isopropylidene groups. Given that all three strategies failed, we postulated that maybe the 
presence of isopropylidene groups hinder the cyclization as they lead to steric constraints being 
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placed on ring closure. A consequence for the failure of the cyclization could lead to a whole 
host of side reactions occurring instead (leading to decomposition or complex mixtures being 
observed).  We therefore aimed to attempt our initial cyclization approach with a substrate 
without any acetonide groups; we postulated that this could be achieved in three steps from 
either of the ketone substrates 389, 394 or 395 (Scheme 165).   
 
Scheme 165: Proposed synthetic approach to target 426 from ketones 389, 394 or 395. 
We chose to attempt this synthesis starting from the TIPS-protected ketone substrate 394. Hence, 
our initial objective was to hydrolyse both acetonide groups in 394 (Scheme 166 and Table 29).  
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Scheme 166: Acetonide hydrolysis attempts on 394. 
Entry Reagents and conditions Results 
181 80% AcOH(aq), 70 
oC  66% 427 
2 80% AcOH(aq), 90 
oC Decomposition 
382 90% TFA(aq), rt, Decomposition 
483 H2O:AcOH:TFA (2:3:5), rt Decomposition 
584 DCM:TFA (2:1), rt Decomposition 
685 BF3.OEt2, DCM:MeOH (1:1), rt Decomposition 
785 BF3.OEt2, DCE:MeOH (1:1), rt Decomposition 
886 1M HCl(aq):THF (1:1), rt Decomposition 
 
Table 29: Conditions and results reported for the attempted acetonide hydrolyses of 427. 
In our first attempt (entry 1), we attempted hydrolysis of  both acetonide groups using 80% 
aqueous acetic acid at 70 oC according to a procedure by Komizo et al.81 However, these 
conditions were not strong enough to hydrolyse the acetonides because only TIPS deprotection 
occurred, affording compound 427 in 66% yield. Heating at longer reaction times (~72 h) made 
no difference. We therefore heated the reaction mixture at higher temperatures (entry 2), but only 
decomposition was observed. Following this, we tested a range of conditions from the 
literature,82–86 such as TFA, Lewis acid and aqueous HCl based procedures (entries 3 to 8), but 
only decomposition was found.  
The lack of success in the three cyclization strategies and in the subsequent acetonide 
deprotections led us to abandon this route. However, in any future route we decided to not 
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incorporate any isopropylidene groups in the synthesis, as they could be hindering the cyclization 
to the bicyclic core by imposing steric constraints on ring closure. 
D-Galactose Route 
In this route, we planned to synthesize target 428 from D-galactose 433, without any use of 
isopropylidene protecting groups (Scheme 167).  
 
Scheme 167: Retrosynthesis of target structure 428 from D-galactose 433 in the D-galactose 
route. 
If successful, this route would be revised and altered to install a carboxylic acid derivative on the 
thiohemiacetal centre in target 428. 
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The bicyclic target structure 428 could be made from thioacetate deprotection of 429 and 
consequent in-situ cyclization of the thiol/thiolate onto the aldehyde. The target precursor 429 
could be made from selective deprotection of the primary hydroxyl group in 430, followed by 
oxidation into an aldehyde. Activation of the primary alcohol in 431 and subsequent substitution 
with a thioacetate nucleophile could form thioacetate 430. Reaction between the anomeric nitrile 
anion of 432 with a formaldehyde electrophile would introduce the hydroxy methylene 
functional group. Intermediate 432 could be made from compound 64 in three steps: 
deacetylation of 64; selective protection of the primary hydroxyl group (e.g. silyl protection); 
and protection of the three secondary hydroxyl groups (e.g. perbenzylation). Compound 64 could 
be made from D-galactose 433 in two steps. The first step would be a peracetylation of D-
galactose to form D-galactose pentaacetate 63, which in turn can then undergo a C-glycosylation 
reaction with TMSCN to form 64; both these steps have already been accomplished in the 
literature.87–89  
The route started with the peracetylation of D-galactose 433 (Scheme 168). Subjecting D-
galactose 433 to typical literature conditions of NaOAc in Ac2O at 120 
oC,87 led to the isolation 
of β-63 in 64% yield. 
 
Scheme 168: Synthesis of β-63. 
The production of three other isomeric pentaacetate compounds (Figure 16) in this reaction 
contributed to the lower than expected yield of β-63. Nevertheless, β-63 was still isolated from 
the mixture using a recrystallization procedure reported by Liu et al.90  
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Figure 16: Other pentaacetate derivatives formed in peracetylation of D-galactose 433.  
It was also inferred that the reaction time was critical in achieving sufficient yields for β-63. For 
example, a reaction time too long (e.g. greater than 5 hours) generated increased amounts of the 
undesired pentaacetate furanoses at the expense of β-63, leading to yields being as low as 5%. 
Conversely, too short reaction times additionally led to low yields because of poor conversion to 
the penta-acetylated derivatives. It was found that the optimum reaction time was 3 hours. 
Compound α-63 was not isolated even though it could be used in the subsequent C-glycosylation 
step. This is because purification and isolation of α-63 from the pentaacetate furanosides α-434 
and β-434 by recrystallization and column chromatography proved difficult. Furthermore, from 
the molar ratios between α-63, β-63, α-434 and β-434 in the 1H NMR spectrum of the crude 
material, if isolated, maximum yields of α-63 would only be ~10-15%.         
The C-glycosylation of β-63 was then performed. According to conditions outlined in the 
literature,88,89 β-63 was treated with TMSCN and a Lewis acid (BF3.OEt2) in a polar aprotic 
solvent, furnishing glycosyl nitrile 64 in 67% yield (Scheme 169).  
 
Scheme 169: C-glycosylation of β-63 with TMSCN. 
The next goal in the route was the deprotection of the acetate groups in 64 followed by the 
selective protection of the primary alcohol (Scheme 170 and Table 30).  
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Scheme 170: Deacetylation of 64 and selective protection of the primary alcohol.  
Entry R Reagents and conditions a Result 
191 PMB NaH (1 equiv.), PMBCl (1 equiv.), DMF, 24 h Complex mixture 
292 TIPS Imidazole (2.5 equiv.), TIPSCl (1.5 equiv.), 
DMF, 72 h 
26% 436b (over 2 steps) 
3 TIPS Imidazole (4 equiv.), TIPSCl (2 equiv.), DMF, 
72 h 
42% 436b (over 2 steps) 
a Temperature: 0 oC to rt. 
Table 30: Conditions and results reported for the regioselective protection.  
From the literature,92  we used sub-stoichiometric quantities of sodium methoxide in methanol 
for the deacetylation. The 1H and 13C NMR spectra of the crude material confirmed that all the 
acetates have been cleaved successfully and that the major product in the mixture was 435. There 
were, however, a number of signals in the spectra belonging to impurities. Purification attempts 
by column chromatography on silica gel or alumina failed because the mixture was ‘lost’ with no 
recovery (perhaps due to its high polarity). We also tried to purify the mixture by 
recrystallization using numerous solvents, but this failed as well. Consequently, the crude 
mixture was used directly for the next step.  
We initially tried to protect the primary alcohol selectively with a PMB group using modified 
conditions from the literature,91 but only a complex mixture was observed (entry 1). We 
therefore tried a protection with the larger TIPS group (entries 2 and 3). Using conditions from 
Balmond et al.92 we successfully isolated compound 436b, albeit only in 26% yield (entry 2). 
This low yield occurred due to the poor conversion of 435 (since unreacted 435 was isolated 
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from the aqueous layer in the work-up). By increasing the equivalents of TIPSCl and imidazole, 
however, higher yields (42%) were reached (entry 3). Regrettably, increasing the equivalents 
further or adding DMAP in catalytic quantities (0.2 equiv.) made no significant improvement to 
the yield.   
We then moved onto the perbenzylation of the TIPS silyl ether 436b (Scheme 171 and Table 
31).  
 
Scheme 171: Perbenzylation attempts of 436b. 
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Entry Reagents and Conditions a Result 
193 NaH (3.7 equiv.), BnBr (4.5 
equiv.), DMF 
44% 437, 15% mono- and di- benzylated products 
(6% 438, 3% 439, 2% 440, 4% 441)   
2 NaH (8 equiv.), BnBr (10 
equiv.), DMF 
41% 437, 20% mono- and di- benzylated products 
(8% 438, 7% 439, 2% 440, 3% 441,)   
3 NaH (8 equiv.), BnBr (10 
equiv.), THF 
57% 437, 20% mono- and di- benzylated products 
(7% 438, 3% 439, 2% 440, 8% 441)   
4 NaH (8equiv.), BnBr (10 
equiv.), THF b 
Decomposition 
594 NaH (4.95 equiv.), BnBr (4.5 
equiv.), THF, TBAI (0.08 
equiv.) 
71% 437 
6 NaH (4.95 equiv.), BnBr (4.5 
equiv.), THF 
39% 437, 36% mono- and di- benzylated products 
(23% 438, 3% 439, 3% 440, 7% 441)   
a Reaction time: 72 h, temperature: 0 oC to rt; b 0 oC to heat under reflux for 4 h. 
Table 31: Conditions and results reported for the attempted perbenzylations of 436b. 
We initially tried standard conditions using sodium hydride and benzyl bromide in DMF,93 but 
got poor yields of the tribenzylated derivative 437 (entry 1). The isolation of mono- and di-
benzylated intermediates accounted for the poor yield, and also indicates that these conditions 
were not powerful enough to induce complete perbenzylation. 
To increase the conversion of these intermediates to the desired tribenzylated compound 437, we 
tried more vigorous conditions by increasing the equivalents of the base and benzyl bromide 
electrophile, but no significant difference was observed (entry 2). Surprisingly, changing the 
solvent from DMF to THF slightly improved the yield for the tribenzylated derivative 437 (entry 
3), though the presence of the mono and di-benzylated intermediates still suggested that more 
forcing conditions were needed. Consequently, we repeated the reaction using THF again but 
instead heated the reaction mixture under reflux (entry 4). These conditions seemed too strong, 
as only decomposition was observed after only a relatively short reaction time (4 h rather than  
72 h).     
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In order to further improve the yield of 437, from a modified procedure in the literature,94 we 
decided to use TBAI as a catalyst in a THF solvent (entry 5). Gratifyingly, under these 
conditions, 437 was isolated in 71% yield. Since the equivalents of sodium hydride and benzyl 
bromide in this reaction (entry 5) were different from all previous attempts (entries 1 to 4), we 
wanted to prove whether the change in equivalents or the use of TBAI were pivotal in optimizing 
the reaction. We therefore repeated the reaction again without the use of TBAI (entry 6) and 
obtained a much lower yield of 437; this result showed that using catalytic TBAI was critical to 
the success of the perbenzylation. The success of the reaction when using TBAI is most likely 
due to the displacement of the bromide in benzyl bromide with an iodide, generating a much 
more reactive benzyl iodide electrophile in-situ.95  
The next step was the attempted formation and reaction of the nitrile anion of 437 with 
formaldehyde (Scheme 172 and Table 32).  
 
Scheme 172: Attempted synthesis of 442 from 437.  
Entry  Base Result 
1 LiHMDS  SM 
2 NaH  SM 
3 LDA SM 
4 t-BuLi SM 
5 t-BuLi a SM  
a DMPU (3 equiv.) additive was used in addition. 
Table 32: Conditions and results reported for the attempted synthesis of 442 from 437. 
Unfortunately, despite using an array of strong bases (increasing in strength from entries 1 to 4), 
only starting material 437 was recovered in each attempt. Even when using a DMPU additive to 
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further increase the reactivity of (the already very strong base) t-BuLi,96 the same result 
occurred.  
In order to identify the failure of this reaction, we decided to repeat all the above attempts 
(entries 1 to 5) but replace the formaldehyde electrophile with D2O (Scheme 173). This would 
establish whether a nitrile anion is formed prior to the addition of formaldehyde. Surprisingly in 
all cases, only starting material (with no diminishment of the anomeric proton signal) was 
recovered. These results suggest, that under each attempted set of conditions (entries 1 to 5 in 
Table 32), the nitrile anion was not formed. While this explains why the reaction with 
formaldehyde failed, it is unclear as to why the nitrile anion not formed.  
 
Scheme 173: Deuteration attempts of 437.  
We also repeated all the previous attempts with D2O at a higher deprotonation temperature (- 20 
oC), but the same results were seen.  
Confronted with these failures, we decided to replace the nitrile in 437 with an ester (Scheme 
174). If successful, this would allow us to attempt a reaction with formaldehyde using an 
anomeric ester enolate of 445 (instead of an anomeric nitrile anion of 437). Compound 445 could 
derive from 446 by selective TIPS protection of the primary hydroxyl group followed by 
perbenzylation. Esterification of carboxylic acid 447 would form compound 446. Finally, 
carboxylic acid 447 could be made by deacetylation and nitrile hydrolysis of 64.  
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Scheme 174: Retrosynthesis for compound 444 from 64. 
By the methodology mentioned in the above retrosynthetic analysis, we successfully synthesized 
the C-glycosyl ester derivative 446 in three steps from 64 (Scheme 175). These involved acetyl 
cleavage of 64, followed by basic nitrile hydrolysis to afford carboxylate 448 in 60% yield (over 
two steps).88 Subsequent treatment of the carboxylate with hydrogen chloride-methanol solution 
(prepared from addition of acetyl chloride to methanol) under reflux then led to Fischer 
esterification yielding 446.88  
 
Scheme 175: Three-step synthesis of 446 from 64. 
Under the optimized conditions previously applied to C-glycosyl nitrile 435, the primary alcohol 
in 446 was successfully protected with a TIPS group, albeit in low yield (Scheme 176).  
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Scheme 176: Selective TIPS protection of 446. 
We then moved onto the perbenzylation of compound 449 (Scheme 177 and Table 33).  
 
Scheme 177: Perbenzylation attempts of compound 449. 
Entry Reagents and Conditions a Result 
194 NaH (4.95 equiv.), BnBr (4.5 equiv.), THF, TBAI 
(0.08 equiv.), 0 oC to rt 
59% 451 
2 NaH (3 equiv.), BnBr (4.5 equiv.), THF, TBAI (0.08 
equiv.), 0 oC to rt 
51% 451 
3 K2CO3 (4.5 equiv.), BnBr (4.5 equiv.), MeCN, reflux SM 
4 K2CO3 (4.5 equiv.), BnBr (4.5 equiv.), DMF, 90
 oC SM 
597 Ag2O (6 equiv.), BnBr (9 equiv.), DMF, 0 
oC to rt Complex mixture 
          a Reaction time: 72 h. 
Table 33: Conditions and results reported for the attempted perbenzylation of 449. 
We initially tried the same optimized conditions previously used for the perbenzylation of the C-
glycosyl nitrile 436 (entry 1), but no trace of the desired tribenzylated compound 450 was 
observed. In fact, the only compound isolated after work-up and purification was the 
dibenzylated glycal 451. Glycal 451 was probably formed by an E1cB elimination of the desired 
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tribenzylated compound 450. In order to suppress the undesired β-elimination, we made the 
conditions less basic by decreasing the equivalents of the sodium hydride base, but again only 
glycal 451 was isolated (entry 2). These disappointing results indicated that milder conditions 
were required to suppress the elimination. We therefore replaced sodium hydride with the 
weaker base, potassium carbonate (entries 3 and 4), but despite heating for prolong times, these 
conditions were too mild for any benzylation to take place. Finally, when the benzylation was 
carried out in near neutral conditions,95 using silver(I)oxide with benzyl bromide in DMF (entry 
6),97 only a complex mixture was observed.   
The lack of success in the perbenzylation of methyl ester 449 and reaction between 
formaldehyde and the tribenzylated nitrile 437, led us to modify the strategy (Scheme 178). 
 
Scheme 178: Retrosynthetic analysis for target 452 from 437. 
The retrosynthesis for target 452 from compound 455 is identical in methodology for the 
previous target 428 from 431, with the only difference being the absence of a nitrile on the C-1 
position (Scheme 167). Compound 455 can be synthesized from 437 by two consecutive 
reduction steps (reductive hydrolysis of the nitrile to an aldehyde and subsequent aldehyde 
reduction to an alcohol). A key disadvantage to this approach is that target 452 has carboxylic 
acid derivatives missing on the C-1 and thiohemiacetal centre, but if this strategy were successful, 
it would be revised to include both carboxylic acid derivatives.  
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We started this sequence with the attempted reduction of the nitrile moiety in 437 to an aldehyde 
using a range of metal hydride reagents (Scheme 179 and Table 34).  
 
Scheme 179: Attempted nitrile reductions of 437. 
Entry Reagents and Conditions Result 
198 DIBAL (1M in DCM, 1 equiv.), 
DCM, - 78 oC, 3 h, then 1M 
NH4Cl(aq) 
Complex mixture 
299 LiAlH4 (1 equiv.), EtOH (3 equiv.), 
Et2O, 0 
oC, 437, 0 oC to rt, 16 h, 
then 1M NH4Cl(aq) 
SM 
3100 Red-Al® (3.5 M in toluene, 1 
equiv.), toluene, - 78 oC to 0 oC, 2 
h, then 1M tartaric acid(aq) 
78% 457, 4% 458 
 
Table 34: Conditions and results tested for the attempted nitrile reductions of 437. 
Initially, from a modified procedure in the literature,98 a diisobutylaluminium hydride (DIBAL) 
based reduction was attempted (entry 1). Unfortunately, despite the relatively mild conditions 
(low temperature and limited equivalents of DIBAL), a complex mixture resulted. Though there 
were distinctive aldehyde proton signals (H-COR) in the 1H NMR spectrum of the crude 
complex mixture, there were no pure isolated products after purification by column 
chromatography.  
We then tried an alkoxyaluminate hydride-based reduction (entry 2).99 In this reaction, we had to 
first synthesize lithium tris(ethoxy)aluminium hydride (LTEA) in-situ (from reaction between 
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absolute ethanol and LAH) prior to the addition of nitrile 437.  However, these conditions were 
too mild for any reduction to take place as only starting material was observed.  
Finally, we used Red-Al® for the nitrile reduction according to a modified procedure from 
Balskus and Jacobsen.100 Unfortunately, the production of amines 457 and 458 showed that 
under these conditions over-reduction readily occurred (i.e. reduction did not cease at the imine 
stage). The formation of amine 457 can be explained by silyl ether cleavage of 458 occurring 
during the acidic work-up.   
These disappointing reductive hydrolysis results led us to abandon this route.   
Exo-Glycal Route 
The failure to synthesize compound 442 by the reaction between formaldehyde and the 
tribenzylated nitrile 437 using nitrile-anion chemistry steered us to an alternative synthetic 
strategy. In this strategy, we aimed to synthesize 442 by the functionalization of an exo-glycal 
(Scheme 180).  
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Scheme 180: Retrosynthesis for target 459 from D-galactose 433 in the Exo-Glycal route.  
The retrosynthetic analysis for target 459 from compound 442 is identical to 428 from 431 in the 
D-galactose route (Scheme 167). Compound 442 could be made by ring opening of the anomeric 
epoxy acetal in 462 using a cyanide nucleophilic source (e.g. TMSCN) and a Lewis acid. 
Compound 462 could derive from an electrophilic epoxidation of the exo-glycal 463, which in 
turn could be made by a Bamford-Stevens reaction of tosylhydrazone 464. Reductive hydrolysis 
of the nitrile in 437 to an aldehyde, followed by trapping with tosylhydrazide, could form 
hydrazone 464.  Finally compound 437 has already been synthesized from D-galactose in five 
steps in the D-galactose route.   
This synthetic approach was largely inspired by the research carried out by Tóth et al.101,102  In 
their work, they successfully synthesized exo-glycal 466 from compound 64 in two steps 
(Scheme 181). In the first step, the authors subjected 64 to Raney-nickel and sodium 
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hypophosphite in aqueous acetic acid and pyridine alongside tosylhydrazide. These conditions 
caused the reduction of the nitrile moiety to an imine, which was then hydrolysed in-situ to an 
aldehyde. Due to the presence of tosylhydrazide, the aldehyde was then trapped with this reagent 
to form tosylhydrazone 465. In the second step, tosylhydrazone 465 was treated with an excess 
of sodium hydride (10 equiv.) in 1,4-dioxane under reflux, which triggered an in-situ generation 
of a C-glycosylmethylene carbene, which eventually yielded exo-glycal 466 in an aprotic 
Bamford-Stevens reaction. 
 
Scheme 181: Tóth and co-workers’ two-step synthesis of exo-glycal 466 from 64.101,102 
We therefore aimed to apply Tóth et al.’s methodology to compound 437. Unfortunately, when 
subjecting 437 to Tóth and co-workers’ reductive hydrolysis conditions, the desired 
tosylhydrazone 464 was not isolated due to the production of a complex mixture (Scheme 182).  
 
Scheme 182: Attempted synthesis of tosylhydrazone 464 from 437.  
Confronted with these failures, we devised an alternative route (simply by changing the order of 
steps) to the tribenzylated exo-glycal 463 (Scheme 183). In this route, we planned to copy Tóth 
and co-workers’ two-step synthesis of 466 from glycosyl cyanide 64 (64 has already been 
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successfully synthesized in the D-galactose route).101,102 Then compound 466 would be 
deacetylated to form 467. Selective silyl protection of the primary hydroxyl group in 467 
followed by perbenzylation would furnish the tribenzylated exo-glycal 463.  
 
Scheme 183: Proposed five-step synthesis of the tribenzylated exo-glycal 463 from 64. 
Using Tóth and co-workers’ conditions, we firstly synthesized tosylhydrazone 465 in 83% yield 
(Scheme 184). We then performed a Bamford-Stevens reaction on 465 to form exo-glycal 466 in 
yields up to 72%. The reaction time was concluded to be pivotal for the yield (of both the final 
product after purification and the crude). For example, reaction times longer than 30 minutes led 
to a decrease in yield, hinting at possible product decomposition under the reaction conditions, 
whereas reaction times that were too short led to poor conversion. Treatment of compound 466 
with sodium methoxide in methanol afforded the deacetylated product 467 in quantitative yield.   
 
Scheme 184: Three-step synthesis of 467 from 64. 
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With compound 467 in hand, we proceeded to the regioselective TIPS protection (Scheme 185 
and Table 35).  
 
Scheme 185: Selective silyl protection attempts of 467.  
Entry Reagents and Conditions a Result 
1 Imidazole (4 equiv.), TIPSCl (2 equiv.), 
DMF 
43% 469, 19% 470, 11% 471 
2 Imidazole (3 equiv.), TIPSCl (1.5 equiv.), 
DMF 
67% 471, 13% 468 
3 Imidazole (2.2 equiv.), TIPSCl (1.1 equiv.), 
DMF 
64% 471, 11% 468 
4 K2CO3 (2.2 equiv.), TIPSCl (1.1 equiv.), 
DMF 
Complex mixture 
5 TIPSCl (1.1 equiv.), Pyridine Complex mixture 
6 2,6-lutidine (2 equiv.), TIPSOTf (1.1 
equiv.), DMF 
3% 472  
a reaction time: 24 h, temperature: 0 oC to rt.  
Table 35: Conditions and results reported for the attempted TIPS protection of 467. 
We initially applied the same optimized conditions used previously for the synthesis of 436 in 
the D-galactose route (entry 1). Under these conditions, however, no trace of the desired 468 was 
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observed; instead compounds 469, 470 and 471 were isolated. The disilylated compounds 469 
and 471 were formed due to the large number of equivalents of TIPSCl used (2 equiv.). The 
probable mechanism to account for these side products arise from the basicity of the exo-glycal 
(Scheme 186).  
 
Scheme 186: Proposed mechanism for the formation of side-products 469, 470 and 471.  
The silylation of alcohol leads to the formation of acid (effectively HCl), although it would be 
expected that the imidazole would neutralize these acidic conditions. Nevertheless, under these 
conditions, the exo-glycal was protonated to form an oxocarbenium ion. The imidazole then 
attacked the oxocarbenium ion in nucleophilic fashion to form the undesired side-products 469, 
470 and 471 after proton transfer.  
The number of equivalents of imidazole and TIPSCl were then reduced (entries 2 and 3). The use 
of lower equivalents of TIPSCl (1.5 equiv. and 1.1 equiv.) led to no disilylated products being 
produced. While we isolated the desired product 468 in these entries, the yields were still very 
low (13% and 11% respectively) because of the large production of compound 471.  
In order to suppress this side reaction, we replaced the imidazole base with potassium carbonate 
(entry 4). This is because potassium carbonate is a stronger base (will more likely neutralize any 
acid and reduce the risk of the exo-glycal being protonated), and also the carbonate or 
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bicarbonate ion is a poor nucleophile (to prevent any nucleophilic addition on the oxocarbenium 
ion if it forms). However, under these conditions, only a complex mixture was formed.  
The TIPS protection was then attempted in a pyridine solvent (entry 5). We anticipated that the 
large excess of pyridine would ‘mop-up’ any protons in solution decreasing the likelihood of the 
exo-glycal being protonated (entry 5). Unfortunately, since a complex mixture resulted, the 
desired product 468 was not isolated.  
Finally, a standard TIPS protection using the more electrophilic TIPSOTf and non-nucleophilic 
base 2,6-lutidine was attempted (entry 6). These conditions led to a complex mixture with the 
only product isolated being compound 472 in 3% yield. The production of a complex mixture in 
these conditions suggests that many undesired side-reactions occurred. We speculate that the 
formation of 472 was due to the exo-glycal being protonated under the TIPS protection 
conditions to form the oxocarbenium ion, which in turn during the work-up underwent 
nucleophilic attack by water. 
The assignment of the stereochemical configuration on the C-1 position in by-products 469, 470, 
471 and 472 was inferred from NOESY spectra analysis (see below).   
In compounds 469, 471 and 472, a nOe was observed between the methyl group of C-1 and H-C-2 
(Figure 17), which suggests a cis relationship between the methyl group and H-C-2. Furthermore, 
with respect to 469 and 471, a nOe was seen between protons of the imidazole moiety and H-C-5, 
which suggests that these also have a cis relationship. This was unlike compound 470, where the 
observed nOes (between H-C-2 and protons of the imidazole moiety as well as between the 
methyl group and H-C-5) suggested a trans relationship between the methyl group and H-C-2.  
 
Figure 17: NOESY spectra analysis to assign stereochemistry on the C-1 position in 469, 470, 
471 and 472. 
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The yield for 469 was higher than its epimer 470. Likewise, the epimers (defined in this context 
as opposite stereochemistry on the C-1 position) for 471 and 472 were not even isolated. These 
results imply that the nucleophile (e.g. imidazole or a water molecule) attacks the bottom face of 
the oxocarbenium ion more favourably than the top face.  
The stereoselectivity can be explained by considering the conformations of the oxocarbenium ion 
(Figure 18). The most stable conformations of the oxocarbenium ion would be the 3H4 and 
4H3 
half chairs (with the former being less stable due to the 1,3-pseudo axial – axial interactions 
between the OR and CH2OTIPS groups). The selectively is under kinetic control. There is less 
steric hindrance to the nucleophile when it attacks the bottom face of the more stable 4H3 
conformation (leading to a less sterically-congested chair-like transition state); hence bottom 
face attack is faster than top face attack. Under these conditions, bottom face attack on the 3H4 
conformation and top face attack on the 4H3 conformation contribute little to the product 
distribution. This is because these non-axial nucleophilic attacks lead to high energy unstable 
twist-boat like transition states.92   
 
Figure 18: Proposed rationale for the stereoselectivity of nucleophilic attack on the 
oxocarbenium ion formed in the TIPS protections.  
We pondered whether to try protecting groups other than TIPS (e.g. Trt, Bn, PMB etc.), but we 
anticipated the same problems regarding the basicity/reactivity of the exo-glycal in the protection 
conditions.  
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We concluded that due to the reactivity of the exo-glycal in these TIPS protection conditions, the 
exo-glycal 466 should be functionalized (i.e. epoxidation on the exo-glycal followed by ring 
opening the epoxide) prior to any of the protections; hence the route to compound 442 was 
modified (Scheme 187).  
 
Scheme 187: Proposed alternative synthetic route to compound 442.  
We subjected 466 to standard electrophilic epoxidation conditions using mCPBA in 
dichloromethane and aqueous sodium bicarbonate,103 which furnished epoxide α-473 in 98% 
yield (Scheme 188).  
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Scheme 188: Epoxidation of 466. 
The stereochemistry on the anomeric centre of epoxide α-473 was determined from the NOESY 
spectrum (Figure 19). The significant nOe between one of the methylene protons of the epoxide 
and H-C-2 indicated a cis relationship between these.  
 
Figure 19: NOESY spectrum analysis to assign stereochemistry on the anomeric centre of 
epoxide α-473. 
The epoxide ring-opening reaction with TMSCN was then attempted using the same conditions 
that Nishikawa et al. applied for their anomeric epoxy acetal 187 (Scheme 36).104 When 
subjecting α-473 to these conditions, however, only a complex mixture formed, with 479 being 
the only product isolated in 4% yield after purification (Scheme 189). 
 
Scheme 189: Attempted synthesis of 474.  
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Unfortunately, due to the stereochemistry at the C-1 position, we could not continue the route 
with 479. The stereochemistry on the C-1 position in 479 was deduced by analysis from its 
NOESY spectrum. The strong nOe observed between the methylene protons of the CH2OTMS 
moiety with H-C-3 and H-C-5 suggested that these have a cis relationship (Figure 20). 
 
Figure 20: NOESY spectrum analysis to assign stereochemistry on the C-1 position in 479. 
We then tried conventional epoxide ring-opening reactions of α-473 with TMSCN using a range 
of Lewis acids (Scheme 190 and Table 36).  
 
Scheme 190: Epoxide ring opening attempts of α-473.  
Entry Lewis Acid Result 
1105 SnCl4 Complex mixture 
2 AlCl3 Complex mixture 
3 ZnCl2 Complex mixture 
4 BF3.Et2O Complex mixture 
5 None SM 
 
Table 36: Conditions and results reported for the epoxide ring-opening attempts of α-473. 
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Regrettably, with each Lewis acid (entries 1 to 4), only complex mixtures were observed, which 
implied that many side-reactions occurred. In an attempt to reduce the number of side reactions, 
we performed the reaction without any Lewis acid (entry 5), though these conditions seemed too 
mild to trigger any reaction, since only starting material was recovered.  
The lack of success in the ring-opening epoxide reaction forced us to once again re-evaluate the 
methodology. A new synthetic strategy towards target 452 was postulated, which involved a 
hydroboration-oxidation reaction on exo-glycal 466 instead of an epoxidation (Scheme 191).  
 
Scheme 191: Retrosynthesis for target 452 from 466. 
The retrosynthesis for target 452 from 455 has already been analysed in a previous route 
(Scheme 178). Compound 455 could be made from 480 in three steps: selective TIPS protection; 
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perbenzylation; and detritylation. Deacetylation and tritylation of compound 481 could yield 
480. Finally, a hydroboration-oxidation reaction on 466 could afford 481.  
Thus, we attempted the hydroboration-oxidation reaction on 466 (Scheme 192 and Table 37).  
 
Scheme 192: Hydroboration-oxidation attempts of 466.  
Entry Hydroboration 
Reagent  
Oxidative Work-Up a Result 
1106 BH3.THF 30% H2O2 (aq)  Decomposition  
2 BH3.DMS 30% H2O2 (aq)  Decomposition 
3 9-BBN 30% H2O2 (aq)  Complex mixture 
4 BH3.THF 1:1 EtOH:THF, phosphate buffer 
(0.1 M, pH 7), 30% H2O2 (aq) 
Decomposition  
5 BH3.DMS 1:1 EtOH:THF, phosphate buffer 
(0.1 M, pH 7), 30% H2O2 (aq) 
Decomposition 
6 9-BBN 1:1 EtOH:THF, phosphate buffer 
(0.1 M, pH 7), 30% H2O2 (aq 
10% 481 b 
a Reaction time: 3 h; temperature: 0 oC to rt. b 481 was part of an inseparable mixture with 
an unknown compound (481:unknown compound, 7:1). Assuming the unknown 
compound is an isomer of 481, the number of moles of 481 in the inseparable mixture 
(used for the yield calculation) were calculated from molar ratios seen in the 1H NMR 
spectrum of the inseparable mixture. 
Table 37: Conditions and results reported for the hydroboration-oxidation attempts of 481. 
We firstly tried the hydroboration using BH3.THF (entry 1) according to a procedure from the 
literature.106  Once full consumption of the starting material was observed by TLC visualization 
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(hinting that the organoborane intermediate was synthesized), we then performed the oxidative 
work-up. Surprisingly, after work-up, a complex mixture was observed with a very low crude 
yield (7%). Replacing the hydroboration agent with BH3.DMS made no difference to the result 
(entry 2). We pondered whether acetate hydrolysis occurred during the oxidative work-up in both 
entries 1 and 2; this would lead to the hydrolysed product dissolving in the aqueous layer rather 
than the organic layer in the work-up, which would account for the very low crude yields. Hence, 
we evaporated the aqueous layer (after quenching any remaining H2O2 with sodium sulfite) 
under reduced pressure, but no acetyl-hydrolysed products were observed.   
9-BBN was then used as the hydroboration agent (entry 3). In this entry, while the crude yield 
increased dramatically (82%), there was no trace of the desired product 481 observed in the 
crude complex mixture. A possible reason for the apparent increase in crude yield could be due 
to the production of cis-1,5-cyclooctanediol (a by-product from 9-BBN hydrolysis).  
The absence of any hydrolysed products upon evaporation of the aqueous layer of the work-up 
under reduced pressure for entries 1 and 2, and the higher crude yield when using 9-BBN in 
entry 3, each suggest that acetate hydrolysis may not have occurred in the work-up. 
Nevertheless, we aimed to repeat all the hydroboration-oxidations using milder oxidative work-
up conditions involving a phosphate buffer according to the literature (entries 4 to 6),107 in order 
to see if that could make a positive difference to the result.  
The milder oxidative work-up for the hydroboration-oxidations using BH3.THF and BH3.DMS 
unfortunately made no difference (entries 4 and 5). For the 9-BBN hydroboration-oxidation, a 
complex mixture still resulted (entry 6), but the desired product was isolated after column 
chromatography in the form of an inseparable mixture with an unknown compound 
(481:unknown compound, 7:1), albeit in very low yields (10%). We speculate that the unknown 
compound is a stereoisomer of 481.   
NMR analysis was used to assign the stereochemistry at the C-1 position in 481. For example, the 
high 3J1,2 (10 Hz) suggested a diaxial and thus trans relationship between H-C-1 and H-C-2. 
Furthermore, the observed nOes between H-C-1 with H-C-3 and H-C-5 from the NOESY spectrum 
suggested that these protons are cis (Figure 21).  
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Figure 21: NOESY spectrum analysis to assign stereochemistry at the C-1 position in 481. 
Conclusion 
At the end of our studies towards the synthesis of tagetitoxin, numerous synthetic routes were 
investigated, leading to several interesting intermediates (Figure 22).   
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Figure 22: The key intermediates formed during the project.  
In the nitrile-Wittig route, we eventually formed alkene 329 from retro-Michael methodology 
after difficulties in directly synthesizing it from Wittig and HWE olefinations of DAM 234. 
Reactivity issues, though, arose with 329 and the protected derivatives 339 and 340 in 
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electrophilic epoxidations, halogenations and/or oxymercuration-demercuration reactions 
presumably due to the alkene being too electron-deficient. The lack of reactivity of these 
electron-deficient alkenes in the nucleophilic epoxidations, however, was surprising and not 
clearly understood.  
In the vinyl-transetherifcation route, the diacetyl 357 and dibenzoyl -359 were each obtained 
after four steps from DAM 234. Regrettably, the C-glycosylation reactions of these intermediates 
with TMSCN failed (with or without the use of Lewis acids), prompting us to reject this strategy.  
In the silyl enol ether route, we replicated Chai and co-workers’ three-step synthesis of glycal 
366 from DAM 234 (though with modification of the conditions in the HWE olefination and 
anomeric dehydration steps).46 Similarly to the nitrile-Wittig route, however, the failure in 
hydrating glycal 366 in an oxymercuration-demercuration reaction, led us to conclude that the 
alkene in glycal 366 was too unreactive with electrophilic mercuric reagents. This was surprising 
considering Yamaguchi and co-workers’ success in their oxymercuration-demercuration of 
glycals 374.49   
The dithiane-reduction route was the strategy that was closest in obtaining the synthetic targets 
379, 400 and 407. The lack of success in the thioacetate deprotections and concomitant 
cyclizations of the liberated thiol/thiolate onto a ketone or sulfonate ester in substrates 389 (and 
analogues) and 402 (and analogues) was a major setback. Changing the cyclization strategy to 
the nucleophilic displacement of two sulfonate esters in substrate 415 (and analogues) with a 
sulfide anion also failed. The failure of these three cyclization strategies was attributed to the 
presence of the isopropylidene groups hindering the cyclization by placing steric constraints on 
ring closure. We therefore aimed to deprotect the thioacetate functionality on a substrate without 
the isopropylidene groups. However, since efforts to hydrolyse both isopropylidene groups in 
ketone 394 were unsuccessful, we ceased work on this route and focused our efforts on a new 
strategy not involving isopropylidene groups.  
In the D-galactose route, the tribenzylated nitrile 437 was isolated after five synthetic steps from 
D-galactose 433. To our disappointment, we were unable to form the nitrile anion of 437 under a 
variety of conditions, which prevented any reaction with formaldehyde. These poor results, 
prompted us to synthesize the tribenzylated methyl ester 449, but after trying numerous 
conditions, benzylations of 449 failed because of either undesired side-reactions or no reactions 
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taking place at all. Endeavours to reductively hydrolyse the nitrile of 437 using a variety of metal 
hydride reagents did not afford the desired aldehyde, which forced us to abandon this route.  
Finally, in the exo-glycal route, compound 467 was successfully synthesized in five steps from 
D-galactose. Attempts to protect exo-glycal 467 proved difficult, however, due to the basic 
nature of the exo-glycal under these conditions leading to many undesired side-reactions. We 
therefore aimed to functionalize the exo-glycal prior to any protections. This allowed us to 
isolate epoxide -473, but we were unsuccessful in ring opening the epoxide with TMSCN and a 
Lewis acid. We thus performed a hydroboration on exo-glycal 466, which furnished 481, though 
in low yield and inseparable with an unknown compound.  
Future Work  
The main objective of this project was the synthesize targets 323a and 323b (Figure 10) which 
both contain the bicyclic core of the proposed structure of tagetitoxin. While we did not achieve 
this feat, the hydroboration-oxidation pathway in the exo-glycal route is promising for future 
research.  
Due to the poor yield (and purity) of 381 (10%), the initial goal in any future work should be the 
optimization of the hydroboration-oxidation of 466 using 9-BBN (Scheme 193). This might 
involve changing the equivalents of 9-BBN and/or temperature of the reaction.  
 
Scheme 193: Synthesis of 481 by the hydroboration-oxidation of 466 using 9-BBN.  
If this reaction can be optimized, the route to target 452 should be continued (Schemes 191 and 
194). If target 452 were to be synthesized, the route should be revised and altered to install 
carboxylic acid derivatives on the C-1 position and thiohemiacetal centre.  
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Scheme 194: Synthetic route to target 452 from 481.  
If, however, the hydroboration-oxidation reaction cannot be optimized, then an alternative route 
towards intermediate 455 should be investigated (Scheme 195).  
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Scheme 195: Alternative synthetic route towards intermediate 455. 
We have already made compound 64 from 433 in the D-galactose route. Furthermore, Dent et al. 
have previously synthesized the imidazolidine derivative 65 from 64 by a Raney-nickel and 
sodium hypophosphite-based reductive hydrolysis alongside N,N′-Diphenylethylenediamine 
(Scheme 9).108 A subsequent three-step sequence of deprotections and protections would lead to 
compound 489. Unmasking of the aldehyde in 489 could then be achieved by imidazolidine 
hydrolysis; typical conditions would involve using p-TsOH (2-3 equiv.) in DCM at 0 oC to rt. 
Finally, reduction of the aldehyde 490 to alcohol 455 could be achieved using a metal hydride 
reductant such as NaBH4. 
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1417–1421. 
60 D. Otzen, J. Voss and G. Adiwidjaja, Phosphorus. Sulfur. Silicon Relat. Elem., 2006, 181, 
1249–1270. 
61 K. Iwasaki, K. K. Wan, A. Oppedisano, S. W. M. Crossley and R. A. Shenvi, J. Am. 
Chem. Soc., 2014, 136, 1300–1303. 
62 O. B. Wallace and D. M. Springer, Tetrahedron Lett., 1998, 39, 2693–2694. 
63 J. R. H. Plet, Studies towards the synthesis of tagetitoxin. Ph.D. Thesis. University 
College London, U.K, 2008. 
64 S. Picard and D. Crich, Tetrahedron, 2013, 69, 5501–5510. 
204 
 
65 H. Hinou, X.-L. Sun and Y. Ito, J. Org. Chem., 2003, 68, 5602–5613. 
66 X. Wu, T. Lipinski, E. Paszkiewicz and D. R. Bundle, Chem. – Eur. J., 2008, 14, 6474–
6482. 
67 J. S. Yadav and A. Maiti, Tetrahedron, 2002, 58, 4955–4961. 
68 K. R. Prasad and A. Chandrakumar, J. Org. Chem., 2007, 72, 6312–6315. 
69 T. Yoshimitsu, T. Makino and H. Nagaoka, J. Org. Chem., 2004, 69, 1993–1998. 
70 T. Momose, Y. Kaiya, J. I. Hasegawa, T. Sato and N. Chida, Synthesis, 2009, 17, 2983–
2991. 
71 H. R. Hoveyda, E. Marsault, R. Gagnon, A. P. Mathieu, M. Vézina, A. Landry, Z. Wang, 
K. Benakli, S. Beaubien, C. Saint-Louis, M. Brassard, J.-F. Pinault, L. Ouellet, S. Bhat, 
M. Ramaseshan, X. Peng, L. Foucher, S. Beauchemin, P. Bhérer, D. F. Veber, M. L. 
Peterson and G. L. Fraser, J. Med. Chem., 2011, 54, 8305–8320. 
72 S. Peyrat, K. Cheng and J. Xie, Synthesis, 2013, 19, 2737–2744. 
73 H. P. Kokatla, R. Lahiri, P. K. Kancharla, V. R. Doddi and Y. D. Vankar, J. Org. Chem., 
2010, 75, 4608–4611. 
74 V. K. Aggarwal, R. Angelaud, D. Bihan, P. Blackburn, R. Fieldhouse, S. J. Fonquerna, G. 
D. Ford, G. Hynd, E. Jones, R. V. H. Jones, P. Jubault, M. J. Palmer, P. D. Ratcliffe and 
H. Adams, J. Chem. Soc. Perkin Trans. 1, 2001, 20, 2604–2622. 
75 P. Passacantilli, C. Centore, E. Ciliberti, F. Leonelli and G. Piancatelli, Eur. J. Org. 
Chem., 2006, 7, 3097–3104. 
76 J. I. Gosling, S. P. Baker, J. M. Haynes, M. Kassiou, C. W. Pouton, L. Warfe, P. J. White 
and P. J. Scammells, ChemMedChem, 2012, 7, 1191–1201. 
77 C. Storkey, M. J. Davies, J. M. White and C. H. Schiesser, Chem. Commun., 2011, 47, 
9693–9695. 
78 V. Ulgar, J. G. Fernández-Bolaños and M. Bols, J. Chem. Soc. Perkin Trans. 1, 2002, 0, 
1242–1246. 
205 
 
79 M. Periasamy, G. Ramani and G. P. Muthukumaragopal, Synthesis, 2009, 10, 1739–1743. 
80 P. A. Fowler, A. H. Haines, R. J. K. Taylor, E. J. T. Chrystal and M. B. Gravestock, J. 
Chem. Soc. Perkin Trans. 1, 1993, 0, 1003–1005. 
81 K. Komizo, H. Ikedo, S. Sato and S. Takenaka, Bioconjug. Chem., 2014, 25, 1547–1555. 
82 B. Watanabe, A. Ichiyanagi, K. Hirokawa, K. Gomi, T. Nakatsu, H. Kato and N. 
Kajiyama, Bioorg. Med. Chem. Lett., 2015, 25, 3910–3913. 
83 M. Guillemineau, S. Singh, M. Grossutti and F.-I. Auzanneau, Carbohydr. Res., 2010, 
345, 2723–2730. 
84 D. Melisi, A. Secondo, P. Montoro, S. Piacente, M. G. Rimoli, M. Minale, P. de Caprariis 
and L. Annunziato, J. Med. Chem., 2006, 49, 4826–4833. 
85 S. Kantevari and S. R. Putapatri, Synlett, 2010, 0, 2251–2256. 
86 J. Lee, S. Wang, G. W. A. Milne, R. Sharma, N. E. Lewin, P. M. Blumberg and V. E. 
Marquez, J. Med. Chem., 1996, 39, 29–35. 
87 Z.-Y. Zhu, D. Cui, H. Gao, F.-Y. Dong, X. Liu, F. Liu, L. Chen and Y. Zhang, Eur. J. 
Med. Chem., 2016, 114, 8–13. 
88 F. W. Lichtenthaler, J. Klotz and K. Nakamura, Tetrahedron: Asymmetry, 2003, 14, 3973–
3986. 
89 G. D. Kini, C. R. Petrie, W. J. Hennen, N. K. Dalley, B. E. Wilson and R. K. Robins, 
Carbohydr. Res., 1987, 159, 81–94. 
90 Z. Liu, H.-S. Byun and R. Bittman, Org. Lett., 2010, 12, 2974–2977. 
91 Y.-Y. Yang, S. Ficht, A. Brik and C.-H. Wong, J. Am. Chem. Soc., 2007, 129, 7690–7701. 
92 E. I. Balmond, D. Benito-Alifonso, D. M. Coe, R. W. Alder, E. M. McGarrigle and M. C. 
Galan, Angew. Chemie, 2014, 126, 8329–8333. 
93 J. C. Lee, S. Francis, D. Dutta, V. Gupta, Y. Yang, J.-Y. Zhu, J. S. Tash, E. Schönbrunn 
and G. I. Georg, J. Org. Chem., 2012, 77, 3082–3098. 
206 
 
94 M. H. Clausen, M. R. Jørgensen, J. Thorsen and R. Madsen, J. Chem. Soc. Perkin Trans. 
1, 2001, 0, 543–551. 
95 G. J. Boons and K. J. Hale, in Organic Synthesis with Carbohydrates, 2008. 
96 T. Mukhopadhyay and D. Seebach, Helv. Chim. Acta, 1982, 65, 385–391. 
97 Y. Suhara, M. Kurihara, A. Kittaka and Y. Ichikawa, Tetrahedron, 2006, 62, 8207–8217. 
98 S. Sipos and I. Jablonkai, Carbohydr. Res., 2011, 346, 1503–1510. 
99 N. Havare and D. A. Plattner, Org. Lett., 2012, 14, 5078–5081. 
100 E. P. Balskus and E. N. Jacobsen, J. Am. Chem. Soc., 2006, 128, 6810–6812. 
101 M. Tóth and L. Somsák, J. Chem. Soc. Perkin Trans. 1, 2001, 0, 942–943. 
102 M. Tóth, K. E. Kövér, A. Bényei and L. Somsák, Org. Biomol. Chem., 2003, 1, 4039–
4046. 
103 A. J. Steiner, A. E. Stütz, C. A. Tarling, S. G. Withers and T. M. Wrodnigg, Carbohydr. 
Res., 2007, 342, 1850–1858. 
104 H. Yamada, M. Adachi and T. Nishikawa, Chem. Commun., 2013, 49, 11221. 
105 M. J. Sofia and J. Du, PCT Int. Appl. WO2009067409 A1, May 28, 2009. 
106 T. V RajanBabu and G. S. Reddy, J. Org. Chem., 1986, 51, 5458–5461. 
107 D. L. Boger and T. Honda, J. Am. Chem. Soc., 1994, 116, 5647–5656. 
108 B. R. Dent, R. H. Furneaux, G. J. Gainsford and G. P. Lynch, Tetrahedron, 1999, 55, 
6977–6996. 
 
 
 
207 
 
Experimental 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
208 
 
General Experimental Details 
Reagents and Solvents 
All reagents obtained commercially were used without any further purification, unless otherwise 
stated. Triethylamine was stored over sodium hydroxide pellets.   
For reactions performed under anhydrous conditions, solvents were obtained commercially dry 
except for: dichloromethane which was distilled over calcium hydride, tetrahydrofuran which 
was distilled under an argon atmosphere from the sodium/benzophenone ketyl radical, toluene 
which was dried over sodium and then distilled, acetonitrile which was stored under an argon 
atmosphere over activated MS 3Å for 24 hours, methanol which was stored under an argon 
atmosphere over activated MS 3Å for 24 hours, and N,N-dimethylformamide which was dried 
over activated MS 4Å overnight, vacuum distilled and then stored over activated MS 4Å under 
an argon atmosphere. Petroleum ether 40/60 was distilled before use to remove higher boiling 
point impurities. Petroleum ether 40/60 has been denoted as petrol.  
Extractions were carried out using the reported organic solvent equivolumetric, unless stated 
otherwise.  
Apparatus 
For reactions requiring anhydrous conditions, glassware was flame-dried and allowed to cool to 
room temperature under a stream of argon or nitrogen. The reaction was then performed under an 
atmosphere of argon or nitrogen.  
All reactions were carried out at room temperature unless otherwise stated. 
Chromatography  
Flash column chromatography on silica gel was carried out using Material Harvest Silica Gel 60 
with 40-63 μm particle size. Individual solvent systems are reported in the experimental 
procedures. 
Thin layer chromatography (TLC) was carried out on Merck aluminium backed plates coated 
with Kieselgel 60 F254 silica gel. The plates were visualized by irradiation of UV light (254nm) 
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and/or staining by aqueous potassium permanganate solution, ethanolic solution of 
phosphomolybdic acid or ethanolic solution of vanillin.  
Compound Characterization Analysis 
Infrared spectra were obtained using a Perkin Elmer Spectrum 100 Fourier Transformation-
Infrared Spectrometer. Samples were dissolved in dichloromethane and applied onto sodium 
chloride plates as thin films.  
High resolution mass spectra were acquired from the EPSRC UK National Mass Spectrometry 
Facility at the University of Swansea.  
Melting points were carried out on a Büchi B-545 instrument. 
Optical rotation measurements were obtained with a Bellingham and Stanley ADP-440 
polarimeter operating at the sodium (D) line emission (=589 nm) at the reported temperature. 
The cell path length was 0.25 dm. The solutions for these measurements were prepared in 
volumetric flasks using solvents of spectrophotometric grade.  
Proton, carbon and fluorine NMR experiments were carried out at 500, 126 and 471 MHz 
respectively using a Bruker Advance III 500 MHz NMR spectrometer or at 400, 101 and 376 
MHz using a Bruker Ultrashield 400 MHz NMR spectrometer. Chemical shifts were reported in 
parts per million (ppm) relative to the residual solvent peak. Abbreviations for signals in proton 
NMR are as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and br (broad). 
Coupling constants (J values) are reported in Hertz (Hz).  
Numbering System 
The assignments of the NMR spectroscopy measurements for any compound with a pyranose or 
furanose core, follow the standard numbering system (Figure 23). 
 
Figure 23: Numbering system used in experimental detail. 
For all other compounds, the numbering system is designed by the author.   
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2,3;5,6-di-O-isopropylidene-α-D-mannofuranose  (234)1 
 
Concentrated sulfuric acid (14 ml) was added to a stirred suspension of D-mannose 235 (20 g, 
110 mmol) in anhydrous acetone (600 ml). After stirring the reaction mixture overnight, the red 
coloured solution was neutralized with anhydrous sodium carbonate and filtered. The filtrate was 
heated under reflux for 1 hour with activated charcoal and sodium carbonate (2-3 g). After 
filtration through a pad of celite, the filtrate was evaporated under reduced pressure to give a 
crude colourless solid. Recrystallization from diethyl ether and petrol furnished the title 
compound as a colourless solid (26.652 g, 92%); IR νmax (film)/cm-1: 3432, 2978, 2947, 2900, 
1458, 1438, 1373, 1227, 1203, 1070; 1H NMR (500 MHz, Chloroform-d) δ 1.32 (s, 3H, CH3 
Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.45 (s, 3H, CH3 Isopropylidene), 1.46 (s, 3H, CH3 
Isopropylidene), 3.04 – 3.13 (m, 1H, OH), 4.04 (dd, J = 8.7, 4.8 Hz, 1H, H’-C-6), 4.08 (dd, J = 8.7, 6.2 
Hz, 1H, H’-C-6), 4.18 (dd, J = 7.2, 3.6 Hz, 1H, H-C-4), 4.40 (ddd, J = 7.2, 6.2, 4.8 Hz, 1H, H-C-
5), 4.61 (d, J = 5.9 Hz, 1H, H-C-2), 4.80 (dd, J = 5.9, 3.6 Hz, 1H, H-C-3), 5.37 (d, J = 2.5 Hz, 1H, 
H-C-1); 
13C NMR (126 MHz, CDCl3) δ 24.6 (1C, CH3 Isopropylidene), 25.2 (1C, CH3 Isopropylidene), 
26.0 (1C, CH3 Isopropylidene), 27.0 (1C, CH3 Isopropylidene), 66.7 (1C, C-6), 73.4 (1C, C-5), 79.8 (1C, C-
4), 80.4 (1C, C-3), 85.6 (1C, C-2), 101.4 (1C, C-1), 109.2 (1C, Cq Isopropylidene), 112.8 (1C, Cq 
Isopropylidene). 
 
The data is in agreement with literature reference.1 
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(Cyanomethyl)triphenylphosphonium Chloride (331)2  
 
Chloroacetonitrile (2.4 ml, 38.2 mmol, 1 equiv.) was added dropwise to a stirred mixture of 
triphenylphosphine 330 (10 g, 38.2 mmol) in EtOAc (30 ml) at rt. The reaction mixture was then 
heated under reflux for 3 hours. After cooling to rt, the mixture was filtered and the precipitate 
was washed with Et2O to afford a pure colourless solid (11.73 g, 91%); mp 260 – 264 oC 
decomposition [lit. 268 – 270 oC],2 [lit. 263 oC decomposition]3; IR νmax (film)/cm-1: 3056, 3010, 
2972, 2715, 2251, 1586, 1439, 1113, 723; 1H NMR (500 MHz, DMSO) δ 6.07 (d, J = 15.9 Hz, 
2H, CH2), 7.81 – 7.93 (m, 12H, 12 X H-CAR), 7.96 – 8.02 (m, 3H, 3 X H-CAR). 13C NMR (126 
MHz, DMSO) δ 14.3 (d, J = 55.1 Hz, 1C, CH2), 112.9 (d, J = 9.2 Hz, 1C, Cq Nitrile), 116.3 (d, J = 
88.7 Hz, 3C, 3 X CAR), 130.6 (d, J = 13.2 Hz, 6C, 6 X CAR), 133.8 (d, J = 10.9 Hz, 6C, 6 X CAR), 
136.0 (d, J = 3.0 Hz, 3C, 3 X CAR).   
The data is in agreement with literature reference.2 
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2-(Triphenylphosphoranylidene)acetonitrile (332)2  
 
Et3N (12.3 ml, 87.9 mmol, 2.53 equiv.) was added to a stirred suspension of 331 (11.73 g, 34.8 
mmol) in dry DCM (160 ml). After stirring the suspension for 30 minutes, water (20 ml) was 
then added. The layers were then separated. and the organic phase was washed with water (2 x 
20 ml). The organic phase was dried over anhydrous Na2SO4, filtered and the solvents were 
removed under reduced pressure. Recrystallization from toluene gave the title compound as a 
colourless solid (8.70 g, 74%); mp 188 – 190 oC [lit. 195 – 197 oC],2 [190 – 192 oC]4; IR νmax 
(film)/cm-1: 3052, 2138, 2972, 1435, 1105, 714; 1H NMR (500 MHz, Chloroform-d) δ 1.58 (s, 
1H), 7.44 – 7.71 (m, 15H);; 13C NMR (126 MHz, Chloroform-d) δ -2.0 (d, J = 136.2 Hz, 1C, 
CH), 127.5 (d, J = 91.8 Hz, 3C, 3 X CAR), 129.2 (d, J = 12.3 Hz, 6C, 6 X CAR), 132.7 (3C, 3 X 
CAR), 132.9 (d, J = 10.1 Hz, 6C, 6 X CAR).  
 
The data is in agreement with the literature reference.2  
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2-((3aR,6R,6aS)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,4-
d][1,3]dioxol-4-yl)acetonitrile (333) 
 
t-BuOK (3.88 g, 34.6 mmol, 1.5 equiv.) was added to a stirred solution of diethyl 
cyanomethylphosphonate (5.6 ml, 34.6 mmol, 1.5 equiv.) in dry THF (115 ml) at 0  oC. The 
mixture was stirred for 30 minutes at 0 oC. To this solution was added a solution of 234 (6.0 g, 
23.1 mmol) in dry THF (156 ml) slowly. The reaction mixture was then warmed to rt and stirred 
overnight. The mixture was then treated with water (ca. 120ml) and DCM (ca. 120ml). The 
layers were separated and the aqueous layer was extracted with DCM twice. The combined 
organic extracts were washed with water, brine, and dried over anhydrous MgSO4. Filtration and 
removal of the solvent under reduced pressure furnished a crude colourless solid. Purification by 
flash column chromatography on silica gel (petrol:EtOAc, 3:1) afforded an inseparable mixture 
(α:β, 1:3) of diastereomers 333  (6.429 g, 98%); IR νmax (film)/cm-1: 2987, 2938, 2878, 2253, 
1373, 1068; 1H NMR (400 MHz, Chloroform-d) δ 1.33 (s, 3H, CH3 Isopropylidene, β isomer), 1.35 (s, 
3H, CH3 Isopropylidene, α isomer), 1.37 (s, 6H, CH3 Isopropylidene, both isomers ), 1.44 (s, 6H, CH3 Isopropylidene, 
both isomers), 1.48 (s, 3H, CH3 Isopropylidene, β isomer), 1.50 (s, 3H,CH3 Isopropylidene, α isomer), 2.54 (d, J = 6.4 
Hz, 2H, CH2, α isomer), 2.72 (d, J = 6.7 Hz, 2H, CH2, β isomer), 3.58 (dd, J = 7.4, 3.6 Hz, 1H, H-C-4, β 
isomer), 3.83 (td, J = 6.7, 3.7 Hz, 1H, H-C-1, β isomer), 3.98 (dd, J = 7.4, 3.7 Hz, 1H, H-C-4, α isomer), 
4.01 – 4.11 (m, 4H, H-C-6, H’-C-6, both isomers), 4.34 (td, J = 6.4, 1.3 Hz, H-C-1  α isomer), 4.36 - 4.41 
(m, 2H, H-C-5 both isomers), 4.66 – 4.72 (m, 2H, H-C-2, both isomers), 4.80 (dd, J = 6.0, 3.6 Hz, 1H, H-
C-3, β isomer), 4.87 (dd, J = 6.0, 3.7 Hz, 1H, H-C-3, α isomer). 
13C NMR (101 MHz, CDCl3) δ 17.7 
(1C, CH2, α isomer), 20.8 (1C, CH2, β isomer), 24.6 (1C, CH3 Isopropylidene, β isomer), 24.8 (1C, CH3 
Isopropylidene, α isomer), 25.2 (1C, CH3 Isopropylidene, α isomer), 25.3 (1C, CH3 Isopropylidene, β isomer), 25.7 (1C, 
CH3 Isopropylidene, β isomer), 26.9 (1C, CH3 Isopropylidene, α isomer), 27.0 (1C, CH3 Isopropylidene, both isomers), 
66.8 (1C, C-6, β isomer), 66.9 (1C, C-6, α isomer), 73.0 (1C, C-5, β isomer), 73.3 (1C, C-5, α isomer), 76.9 
(1C, C-1, β isomer), 80.3 (1C, C-1, α isomer), 80.6 (1C, C-2, β isomer), 80.8 (1C, C-3, β isomer), 80.9 (1C, C-3, 
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α isomer), 81.6 (1C, C-4, α isomer), 82.2 (1C, C-4, β isomer), 84.6 (1C, C-2, α isomer), 109.3 (1C, Cq 
Isopropylidene, β isomer), 109.5 (1C, Cq Isopropylidene, α isomer), 113.4 (1C, Cq Isopropylidene, β isomer), 113.7 (1C, 
Cq Isopropylidene, α isomer), 116.9 (1C, Cq Nitrile, α isomer), 117.2(1C, Cq Nitrile, β isomer); HRMS (NSI-FTMS) 
m/z found for [M+NH4]
+: 301.1757; [C14H21NO5+NH4]
+ requires 301.1758. 
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(E)-3-((4R,5S)-5-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)acrylonitrile (E-329) 
 
n-Butyl lithium (4.3 ml, 2.5 M in hexanes, 10.6 mmol, 3 equiv.) was added dropwise to a stirred 
solution of diisopropylamine (1.9 ml, 10.6 mmol, 3 equiv.) in dry THF (64 ml) at -78 oC.  The 
solution was stirred for 1 hour at this temperature. A solution of 333 (1.008 g, 3.56 mmol) in dry 
THF (108 ml) at -78 oC was cannulated into the LDA solution. The dark orange solution was 
then stirred at -78 oC until TLC showed complete consumption of the starting material (~ 45 
minutes).  Glacial acetic acid (0.8 ml) and ethyl acetate (240 ml) were then added. The mixture 
was then warmed to rt slowly and then concentrated in vacuo. Purification by flash column 
chromatography on silica gel (petrol:EtOAc, 5:1) afforded the title compound as a colourless oil 
(0.564 g, 56%); [α]D 25 = + 31.1 (c 1.31 in CHCl3); IR νmax (film)/cm-1: 3486, 2988, 2937, 2265, 
1638, 1376, 1215, 1070; 1H NMR (400 MHz, Chloroform-d) δ 1.35 (s, 3H, CH3 Isopropylidene), 1.41 
(s, 6H, 2 X CH3 Isopropylidene), 1.53 (s, 3H, CH3 Isopropylidene), 2.15 (d, J = 8.3 Hz, 1H, OH), 3.40 (td, 
J = 8.3, 2.3 Hz, 1H, H-C-5), 3.92 – 4.01 (m, 2H, H-C-7, H-C-6), 4.06 – 4.16 (m, 1H, H’-C-7), 4.47 
(dd, J = 7.4, 2.4 Hz, 1H, H-C-4), 4.76 (ddd, J = 7.4, 5.4, 1.7 Hz, 1H, H-C-3), 5.66 (dd, J = 16.2, 
1.7 Hz, 1H, H-C-1), 6.88 (dd, J = 16.2, 5.4 Hz, 1H, H-C-2); 
13C NMR (101 MHz, CDCl3) δ 24.9 
(1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 26.9 (1C, CH3 Isopropylidene), 27.0 (1C, CH3 
Isopropylidene), 67.5 (1C, C-7), 70.5 (1C, C-5), 76.2 (1C, C-6), 76.6 (1C, C-3), 77.5 (1C, C-4), 101.7 
(1C, C-1), 109.8 (1C, Cq Isopropylidene), 109.8 (1C, Cq Isopropylidene), 116.9 (1C, Cq Nitrile), 150.8 (1C, C-
2); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 301.1758; [C14H21NO5+NH4]
+ requires 
301.1758. 
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(E)-3-((4R,5R)-5-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-
yl)((isopropyldimethylsilyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)acrylonitrile (339) 
 
IPDMSCl (0.67 ml, 3.97 mmol, 2.0 equiv.) was added dropwise to a mixture of alkene E-329 
(0.562 g, 1.99 mmol) and imidazole (0.270 g, 3.97 mmol, 2.0 equiv.) in dry DCM at 0 oC. The 
reaction mixture was stirred for 24 hours at rt. The reaction mixture was quenched with saturated 
aqueous NH4Cl and extracted with DCM three times. The combined organic extracts were 
washed with water, brine, and dried over anhydrous MgSO4. After filtration, the solvent was 
evaporated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 6:1) to furnish 339 as a pure colourless oil (0.622 g, 
82%);[α]D 25 = + 64.2 (c 0.9 in CHCl3); IR νmax (film)/cm-1: 2988, 2940, 2866, 2226, 1635, 1372, 
1079; 1H NMR (500 MHz, Chloroform-d) δ 0.06 (s, 3H, CH3 IPDMS), 0.07 (s, 3H, CH3 IPDMS), 
0.75 – 0.84 (m, 1H, H-CMe2 IPDMS), 0.95 – 0.90 (m, 6H, 2 X CH3 ipr(IPDMS)), 1.33 (s, 3H, CH3 
Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.42 (s, 3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 
Isopropylidene), 3.63 (dd, J = 8.9, 7.9 Hz, 1H, H-C-5), 3.77 (dd, J = 8.3, 7.4 Hz, 1H, H-C-7), 3.92 – 
3.99 (m, 1H, H-C-6), 4.10 – 4.18 (m, 2H, H’-C-7, H-C-4), 4.69 (ddd, J = 6.2, 4.4, 1.9 Hz, 1H, H-C-
3), 5.67 (dd, J = 16.3, 1.9 Hz, 1H, H-C-1), 6.95 (dd, J = 16.3, 4.4 Hz, 1H, H-C-2); 
13C NMR (126 
MHz, CDCl3) δ -3.6 (1C, CH3 Me (IPDMS)), -3.0 (1C, CH3 Me (IPDMS)), 15.4 (1C, CHMe2 ipr (IPDMS)), 
17.0 (1C, CH3 ipr (IPDMS)), 17.1 (1C, CH3 ipr (IPDMS)), 25.3 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 
Isopropylidene), 26.4 (1C, CH3 Isopropylidene), 27.8 (1C, CH3 Isopropylidene), 68.6 (1C, C-7), 72.9 (1C, C-5), 
76.5 (1C, C-3), 77.4 (1C, C-6), 81.4 (1C, C-4), 101.5 (1C, C-1), 109.0 (1C, Cq Isopropylidene), 110.2 
(1C, Cq Isopropylidene), 117.4 (1C, Cq Nitrile), 152.6 (1C, C-2); HRMS (NSI-FTMS) m/z found for 
[M+H]+: 384.2203; [C19H33NO5Si+H]
+ requires 384.2201. 
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(R)-((4R,5R)-5-((E)-2-cyanovinyl)-2,2-dimethyl-1,3-dioxolan-4-yl)((R)-2,2-dimethyl-1,3-
dioxolan-4-yl)methyl benzoate (340) 
 
DMAP (0.039 g, 0.32 mmol, 0.2 equiv.) was added to a stirred solution of Et3N (0.99 ml, 7.07 
mmol, 4.42 equiv.) in dry DCM (12 ml) at 0 oC. Benzoyl chloride (0.62 ml, 5.30 mmol, 3.31 
equiv.) was then added dropwise. To this solution at 0 oC, was then added a solution of E-329 
(0.454 g, 1.60 mmol) in dry DCM (4 ml) dropwise. The reaction mixture was stirred at rt 
overnight. The reaction mixture was quenched with saturated aqueous NaHCO3 and extracted 
with DCM three times. The combined organic extracts were washed with water, then brine, and 
dried over anhydrous Na2SO4. Filtration and removal of the solvent under reduced pressure 
afforded a crude residue. The crude residue was purified by flash column chromatography on 
silica gel (petrol:EtOAc, 3:1)  to furnish the title compound as a pure yellow oil (0.620 g, 
quant.); [α]D25 = - 29.7 (c 0.9 in CHCl3); IR νmax (film)/cm-1: 3072, 2988, 2229, 1724, 1372, 
1268; 1H NMR (500 MHz, Chloroform-d) δ 1.36 (s, 6H, 2 X CH3 Isopropylidene), 1.42  (s, 3H, CH3 
Isopropylidene), 1.61 (s, 3H, CH3 Isopropylidene), 3.98 (dd, J = 8.8, 6.2 Hz, 1H, H-C-7), 4.03 (dd, J = 8.8, 
6.2 Hz, 1H, H’-C-7), 4.34 (dt, J = 7.2, 6.2 Hz, 1H, H-C-6), 4.67 (dd, J = 7.6, 2.3 Hz, 1H, H-C-4), 
4.85 (ddd, J = 7.6, 4.1, 2.1 Hz, 1H, H-C-3), 5.27 (dd, J = 7.2, 2.3 Hz, 1H, H-C-5), 5.47 (dd, J = 
16.1, 2.1 Hz, 1H, H-C-1), 6.64 (dd, J = 16.1, 4.1 Hz, 1H, H-C-2), 7.43 – 7.50 (m, 2H, 2 X H-CAR), 
7.56 – 7.64 (m, 1H, H-CAR), 8.01 – 8.06 (m, 2H, 2 X H-CAR).;13C NMR (126 MHz, CDCl3) δ 
25.0 (1C, CH3 Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 26.6 (1C, CH3 Isopropylidene), 26.9 (1C, CH3 
Isopropylidene), 66.5 (1C, C-7), 71.0 (1C, C-5), 75.2 (1C, C-6), 75.6 (1C, C-3), 76.8 (1C, C-4), 101.0 
(1C, C-1), 109.7 (1C, Cq Isopropylidene), 109.8 (1C, Cq Isopropylidene), 116.2 (1C, Cq Nitrile), 128.6 (2 X 
CAR), 129.5 (1C, CAR), 129.9 (2C, 2 X CAR), 133.6 (1C, Cq AR), 148.2 (1C, C-2), 165.7 (1C, Cq 
Benzoate); HRMS (NSI-FTMS) m/z found for [M+H]
+: 388.1756; [C21H25NO6+H]
+ requires 
388.1755. 
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(R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)((4S,5R)-5-(2-methoxyvinyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)methanol (354)  
 
n-Butyl lithium (36.0 ml, 1.6M in hexanes, 57.6 mmol, 3 equiv.) was added dropwise to a stirred 
solution of diisopropylamine (8.1 ml, 57.6 mmol, 3 equiv.) in dry THF (140 ml) at -78 oC. After 
stirring for 1 hour at this temperature methoxymethyltriphenylphosphonium chloride (19.76 g, 
57.6 mmol, 3 equiv.) was then added cautiously portion wise. The red-coloured solution was 
then stirred for 1 hour at -78 oC. A solution of 234 (5.0 g, 19.2 mmol) in dry THF (40 ml) at -78 
oC was added to the ylide-solution slowly via a cannula transfer.  The resultant mixture was then 
warmed to rt gradually before being refluxed overnight. The reaction mixture was then cooled to 
rt and quenched with brine (ca. 60 ml), and the layers were then separated. The aqueous layer 
was extracted with Et2O three times. The combined organic extracts were dried over anhydrous 
MgSO4. Filtration and removal of the solvent in vacuo furnished a crude dark brown oil. The 
crude product was purified by flash column chromatography on silica gel (petrol:EtOAc, 6:1) 
furnishing an inseparable mixture (E:Z, 5:1) of geometric isomers of vinyl ether 354 as a yellow 
oil (3.125 g, 57%); IR νmax (film)/cm-1: 3530, 2987, 2937, 1655, 1372, 1212, 1070; 1H NMR (500 
MHz, Chloroform-d) δ1.35 (s, 6H, CH3 Isopropylidene, Both Isomers,), 1.38 – 1.41 (m, 12H, 2 X CH3 
Isopropylidene, Both Isomers), 1.50 (s, 3H, CH3 Isopropylidene, Z Isomer), 1.51 (s, 3H, CH3, Isopropylidene, Z Isomer), 
2.17 (d, J = 8.1 Hz, 1H, OH, Z Isomer), 2.20 (d, J = 8.7 Hz, 1H, OH, E Isomer), 3.45 – 3.51 (m, 2H, 
H-C-6, Both Isomers), 3.61 (s, 3H, CH3 Methoxy, E Isomer), 3.63 (s, 3H, CH3 Methoxy, Z Isomer), 3.98 – 4.13 (m, 
6H, H-C-7, H’-C-7, H-C-5, Both Isomers), 4.30 (dd, J = 7.4, 1.1 Hz, 1H, H-C-4, E Isomer), 4.34 (dd, J = 
7.4, 1.4 Hz, 1H, H-C-4, Z Isomer), 4.66 (dd, J = 9.6, 7.4 Hz, 1H, H-C-3, E Isomer), 4.74 (dd, J = 8.7, 
6.3 Hz, 1H, H-C-2, Z Isomer), 5.05 (dd, J = 12.7, 9.6 Hz, 1H, H-C-2, E Isomer), 5.27 (ddd, J = 8.7, 7.4, 
1.2 Hz, 1H, H-C-3, Z Isomer), 6.13 (dd, J = 6.3, 1.2 Hz, 1H, H-C-1, Z Isomer), 6.64 (d, J = 12.7 Hz, 1H, 
H-C-1, E Isomer); 
13C NMR (126 MHz, CDCl3) δ 24.4 (1C, CH3 Isopropylidene, E isomer), 24.5 (1C, CH3 
Isopropylidene, Z isomer), 25.4 (1C, CH3 Isopropylidene, E isomer), 25.5 (1C, CH3 Isopropylidene, Z isomer), 26.8 (2C, 
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CH3 Isopropylidene, Both isomers), 26.9 (1C, CH3 Isopropylidene, Z isomer), 27.0 (1C, CH3 Isopropylidene, E isomer), 
56.3 (1C, CH3, Methoxy, E Isomer), 60.2 (1C, CH3, Methoxy, Z Isomer), 67.0 (1C, C-7, Z Isomer), 67.2 (1C, C-7, 
E Isomer), 70.9 (1C, C-6, Z isomer), 71.0 (1C, C-6, E Isomer), 71.4 (1C, C-3, Z Isomer), 76.1 (1C, C-4, Z Isomer), 
76.3 (1C, C-5, Z Isomer), 76.3 (1C, C-5 or C-4, E Isomer), 76.4 (1C, C-5 or C-4, E Isomer), 76.9 (1C, C-3, E 
Isomer), 98.1 (1C, C-2, E Isomer), 102.1 (1C, C-2, Z Isomer), 107.9 (1C, Cq Isopropylidene, E Isomer), 108.0 (1C, 
Cq Isopropylidene, Z Isomer), 109.3 (1C, Cq Isopropylidene, Z Isomer), 109.4 (1C, Cq Isopropylidene, E Isomer), 150.3 
(1C, C-1, Z Isomer), 153.2 (1C, C-1, E Isomer); HRMS (ESI-TOF) m/z found for [M+Na]
+: 311.1465; 
[C14H24O6Na]
+ requires 311.1465. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
220 
 
(2R,3R,4R,5R)-3-Hydroxy-1,2;4,5-di-O-isopropylidene-6-decene (355)5 
 
n-Butyl lithium (2.08 ml, 2.5M in hexanes, 5.21 mmol, 3 equiv.) was added dropwise to a stirred 
mixture of methoxymethyltriphenylphosphonium chloride (1. 786 g, 5.21 mmol, 3 equiv.) in dry 
THF (15.6 ml) at -78 oC. The red-coloured solution was then stirred for 1 hour at -78 oC. A 
solution of 234 (0.5 g, 1.96 mmol) in dry THF (3.1 ml) at -78 oC was added to the ylide-solution 
slowly via a cannula transfer.  The resultant mixture was then warmed to rt gradually and left to 
stir overnight. The reaction mixture was then cooled to rt and quenched with brine, and the layers 
were then separated. The aqueous layer was extracted with Et2O three times. The combined 
organic extracts were dried over anhydrous MgSO4. Filtration and removal of the solvent in 
vacuo furnished a crude dark brown oil. The crude mixture was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 8:1) furnishing compound 355 as a colourless oil 
(0.099 g, 17%);1H NMR (500 MHz, Chloroform-d) δ 0.91 (t, J = 7.4 Hz, 3H, CH3 Propyl), 1.35 (s, 
3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.41 – 1.46 (m, 
2H, CH2 Propyl), 1.52 (s, 3H, CH3 Isopropylidene), 2.12 – 2.13 (m, 2H, CH2 Propyl), 3.43 – 3.49 (m, 1H, 
H-C-5), 3.97 – 4.05 (m, 2H, H-C-6, H-C-7), 4.06 – 4.12 (m, 1H, H’-C-7), 4.33 (dd, J = 7.4, 1.3 Hz, 
1H, H-C-4), 4.69 (t, J = 7.8 Hz, 1H, H-C-3), 5.73 (ddt, J = 15.4, 8.4, 1.3 Hz, 1H, H-C-2), 5.84 (dt, 
J = 15.5, 6.7 Hz, 1H, H-C-1); 
13C NMR (126 MHz, CDCl3) δ 13.7 (1C, CH3 Propyl), 22.2 (1C, CH2 
Propyl), 24.5 (1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 26.8 (1C, 
CH3 Isopropylidene), 34.4 (1C, CH2 Propyl), 67.0 (1C, C-7), 70.7 (1C, C-5), 76.1 (1C, C-6), 76.6 (1C, C-
4), 79.1 (1C, C-3), 108.3 (1C, Cq Isopropylidene), 109.3 (1C, Cq Isopropylidene), 125.5 (1C, C-2), 137.8 
(1C, C-1).  
The data is in agreement with the literature reference.5  
Further elution (petrol:EtOAc, 5:1) gave vinyl ether 354 as an inseparable mixture of geometric 
isomers (E:Z, 7:3) as a yellow oil (0.2 g, 36%).  
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(3aR,4R,7aR)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-4,7a-dihydro-3aH-
[1,3]dioxolo[4,5-c]pyran (353) 
 
Mercuric acetate (0.135 g, 0.42 mmol, 0.2 equiv.) was added to a solution of 354 (0.610 g, 2.12 
mmol) in a minimal volume of dry DCM in a Kugelrohr flask. The solution was evaporated to 
give a crude viscous oil (in a Buchi Kugelrohr apparatus) when heated at 110 oC and 20 mm Hg 
for 2 hours. The crude product was purified by flash column chromatography (petrol:EtOAc, 
2:1) to yield the title compound as a pure colourless solid (0.312 g, 57%); mp 38 – 39 oC; [α]D 21 
= -6.8 (c 1.18 in CHCl3); IR νmax (film)/cm-1: 2986, 2935, 1648, 1371, 1084; 1H NMR (400 MHz, 
Chloroform-d) δ1.38 (s, 6H, CH3 Isopropylidene), 1.43 (s, 3H, CH3 Isopropylidene), 1.45 (s, 3H, CH3 
Isopropylidene), 3.77 (dd, J = 8.0, 1.2 Hz, 1H, H-C-5), 4.03 – 4.15 (m, 2H, H-C-7, H’-C-7), 4.37 (ddd, 
J = 8.0, 6.1, 5.0 Hz, 1H, H-C-6), 4.41 – 4.45 (dt, J = 6.2, 1.2 Hz, 1H, H-C-4), 4.66 (dd, J = 6.2, 2.8 
Hz, 1H, H-C-3), 4.76 – 4.82 (ddd, J = 6.3, 2.8, 1.2 Hz, 1H, H-C-2), 6.35 (d, J = 6.3 Hz, 1H, H-C-
1); 
13C NMR (101 MHz, CDCl3) δ 25.4 (1C, CH3 Isopropylidene), 27.0 (1C, CH3 Isopropylidene), 27.2 
(1C, CH3 Isopropylidene), 28.3 (1C, CH3 Isopropylidene), 66.8 (1C, C-7), 68.6 (1C, C-3), 72.2 (1C, C-4), 
74.3 (1C, C-6), 75.2 (1C, C-5), 103.2 (1C, C-2), 109.6 (1C, Cq Isopropylidene), 110.7 (1C, Cq 
Isopropylidene), 144.6 (1C, C-1); HRMS (ESI-TOF) m/z found for [M+Na]
+: 279.1203; 
[C13H20O5+Na]
+ requires 279.1203. 
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(3aS,4R,6S,7R,7aR)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6,7-diol (352) 
 
OsCl3 (0.012 g, 0.04 mmol, 0.0167 equiv.) and NMO (0.832 g, 7.10 mmol, 2.9 equiv.) were 
added to a stirred solution of glycal 353 (0.628 g, 2.45 mmol) in 1:1 THF:H2O (32.6 ml). The 
mixture was stirred overnight. Excess anhydrous Na2SO3 was then added to the mixture. After 1 
hour, water and CHCl3 were added to the mixture. The layers were separated and the aqueous 
layer was extracted with CHCl3 twice. The combined organic extracts were washed with 
saturated aqueous Na2SO3, water, brine, and dried over anhydrous MgSO4. Filtration and 
evaporation of the solvent under reduced pressure gave a crude residue. Purification by flash 
column chromatography on silica gel (petrol:EtOAc, 1:2) furnished an inseparable anomeric 
mixture 352 (:, 14:1) as a colourless solid (0.453 g, 64%); mp 133 - 135 oC; [α]D21 = + 65.1 (c 
0.99 in MeOH); IR νmax (film)/cm-1: 3363, 2988, 1378, 1220, 1065; 1H NMR (500 MHz, DMSO-
d6) δ 1.26 (s, 3H, CH3 Isopropylidene -352), 1.27 (s, 6H, CH3 Isopropylidene -352, CH3 Isopropylidene -352), 1.32 
(s, 3H, CH3 Isopropylidene -352), 1.34 (s, 3H, CH3 Isopropylidene -352), 1.38 (s, 3H, CH3 Isopropylidene -352), 
1.39 (s, 6H, 2 X CH3 Isopropylidene -352), 3.15 (td, J = 7.9, 4.8 Hz, 1H, H-C-2 -352), 3.44 (td, J = 6.4, 
3.4 Hz, 1H, H-C-2 -352), 3.65 (dd, J = 7.7, 2.1 Hz, 1H, H-C-5 -352), 3.82 (dd, J = 8.4, 5.2 Hz, 1H, 
H-C-7 -352), 3.86 (dd, J = 8.4, 5.3 Hz, 1H, H-C-7 -352), 3.90 – 3.93 (m, 1H, H-C-3 -352),  3.94 – 
4.01 (m, 3H, H-C-5 -352, H’-C-7 -352, H’-C-7 -352), 4.06 – 4.12 (m, 2H, H-C-3 -352, H-C-4  -352), 
4.12 – 4.16 (m, 2H, H-C-6 -352, H-C-6 -352), 4.17 (dd, J = 6.0, 2.2 Hz, 1H H-C-4 -352), 4.29 (dd, J 
= 7.9, 6.8 Hz, 1H, H-C-1 -352),  4.88 (dd, J = 5.5, 3.4 Hz, 1H, H-C-1 -352), 4.97 (d, J = 6.4 Hz, 1H, 
C-2-OH -352), 5.10 (d, J = 4.8 Hz, 1H, C-2-OH -352), 6.39 (d, J = 5.5 Hz, 1H, C-1-OH -352), 6.70 
(d, J = 6.8 Hz, 1H, C-1-OH -352); 
13C NMR (126 MHz, DMSO) δ 25.2 (1C, CH3 Isopropylidene -352), 
26.1 (1C, CH3 Isopropylidene -352),  26.6 (2C, 2 X CH3 Isopropylidene -352), 26.7 (1C, CH3 Isopropylidene -
352), 27.8 (1C, CH3 Isopropylidene -352), 28.1 (1C, CH3 Isopropylidene -352), 28.5 (1C, CH3 Isopropylidene -
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352), 66.3 (1C, C-7 -352) 66.4 (1C, C-7 -352), 67.9 (1C, C-5 -352), 69.2 (1C, C-2 -352), 72.4 (1C, C-4 
-352), 72.4 (1C, C-5 -352), 73.1 (1C, C-4 -352), 73.7 (1C, C-2 -352) 73.8 (2C, C-6 -352, C-6 -352), 75.7 
(1C, C-3 -352), 79.3 (1C, C-3 -352) 91.6 (1C, C-1 -352), 96.7 (1C, C-1 -352) 107.8 (1C, Cq Isopropylidene 
-352), 108.3 (1C, Cq Isopropylidene -352), 108.5 (1C, Cq Isopropylidene -352), 108.5 (1C, Cq Isopropylidene -
352); HRMS (NSI-FTMS) m/z found for [M+Na]
+: 313.1257; [C13H27O7+Na]
+ requires 313.1258.     
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(3aS,4R,6R,7R,7aS)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6,7-diyl diacetate (357)  
 
Ac2O (0.49 ml, 5.17 mmol, 7.5 equiv.) was added dropwise to a stirred solution of 352 (0.200 g, 
0.69 mmol) in pyridine (2.5 ml) at 0 oC. The reaction mixture was stirred at rt overnight. The 
mixture was then concentrated in vacuo. The residue was dissolved in DCM and treated with 
water. The layers were separated and the aqueous layer was extracted with DCM twice. The 
combined organic layers were washed with saturated aqueous copper (II) sulfate, saturated 
aqueous NH4Cl, saturated aqueous NaHCO3, water, brine, and dried over anhydrous MgSO4. 
Filtration and removal of the solvent under reduced pressure gave a crude colourless oil. 
Purification by flash column chromatography on silica gel (petrol:EtOAc, 9:2), furnished 357 
(α:β, 14:1) as a colourless oil (0.176 g, 68%); [α]D21 = + 72.4 (c 1.15 in CHCl3); IR νmax 
(film)/cm-1: 2988, 2937, 1758, 1216, 1150, 1069; 1H NMR (500 MHz, Chloroform-d) δ 1.37 (s, 
3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.43 (s, 3H, CH3 Isopropylidene), 1.52 (s, 3H, CH3 
Isopropylidene), 2.08 (s, 3H, CH3 Acetate), 2.10 (s, 3H, CH3 Acetate), 3.92 – 4.00 (m, 2H, H-C-5, H-C-7), 
4.07 (dd, J = 8.9, 6.2 Hz, 1H, H’-C-7), 4.29 – 4.41 (m, 3H, H-C-3, H-C-4, H-C-6), 5.13 (dd, J = 
6.7, 3.8 Hz, 1H, H-C-2), 6.20 (d, J = 3.8 Hz, 1H, H-C-1); 
13C NMR (126 MHz, CDCl3) δ 20.9 
(1C, CH3 Acetate), 21.0 (1C, CH3 Acetate), 25.3 (1C, CH3 Isopropylidene), 26.6 (1C, CH3 Isopropylidene), 27.1 
(1C, CH3 Isopropylidene), 27.6 (1C, CH3 Isopropylidene), 66.9 (1C, C-7), 69.3 (1C, C-2), 70.8 (1C, C-5), 
72.7 (1C, C-3 or C-4 or C-6), 72.8 (1C, C-3 or C-4 or C-6), 74.0 (1C, C-3 or C-4 or C-6), 89.4 (1C, C-
1), 109.6 (1C, Cq Isopropylidene), 110.4 (1C, Cq Isopropylidene), 169.1 (1C, Cq Acetate), 170.1 (1C, Cq 
Acetate); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 392.1915; [C17H26O9+NH4]
+ requires 
392.1915. 
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(3aS,4R,6R,7R,7aS)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6,7-diyl dibenzoate (359)  
 
BzCl (0.24 ml, 2.087 mmol, 3 equiv.) was added dropwise to a stirred solution of 352 (0.201 g, 
0.69 mmol) in pyridine (1 ml) at 0 oC. After 24 hours stirring at rt, the reaction mixture was 
diluted with DCM and quenched with water. The layers were separated and the aqueous layer 
was extracted with DCM twice. The combined organic extracts were washed with saturated 
aqueous copper (II) sulfate, saturated aqueous NH4Cl, saturated aqueous NaHCO3, water, brine, 
and dried over anhydrous MgSO4. Filtration and removal of the solvent under reduced pressure 
gave a crude residue. The crude residue was purified by flash column chromatography on silica 
gel (petrol:EtOAc, 8:1), yielding 359 as a pure colourless solid (0.223 g, 65%); mp 114 – 116 oC; 
[α]D21 = + 104.3 (c 0.97 in CHCl3); IR νmax (film)/cm-1: 3063, 2988, 2937, 1732, 1602, 1452, 
1248, 1068; H NMR (500 MHz Chloroform-d) δ 1.37 (s, 3H, CH3 Isopropylidene), 1.43 (s, 6H, 2 X 
CH3 Isopropylidene), 1.61 (s, 3H, CH3 Isopropylidene), 4.00 (dd, J = 9.0, 4.4 Hz, 1H, H-C-7), 4.06 – 4.16 
(m, 2H, H’-C-7, H-C-5), 4.41 (ddd, J = 7.9, 6.2, 4.4 Hz, 1H, H-C-6), 4.54 (dd, J = 6.3, 2.3 Hz, 1H, 
H-C-4), 4.67 (t, J = 6.3 Hz, 1H, H-C-3), 5.57 (dd, J = 6.3, 3.8 Hz, 1H, H-C-2), 6.56 (d, J = 3.8 Hz, 
1H, H-C-1), 7.38 – 7.43 (m, 4H, 4 X H-CAR), 7.53 – 7.60 (m, 2H, 2 X H-CAR), 7.93 – 8.00 (m, 
4H, 4 X H-CAR); 
13C NMR (126 MHz, CDCl3) δ 25.4 (1C, CH3 Isopropylidene), 26.1 (1C, CH3 
Isopropylidene), 27.1 (1C, CH3 Isopropylidene), 27.5 (1C, CH3 Isopropylidene), 67.1 (1C, C-7), 69.5 (1C, C-2), 
71.5 (1C, C-5), 72.8 (1C, C-4), 73.1 (1C, C-3), 74.0 (1C, C-6), 90.2 (1C, C-1), 109.6 (1C, Cq 
Isopropylidene), 110.7 (1C, Cq Isopropylidene), 128.6 (2C, 2 X CAR), 128.7 (2C 2 X CAR), 129.4 (1C, 
CAR), 129. 4 (1C, CAR), 130.0 (2C, 2 X CAR), 130.0 (2C, 2 X CAR), 133.6 (1C, Cq AR), 133.7 (1C, 
Cq AR), 164.6 (1C, Cq Benzoyl), 165.6 (1C, Cq Benzoyl); HRMS (ASAP-TOF) m/z found for 
[M+NH4]
+: 516.2231; [C27H30O69+NH4]
+ requires 516.2233. 
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Ethyl 2-(dimethoxyphosphoryl)-2-hydroxyacetate (371) 
 
Sodium periodate (10.37 g, 48.5 mmol, 2 equiv.) and water (10 ml) were added to a stirred 
solution of diethyl-L-tartrate (4.15 ml, 24.3 mmol) in DCM (50 ml). The biphasic mixture was 
then heated under reflux for 3 hours. The solution was then cooled to 0 oC before anhydrous 
MgSO4 was added portion wise. Filtration and removal of the solvent under reduced pressure 
afforded ethyl glyoxylate in an unpurified state (4.433 g) and was used directly in the next step 
without any purification. 
Et3N (15.9 ml, 114.1 mmol, 3.09 equiv.) was added dropwise to a solution of dimethyl phosphite 
(3.99 ml, 43.6 mmol, 1.18 equiv.) in dry toluene (40 ml) at 0 oC. After leaving the solution to stir 
for 15 minutes at 0 oC, a solution of crude ethyl glyoxylate (4.433 g) in dry toluene (20 ml) was 
added. The reaction mixture was then warmed to rt and stirred overnight. The mixture was 
concentrated in vacuo forming a pale-yellow crude residue. Purification by flash column 
chromatography on silica gel (petrol:EtOAc, 1:3) afforded phosphonate 370 as a colourless solid 
(4.262 g, 41% over two steps); IR νmax (film)/cm-1: 3269, 2963, 2858, 1745, 1250, 1103, 1035; 
1H NMR (500 MHz, CDCl3) δ 1.32 (t, J = 7.1 Hz, 3H, CH3 Ester), 3.83 (d, J = 6.7 Hz, 3H, OCH3), 
3.86 (d, J = 6.6 Hz, 3H, OCH3), 4.29 – 4.37 (m, 2H, CH2 Ester), 4.57 (d, J = 16.1 Hz, 1H, H-
COH). 13C NMR (126 MHz, CDCl3) δ 14.1 (1C, CH3 Ester), 54.0 (d, J = 6.9 Hz, 1C, OCH3), 54.4 
(d, J = 6.8 Hz, 1C, OCH3), 63.1 (1C, CH2 Ester), 68.6 (d, J = 156.1 Hz, 1C, CHOH), 169.3 (d, J = 
1.2 Hz, 1C, Cq Ester); HRMS (ASAP-TOF) m/z found for [M+H]
+: 213.0527; [C6H13O6P+H]
+ 
requires 213.0528. 
Organophosphate 371 was also isolated as a pure colourless oil (3.233g, 31% over two steps); 1H 
NMR (500 MHz, Chloroform-d) δ 1.27 (t, J = 7.1 Hz, 3H, CH3 Ester), 3.80 (d, J = 11.3 Hz, 6H, 2 
X OCH3), 4.23 (q, J = 7.1 Hz, 1H, CH2 Ester), 4.55 (d, J = 11.4 Hz, 2H, CH2); 
13C NMR (126 
MHz, CDCl3) δ 14.2 (1C, CH3 Ester), 54.8 (d, J = 6.1 Hz, 2C, 2 X OCH3), 61.7 (1C, CH2 Ester), 
63.6 (d, J = 5.0 Hz, 1C, OCH2), 167.9 (d, J = 5.6 Hz, 1C, Cq Ester); HRMS (CI) m/z found for 
[M+H]+: 213.0525; [C6H13O6P+H]
+ requires 213.0528. 
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Ethyl 2-((tert-butyldimethylsilyl)oxy)-2-(dimethoxyphosphoryl)acetate (367)6 
 
Imidazole (0.949 g, 13.9 mmol, 1.6 equiv.) and then TBSCl (1.580 g, 10.46 mmol, 1.2 equiv.) 
were added to a stirred solution of 370 (1.848 g, 8.71 mmol) in dry DCM (15.8 ml) at 0 oC. The 
resultant heterogenous mixture was stirred overnight at rt. The reaction mixture was then 
quenched with saturated aqueous NH4Cl and extracted with DCM three times. The combined 
organic extracts were washed with water, brine, and dried over anhydrous MgSO4. Filtration and 
removal of the solvent under reduced pressure gave a crude yellow oil. The crude oil was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 3:2) to furnish the title 
compound as a pure colourless oil (2.60 g, 91%); IR νmax (film)/cm-1: 2958, 2931, 2897, 2858, 
1754, 1262, 1139, 1035; 1H NMR (500 MHz, CDCl3) δ 0.11 (s, 3H, CH3 Me (TBS)), 0.12 (s, 3H, 
CH3 Me (TBS)), 0.92 (s, 9H, 3 X CH3 tBu (TBS)), 1.30 (t, J = 7.1 Hz, 3H, CH3 Ester), 3.83 (d, J = 8.5 
Hz, 3H, OCH3), 3.85 (d, J = 8.5 Hz, 3H, OCH3), 4.21 – 4.33 (m, 2H, CH2 Ester), 4.61 (d, J = 18.1 
Hz, 1H, H-COTBDMS). 13C NMR (126 MHz, CDCl3) δ -5.2 (1C, CH3 Me (TBS)), -5.4 (1C, CH3 Me 
(TBS)), 14.2 (1C, CH3 Ester), 18.5 (1C, Cq tBu (TBS)), 25.7 (3C, 3 X CH3 tBu (TBS)), 54.2 (d, J = 6.9 Hz, 
1C, OCH3), 54.3 (d, J = 6.7 Hz, 1C, OCH3), 62.0 (1C, CH2 Ester), 70.8 (d, J = 162.1 Hz, 1C, 
CHOTBS), 168.6 (d, J = 2.8 Hz, Cq Ester).  
The data is in agreement with the literature reference.6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
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(Z)- and (E)-ethyl 2-((tert-butyldimethylsilyl)oxy)-3-((4R,5S)-5-((R)-((R)-2,2-dimethyl-1,3-
dioxolan-4-yl)(hydroxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)acrylate (E-364) and (Z-
364) 
 
A solution of phosphonate 367 (1.158 g, 7.78 mmol, 1.5 equiv.) in dry THF (12.5 ml) was added 
dropwise to a stirred suspension of NaH (0.187 g, 7.78 mmol, 1.5 equiv.) in dry THF (12.5 ml) at 
0 oC. The mixture was stirred at 0 oC for 1 hour. A solution of 234 (1.35 g, 5.19 mmol) in dry 
THF (12.5 ml) was then added dropwise to the suspension. The mixture was then warmed to rt 
and heated at 50 oC for 24 hours. The reaction was then cooled to rt and quenched with saturated 
aqueous NH4Cl. Most of the THF was removed under reduced pressure. The aqueous layer was 
extracted with EtOAc three times. The combined organic extracts were dried over anhydrous 
MgSO4. Filtration and removal of the solvent in vacuo gave the crude product. The crude 
product was purified by flash column chromatography on silica gel (petrol:EtOAc, 15:2) to give 
an inseparable mixture (0.878 g, E-364:372, 50:1) of E-364 (0.864 g, 36%) and by-product 372 
(0.014 g, 1%) as a colourless oil.**   
Characterization data for E silyl enol ether E-364; IR νmax (film)/cm-1: 3510, 2986, 2934, 2887, 
2860, 1714, 1639, 1473, 1212, 1179, 1033; 1H NMR (500 MHz, Chloroform-d) δ 0.17 (s, 6H, 2 
X CH3 Me (TBS)), 0.95 (s, 9H, 3 X CH3 tBu (TBS)), 1.34 (s, 3H, CH3 Isopropylidene), 1.37 (s, 3H, CH3 
Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.52 (s, 3H, CH3 Isopropylidene), 3.35 (t, J = 7.5 Hz, 1H, H-
C-7), 3.96 – 4.01 (m, 2H, H-C-5, H’-C-7), 4.03 – 4.08 (m, 1H, H-C-6), 4.16 – 4.24 (m, 2H, CH2 
Ester), 4.64 (dd, J = 7.4, 1.1 Hz, 1H, H-C-4), 5.48 (t, J = 7.4 Hz, 1H, H-C-3), 5.73 (d, J = 7.4 Hz, 
1H, H-C-2); 
13C NMR (126 MHz, CDCl3) δ -4.8 (1C, CH3 Me (TBS)), -4.7 (1C, CH3 Me (TBS)), 14.3 
(1C, CH3 Ester), 18.3 (1C, Cq tBu (TBS)), 24.2 (1C, CH3 Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 25.7 
(3C, 3 X CH3 tBu (TBS)), 26.8 (1C, CH3 Isopropylidene), 27.0 (1C, CH3 Isopropylidene), 61.3 (1C, CH2 Ester), 
67.1 (1C, C-7), 70.3 (1C, C-5), 74.3 (1C, C-3), 76.4 (1C, C-6), 77.2 (1C, C-4), 108.4 (1C, Cq 
Isopropylidene), 109.4(1 C, Cq Isopropylidene), 122.9 (1C, C-2), 141.8 (1C, C-1), 164.4 (1C, Cq Ester).  
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Characterization data for by-product 372; [α]D 22 = -13.8 (c 1.45 in CHCl3); IR νmax (film)/cm-1: 
2985, 2931, 2858, 1372, 1252, 1212, 1048; 1H NMR (400 MHz, Chloroform-d) δ 0.13 (s, 6H, 2 
X CH3 Me (TBS)), 0.92 (s, 9H, 3 X CH3 tBu (TBS)), 1.36 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 
Isopropylidene), 1.44 (s, 3H, CH3 Isopropylidene), 1.51 (s, 3H, CH3 Isopropylidene), 3.55 (dd, J = 7.7, 3.8 Hz, 
1H, H-C-4), 4.03 – 4.11 (m, 2H, H-C6, H’-C-6), 4.44 (ddd, J = 7.7, 5.9, 4.9 Hz, 1H, H-C-5), 4.49 
(dd, J = 6.1, 3.6 Hz, 1H, H-C-2), 4.69 (dd, J = 6.1, 3.8 Hz, 1H, H-C-3), 5.01 (d, J = 3.6 Hz, 1H, H-
C-1). 
13C NMR (126 MHz, CDCl3) δ -4.5 (1C, CH3 Me (TBS)), -4.3 (1C, CH3 Me (TBS)), 18.4 (1C, Cq 
tBu (TBS)), 25.5 (1C, CH3 Isopropylidene), 25.7 (1C, CH3 Isopropylidene), 25.9 (3C, 3 X CH3 tBu (TBS)), 26.0 
(1C, CH3 Isopropylidene), 27.2 (1C, CH3 Isopropylidene), 67.1 (1C, C-6), 73.5 (1C, C-5), 76.9 (1C, C-4), 
79.6 (1C, C-3), 80.7 (1C, C-2), 98.1 (1C, C-1), 109.3 (1C, Cq Isopropylidene), 113.7 (1C, Cq Isopropylidene); 
HRMS (ASAP-TOF) m/z found for [M-H]-: 373.2047; [C18H34O6Si-H]
- requires 373.2040. 
Further elution (petrol:EtOAc, 5:1) gave the Z silyl enol ether Z-364 as a pure colourless oil 
(0.440 g, 18%); [α]D 22 = +40.8 (c 0.93 in CHCl3); IR νmax (film)/cm-1: 3513, 2995, 2933, 2859, 
1726, 1650, 1251, 1130, 1071; 1H NMR (500 MHz, Chloroform-d) δ 0.19 (s, 3H, CH3 Me (TBS)), 
0.21 (s, 3H, CH3 Me (TBS)), 0.95 (s, 9H, 3 X CH3 tBu (TBS)), 1.31 (t, J = 7.1 Hz, 3H, CH3 Ester), 1.34 
(s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.53 (s, 3H, 
CH3 Isopropylidene), 2.10 (d, J = 8.4 Hz, 1H, OH), 3.37 – 3.42 (m, 1H, H-C-5), 3.97 – 4.03 (m, 2H, 
H-C-7, H’-C-7), 4.08 (td, J = 8.0, 2.6 Hz, 1H, H-C-6), 4.18 (dq, J = 10.8, 7.1 Hz, 1H, 1H of CH2 
Ester), 4.27 (dq, J = 10.8, 7.1 Hz, 1H, 1H of CH2 Ester), 4.45 (dd, J = 7.5, 1.3 Hz, 1H, H-C-4), 5.30 
(dd, J = 8.6, 7.5 Hz, 1H, H-C-3), 6.21 (d, J = 8.6 Hz, 1H, H-C-2). 
13C NMR (126 MHz, CDCl3) δ -
4.2 (1C, CH3 Me (TBS)), -4.0 (1C, CH3 Me (TBS)), 14.3 (1C, CH3 Ester), 18.7 (1C, Cq tBu (TBS)), 24.4 
(1C, CH3 Isopropylidene), 25.4 (1C, CH3 Isopropylidene), 26.0 (3C, 3 X CH3 tBu (TBS)), 26.7 (1C, CH3 
Isopropylidene), 26.9 (1C, CH3 Isopropylidene), 61.6 (1C, CH2 Ester), 67.0 (1C, C-7), 70.9 (1C, C-5), 72.3 
(1C, C-3), 76.2 (1C, C-6), 76.6 (1C, C-4), 108.8 (1C, Cq Isopropylidene), 109.4 (1C, Cq Isopropylidene), 
116.3 (1C, C-2), 143.7 (1C, C-1), 164.1 (1C, Cq Ester); HRMS (ESI-TOF) m/z found for [M+Na]
+: 
483.2377; [C22H40O8Si+Na]
+ requires 483.2390. 
*In the subsequent silyl enol ether deprotection step using TBAF, the by-product 372 was 
isolated and therefore fully characterized. The 1H and 13C NMR spectral interpretations of E-364 
were determined by comparison between the NMR spectra of the inseparable mixture of E silyl 
E-364 and 372 with the NMR spectra for pure 372. 
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* The number of moles of E-364 and 372 in the inseparable mixture were calculated from molar 
ratios observed in the 1H NMR spectrum. Since the yield of the E-364 is based on the number of 
moles of E-364 in the inseparable mixture, the yield of E-364 derives from the aforementioned 
molar ratios seen in the 1H NMR spectrum (same applies to 372); b Reaction time: 72 h; c 1.5 
equiv. of base and 367 were added. 
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(3aR,4R,7aR)-ethyl 4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-6-hydroxy-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-carboxylate (365)6 
 
Compound Z-364 (0.339 g, 0.76 mmol) and an inseparable mixture (0.601 g, E-364:372, 50:1) of 
E-364 (0.591 g, 1.28 mmol) and 372 (0.01 g, 0.026 mmol) were dissolved in THF (2.1 ml). After 
cooling the stirred solution to 0 oC, 20% acetic acid (2.7 ml, 9.38 mmol, 4.6 equiv.) was added, 
followed by the dropwise addition of TBAF (2.04 ml, 1M in THF, 2.04 mmol, 1 equiv.). The 
reaction mixture was stirred at rt until the starting material was fully consumed (monitored by 
TLC). The reaction mixture was then neutralized with NaHCO3, filtered and concentrated in 
vacuo. The residue was then treated with saturated aqueous NaHCO3 and EtOAc. After 
separating the layers, the aqueous layer was extracted with EtOAc twice. The combined organic 
extracts were dried over anhydrous MgSO4. Filtration and removal of the solvent under reduced 
pressure gave a crude residue. Purification by flash column chromatography on silica gel 
(petrol:EtOAc, 3:1) furnished an inseparable mixture (α:β, 5:1) of anomers 365 as a colourless 
oil (0.558 g, 79%)*; IR νmax (film)/cm-1: 3401, 2986, 2937, 1745, 1457, 1371, 1218, 1070; 1H 
NMR (500 MHz, Chloroform-d) δ 1.30 (t, J = 7.1 Hz, 3H, CH3 Ester, α anomer), 1.33 (t, J = 7.2 Hz, 
3H, CH3 Ester, β anomer), 1.35 (s, 3H, CH3 Isopropylidene, both anomers), 1.36 (s, 3H, CH3 Isopropylidene, α anomer), 
1.38 (s, 3H, CH3 Isopropylidene, β anomer), 1.41 (s, 3H, CH3 Isopropylidene, β anomer), 1.42 (s, 3H, CH3 
Isopropylidene, α anomer), 1.46 (s, 3H, CH3 Isopropylidene, α anomer), 1.56 (s, 3H, CH3 Isopropylidene, β anomer), 1.88 
(dd, J = 14.4, 4.9 Hz, 1H, H-C-2, α anomer), 2.33 (d, J = 2.9 Hz, 2H,  H-C-2, H’C-2, β anomer), 2.49 (dd, 
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J = 14.4, 6.7 Hz, 1H, H’-C-2, α anomer), 3.44 (dd, J = 8.7, 1.8 Hz, 1H, H-C-5, β anomer), 3.61 (br, 1H, 
OH, α anomer), 3.90 (dd, J = 8.0, 2.2 Hz, 1H, H-C-5, α anomer), 3.97 –  4.02 (m, 1H, H-C-7, both anomers), 
4.05 – 4.11 (m, 1H, H’-C-7, both anomers), 4.21 – 4.31 (m, 3H, CH2 Ester, H-C-4, both anomers), 4.32 – 
4.37 (m, 1H, H-C-6, α anomer), 4.43 (dd, J = 8.0, 1.8 Hz, 1H, H-C-6, β anomer), 4.48 – 4.53 (m, 1H, H-
C-3, α anomer), 4.72 – 4.75 (m, 2H, H-C-3, OH, β anomer). 13C NMR (126 MHz, CDCl3) δ 14.2 (1C, 
CH3 ester, α anomer), 14.3 (1C, CH3 ester, β anomer), 24.4 (1C, CH3 Isopropylidene, β anomer), 25.2 (1C, CH3 
Isopropylidene, β anomer), 25.5 (1C, CH3 Isopropylidene, α anomer), 25.9 (1C, CH3 Isopropylidene, α anomer), 26.2 (1C, 
CH3 Isopropylidene, β anomer), 27.1 (1C, CH3 Isopropylidene, α anomer), 27.2 (1C, CH3 Isopropylidene, β anomer), 27.3 
(1C, CH3 Isopropylidene, α anomer), 31.1 (1C, C-2, β anomer), 32.4 (1C, C-2, α anomer), 62.1 (1C, CH2 Ester, β 
anomer), 62.5 (1C, CH2 Ester, α anomer), 67.0 (1C, C-7, α anomer), 67.3 (1C, C-7, β anomer), 70.0 (1C, C-3, α 
anomer), 70.8 (1C, C-5, α anomer), 70.8 (1C, C-3, β anomer), 71.4 (1C, C-4, α anomer), 72.5 (1C, C-6, β anomer), 
73.5 (1C, C-4, β anomer), 74.0 (1C, C-5, β anomer), 74.1 (1C, C-6, α anomer), 94.5 (1C, C-1, α anomer), 95.7 
(1C, C-1, β anomer), 109.3 (1C, Cq Isopropylidene, α anomer), 109.5 (1C, Cq Isopropylidene, α anomer), 109.7 (1C, 
Cq Isopropylidene, β anomer), 109.7 (1C, Cq Isopropylidene, β anomer), 169.0 (1C, Cq Ester, β anomer), 169.75 (1C, Cq 
Ester, α anomer).  
*The number of moles of E-364 and 372 in the starting material inseparable mixture were 
calculated from molar ratios seen in the 1H NMR spectrum. Yield of 365 is based on the total 
number of moles of  E-364 in the inseparable mixture and  Z-364. 
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(3aR,4R,7aR)-ethyl 4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-6-hydroxy-2,2-
dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-carboxylate (365) 
 
An inseparable mixture (0.4964 g, E-364:372, 4:1) of E-364 (0.390 g, 0.85 mmol) and 372 
(0.106 g, 0.21 mmol) were dissolved in THF (1.1 ml). After cooling the stirred solution to 0 oC, 
20% acetic acid (1.12 ml, 3.90 mmol, 4.6 equiv.) was added, followed by the dropwise addition 
of TBAF (0.85 ml, 1M in THF,  0.85 mmol, 1 equiv.). The reaction mixture was stirred at rt until 
E-364 was fully consumed (monitored by TLC with UV visualization). The reaction mixture was 
then neutralized with NaHCO3, filtered and concentrated in vacuo. The residue was then treated 
with saturated aqueous NaHCO3 and EtOAc. After separating the layers, the aqueous layer was 
extracted with EtOAc twice. The combined organic extracts were dried over anhydrous MgSO4. 
Filtration and removal of the solvent under reduced pressure gave a crude residue. Purification 
by flash column chromatography on silica gel (petrol:EtOAc, 7:2) furnished the unreacted 372 
(0.054 g), 234 (0.017 g, 31%) and an inseparable mixture (α:β, 4:1) of anomers 365 as a 
colourless oil (0.166 g, 57%). * 
*The number of moles of E-364 and 372 in the starting material inseparable mixture were 
calculated from molar ratios seen in the 1H NMR spectrum. Yield of 365 is based on the total 
number of moles of  E-364 in the inseparable mixture. Yield of DAM 234 is based on the moles 
of 372 in inseparable mixture.  
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 (3aR,4R,7aR)-ethyl 4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-4,7a-dihydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6-carboxylate (366)6 
 
MsCl (0.12 ml, 1.55 mmol, 3 equiv.) was added dropwise over 5 minutes to a stirred solution of 
365 (0.179 g, 0.52 mmol) and Et3N (0.24 ml, 1.76 mmol, 3.4 equiv.) in dry DCM (5 ml) at 0
 oC. 
After 3 hours stirring at rt (i.e. monitored by TLC until full consumption of starting material was 
observed), DBU (0.23 ml, 1.55 mmol, 3 equiv.) was added dropwise and the mixture was stirred 
at rt overnight. The mixture was then concentrated in vacuo furnishing a crude residue. 
Purification by flash column chromatography on silica gel (petrol:EtOAc, 4:1) gave glycal 366 
as a colourless solid (0.120 g, 71%); mp 68-70 oC [lit. 69-71 oC]2; [α]D 22 = +38.4 (c 1.24 in 
CHCl3) [lit. [α]D 20 = +40.4 (c 0.47 in CHCl3)]2; IR νmax (film)/cm-1: 2986, 2918, 2854, 1733, 
1652, 1221, 846; 1H NMR (500 MHz, CDCl3) δ 1.30 (t, J = 7.2 Hz, 3H, CH3 Ester), 1.39 (s, 9H, 3 
X CH3 Isopropylidene), 1.45 (s, 3H, CH3 Isopropylidene), 3.83 (dd, J = 8.1, 1.0 Hz, 1H, H-C-5), 4.14 – 4.27 
(m, 4H, CH2 Ester, H-C-7, H’-C-7), 4.42 – 4.47 (m, 2H, H-C-4, H-C-6), 4.78 (dd, J = 6.1, 3.3 Hz, 1H, 
H-C-3), 5.97 – 6.01 (m, 1H, H-C-2). 13C NMR (126 MHz, CDCl3) δ 14.2 (1C, CH3 Ester), 25.5 (1C, 
CH3 Isopropylidene), 26.8 (1C, CH3 Isopropylidene), 27.1 (1C, CH3 Isopropylidene), 28.2 (1C, CH3 Isopropylidene), 
61.6 (1C, CH2 Ester), 66.8 (1C, C-7), 68.9 (1C, C-3), 71.4 (1C, C-6), 74.1 (1C, C4), 76.5 (1C, C-5), 
109.8 (1C, Cq Isopropylidene), 110.2 (1C, C-2), 111.2 (1C, Cq Isopropylidene), 144.3 (1C, C-1), 162.2 (1C, 
Cq Ester). 
The data is in agreement with the literature reference.6 
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Ethyl 2-((R)-((4R,5S)-5-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-
2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-1,3-dithiane-2-carboxylate (252)1,7  
 
n-Butyl lithium (50.7 ml, 2.5M in hexanes, 126.8 mmol, 3.3 equiv.) was added dropwise to a 
stirred solution of diisopropylamine (17.8 ml, 126.8 mmol, 3.3 equiv.) in dry THF (200 ml) at -
20 oC. After 30 minutes, ethyl 1,3-dithiane-2-carboxylate (18.2 ml, 115.3 mmol, 3.0 equiv.), was  
added dropwise to the solution at - 20 oC. The solution was stirred for 2 hours at -20 oC. This 
dark-red solution was then cannulated slowly into a suspension of MgBr2 in dry THF (250 ml) at 
-20 oC, prepared from magnesium (4.2 g, 173.0 mmol, 4.5 equiv.) and 1,2-dibromoethane (13.3 
ml, 153.7 mmol, 4.0 equiv.). Compound 234 (10 g, 38.4 mmol) was then added to the solution in 
one portion. The stirred reaction mixture was warmed to rt gradually overnight and then heated 
for 5 hours at 50 oC. After cooling to rt, the reaction mixture was poured into ice-cold saturated 
aqueous NH4Cl (450 ml). After adding EtOAc (300 ml), the layers were then separated. The 
aqueous layer was then extracted with EtOAc (2 x 300 ml).  The combined organic extracts were 
washed with water and dried over anhydrous MgSO4. Filtration and removal of the solvent in 
vacuo gave a crude yellow oil. The crude product was purified by flash column chromatography 
on silica gel (toluene:EtOAc, 3:1) to yield the title compound as a pure yellow oil (16.932 g, 
97%); [α]D 25 = -1.4 (c 1.12 in CHCl3) [lit. [α]D  = -1.8 (c 1.0 in CHCl3)]7; IR νmax (film)/cm-1: 
3454, 3054, 29885, 2935, 1728, 1424, 1381, 1215, 1064; 1H NMR (500 MHz, Chloroform-d) δ 
1.33 (t, J = 7.1 Hz, 3H, CH3 Ester), 1.35 (s, 3H, CH3 Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.41 
(s, 3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 Isopropylidene), 1.84 – 1.94 (m, 1H of CH2 Dithiane), 2.05 – 
2.14 (m, 1H, 1H of CH2 Dithiane), 2.72 – 2.81 (m, 2H, CH2 Dithiane), 3.02 (ddd, J = 14.4, 11.5, 2.8 
Hz, 1H of CH2 Dithiane), 3.22 (ddd, J = 14.4, 11.3, 3.0 Hz, 1H, 1H of CH2 Dithiane), 3.64 (ddd, J = 
8.1, 3.1, 1.1 Hz, 1H, H-C-6), 4.01 – 4.07 (m, 1H, H-C-7), 4.09 – 4.15 (m, 2H, H’-C-7, H-C-5), 4.23 
– 4.33 (m, 3H, CH2 Ester, H-C-4), 4.43 (dd, J = 7.5, 1.1 Hz, 1H, H-C-3), 4.58 (d, J = 7.5 Hz, 1H, H-
C-2); 
13C NMR (126 MHz, CDCl3) δ 14.2 (1C, CH3 Ester), 24.3 (1C, CH2 Dithiane), 25.2 (1C, CH3 
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Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 26.2 (1C, CH3 Isopropylidene), 27.0 (1C, CH3 Isopropylidene), 27.4 
(1C, CH2 Dithiane), 27.7 (1C, CH2 Dithiane), 58.8 (1C, C-1), 62.8 (1C, CH2 Ester), 67.7 (1C, C-7), 70.7 
(1C, C-6), 72.6 (1C, C-4), 77.1 (1C, C-2), 74.3 (1C, C-5), 75.8 (1C, C-3), 109.3 (1C, Cq Isopropylidene), 
109.4 (1C, Cq Isopropylidene), 170.0 (1C, Cq Ester).  
The data is in agreement with the literature references.1,7  
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(R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)((4S,5R)-5-((R)-hydroxy(2-(hydroxymethyl)-1,3-
dithian-2-yl)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol (264)1 
 
LiAlH4 (1.104g, 29.10 mmol, 2 equiv.) was added cautiously portion wise to a solution of 252 
(6.584 g, 14.55 mmol) in dry THF (100 ml) at 0 °C. The grey suspension was stirred at rt 
overnight. Then the excess LiAlH4 was carefully quenched by the addition of anhydrous Na2SO4 
(ca. 2 g), followed carefully by the dropwise addition of water until no effervescence was 
observed. The solution was then filtered through a pad of celite and the solvent was evaporated 
under reduced pressure. The crude residue was purified by flash column chromatography 
(petrol:EtOAc, 1:1) to afford 264 as a colourless gum (5.714 g, 96%); [α]D 25 = -2.7 (c 1.10 in 
CHCl3); IR νmax (film)/cm-1: 3410, 2984, 2934, 1371, 1245, 1214, 1138, 1064, 853; 1H NMR 
(500 MHz, Chloroform-d) δ 1.36 (s, 3H, CH3 Isopropylidene), 1.42 (s, 3H, CH3 Isopropylidene), 1.43 (s, 
3H, CH3 Isopropylidene), 1.57 (s, 3H, CH3 Isopropylidene), 1.98 – 2.06 (m, 2H, CH2 Dithiane), 2.72 – 2.84 
(m, 4H, 2 X CH2 Dithiane), 3.35 (t, J = 7.4 Hz, 1H, OH), 3.61 – 3.65 (m, 1H, H-C-4), 3.87 – 3.94 
(m, 2H, 2 X OH), 3.94 – 3.98 (m, 2H, CH2OH), 4.02 – 4.07 (m, 1H, H-C-7), 4.08 – 4.11 (m, 1H, 
H-C-6), 4.11 – 4.18 (m, 2H, H’-C-7, H-C-5), 4.46 (dd, J = 7.4, 0.9 Hz, 1H, H-C-3), 4.83 (d, J = 7.4 
Hz, 1H, H-C-2); 
13C NMR (126 MHz, CDCl3) δ 24.6 (1C, CH2 Dithiane), 25.1 (1C, CH2 Dithiane), 
25.4 (1C, CH2 Dithiane), 25.6 (1C, CH3 Isopropylidene), 25.6 (1C, CH3 Isopropylidene), 26.1 (1C, CH3 
Isopropylidene), 27.1 (1C, CH3 Isopropylidene), 58.5 (1C, C-1), 65.1 (1C, CH2OH), 67.5 (1C, C-7), 70.7 
(1C, C-4), 71.2 (1C, C-6), 73.5 (1C, C-2), 75.9 (1C, C-5), 77.0 (1C, C-3), 109.4 (1C, Cq Isopropylidene), 
109.5 (1C, Cq Isopropylidene). 
The data is in agreement with the literature reference.1 
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(2-((R)-((4R,5S)-5-((R)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)(hydroxy)methyl)-1,3-dithian-2-yl)methyl acetate (266)1 
 
Acetic anhydride (0.32 ml, 3.36 mmol, 1.12 equiv.) was added to a stirred solution of 264 (1.230 
g, 3.00 mmol) and Et3N (0.47 ml, 3.36 mmol, 1.12 equiv.) in DCM (12 ml) at 0
 oC. The reaction 
mixture was stirred overnight at rt. Saturated aqueous NaHCO3 solution was then added, and the 
layers were separated. The aqueous layer was then extracted with DCM two times.  The 
combined organic extracts were washed with water, brine, and dried over anhydrous MgSO4. 
After filtration, the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 3:1) to yield the title 
compound as a pure colourless oil (1.022 g, 75% ); [α]D 25 = -6.1 (c 1.05 in CHCl3); IR νmax 
(film)/cm-1: 3456, 2985, 2941, 1743, 1379, 1218, 1066; 1H NMR (500 MHz, Chloroform-d) δ 
1.36 (s, 3H, CH3 Isopropylidene), 1.42 (s, 6H, 2 X CH3 Isopropylidene), 1.54 (s, 3H, CH3 Isopropylidene), 1.84 
– 1.93 (m, 1H, 1H of CH2 Dithiane), 2.03 – 2.10 (m, 1H of CH2 Dithiane), 2.12 (s, 3H, CH3 Acetate), 
2.65 – 2.79 (m, 2H, CH2 Dithiane), 2.88 – 3.01 (m, 2H, CH2 Dithiane), 3.51 (d, J = 8.8 Hz, 1H, OH), 
3.59 – 3.64 (m, 2H, OH, H-C-4), 3.98 – 4.02 (m, 1H, H-C-6), 4.06 (dd, J = 7.2, 4.2 Hz, 1H, H-C-
7), 4.10 – 4.16 (m, 2H, H’-C-7, H-C-5), 4.41 – 4.49 (m, 2H, 1H of CH2OAc, H-C-3), 4.69 – 4.74 
(m, 1H, H-C-2), 4.80 (d, J = 11.9 Hz, 1H, 1H of CH2OAc); 
13C NMR (101 MHz, CDCl3) δ 21.2 
(1C, CH3 Acetate), 24.5 (1C, CH2 Dithiane), 25.2 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 Isopropylidene), 25.9 
(1C, CH2 Dithiane), 26.0 (1C, CH2 Dithiane), 26.2 (1C, CH3 Isopropylidene), 27.1 (1C, CH3 Isopropylidene), 
56.7 (1C, Cq Dithiane),  63.8 (1C, CH2OAc), 67.5 (1C, C-7), 70.7 (1C, C-4), 72.3 (1C, C-6), 73.7 (1C, 
C-2), 75.9 (1C, C-5), 77.1 (1C, C-3), 109.2 (1C, Cq Isopropylidene), 109.4 (1C, Cq Isopropylidene), 170.4 
(1C, Cq Acetate). 
The data is in agreement with the literature reference.1 
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((3aR,5R,5aS,8aS,8bR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl acetate (383) 
 
Freshly recrystallized DBDMH (1.166 g, 4.08 mmol, 2 equiv.) was added to a stirred solution of  
266 (0.923 g, 2.04 mmol) in reagent grade acetone (34 ml) at 0 oC which formed a yellow 
coloured solution. After stirring at 0 oC for 30 mins, saturated aqueous solutions of Na2S2O3 and 
NaHCO3 were added. The mixture was then extracted four times with EtOAc. The combined 
organic extracts were washed with water, brine, and dried over anhydrous MgSO4. Filtration and 
removal of the solvent under reduced pressure gave a crude residue. The crude residue was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 5:1) to furnish 383 as a 
pure colourless oil (0.678 g, 83%);[α]D 25 = -8.7 (c 1.01 in CHCl3); IR νmax (film)/cm-1: 2989, 
2937, 1752, 1259, 1224, 1073; 1H NMR (400 MHz, Chloroform-d) δ 1.35 (s, 6H, 2 X CH3 
Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.41 (s, 3H, CH3 Isopropylidene), 1.43 (s, 3H, CH3 
Isopropylidene), 1.52 (s, 3H, CH3 Isopropylidene), 2.08 (s, 3H, CH3 Acetate), 3.71 (dd, J = 8.8, 1.9 Hz, 1H, 
H-C-5), 3.94 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 3.99 (dd, J = 8.8, 3.8 Hz, 1H, H-C-7), 4.05 
(dd, J = 8.8, 6.0 Hz, 1H, H’-C-7), 4.20 – 4.26 (m, 1H, H-C-6), 4.34 (d, J = 2.7 Hz, 1H, H-C-2), 
4.38 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.43 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 4.65 (dd, J = 
7.9, 2.7 Hz, 1H, H-C-3); 
13C NMR (101 MHz, CDCl3) δ 21.0 (1C, CH3 Acetate), 24.4 (1C, CH3 
Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 Isopropylidene), 26.7 
(1C, CH3 Isopropylidene), 27.3 (1C, CH3 Isopropylidene), 64.8 (1C, CH2OAc), 67.2 (1C, C-7), 69.6 (1C, C-
5), 70.7 (1C, C-4), 70.8 (1C, C-2), 70.9 (1C, C-3), 73.4 (1C, C-6), 102.3 (1C, C-1), 109.1 (1C, Cq 
Isopropylidene), 109.6 (1C, Cq Isopropylidene), 109.7 (1C, Cq Isopropylidene), 170.2 (1C, Cq Acetate); HRMS 
(ESI-TOF) m/z found for [M+Na]+: 425.1786; [C19H30O9+Na]
+ requires 425.1782. 
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((3aR,5R,5aS,8aS,8bR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methanol (384) 
 
Anhydrous K2CO3 (0.38 g, 2.74 mmol, 1.21 Equiv.) was added to a stirred solution of 383 (0.912 
g, 2.27 mmol) in dry methanol (23 ml). The mixture was stirred at rt overnight. The solvent was 
then removed under reduced pressure. The residue was treated with water (ca. 25 ml) and Et2O 
(ca. 25 ml), and the layers were separated. The aqueous layer was then extracted with Et2O two 
times.  The combined organic extracts were washed with water, brine, and dried over anhydrous 
MgSO4. Filtration and removal of the solvent under reduced pressure gave a crude residue. The 
crude product was purified by flash column chromatography on silica gel (petrol:EtOAc, 2:1) to 
yield the title compound as a pure colourless oil (0.792 g, 97%); [α]D 25 = -25.6 (c 0.78 in 
CHCl3); IR νmax (film)/cm-1: 3501, 2989, 2941, 1372, 1211, 1072; 1H NMR (400 MHz, 
Chloroform-d) δ 1.36 (s, 3H, CH3 Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 
Isopropylidene), 1.42 (s, 3H, CH3 Isopropylidene), 1.45 (s, 3H, CH3 Isopropylidene), 1.54 (s, 3H, CH3 
Isopropylidene), 3.59 – 3.69 (m, 2H, 2H of CH2OAc), 3.68 – 3.75 (m, 1H, H-C-5), 3.99 (dd, J = 8.8, 
3.7 Hz, 1H, H-C-7), 4.06 (dd, J = 8.8, 6.0 Hz, 1H, H’-C-7), 4.25 (ddd, J = 9.2, 6.0, 3.7 Hz, 1H, H-
C-6), 4.36 (d, J = 2.7 Hz, 1H, H-C2), 4.40 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.66 (dd, J = 7.9, 2.7 
Hz, 1H, H-C-3);
13C NMR (101 MHz, CDCl3) δ 24.3 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 
Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 25.8 (1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 27.4 
(1C, CH3 Isopropylidene), 65.4 (1C, CH2OH), 67.3 (1C, C-7), 69.7 (1C, C-5), 70.8 (1C, C-2), 70.9 (1C, 
C-3), 71.5 (1C, C-4), 73.4 (1C, C-6), 103.9 (1C, C-1), 109.0 (1C, Cq Isopropylidene), 109.6 (1C, Cq 
Isopropylidene), 109.7 (1C, Cq Isopropylidene); HRMS (ESI-TOF) m/z found for [M+Na]
+: 383.1677; 
[C17H28O8+Na]
+ requires 383.1676. 
 
241 
 
((3aR,5R,5aS,8aS,8bR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl 
trifluoromethanesulfonate (385) 
 
Pyridine (0.34 ml, 4.21 mmol, 1.5 equiv.) was added to a stirred solution of 384 (1.011 g, 2.81 
mmol) in dry DCM (28 ml). After cooling the solution to 0 oC, trifluoromethanesulfonic 
anhydride (0.47 ml, 2.81 mmol, 1.0 Equiv.) was added dropwise over 15 minutes. The reaction 
mixture was stirred at 0 oC for 30 minutes then allowed to warm up to rt and monitored by TLC 
until full consumption of the starting material was observed. The mixture was diluted with DCM 
and was treated with ice-cold water (ca. 30 ml), and the layers were separated. The aqueous layer 
was then extracted with DCM twice.  The combined organic extracts were then washed with 
water and dried over anhydrous MgSO4. Filtration and removal of the solvent under reduced 
pressure gave the title compound as a pure yellow oil (1.374 g, 99%);[α]D 25 = -6.0 (c 1.68 in 
CHCl3); IR νmax (film)/cm-1: 2991, 2939, 1383, 1210, 1146, 1074, 983; 1H NMR (400 MHz, 
Chloroform-d) δ 1.36 (s, 3H, CH3 Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 
Isopropylidene), 1.42 (s, 3H, CH3 Isopropylidene), 1.44 (s, 3H, CH3 Isopropylidene), 1.55 (s, 3H, CH3 
Isopropylidene), 3.74 (dd, J = 8.8, 1.9 Hz, 1H, H-C-5), 3.98 (dd, J = 8.9, 3.7 Hz, 1H, H-C-7), 4.05 (dd, 
J = 8.9, 5.9 Hz, 1H, H’-C-7), 4.22 (ddd, J = 8.8, 5.9, 3.7 Hz, 1H, H-C-6), 4.32 (d, J = 2.7 Hz, 1H, 
H-C-2), 4.38 (d, J = 10.5 Hz, 1H, 1H of CH2OTf), 4.40 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.52 (d, J 
= 10.5 Hz, 1H, 1H of CH2OTf), 4.69 (dd, J = 7.9, 2.7 Hz, 1H, H-C-3); 
13C NMR (101 MHz, 
CDCl3) δ 24.3 (1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 Isopropylidene), 25.8 
(1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 27.3 (1C, CH3 Isopropylidene), 67.1 (1C, C-7), 70.1 
(1C, C-5), 70.5 (1C, C-4), 70.6 (2C, C-2, C-3), 73.3 (1C, C-6), 74.1 (1C, CH2OTf), 100.6 (1C, C-1), 
109.7 (1C, Cq Isopropylidene), 109.8 (1C, Cq Isopropylidene), 110.3 (1C, Cq Isopropylidene); 
19F NMR (376 
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MHz, CDCl3) δ -74.41; HRMS (ESI-TOF) m/z found for [M+Na]+: 515.1175; 
[C18H27O10F3S+Na]
+ requires 515.1174. 
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S-(((3aS,5R,5aS,8aS,8bR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (386) 
 
Potassium thioacetate (0.658 g, 5.76 mmol, 4.4 equiv.) was added to a stirred solution of 385 
(0.645 g, 1.31 mmol) in dry MeCN (87 ml), which formed a brown coloured solution. The 
mixture was heated under reflux for 16 h, then cooled to rt after which the solvent was removed 
in vacuo. The residue was treated with water (ca. 30 ml) and EtOAc (ca. 30 ml), and the layers 
were separated. The aqueous layer was then extracted with EtOAc two times.  The combined 
organic extracts were washed with water, brine, and dried over anhydrous MgSO4. Filtration and 
removal of the solvent under reduced pressure gave a crude brown oil. The crude product was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 6:1) to furnish 386 as a 
pure yellow oil (0.548 g, quant.); [α]D 25 = -24.4 (c 0.87 in CHCl3); IR νmax (film)/cm-1: 2994, 
2937, 1697, 1210, 1070; 1H NMR (500 MHz, Chloroform-d) δ 1.36 (s, 6H, 2 X CH3 Isopropylidene), 
1.40 (s, 3H, CH3 Isopropylidene), 1.41 (s, 3H, CH3 Isopropylidene), 1.49 (s, 3H, CH3 Isopropylidene), 1.50 (s, 
3H, CH3 Isopropylidene), 2.35 (s, 3H, CH3 Thioacetate), 3.33 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.39 
(d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.68 (dd, J = 8.5, 1.9 Hz, 1H, H-C-5), 3.98 (dd, J = 8.8, 4.0 
Hz, 1H, H-C-7), 4.06 (dd, J = 8.8, 6.1 Hz, 1H, H’-C-7), 4.21 (d, J = 2.6 Hz, 1H, H-C-2), 4.24 (ddd, 
J = 8.5, 6.1, 4.0 Hz, 1H, H-C-6), 4.36 (dd, J = 7.9, 1.9 Hz, 1H H-C-4), 4.62 (dd, J = 7.9, 2.6 Hz, 
1H, H-C-3); 
13C NMR (101 MHz, CDCl3) δ 24.5 (1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 
25.5 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 Isopropylidene), 26.6 (1C, CH3 Isopropylidene), 27.3 (1C, CH3 
Isopropylidene), 30.6 (1C, CH3 Thioacetate), 37.3 (1C, CH2SAc), 67.2 (1C, C-7), 69.9 (1C, C-5), 70.6 (1C, 
C-4), 71.2 (1C, C-3), 73.2 (1C, C-2), 73.5 (1C, C-6), 103.1 (1C, C-1), 108.9 (1C, Cq Isopropylidene), 
109.5 (1C, Cq Isopropylidene), 109.7 (1C, Cq Isopropylidene), 194.8 (1C, Cq Thioacetate); HRMS (ESI-TOF) 
m/z found for [M+Na]+: 441.1571; [C19H30O8S+Na]
+ requires 441.1559. 
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S-(((3aS,5R,5aS,8aS,8bR)-5-((R)-1,2-dihydroxyethyl)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) ethanethioate (387) 
 
Compound 386 (0.532 g, 1.27 mmol), was dissolved in 90% Acetic acid (54 ml). The stirred 
reaction mixture was left at 40 oC for 24 hours. The mixture was then concentrated in vacuo. The 
crude residue was purified by flash column chromatography on silica gel (petrol:EtOAc, 3:2) to 
afford the title compound as a pure colourless solid (0.387 g, 80%); mp 82-85 oC; [α]D 25 = -27.1 
(c 1.05 in CHCl3); IR νmax (film)/cm-1: 3434, 2989, 2937, 1697, 1210, 1071; 1H NMR (400 MHz, 
Chloroform-d) δ 1.35 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.49 (s, 6H, 2 X CH3 
Isopropylidene), 2.35 (s, 3H), 3.34 (d, J = 13.7 Hz, 1H, 1H of CH2SAc), 3.38 (d, J = 13.7 Hz, 1H, 1H 
of CH2SAc), 3.73 – 3.83 (m, 3H, H-C-7, H’-C-7, H-C-5), 3.88 (ddd, J = 8.2, 4.7, 3.4 Hz, 1H, H-C-
6), 4.21 (d, J = 2.6 Hz, 1H, H-C-2), 4.42 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.64 (dd, J = 7.9, 2.6 
Hz, 1H, H-C-3); 
13C NMR (101 MHz, CDCl3) δ  24.4 (1C, CH3 Isopropylidene), 25.0 (1C, CH3 
Isopropylidene), 25.8 (1C, CH3 Isopropylidene), 26.3 (1C, CH3 Isopropylidene), 30.4 (1C, CH3 Thioacetate), 37.4 
(1C, CH2SAc), 64.1 (1C, C-7), 69.1 (1C, C-5), 70.0 (1C, C-6), 70.6 (1C, C-4), 71.2 (1C, C-3), 73.0 
(1C, C-2), 102.9 (1C, C-1), 108.8 (1C, Cq Isopropylidene), 109.6 (1C, Cq Isopropylidene), 194.6 (1C, Cq 
Thioacetate); HRMS (ESI-TOF) m/z found for [M+Na]
+: 401.1237; [C16H26O8S+Na]
+ requires 
401.1246. 
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S-(((3aS,5R,5aS,8aS,8bR)-5-((R)-2-((tert-butyldimethylsilyl)oxy)-1-hydroxyethyl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (388) 
 
TBSCl (0.065 g, 0.43 mmol) was added to a stirred solution of 387 (0.136 g, 0.36 mmol) and 
imidazole (0.060 g, 0.90 mmol, 2.5 equiv.) in dry DCM (3.6 mL) at 0 oC. The resultant mixture 
was stirred overnight at rt. The reaction mixture was then quenched with saturated aqueous 
NH4Cl and extracted with DCM three times. The combined organic extracts were washed with 
water, brine, and dried over anhydrous MgSO4. Filtration and removal of the solvent under 
reduced pressure gave a crude yellow oil. The crude oil was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 5:1) to furnish the title compound as a pure 
colourless oil (0.112 g, 63%); [α]D 25 = -14.3 (c 1.15 in CHCl3); IR νmax (film)/cm-1: 3530, 2934, 
2857, 1698, 1382, 1210, 1073; 1H NMR (500 MHz, Chloroform-d) δ 0.08 (s, 3H, CH3 Me (TBS)), 
0.09 (s, 3H, CH3 Me (TBS)), 0.90 (s, 9H, 3 X CH3 tBu (TBS)), 1.36 (s, 3H, CH3 Isopropylidene), 1.39 (s, 
3H, CH3 Isopropylidene), 1.48 (s, 3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 Isopropylidene), 2.35 (s, 3H, CH3 
Thioacetate), 3.34 (d, J = 13.7 Hz, 1H, 1H of CH2SAc), 3.38 (d, J = 13.7 Hz, 1H, 1H of CH2SAc), 
3.61 – 3.67 (m, 1H, H-C-7), 3.68 – 3.73 (m, 1H, H-C-5), 3.79 – 3.87 (m, 2H, H-C-6, H’-C-7), 4.19 
(d, J = 2.5 Hz, 1H, H-C-2), 4.45 (dd, J = 8.9, 1.9 Hz, 1H, H-C-4), 4.62 (dd, J = 8.0, 2.5 Hz, 1H, H-
C-3); 
13C NMR (101 MHz, CDCl3) δ -5.3 (1C, CH3 Me (TBS)), -5.2 (1C, CH3 Me (TBS)), 18.4 (1C, Cq 
tBu (TBS)), 24.5 (1C, CH3 Isopropylidene), 25.2 (1C, CH3 Isopropylidene), 25.9 (3C, 3 X CH3 tBu (TBS)), 26.1 
(1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.6 (1C, CH2SAc), 
64.1 (1C, C-7), 68.5 (1C, C-5), 69.7 (1C, C-6), 70.7 (1C, C-4), 71.3 (1C, C-3), 73.1 (1C, C-2), 103.0 
(1C, C-1), 108.7 (1C, Cq Isopropylidene), 109.5 (1C, Cq Isopropylidene), 194.9 (1C, Cq Thioacetate); HRMS 
(NSI-FTMS) m/z found for [M+NH4]
+: 510.2536; [C22H40O8SSi+NH4]
+ requires 510.2551.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
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S-(((3aS,5S,5aR,8aS,8bR)-5-(2-((tert-butyldimethylsilyl)oxy)acetyl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (389) 
 
DMSO (0.13 ml, 1.92 mmol, 3.5 equiv.) was added dropwise to a stirred solution of oxalyl 
chloride (0.07 ml, 0.82 mmol, 1.5 equiv.)  in DCM (4 ml) at -78 oC. The resultant stirred mixture 
was left for 30 minutes at this temperature. Then a solution of compound 388 (0.271 g, 0.55 
mmol) dissolved in DCM was added dropwise to the reaction mixture at -78 oC.  The reaction 
mixture was stirred for a 1 hour at this temperature. To this mixture was then added Et3N (0.37 
ml, 2.74 mmol, 5.0 equiv.) and was stirred at -78 oC for 10 minutes before being warmed slowly 
to rt. The mixture was then stirred at rt until the reaction was complete (monitored by TLC). 
Once complete, the reaction mixture was quenched with saturated aqueous NH4Cl and extracted 
with DCM three times. The combined organic extracts were washed with water, brine, and dried 
over anhydrous MgSO4. Filtration and removal of the solvent under vacuo furnished 389 as a 
pure colourless oil (0.232 g, 86%); [α]D 25 = -64.7 (c 1.10 in CHCl3); IR νmax (film)/cm-1: 2990, 
2932, 2857, 1742, 1699, 1384, 1211, 1071; 1H NMR (500 MHz, Chloroform-d) δ 0.07 (s, 3H, 
CH3 Me (TBS)), 0.10 (s, 3H, CH3 Me (TBS)), 0.92 (s, 9H, 3 X CH3 tBu (TBS)), 1.29 (s, 3H, CH3 
Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.47 (s, 3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 
Isopropylidene), 2.38 (s, 3H, CH3 Thioacetate), 3.31 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.53 (d, J = 
13.8 Hz, 1H, 1H of CH2SAc), 4.23 (d, J = 2.6 Hz, 1H, H-C-2), 4.37 (d, J = 2.2 Hz, 1H, H-C-5), 
4.49 (d, J = 19.6 Hz, 1H, H-C-7), 4.56 (dd, J = 7.8, 2.2 Hz, 1H, H-C-4), 4.60 (d, J = 19.6 Hz, 1H, 
H’-C-7), 4.61 – 4.64 (m, 1H, H-C-3); 13C NMR (126 MHz, CDCl3) δ -5.4 (1C, CH3 Me (TBS)), -5.1 
(1C, CH3 Me (TBS)), 18.6 (1C, Cq tBu (TBS)), 24.1 (1C, CH3 Isopropylidene), 25.0 (1C, CH3 Isopropylidene), 
25.7 (1C, CH3 Isopropylidene), 26.0 (3C, 3 X CH3 tBu (TBS)), 26.5 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 
Thioacetate), 37.6 (1C, CH2SAc), 68.9 (1C, C-7), 71.1 (1C, C-3), 72.0 (1C, C-4), 73.1 (1C, C-2), 74.8 
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(1C, C-5), 102.9 (1C, C-1), 109.2 (1C, Cq Isopropylidene), 109.9 (1C, Cq Isopropylidene), 194.4 (1C, Cq 
Thioacetate), 205.8 (1C, C-6 Ketone); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 508.2382; 
[C22H38O8SSi+NH4]
+ requires 508.2395. 
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S-(((3aS,5R,5aS,8aS,8bR)-5-((R)-1-hydroxy-2-((triisopropylsilyl)oxy)ethyl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (392) 
 
To a stirred solution of 387 (0.425 g, 1.12 mmol) in dry DCM (11 mL) at 0 oC, was added 
imidazole (0.191 g, 2.808 mmol, 2.5 equiv.) and DMAP (0.027 g, 0.225 mmol, 0.2 equiv.). 
TIPSCl (0.29 mL, 1.348 mmol, 1.2 equiv.), was then added dropwise to this suspension. The 
resultant mixture was stirred overnight at rt. The reaction mixture was then quenched with 
saturated aqueous NH4Cl and extracted with DCM three times. The combined organic extracts 
were washed with water, brine, and dried over anhydrous MgSO4. After filtration, the solvent 
was removed in vacuo. The crude product was purified by flash column chromatography on 
silica gel (petrol:EtOAc, 6:1) to furnish the title compound as a pure colourless oil (0.538 g, 
90%); [α]D 25 = -25.7 (c 0.56 in CHCl3); IR νmax (film)/cm-1: 3548, 2941, 2867, 1698, 1382, 1210, 
1072; 1H NMR (500 MHz, Chloroform-d) δ 1.04 – 1.08 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.17 (m, 
3H, 3 X H-CMe2 TIPS), 1.37 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.48 (s, 3H, 
CH3 Isopropylidene), 1.50 (s, 3H, CH3 Isopropylidene), 2.34 (s, 3H, CH3 Thioacetate), 3.33 (d, J = 13.6 Hz, 
1H, 1H of CH2SAc), 3.38 (d, J = 13.6 Hz, 1H, 1H of CH2SAc), 3.68 – 3.74 (m, 2H, H-C-7, H-C-
5), 3.88 (ddd, J = 8.4, 5.9, 3.8 Hz, 1H, H-C-6), 3.92 (dd, J = 9.6, 3.8 Hz, 1H, H’-C-7), 4.19 (d, J = 
2.5 Hz, 1H, H-C-2), 4.46 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.62 (dd, J = 7.9, 2.5 Hz, 1H, H-C-3); 
13C NMR (126 MHz, CDCl3) δ 12.1 (6C, 6 X CH3 TIPS), 18.1 (3C, 3 X CHMe2 TIPS), 24.5 (1C, 
CH3 Isopropylidene), 25.2 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 
30.5 (1C, CH3 Thioacetate), 37.7 (1C, CH2SAc), 64.6 (1C, C-7), 68.6 (1C, C-5), 69.8 (1C, C-6), 70.8 
(1C, C-4), 71.3 (1C, C-3), 73.2 (1C, C-2), 102.9 (1C, C-1), 108.7 (1C, Cq Isopropylidene), 109.5 (1C, Cq 
Isopropylidene), 194.9 (1C, Cq Thioacetate); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 552.3015; 
[C25H46O8SSi+NH4]
+ requires 552.3021. 
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S-(((3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-(2-
((triisopropylsilyl)oxy)acetyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-
yl)methyl) ethanethioate (394) 
 
To a stirred solution of oxalyl chloride (0.08 ml, 1.01 mmol, 1.5 equiv.)  in DCM (4 ml) at -78 
oC, was added dropwise DMSO (0.16 ml, 2.34 mmol, 3.5 equiv.). The reaction mixture was 
stirred for 30 minutes at this temperature. Then a solution of compound 392 (0.359 g, 0.67 
mmol) dissolved in DCM was added dropwise to the reaction mixture.  The reaction mixture was 
stirred for a further hour at this temperature. To this mixture was then added Et3N (0.45 ml, 3.36 
mmol, 5.0 equiv.) and was stirred at -78 oC for 10 minutes before being warmed slowly to rt. The 
mixture was stirred at rt until the reaction was complete (monitored by TLC). Once complete, the 
reaction mixture was quenched with saturated aqueous NH4Cl and extracted with DCM three 
times. The combined organic extracts were washed with water, brine, and dried over anhydrous 
MgSO4. Filtration and evaporation of the solvent under reduced pressure afforded the title 
compound as a pure colourless oil (0.322 g, 91%);[α]D 25 = -68.2 (c 0.98 in CHCl3); IR νmax 
(film)/cm-1: 2942, 2894, 2867, 1743, 1699, 1256, 1130, 1071; 1H NMR (500 MHz, Chloroform-
d) δ 1.04 – 1.08 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.17 (m, 3H, 3 X HCMe2 TIPS), 1.28 (s, 3H, CH3 
Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.46 (s, 3H, CH3 Isopropylidene), 1.47 (s, 3H, CH3 
Isopropylidene), 2.37 (s, 3H, CH3 Thioacetate), 3.32 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.52 (d, J = 
13.8 Hz, 1H, 1H of CH2SAc), 4.22 (d, J = 2.2 Hz, 1H, H-C-2), 4.41 (d, J = 1.7 Hz, 1H, H-C-5), 
4.55 (d, J = 19.3 Hz, 1H, H-C-7), 4.59 – 4.63 (m, 2H, H-C-4, H-C-3), 4.65 (d, J = 19.3 Hz, 1H, H’-
C-7); 
13C NMR (126 MHz, CDCl3) δ 12.1 (3C, 3 X CHMe2 TIPS), 18.0 (3C, 3 X CH3 TIPS), 18.0 
(3C, 3 X CH3 TIPS), 24.2 (1C, CH3 Isopropylidene), 25.0 (1C, CH3 Isopropylidene), 25.7 (1C, CH3 
Isopropylidene), 26.5 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.6 (1C, CH2SAc), 68.9 (1C, C-
7), 71.1 (1C, C-3), 72.0 (1C, C-4), 73.2 (1C, C-2), 74.7 (1C, C-5), 102.9 (1C, C-1), 109.2 (1C, Cq 
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Isopropylidene), 109.9 (1C, Cq Isopropylidene), 194.4 (1C, Cq Thioacetate), 205.2 (1C, C-6 Ketone); HRMS 
(ASAP-OTF) m/z found for [M+H]+: 533.2606; [C25H44O8SSi+H]
+ requires 533.2604.  
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S-(((3aS,5R,5aS,8aS,8bR)-5-((R)-2-((tert-butyldiphenylsilyl)oxy)-1-hydroxyethyl)-
2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (393) 
 
To a stirred solution of 387 (0.173 g, 0.46 mmol) in dry DCM (5 ml) at 0 oC, was added 
imidazole (0.094 g, 1.38 mmol, 3.0 equiv.l) and DMAP (11 mg, 0.0916 mmol, 0.2 equiv.). 
TBDPSCl (0.14 mL, 0.55 mmol, 1.2 equiv.), was then added dropwise to this suspension. The 
resultant mixture was stirred at rt for 24 hours. The reaction mixture was then quenched with 
saturated aqueous NH4Cl and extracted with DCM three times. The combined organic extracts 
were washed with water, brine, and dried over anhydrous MgSO4. After filtration, the solvent 
was removed under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 5:1) to furnish the title compound as a pure 
colourless oil (0.209 g, 74%); [α]D 25 = -20.2 (c 0.98 in CHCl3); IR νmax (film)/cm-1: 3072, 3049, 
2890, 2934, 2858, 1742, 1699, 1428,1211, 1113, 1071; 1H NMR (500 MHz, Chloroform-d) δ 
1.06 (s, 9H, 3 X CH3 tBu (TBDPS)), 1.35 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.41 
(s, 3H, CH3 Isopropylidene), 1.47 (s, 3H, CH3 Isopropylidene), 2.30 (s, 3H, CH3 Thioacetate), 3.34 (s, 2H, 
CH2SAc), 3.78 – 3.87 (m, 3H, H-C-5, H-C-7, H’-C-7), 3.92 (ddd, J = 8.7, 5.2, 3.9 Hz, 1H, H-C-6), 
4.19 (d, J = 2.5 Hz, 1H, H-C-2), 4.45 (dd, J = 7.9, 2.0 Hz, 1H, H-C-4), 4.62 (dd, J = 7.9, 2.5 Hz, 
1H, H-C-3), 7.34 – 7.46 (m, 6H, 6 X H-CAR), 7.66 – 7.72 (m, 4H, 4 X H-CAR); 13C NMR (126 
MHz, CDCl3) δ 19.4 (1C, Cq tBu (TBDPS)), 24.5 (1C, CH3 Isopropylidene), 25.1 (1C, CH3 Isopropylidene), 
25.9 (1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 27.1 (3C, 3 X CH3 tBu (TBDPS)), 30.5 (1C, 
CH3 Thioacetate), 37.7 (1C, CH2SAc), 64.7 (1C, C-7), 68.3 (1C, C-5), 70.0 (1C, C-6), 70.8 (1C, C-4), 
71.3 (1C, C-3), 73.1 (1C, C-2), 103.0 (1C, C-1), 108.7 (1C, Cq Isopropylidene), 109.5 (1C, Cq 
Isopropylidene), 127.87 (2C, 2 X CAR), 127.93 (2C, 2 X CAR), 129.82 (1C, CAR), 129.95 (1C, CAR), 
133.07 (1C, Cq AR), 133.24 (1C, Cq AR), 135.81 (2C, 2 X CAR), 135.83 (2C, 2 X CAR), 195.0 (1C, 
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Cq Thioacetate); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 634.2855; [C32H44O8SSi+NH4]
+ 
requires 634.2864. 
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S-(((3aS,5S,5aR,8aS,8bR)-5-(2-((tert-butyldiphenylsilyl)oxy)acetyl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) 
ethanethioate (395) 
 
DMSO (0.08 ml, 1.10 mmol, 3.5 equiv.) was added dropwise to a stirred solution of oxalyl 
chloride (0.04 ml, 0.47 mmol, 1.5 equiv.)  in DCM (4 ml) at -78 oC and was left stirring for 30 
minutes. Then a solution of alcohol 393 (0.193 g, 0.31 mmol) dissolved in DCM was added 
dropwise to the reaction mixture at -78 oC.  The reaction mixture was stirred for a further hour at 
this temperature. To this mixture was then added dropwise Et3N (0.21 ml, 1.56 mmol, 5.0 equiv.) 
and was stirred at -78 oC for 10 minutes before being warmed slowly to rt. The mixture was 
stirred at rt until the reaction was complete (monitored by TLC). Once complete, the reaction 
mixture was quenched with saturated aqueous NH4Cl and extracted with DCM three times. The 
combined organic extracts were washed with water, brine, and dried over anhydrous MgSO4. 
Filtration and evaporation of the solvent under reduced pressure afforded the title compound as a 
pure colourless oil (0.160 g, 83%); [α]D 24 = -59.3 (c 1.09 in CHCl3); IR νmax (film)/cm-1: 3552, 
2989, 2934, 2858, 1695, 1473, 1428, 1210, 1105, 1072; 1H NMR (500 MHz, Chloroform-d) δ 
1.09 (s, 9H, 3 X CH3 tBu (TBDPS)), 1.25 (s, 3H, CH3 Isopropylidene), 1.25 (s, 3H, CH3 Isopropylidene), 1.37 
(s, 3H, CH3 Isopropylidene), 1.44 (s, 3H, CH3 Isopropylidene), 2.22 (s, 3H, CH3 Thioacetate), 3.23 (d, J = 13.8 
Hz, 1H, 1H of CH2SAc), 3.40 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 4.18 (d, J = 2.2 Hz, 1H, H-C-
2), 4.36 (d, J = 1.8 Hz, 1H, H-C-5), 4.49 (d, J = 19.3 Hz, 1H, H-C-7), 4.55 – 4.61 (m, 2H, H-C-3, 
H-C-4), 4.67 (d, J = 19.3 Hz, 1H, H’-C-7), 7.34 – 7.42 (m, 6H, 6 X H-CAR), 7.65 – 7.70 (m, 4H, 4 
X H-CAR); 
13C NMR (126 MHz, CDCl3) δ 19.5 (1C, Cq tBu (TBDPS)), 24.2 (1C, CH3 Isopropylidene), 
25.0 (1C, CH3 Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 26.4 (1C, CH3 Isopropylidene), 26.9 (3C, 3 X 
CH3 tBu (TBDPS)), 30.3 (1C, CH3 Thioacetate), 37.4 (1C, CH2SAc), 69.1 (1C, C-7), 71.0 (1C, C-3), 72.0 
(1C, C-4), 73.1 (1C, C-2), 74.8 (1C, C-5), 102.9 (1C, C-1), 109.1 (1C, Cq Isopropylidene), 110.0 (1C, Cq 
Isopropylidene), 127.8 (2C, 2 X CAR), 127.9 (2C, 2 X CAR), 129.8 (1C, CAR), 129.8 (1C, CAR), 133.1 
254 
 
(1C, Cq AR), 133.4 (1C, Cq AR), 135.7 (2C, 2 X CAR), 135.8 (2C, 2 X CAR), 194.3 (1C, Cq 
Thioacetate), 204.8 (1C, C-6 Ketone); HRMS (ASAP-OTF) m/z found for [M+NH4]
+: 632.2711; 
[C32H42O8SSi+NH4]
+ requires 632.2714. 
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S-(((3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-((R)-1-(((trifluoromethyl)sulfonyl)oxy)-2-
(tert-butyldimethylsilyloxy)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-
yl)methyl) ethanethioate 
 (402) 
 
Trifluoromethanesulfonic anhydride (0.035 ml, 0.21 mmol, 1.0 Equiv.) was added dropwise over 
15 minutes to a stirred solution of 388 (0.102 g, 0.21 mmol) and pyridine (0.025 ml, 0.31 mmol, 
1.5 equiv.) in dry DCM (2 ml) at 0 oC. The reaction mixture was stirred at 0 oC for 30 minutes 
then allowed to warm up to rt and monitored by TLC until full consumption of the starting 
material was observed. The mixture was diluted with DCM and was treated with ice-cold water 
(ca. 15 ml), and the layers were separated. The aqueous layer was extracted with DCM twice.  
The combined organic extracts were then washed with water and dried over anhydrous MgSO4. 
Filtration and removal of the solvent under reduced pressure gave the title compound as a pure 
yellow oil (0.124 g, 96%); [α]D 24 = -15.0 (c 0.99 in CHCl3); IR νmax (film)/cm-1: 2992, 2935, 
2859, 1699, 1385, 1211, 1146, 1072, 837; 1H NMR (500 MHz, Chloroform-d) δ 0.08 (s, 6H, 2 X 
CH3 Me (TBS)), 0.90 (s, 9H, 3 X CH3 tBu (TBS)), 1.32 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 
Isopropylidene), 1.48 (s, 3H, CH3 Isopropylidene), 1.49 (s, 3H, CH3 Isopropylidene), 2.34 (s, 3H, CH3 Thioacetate), 
3.29 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.40 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.88 (dd, J 
= 12.3, 5.3 Hz, 1H, H-C-7), 4.07 (dd, J = 12.3, 2.4 Hz, 1H, H’-C-7), 4.15 (dd, J = 7.2, 1.9 Hz, 1H, 
H-C-5), 4.20 (d, J = 2.6 Hz, 1H, H-C-2), 4.28 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.63 (dd, J = 7.9, 
2.6 Hz, 1H, H-C-3), 5.04 (ddd, J = 7.2, 5.3, 2.4 Hz, 1H, H-C-6); 
13C NMR (126 MHz, CDCl3) δ -
5.5 (1C, CH3 Me (TBS)), -5.4 (1C, CH3 Me (TBS)), 18.5 (1C, Cq tBu (TBS)), 24.0 (1C, CH3 Isopropylidene), 
25.1 (1C, CH3 Isopropylidene), 25.7 (1C, CH3 Isopropylidene), 26.0 (3C, 3 X CH3 tBu (TBS)), 26.7 (1C, CH3 
Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.3 (1C, CH2SAc), 61.5 (1C, C-7), 67.1 (1C, C-5), 69.8 (1C, 
C-4), 71.3 (1C, C-3), 73.0 (1C, C-2), 87.3 (1C, C-6), 103.0 (1C, C-1), 109.1 (1C, Cq Isopropylidene), 
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110.0 (1C, Cq Isopropylidene), 119.9 (1C, Cq CF3 (OTf)), 194.6 (1C, Cq Thioacetate); 
19F NMR (376 MHz, 
CDCl3) δ -75.09; HRMS (ASAP-TOF) m/z found for [M+H]+: 625.1786; [C23H39F3O10S2Si+H]+ 
requires 625.1784. 
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S-(((3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-((R)-1-((methylsulfonyl)oxy)-2-(tert-
butyldimethylsilyloxy)ethyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-
yl)methyl) ethanethioate 
 (404) 
 
MsCl (0.058 ml, 0.75 mmol, 2 equiv.), was added dropwise to a stirred solution of 388 (0.185 g, 
0.38 mmol) and Et3N (0.26 ml, 1.87 mmol, 5 equiv.) in dry DCM (3.8 ml) at 0
 oC. The orange 
mixture was stirred at rt for 3 hours. The reaction mixture was then quenched with brine and 
extracted with DCM three times. The combined organic extracts were washed with saturated 
aqueous NH4Cl solution, water, brine, and dried over anhydrous MgSO4. Filtration and removal 
of the solvent under reduced pressure furnished a crude yellow oil. The crude residue was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 5:1) to afford 404 as a 
pure colourless oil (0.142 g, 66%); [α]D 25 = -21.6 (c 0.96 in CHCl3); IR νmax (film)/cm-1: 2989, 
2935, 2857, 1698, 1360, 1176, 1072, 835; 1H NMR (500 MHz, Chloroform-d) δ 0.09 (s, 6H, 2 X 
CH3 Me (TBS)), 0.91 (s, 9H, 3 X CH3 tBu (TBS)), 1.33 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 
Isopropylidene), 1.49 (s, 3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 Isopropylidene), 2.35 (s, 3H, CH3 Thioacetate), 
3.09 (s, 3H, CH3 OMs), 3.31 (d, J = 13.7 Hz, 1H, 1H Of CH2SAc), 3.40 (d, J = 13.7 Hz, 1H, 1H of 
CH2SAc), 3.87 (dd, J = 11.9, 4.8 Hz, 1H, H-C-7), 4.05 – 4.09 (m, 1H, H’-C-7), 4.13 (dd, J = 7.5, 
1.9 Hz, 1H, H-C-5), 4.19 (d, J = 2.6 Hz, 1H, H-C-2), 4.33 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.63 
(dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 4.71 (ddd, J = 7.5, 4.8, 2.4 Hz, 1H, H-C-6); 
13C NMR (126 MHz, 
CDCl3) δ -5.3 (1C, CH3 Me (TBS)), -5.2 (1C, CH3 Me (TBS)), 18.6 (3C, 3 X CH3 tBu (TBS)), 24.4 (1C, 
CH3 Isopropylidene), 25.2 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 Isopropylidene), 26.2 (3C, 3 X CH3 tBu 
(TBS)), 26.7 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.4 (1C, CH2SAc), 38.6 (1C, CH3 
OMs), 62.3 (1C, C-7), 67.0 (1C, C-5), 70.2 (1C, C-4), 71.4 (1C, C-3), 73.0 (1C, C-2), 81.6 (1C, C-6), 
103.0 (1C, C-1), 109.1 (1C, Cq Isopropylidene), 109.7 (1C, Cq Isopropylidene), 194.7 (1C, Cq Thioacetate); 
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HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 588.2319; [C23H42O10S2Si+NH4]
+ requires 
588.2327. 
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(S-(((3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-((R)-1-(((trifluoromethyl)sulfonyl)oxy)-2-
(triisopropylsilyloxy)ethyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-
yl)methyl) ethanethioate 
(405) 
 
Trifluoromethanesulfonic anhydride (0.035 ml, 0.21 mmol, 1.0 Equiv.) was added dropwise over 
15 minutes to a stirred solution of 392 (0.111 g, 0.21 mmol) and pyridine (0.025 ml, 0.31 mmol, 
1.5 equiv.) in dry DCM (2 ml) at 0 oC. The reaction mixture was stirred at 0 oC for 30 minutes 
then allowed to warm up to rt and monitored by TLC until full consumption of the starting 
material was observed. The mixture was diluted with DCM and was treated with ice-cold water 
(ca. 15 ml), and the layers were separated. The aqueous layer was extracted with DCM twice.  
The combined organic extracts were then washed with water and dried over anhydrous MgSO4. 
Filtration and evaporation of the solvent in vacuo gave 405 as a pure yellow oil (0.135 g, 98%); 
[α]D 24 = -14.6 (c 0.85 in CHCl3); IR νmax (film)/cm-1: 2943, 2896, 2869, 1699, 1385, 1211, 1146, 
1071, 908; 1H NMR (400 MHz, Chloroform-d) δ 1.03 – 1.14 (m, 21H, 6 X CH3 TIPS, 3 X H-
CMe2 TIPS), 1.31 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.47 (s, 3H, CH3 
Isopropylidene), 1.48 (s, 3H, CH3 Isopropylidene), 2.34 (s, 3H, CH3 Thioacetate), 3.28 (d, J = 13.8 Hz, 1H, 1H 
of CH2SAc), 3.40 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 3.96 (dd, J = 12.4, 6.2 Hz, 1H, H-C-7), 
4.13 (dd, J = 6.2, 2.0 Hz, 1H, H-C-5), 4.19 (d, J = 2.6 Hz, 1H, H-C-2) 4.20 (dd, J = 12.4, 2.4 Hz, 
1H, H’-C-7), 4.28 (dd, J = 7.9, 2.0 Hz, 1H, H-C-4), 4.62 (dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 5.09 (td, 
J = 6.2, 2.4 Hz, 1H, H-C-6); 
13C NMR (101 MHz, CDCl3) δ 12.1 (3C, 3 X CHMe2 TIPS), 18.0 (3C, 
3 X CH3 TIPS), 18.0 (3C, 3 X CH3 TIPS), 24.0 (1C, CH3 Isopropylidene), 25.0 (1C, CH3 Isopropylidene), 25.7 
(1C, CH3 Isopropylidene), 26.5 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.4 (1C, CH2SAc), 
62.1 (1C, C-7), 67.9 (1C, C-5), 70.1 (1C, C-4), 71.3 (1C, C-3), 73.0 (1C, C-2), 88.4 (1C, C-6), 103.0 
(1C, C-1), 109.1 (1C, Cq Isopropylidene), 110.0 (1C, Cq Isopropylidene), 194.6 (1C, Cq Thioacetate); 
19F NMR 
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(376 MHz, CDCl3) δ -75.02; HRMS (ASAP-TOF) m/z found for [M+H]+: 667.2260; 
[C26H45F3O10S2Si+H]
+ requires 667.2254.  
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S-(((3aS,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-5-((R)-1-((methylsulfonyl)oxy)-2-
(triisopropylsilyloxy)ethyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-
yl)methyl) ethanethioate 
 (406) 
 
MsCl (0.039 ml, 0.51 mmol, 2 equiv.), was added dropwise to a stirred solution of 392 (0.136 g, 
0.25 mmol) and Et3N (0.18 ml, 1.27 mmol, 5 equiv.) in dry DCM (2.6 ml) at 0
 oC.  The mixture 
was stirred at rt until TLC showed complete consumption of starting material. The reaction 
mixture was then quenched with brine and extracted with DCM three times. The combined 
organic extracts were washed with saturated aqueous NH4Cl solution, water, brine, and dried 
over anhydrous MgSO4. Filtration and removal of the solvent in vacuo furnished a crude residue. 
The crude residue was purified by flash column chromatography on silica gel (petrol:EtOAc, 
5:1) to afford the title compound as a pure colourless oil (0.099 g, 64%); [α]D 24 = -17.0 (c 0.99 in 
CHCl3); IR νmax (film)/cm-1: 2942, 2894, 2867, 1698, 1360, 1175, 1071, 907; 1H NMR (500 
MHz, Chloroform-d) δ 1.05 – 1.16 (m, 21H, 6 X CH3 TIPS, 3 X H-CMe2 TIPS), 1.33 (s, 3H, CH3 
Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.49 (s, 6H, 2 X CH3 Isopropylidene), 2.34 (s, 3H, CH3 
Thioacetate), 3.09 (s, 3H, CH3 OMs), 3.30 (d, J = 13.7 Hz, 1H, 1H of CH2SAc), 3.39 (d, J = 13.7 Hz, 
1H, 1H of CH2SAc), 3.92 (dd, J = 11.8, 5.8 Hz, 1H, H-C-7), 4.12 (dd, J = 6.7, 1.9 Hz, 1H, H-C-5), 
4.16 (dd, J = 11.8, 2.4 Hz, 1H, H’-C-7), 4.18 (d, J = 2.6 Hz, 1H, H-C-2), 4.35 (dd, J = 7.9, 1.9 Hz, 
1H, H-C-4), 4.63 (dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 4.78 (ddd, J = 6.7, 5.8, 2.4 Hz, 1H, H-C-6); 
13C 
NMR (126 MHz, CDCl3) δ 12.1 (3C, 3 X CHMe2 TIPS), 18.1 (3C, 3 X CH3 TIPS), 18.1 (3C, 3 X 
CH3 TIPS), 24.3 (1C, CH3 Isopropylidene), 25.1 (1C, CH3 Isopropylidene), 25.8 (1C, CH3 Isopropylidene), 26.6 
(1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.5 (1C, CH2SAc), 38.5 (1C, CH3 OMs), 62.6 (1C, 
C-7), 67.7 (1C, C-5), 70.4 (1C, C-4), 71.4 (1C, C-3), 73.1 (1C, C-2), 82.3 (1C, C-6), 103.0 (1C, C-1), 
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109.1 (1C, Cq Isopropylidene), 109.7 (1C, Cq Isopropylidene), 194.7 (1C, Cq Thioacetate); HRMS (ASAP-
TOF) m/z found for [M+H]+: 613.2537; [C26H48O10S2Si+H]
+ requires 613.2537. 
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((3aR,5R,5aS,8aS,8bR)-5-((R)-1,2-dihydroxyethyl)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl acetate (411) 
 
Compound 383 (2.705 g, 6.72 mmol), was dissolved in 80% Acetic acid (67 ml). The stirred 
reaction mixture was heated at 50 oC until TLC showed complete consumption of starting 
material was observed, after which the solvent was removed under reduced pressure. The crude 
residue was purified by flash column chromatography on silica gel (petrol:EtOAc, 1:1) to afford 
411 as a pure colourless white solid (2.202 g, 90%); mp 118-119 oC; [α]D 22 = -2.1 (c 0.95 in 
CHCl3); IR νmax (film)/cm-1: 3449, 2991, 2939, 1750, 1208, 1071; 1H NMR (400 MHz, 
Chloroform-d) δ 1.35 (s, 3H, CH3 Isopropylidene), 1.38 (s, 3H, CH3 Isopropylidene), 1.44 (s, 3H, CH3 
Isopropylidene), 1.53 (s, 3H, CH3 Isopropylidene), 2.09 (s, 3H, CH3 Acetate), 3.71 – 3.84 (m, 2H, H-C-7, H’-
C-7), 3.84 – 3.90 (m, 2H, H-C-5, H-C-6), 3.96 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 4.33 (d, J = 
2.7 Hz, 1H, H-C-2), 4.43 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 4.43 – 4.47 (m, 1H, H-C-4), 4.67 
(dd, J = 7.9, 2.7 Hz, 1H, H-C-3); 
13C NMR (101 MHz, CDCl3) δ 21.0 (1C, CH3 Acetate), 24.5 (1C, 
CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 26.0 (1C, CH3 Isopropylidene), 26.6 (1C, CH3 Isopropylidene), 
63.9 (1C, C-7), 64.9 (1C, CH2OAc), 68.5 (1C, C-5), 70.2 (1C, C-6), 70.7 (1C, C-2), 70.9 (1C, C-4), 
71.1 (1C, C-3), 102.3 (1C, C-1), 109.3 (1C, Cq Isopropylidene), 109.7 (1C, Cq Isopropylidene), 170.2 (1C, 
Cq Acetate); HRMS (ESI-TOF) m/z found for [M+Na]
+: 385.1467; [C16H26O9+Na]
+ requires 
385.1469; 
Compound 412 was also isolated as a colourless oil (0.095 g, 3%); [α]D 26 = +5.7 (c 0.84 in 
CHCl3); IR νmax (film)/cm-1: 3448, 2990, 2940, 1745, 1250, 1072; 1H NMR (500 MHz, 
Chloroform-d) δ 1.36 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.45 (s, 3H, CH3 
Isopropylidene), 1.53 (s, 3H, CH3 Isopropylidene), 2.09 (s, 3H, CH3 Acetate), 2.09 (s, 3H, CH3 Acetate), 3.86 
(dd, J = 8.9, 2.0 Hz, 1H, H-C-5), 3.96 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 4.04 (ddd, J = 8.9, 
5.4, 2.6 Hz, 1H, H-C-6), 4.19 (dd, J = 11.8, 5.4 Hz, 1H, H-C-7), 4.35 (d, J = 2.7 Hz, 1H, H-C-2), 
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4.41 (dd, J = 11.8, 2.6, H’-C-7), 4.43 (d, J = 11.7 Hz, 1H, 1H of CH2OAc), 4.47 (dd, J = 7.9, 2.0 
Hz, 1H, H-C-4), 4.68 (dd, J = 7.9, 2.7 Hz, 1H, H-C-3); 
13C NMR (126 MHz, CDCl3) δ 21.0 (2C, 2 
X CH3 Acetate), 24.5 (1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 26.0 (1C, CH3 Isopropylidene), 
26.6 (1C, CH3 Isopropylidene), 64.9 (1C, CH2OAc), 66.1 (1C, C-7), 67.9 (1C, C-5), 68.8 (1C, C-6), 
70.7 (2C, C-4, C-2), 71.1 (1C, C-3), 102.3 (1C, C-1), 109.1 (1C, Cq Isopropylidene), 109.8 (1C, Cq 
Isopropylidene), 170.2 (1C, Cq Acetate), 171.6 (1C, Cq Acetate); HRMS (NSI-FTMS) m/z found for 
[M+NH4]
+: 422.2014; [C18H28O10+NH4]
+ requires 422.2021; 
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((3aR,5R,5aS,8aS,8bR)-5-((R)-1-hydroxy-2-(trityloxy)ethyl)-2,2,7,7-tetramethyltetrahydro-
3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl acetate (413) 
 
Et3N (0.10 ml, 0.74 mmol, 2 equiv.) was added to a stirred solution of 411 (0.134 g, 0.37 mmol) 
in dry DCM (2.2 ml). After cooling the resultant solution to 0 oC, trityl chloride (0.124 g, 0.44 
mmol, 1.2 equiv.) was added in one portion. The mixture was stirred at rt overnight. The solvent 
was then removed under reduced pressure. The residue was treated with water and EtOAc. The 
layers were separated. The aqueous layer was then extracted with EtOAc twice.  The combined 
organic extracts were dried over anhydrous MgSO4. Filtration and removal of the solvent under 
reduced pressure gave a crude residue. The crude residue was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 4:1) to yield the title compound as a pure colourless 
solid (0.199 g, 89%); mp 64-67 oC; [α]D 26 = +4.9 (c 0.97 in CHCl3); IR νmax (film)/cm-1: 3473, 
3059, 3025, 2890, 2936, 1750, 1491, 1448, 1208, 1072; 1H NMR (500 MHz, Chloroform-d) δ 
1.33 (s, 3H, CH3 Isopropylidene), 1.37 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.41 (s, 
3H, CH3 Isopropylidene), 2.08 (s, 3H, CH3 Acetate), 2.65 (d, J = 6.6 Hz, 1H, OH), 3.32 (dd, J = 9.6, 4.0 
Hz, 1H, H-C-7,), 3.39 (dd, J = 9.6, 4.3 Hz, 1H, H’-C-7), 3.88 – 3.97 (m, 2H, 1H of CH2OAc, H-C-
6), 3.98 (dd, J = 8.2, 1.9 Hz, 1H, H-C-5), 4.32 (d, J = 2.6 Hz, 1H, H-C-2), 4.39 – 4.44 (m, 2H, H-
C-4, 1H of CH2OAc), 4.63 (dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 7.20 – 7.25 (m, 3H, 3 X H-CAR), 7.27 
– 7.32 m, 6H, 6 X H-CAR), 7.43 – 7.47 (m, 6H, 6 X H-CAR); 13C NMR (126 MHz, CDCl3) δ 21.1 
(1C, CH3 Acetate), 24.4 (1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 26.0 (1C, CH3 Isopropylidene), 
26.6 (1C, CH3 Isopropylidene), 65.0 (1C, C-7), 68.0 (1C, CH2OAc), 69.6 (1C, C-5), 70.7 (1C, C-6), 
71.1 (1C, C-2), 71.1 (2C, C-3, C-4), 86.9 (1C, Cq Trityl), 102.3 (1C, C-1), 109.0 (1C, Cq Isopropylidene), 
109.5 (1C, Cq Isopropylidene), 127.2 (3C, 3 X CAR), 128.0 (6C, 6 X CAR), 128.9 (6C, 6 X CAR), 143.9 
(3C, 3 X Cq AR), 170.2 (1C, Cq Acetate); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 622.3007; 
[C35H40O9+NH4]
+ requires 622.3011. 
266 
 
(R)-1-((3aR,5R,5aS,8aS,8bR)-3a-(hydroxymethyl)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-2-(trityloxy)ethanol (414) 
 
A methanolic solution of sodium methoxide (1.68 ml, 3.37 mmol, 2M in methanol, 3 equiv.) was 
added slowly to a stirred solution of 413 (0.678 g, 1.12 mmol) in dry methanol (11.2 ml). The 
mixture was stirred at rt until TLC showed complete consumption of starting material. The 
solvent was then removed in vacuo. The residue was treated with water (ca. 10 ml) and Et2O (ca. 
10 ml), and the layers were separated. The aqueous layer was extracted with Et2O two times.  
The combined organic extracts were washed with water, brine, and dried over anhydrous 
MgSO4. Filtration and removal of the solvent under reduced pressure gave a crude residue. The 
crude product was purified by flash column chromatography on silica gel (petrol:EtOAc, 3:1) to 
yield the title compound as a pure colourless solid (0.591 g, 94%); mp 70-72 oC; [α]D 26 = +3.8 (c 
1.36 in CHCl3); IR νmax (film)/cm-1: 3476, 3059, 3033, 2989, 2936, 1491, 1449, 1213, 1072; 1H 
NMR (400 MHz, Chloroform-d) δ 1.32 (s, 3H, CH3 Isopropylidene), 1.35 (s, 3H, CH3 Isopropylidene), 
1.40 (s, 3H, CH3 Isopropylidene), 1.42 (s, 3H, CH3 Isopropylidene), 1.98 – 2.00 (m, 1H, OH), 2.69 (d, J = 
6.5 Hz, 1H, OH), 3.32 (dd, J = 9.6, 4.1 Hz, 1H, H-C-7), 3.39 (dd, J = 9.6, 4.2 Hz, 1H, H’-C-7), 
3.54 – 3.70 (m, 2H, 2H of CH2OH), 3.87 – 4.00 (m, 2H, H-C-6, H-C-5), 4.32 (d, J = 2.6 Hz, 1H, 
H-C-2), 4.39 (dd, J = 7.9, 1.8 Hz, 1H, H-C-4), 4.62 (dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 7.19 – 7.31 
(m, 9H, 9 X H-CAR), 7.42 – 7.47 (m, 6H, 6 X H-CAR); 13C NMR (101 MHz, CDCl3) δ 24.3 (1C, 
CH3 Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 25.8 (1C, CH3 Isopropylidene), 26.6 (1C, CH3 Isopropylidene), 
64.0 (1C, C-7), 65.7 (1C, CH2OH), 68.0 (1C, C-6), 69.7 (1C, C-5), 71.0 (1C, C-3), 71.1 (1C, C-4), 
71.4 (1C, C-2), 86.9 (1C, Cq Trityl), 103.8 (1C, C-1), 108.8 (1C, Cq Isopropylidene), 109.4 (1C, Cq 
Isopropylidene), 127.2 (3C, 3 X CAR), 128.0 (6C, 6 X CAR), 129.0 (6C, 6 X CAR), 143.9 (3C, 3 X Cq 
AR); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 580.2901; [C33H38O8+NH4]
+ requires 
580.2905. 
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(R)-1-((3aR,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-3a-
(((methylsulfonyl)oxy)methyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-2-
(trityloxy)ethyl methanesulfonate (415) 
 
MsCl (0.036 ml, 0.47 mmol, 2.5 equiv.) was added dropwise to a stirred solution of 414 (0.106 
g, 0.19 mmol) and Et3N (0.09 ml, 0.66 mmol, 3.5 equiv.) in dry DCM (1.9 ml) at 0 
oC. The 
mixture was stirred at rt for 2 hours. Saturated aqueous NaHCO3 was then added and the mixture 
was extracted three times with DCM. The combined organic extracts were washed with water 
twice, brine, and dried over anhydrous MgSO4. Filtration and removal of the solvent under 
reduced pressure gave a crude yellow oil. The crude product was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 3:1) to yield the title compound as a pure colourless 
solid (0.133g, 70%); mp 75-79 oC; [α]D 22 = +7.2 (c 0.67 in CHCl3); IR νmax (film)/cm-1: 3026, 
2925, 2854, 1491, 1450, 1360 1176, 1073, 969; 1H NMR (500 MHz, Chloroform-d) δ 1.31 (s, 
6H, 2 X CH3 Isopropylidene), 1.32 (s, 3H, CH3 Isopropylidene), 1.34 (s, 3H, CH3 Isopropylidene), 2.96 (s, 3H, 
CH3 OMs), 3.00 (s, 3H, CH3 OMs), 3.25 (dd, J = 11.2, 3.8 Hz, 1H, H-C-7), 3.68 (dd, J = 11.2, 2.3 
Hz, 1H, H’-C-7), 4.05 (d, J = 10.9 Hz, 1H, 1H of CH2OMs), 4.17 (d, J = 10.9 Hz, 1H, 1H of 
CH2OMs), 4.30 (d, J = 2.7 Hz, 1H, H-C-2), 4.37 – 4.40 (m, 2H, H-C-4, H-C-5), 4.66 – 4.70 (m, 
1H, H-C-3), 4.85 (ddd, J = 7.3, 3.8, 2.3 Hz, 1H, H-C-6), 7.20 – 7.25 (m, 3H, 3 x H-CAR), 7.27 – 
7.32 (m, 6H, 6 x H-CAR), 7.45 – 7.49 (m, 6H, 6 x H-CAR); 13C NMR (126 MHz, CDCl3) δ 24.2 
(1C, CH3 Isopropylidene), 25.3 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 Isopropylidene), 26.5 (1C, CH3 
Isopropylidene), 37.8 (1C, CH3 OMs), 38.8 (1C, CH3 OMs), 61.9 (1C, C-7), 67.0 (1C, C-4), 69.1 (1C, 
CH2OMs), 70.1 (1C, C-5), 70.4 (1C, C-2), 80.0 (1C, C-3), 79.9 (1C, C-6), 87.1 (1C, Cq Trityl), 101.4 
(1C, C-1), 109.8 (1C, Cq Isopropylidene), 110.0 (1C, Cq Isopropylidene), 127.2 (3C, 3 X CAR), 127.9 (6C, 6 
X CAR), 129.0 (6C, 6 X CAR), 143.6 (3C, 3 X Cq AR); HRMS (ASAP-TOF) m/z found for 
[M+NH4]
+: 736.2462; [C35H42O12S2+NH4]
+ requires 736.2465. 
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(R)-1-((3aR,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-3a-
((((trifluoromethyl)sulfonyl)oxy)methyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-
d]pyran-5-yl)-2-(trityloxy)ethyl trifluoromethanesulfonate (417) 
 
Trifluoromethanesulfonic anhydride (0.071 ml, 0.43 mmol, 2.4 equiv.) was added dropwise over 
15 minutes to a stirred solution of pyridine (0.057 ml, 0.71 mmol, 4 equiv.) and 417 (0.100 g, 
0.18 mmol) in dry DCM (1.8 ml) at 0 oC. The reaction mixture was stirred at 0 oC and monitored 
by TLC until full consumption of the starting material was observed. The mixture was diluted 
with DCM and was treated with ice-cold water (ca. 10 ml), and the layers were separated. The 
aqueous layer was then extracted with DCM twice.  The combined organic extracts were washed 
with water, saturated aqueous copper sulfate solution and dried over anhydrous MgSO4. 
Filtration and removal of the solvent in vacuo afforded a pure yellow oil (0.128 g, 87%); [α]D 22 
= +4.9 (c 0.89 in CHCl3); IR νmax (film)/cm-1: 3000, 2925, 2853, 1491, 1450, 1417, 1385, 1210, 
1074, 983; 1H NMR (500 MHz, Chloroform-d) δ 1.29 (s, 3H, CH3 Isopropylidene), 1.31 (s, 3H, CH3 
Isopropylidene), 1.33 (s, 3H, CH3 Isopropylidene), 1.35 (s, 3H, CH3 Isopropylidene), 3.43 (dd, J = 11.8, 3.5 Hz, 
1H, H-C-7), 3.62 (dd, J = 11.8, 2.3 Hz, 1H, H’-C-7), 4.25 (d, J = 10.5 Hz, 1H, 1H of CH2OTf), 
4.31 (d, J = 2.7 Hz, 1H, H-C-2), 4.37 (dd, J = 7.8, 2.1 Hz, 1H, H-C-4), 4.39 (d, J = 10.5 Hz, 1H, 
1H of CH2OTf), 4.50 (dd, J = 7.7, 2.1 Hz, 1H, H-C-5), 4.71 (dd, J = 7.8, 2.7 Hz, 1H, H-C-3), 5.11 
(ddd, J = 7.7, 3.5, 2.3 Hz, 1H, H-C-6), 7.22 – 7.27 (m, 3H, 3 X H-CAR), 7.27 – 7.33 (m, 6H, 6 X 
H-CAR), 7.44 – 7.48 (m, 6H, 6 X H-CAR); 13C NMR (126 MHz, CDCl3) δ 23.7 (1C, CH3 
Isopropylidene), 25.0 (1C, CH3 Isopropylidene), 25.6 (1C, CH3 Isopropylidene), 26.5 (1C, CH3 Isopropylidene), 61.2 
(1C, C-7), 66.8 (1C, C-5), 69.5 (1C, C-4), 70.3 (1C, C-2), 70.6 (1C, C-3), 73.5 (1C, CH2OTf), 85.3 
(1C, C-6), 87.3 (1C, Cq Trityl), 100.6 (1C, C-1), 110.0 (1C, Cq Isopropylidene), 110.7 (1C, Cq Isopropylidene), 
127.4 (3C, 3 X CAR), 128.0 (6C, 6 X CAR), 129.0 (6C, 6 X CAR), 143.2 (3C, 3 X Cq AR);
 19F NMR 
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(471 MHz, CDCl3) δ -74.40, -75.08; HRMS (ASAP-TOF) m/z found for [M]+: 826.1537; 
[C35H36F6O12S2]
+ requires 826.1552. 
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((3aR,5R,5aS,8aS,8bR)-5-((R)-1-hydroxy-2-((triisopropylsilyl)oxy)ethyl)-2,2,7,7-
tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl acetate (418) 
 
To a stirred solution of 411 (0.753 g, 2.08 mmol) in dry DCM at 0 oC, was added imidazole 
(0.353 g, 5.19 mmol, 2.5 equiv.) and DMAP (0.051 g, 0.42 mmol, 0.2 equiv.). TIPSCl (0.53 ml, 
2.49 mmol, 1.2 equiv.), was then added dropwise to this suspension. The resultant mixture was 
stirred at rt for 24hr. The reaction mixture was then quenched with saturated aqueous NH4Cl and 
extracted with DCM three times. The combined organic extracts were washed with water, brine, 
and dried over anhydrous MgSO4. After filtration, the solvent was removed in vacuo. The crude 
product was purified by flash column chromatography on silica gel (petrol:EtOAc, 11:2) to 
furnish the title compound as a pure colourless oil (0.961 g, 89%); [α]D 22 = +2.6 (c 0.91 in 
CHCl3); IR νmax (film)/cm-1: 3543, 2990, 2943, 2895, 2867, 1753, 1230, 1073; 1H NMR (500 
MHz, Chloroform-d) δ 1.04 – 1.08 (m, 18H, 6 X CH3 TIPS), 1.08 – 1.16 (m, 3H, 3 X H-CMe2 
TIPS), 1.36 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 Isopropylidene), 1.45 (s, 3H, CH3 Isopropylidene), 1.51 
(s, 3H, CH3 Isopropylidene), 2.09 (s, 3H, CH3 Acetate), 2.80 (d, J = 5.3 Hz, 1H, OH), 3.72 (dd, J = 9.6, 
5.4 Hz, 1H, H-C-7), 3.80 (dd, J = 8.4, 1.9 Hz, 1H, H-C-5), 3.84 – 3.89 (m, 1H,  H-C-6), 3.91 (dd, J 
= 9.6, 3.8 Hz, 1H, H’-C-7), 3.96 (d, J = 11.6 Hz, 1H, 1H of CH2OAc), 4.33 (d, J = 2.6 Hz, 1H, H-
C-2), 4.42 (d, J = 11.6 Hz, 1H, 1H of CH2OAc), 4.49 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.66 (dd, J 
= 7.9, 2.6 Hz, 1H, H-C-3); 
13C NMR (126 MHz, CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 18.1 (3C, 3 
X CH3 TIPS), 18.1 (3C, 3 X CH3 TIPS), 21.0 (1C, CH3 Isopropylidene), 24.4 (1C, CH3 Isopropylidene), 25.3 
(1C, CH3 Isopropylidene), 26.0 (1C, CH3 Isopropylidene), 26.8 (1C, CH3 Acetate), 64.4 (1C, C-7), 65.0 (1C, 
CH2OAc), 68.3 (1C, C-5), 69.6 (1C, C-6), 70.7 (1C, C-2), 71.0 (1C, C-4), 71.0 (1C, C-2), 102.2 (1C, 
C-1), 109.0 (1C, Cq Isopropylidene), 109.5 (1C, Cq Isopropylidene), 170.2 (1C, Cq Acetate); HRMS (ESI-
TOF) m/z found for [M+Na]+: 541.2821; [C25H46O9Si+Na]
+ requires 541.2809. 
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(R)-1-((3aR,5R,5aS,8aS,8bR)-3a-(hydroxymethyl)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-2-((triisopropylsilyl)oxy)ethanol (419) 
 
Anhydrous K2CO3 (0.156 g, 1.13 mmol, 1.21 equiv.) was added to a stirred solution of 418 
(0.485 g, 0.93 mmol) in dry methanol (9.4 ml). The mixture was stirred at rt until TLC showed 
complete consumption of starting material. The solvent was then removed under reduced 
pressure. The residue was treated with water and Et2O, and the layers were separated. The 
aqueous layer was then extracted with Et2O two times. The combined organic extracts were 
washed with water, brine, and dried over anhydrous MgSO4. Filtration and removal of the 
solvent under reduced pressure gave a crude oil. The crude product was purified by flash column 
chromatography (petrol:EtOAc, 4:1) to yield the title compound as a pure colourless oil (0.344 g, 
77%); [α]D 22 = -14.2 (c 0.73 in CHCl3); IR νmax (film)/cm-1: 3503, 2942, 2894, 2867, 1101, 1072; 
1H NMR (400 MHz, Chloroform-d) δ1.02 – 1.17 (m, 21H, 6X CH3 TIPS, 3 X H-CMe2 TIPS), 1.38 
(s, 6H, 2 X CH3 Isopropylidene), 1.46 (s, 3H, CH3 Isopropylidene), 1.52 (s, 3H, CH3 Isopropylidene), 2.81 (br, 
1H, OH), 3.63 (d, J = 11.6 Hz, 1H, 1H of CH2OH), 3.69 (d, J = 11.6 Hz, 1H, 1H of CH2OH), 
3.73 – 3.79 (m, 1H, H-C-7), 3.83 (dd, J = 8.4, 1.8 Hz, 1H, H-C-5), 3.85 – 3.94 (m, 2H, H-C-6, H’-
C-7), 4.35 (d, J = 2.6 Hz, 1H, H-C-2), 4.51 (dd, J = 7.9, 1.8 Hz, 1H, H-C-4), 4.67 (dd, J = 7.9, 2.6 
Hz, 1H, H-C-3); 
13C NMR (101 MHz, CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 18.1 (6C, 6 X CH3 
TIPS), 24.3 (1C, CH3 Isopropylidene), 25.5 (1C, CH3 Isopropylidene), 25.8 (1C, CH3 Isopropylidene), 26.7 (1C, 
CH3 Isopropylidene), 64.3 (1C, C-7), 65.6 (1C, CH2OH), 68.3 (1C, C-5), 69.9 (1C, C-6), 70.9 (1C, C-4), 
71.0 (1C, C-3), 71.5 (1C, C-2), 103.8 (1C, C-1), 108.8 (1C, Cq Isopropylidene), 109.4 (1C, Cq 
Isopropylidene); HRMS (ASAP-TOF) m/z found for [M+H]
+: 472.2888; [C23H44O8Si+H]
+ requires 
477.2884. 
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(R)-1-((3aR,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-3a-
(((methylsulfonyl)oxy)methyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-2-
((triisopropylsilyl)oxy)ethyl methanesulfonate (420) 
 
MsCl (0.039 ml, 0.50 mmol, 2.5 equiv.) was added dropwise to a stirred solution of 419 (0.095 
g, 0.20 mmol) and Et3N (0.084 ml, 0.60 mmol, 3 equiv.) in dry DCM (2 ml) at 0 
oC. The mixture 
was stirred at rt for 2 hours. Saturated aqueous NaHCO3 was then added and the mixture was 
extracted three times with DCM. The combined organic extracts were washed with water twice, 
brine, and dried over anhydrous MgSO4. Filtration and removal of the solvent under reduced 
pressure gave a crude yellow oil. The crude product was purified by flash column 
chromatography (petrol:EtOAc, 5:2) to yield 420 as a pure colourless oil (0.107 g, 85%); [α]D 26 
= -12.4 (c 0.97 in CHCl3); IR νmax (film)/cm-1: 2942, 2867, 1359, 1210, 1177, 1070, 969; 1H 
NMR (500 MHz, Chloroform-d) δ 1.05 – 1.09 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.16 (m, 3H, 3 X 
H-CMe2 TIPS), 1.33 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.44 (s, 3H, CH3 
Isopropylidene), 1.55 (s, 3H, CH3 Isopropylidene), 3.05 (s, 3H, CH3 OMs), 3.09 (s, 3H, CH3 OMs), 3.92 (dd, J 
= 11.8, 5.5 Hz, 1H, H-C-7), 4.16 – 4.22 (m, 2H, H’-C-7, 1H of CH2OMs), 4.25 (dd, J = 6.5, 1.8 
Hz, 1H, H-C-5), 4.27 (d, J = 10.9 Hz, 1H of CH2OMs ), 4.33 (d, J = 2.6 Hz, 1H, H-C-2), 4.38 (dd, 
J = 7.9, 1.8 Hz, 1H, H-C-4), 4.68 (dd, J = 7.9, 2.6 Hz, 1H, H-C-3), 4.75 (ddd, J = 6.4, 5.5, 2.3 Hz, 
1H, H-C-6); 
13C NMR (126 MHz, CDCl3) δ 12.1 (3C, 3 X CHMe2 TIPS), 18.1 (3C, 3 X CH3 TIPS), 
18.1 (3C, 3 X CH3 TIPS), 24.1 (1C, CH3 Isopropylidene), 25.4 (1C, CH3 Isopropylidene), 25.9 (1C, CH3 
Isopropylidene), 26.8 (1C, CH3 Isopropylidene), 37.7 (1C, CH3 OMs), 38.5 (1C, CH3 OMs), 62.4 (1C, C-7), 
67.9 (1C, C-5), 69.1 (1C, CH2OMs), 70.4 (2C, C-2, C-4), 71.0 (1C, C-3), 82.2 (1C, C-6), 101.4 (1C, 
C-1), 109.8 (1C, Cq Isopropylidene), 110.0 (1C, Cq Isopropylidene); HRMS (ASAP-TOF) m/z found for 
[M+H]+: 633.2449; [C25H48O12S2Si+H]
+ requires 633.2435. 
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(R)-1-((3aR,5S,5aR,8aS,8bR)-2,2,7,7-tetramethyl-3a-
((((trifluoromethyl)sulfonyl)oxy)methyl)tetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-
d]pyran-5-yl)-2-( triisopropylsilyl)oxy)ethyl trifluoromethanesulfonate (422) 
 
Trifluoromethanesulfonic anhydride (0.075 ml, 0.45 mmol, 2.4 equiv.) was added dropwise over 
15 minutes to a stirred solution of 419 (0.089 g, 0.19 mmol) and pyridine (0.06 ml, 0.75 mmol, 4 
equiv.) in dry DCM (1.9 ml) at 0 oC. The reaction mixture was stirred at 0 oC and monitored by 
TLC until full consumption of the starting material was observed. The mixture was diluted with 
DCM and was treated with ice-cold water (ca. 10 ml), and the layers were separated. The 
aqueous layer was extracted with DCM twice.  The combined organic extracts were washed with 
water, saturated aqueous copper sulfate solution, and dried over anhydrous MgSO4. Filtration 
and removal of the solvent in vacuo afforded the title compound as a pure yellow oil (0.131 g, 
99%); [α]D26 = -6.5 (c 0.93 in CHCl3); IR νmax (film)/cm-1: 2945, 2869, 1416, 1385, 1210, 
1145, 1071, 920; 1H NMR (500 MHz, Chloroform-d) δ 1.05 – 1.09 (m, 18H, 6 X CH3 TIPS), 
1.09 – 1.16 (m, 3H, 3 X H-CMe2 TIPS), 1.34 (s, 3H, CH3 Isopropylidene), 1.39 (s, 3H, CH3 
Isopropylidene), 1.43 (s, 3H, CH3 Isopropylidene), 1.54 (s, 3H, CH3 Isopropylidene), 4.00 (dd, J = 12.2, 5.7 Hz, 
1H, H-C-7), 4.20 (dd, J = 12.2, 2.5 Hz, 1H, H’-C-7), 4.28 (dd, J = 5.7, 1.9 Hz, 1H, H-C-5), 4.31 
(d, J = 2.7 Hz, 1H, H-C-2), 4.34 (dd, J = 7.9, 1.9 Hz, 1H, H-C-4), 4.37 (d, J = 10.6 Hz, 1H, 1H of 
CH2OTf), 4.50 (d, J = 10.6 Hz, 1H, 1H of CH2OTf), 4.70 (dd, J = 7.9, 2.7 Hz, 1H, H-C-3), 5.07 
(td, J = 5.7, 2.5 Hz, 1H, H-C-6); 13C NMR (101 MHz, CDCl3) δ 12.1(3C, 3 X CHMe2 TIPS), 
18.0 (3C, 3 X CH3 TIPS), 18.0 (3C, 3 X CH3 TIPS), 23.7 (1C, CH3 Isopropylidene), 25.0 (1C, 
CH3 Isopropylidene), 25.6 (1C, CH3 Isopropylidene), 26.7 (1C, CH3 Isopropylidene), 61.8 (1C, 
C-7), 67.8 (1C, C-5), 69.9 (1C, C-4), 70.5 (1C, C-2), 70.6 (1C, C-3), 74.1 (1C, CH2OTf), 87.6 
(1C, C-6), 100.6 (1C, C-1), 110.1 (1C, Cq Isopropylidene), 110.5 (1C, Cq Isopropylidene); 19F 
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NMR (471 MHz, CDCl3) δ -74.38, -74.93; HRMS (ASAP-TOF) m/z found for [M+H]+: 
741.1870; [C25H42O12F6S2Si+H]+ requires 741.1870. 
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S-(((3aS,5S,5aR,8aS,8bR)-5-(2-hydroxyacetyl)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl) ethanethioate (427) 
 
Compound 394 (0.084 g, 0.16 mmol), was dissolved in 80% Acetic acid (0.20 ml). The stirred 
reaction mixture was heated at 70 oC for 72 hours, after which the solvent was removed under 
reduced pressure. The crude residue was purified by flash column chromatography on silica gel 
(petrol:EtOAc, 1:1) to afford the title compound as a colourless oil (0.039 g, 66%);  [α]D 25 = -
80.3 (c 1.17 in CHCl3); IR νmax (film)/cm-1: 3496, 2890, 2937, 1731, 1698, 1211, 1070; 1H NMR 
(400 MHz, Chloroform-d) δ 1.30 (s, 3H, CH3 Isopropylidene), 1.40 (s, 3H, CH3 Isopropylidene), 1.47 (s, 
3H, CH3 Isopropylidene), 1.50 (s, 3H, CH3 Isopropylidene), 2.39 (s, 3H, CH3 Thioacetate), 3.31 (d, J = 13.8 
Hz, 1H, 1H of CH2SAc), 3.52 (d, J = 13.8 Hz, 1H, 1H of CH2SAc), 4.25 (d, J = 2.7 Hz, 1H, H-C-
2), 4.36 (d, J = 20.5 Hz, 1H, H-C-7), 4.41 (d, J = 2.2 Hz, 1H, H-C-5), 4.55 (dd, J = 7.8, 2.2 Hz, 
1H, H’-C-4), 4.56 (d, J = 20.5 Hz, 1H, H’-C-7), 4.65 (dd, J = 7.8, 2.7 Hz, 1H, H-C-3); 13C NMR 
(101 MHz, CDCl3) δ 24.1 (1C, CH3 Isopropylidene), 24.9 (1C, CH3 Isopropylidene), 25.7 (1C, CH3 
Isopropylidene), 26.5 (1C, CH3 Isopropylidene), 30.5 (1C, CH3 Thioacetate), 37.5 (1C, CH2SAc), 68.0 (1C, C-
7), 71.1 (1C, C-3), 72.1 (1C, C-4), 73.2 (1C, C-2), 74.6 (1C, C-5), 103.0 (1C, C-1), 109.3 (1C, Cq 
Isopropylidene), 110.2 (1C, Cq Isopropylidene), 194.3 (1C, Cq Thioacetate), 208.7 (1C, C-6 Ketone); HRMS (NSI-
FTMS) m/z found for [M+NH4]
+: 394.1528; [C16H26O8S+NH4]
+ requires 394.1530. 
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(2S,3R,4S,5S,6R)-6-(acetoxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate (-
63)8–11 
 
Sodium acetate (2.0 g, 24.4 mmol, 1.09 equiv.) was added to acetic anhydride (40 ml) at rt. The 
mixture was then heated to 120 oC and stirred for 30 minutes. Then D-galactose 433 (4.0 g, 22.2 
mmol) was added portion wise to the stirred solution. The reaction mixture was stirred at 120 oC 
for 3 hours. The mixture was then cooled and poured into ice-cold water (ca. 40 ml), then 
neutralized with saturated aqueous NaHCO3. The mixture was then extracted with DCM (ca. 200 
X 3). The combined organic extracts were washed with water, brine, and dried over anhydrous 
MgSO4. Filtration and removal of the solvent under reduced pressure gave a crude colourless 
residue. Recrystallization from hexane/ethyl acetate (2:1) afforded the title compound as a 
colourless solid (5.563 g, 64%); mp 140 – 143 oC [lit. 143-144 oC],8 [lit. 139-142 oC]9; [α]D22 = 
+22.7 (c 1.04 in CHCl3) [lit. [α]D20 = +22 (c 1 in CHCl3)],10 [lit. [α]D23.5 = +27.1 (c 1.03 in 
CHCl3)]
11; IR νmax (film)/cm-1: 2984, 2941, 1752, 1223, 1067; 1H NMR (400 MHz, Chloroform-
d) δ 1.99 (s, 3H, CH3 Acetate), 2.04 (s, 6H, 2 X CH3 Acetate), 2.12 (s, 3H, CH3 Acetate), 2.16 (s, 3H, 
CH3 Acetate), 4.05 (ddd, J = 7.1, 6.1, 1.2 Hz, 1H, H-C-5), 4.09-4.18 (m, 2H, H-C-7, H’-C-7), 5.07 
(dd, J = 10.4, 3.4 Hz, 1H, H-C-3), 5.33 (dd, J = 10.4, 8.3 Hz, 1H, H-C-2), 5.42 (dd, J = 3.4, 1.2 
Hz, 1H, H-C-4), 5.70 (d, J = 8.3 Hz, 1H, H-C-1 ); 
13C NMR (101 MHz, CDCl3) δ 20.6 (1C, CH3 
Acetate), 20.7 (1C, CH3 Acetate), 20.7 (2C, 2 X CH3 Acetate), 20.9 (1C, CH3 Acetate), 61.1 (1C, C-6), 66.9 
(1C, C-4), 67.9 (1C, C-2), 70.9 (1C, C-3), 71.8 (1C, C-5), 92.2 (1C, C-1), 169.1 (1C, Cq Acetate), 
169.5 (1C, Cq Acetate), 170.0 (1C, Cq Acetate), 170.2 (1C, Cq Acetate), 170.4 (1C, Cq Acetate). 
Data is in agreement with the literature references.8–11  
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((2R,3S,4R,5S,6S)-2-(acetoxymethyl)-6-cyanotetrahydro-2H-pyran-3,4,5-triyl triacetate 
 (64)12,13  
 
TMSCN (9.6 ml, 76. 7 mmol, 3 equiv.) was added dropwise to a stirred solution of compound -
63 (10.0 g, 25.6 mmol) in anhydrous nitromethane (42 ml), which formed a brown solution. 
After heating the solution to 35-37 oC, BF3.OEt2  (3.5 ml, 28.4 mmol, 1.1 equiv.) was added 
dropwise. The dark brown solution was stirred at 35-37 oC for 2 hours. The mixture was then 
concentrated in vacuo. The brown residue was dissolved in DCM and washed with water, then 
saturated aqueous NaHCO3 three times, water, brine, and dried over anhydrous MgSO4. 
Filtration and evaporation of the solvent in vacuo gave a crude brown residue. Recrystallization 
from methanol furnished 64 as yellow crystals (6.166 g, 67%); mp 166 -168 oC [lit. 169-170 
oC]12,13; [α]D22 = +36.0 (c 1.10 in CHCl3) [lit. [α]D18 = +34.1 (c 1.33 in CHCl3)],12 [lit. [α]D25 = 
+35.7 (c 3.74 in CHCl3)]
13; IR νmax (film)/cm-1: 2984, 2941, 1752, 1223, 1067; 1H NMR (400 
MHz, CDCl3) δ  2.00 (s, 3H, CH3 Acetate), 2.06 (s, 3H, CH3 Acetate), 2.12 (s, 3H, CH3 Acetate), 2.18 (s, 
3H, CH3 Acetate), 3.91 – 3.97 (m, H-C-5), 4.12 (d, J = 6.4 Hz, 2H, H-C-6, H’-C-6 ), 4.28 (d, J = 10.2 
Hz, 1H, H-C-1), 5.00 (dd, J = 10.2, 3.2 Hz, 1H, H-C-3), 5.40-5.45 (m, 1H, H-C-4), 5.53 (t, J = 10.2 
Hz, 1H, H-C-2).  
13C NMR (101 MHz, CDCl3) δ 20.6 (2C, 2 X CH3 Acetate), 20.7 (1C, CH3 Acetate), 
20.8 (1C, CH3 Acetate), 61.4 (1C, C-6), 66.2 (1C, C-2), 66.9 (1C, C-4), 67.0 (1C, C-1), 71.0 (1C, C-3), 
75.6 (1C, C-5), 114.5 (1C, Cq Nitrile), 168.9 (1C, Cq Acetate), 170.0 (1C, Cq Acetate), 170.1 (1C, Cq 
Acetate), 170.5 (1C, Cq Acetate); HRMS (NSI-FTMS) m/z found for [M+NH4]
+: 375.1398; 
[C15H19NO9+NH4]
+ requires 375.1398. 
Data is in agreement with the literature references.12,13  
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(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-
2-carbonitrile (436b) 
 
A solution of methanolic sodium methoxide (69 ml, 0.1M in MeOH, 6.9 mmol) was added 
dropwise to a stirred solution of 64 (13.970 g, 39.1 mmol) in dry methanol (30 ml). The mixture 
was stirred at rt for 2 h. The mixture was then concentrated in vacuo affording 435 (7.394 g) in 
an unpurified state, which was then used directly in the next step without any purification.  
Crude 435 (7.394 g) was then dissolved in dry DMF (143 ml) and cooled to 0 oC. To this stirred 
solution was added imidazole (2.66 g, 156.4 mmol, 4 equiv.) and TIPSCl (16.7 ml, 78.2 mmol, 2 
equiv.). The mixture was stirred for 72 hours at rt and was then concentrated in vacuo. The 
residue was then treated with water and DCM, and the layers were then separated. The aqueous 
layer was extracted with DCM twice. The combined organic extracts were washed with water, 
brine, and dried over anhydrous MgSO4. Filtration and evaporation of the solvent under reduced 
pressure furnished a colourless crude residue. The crude residue was purified by flash column 
chromatography on silica gel (petrol:EtOAc, 1:1) to yield 436b as a pure colourless oil (5.677 g, 
42%); [α]D24 = +28.1 (c 1.01 in CHCl3); IR νmax (film)/cm-1: 3391, 2942, 2892, 2867, 1463, 1142, 
1073; 1H NMR (400 MHz, CDCl3) δ 1.09 – 1.03 (m, 18H, 6 X CH3 TIPS), 1.17 – 1.09 (m, 3H, H-
CMe2 TIPS), 2.93 (br, 3H, 3 X OH), 3.44 – 3.49 (m, 1H, H-C-5), 3.52 (dd, J = 8.6, 3.1 Hz, 1H, H-
C-3), 4.11 – 3.96 (m, 4H, H-C-6, H’-C-6, H-C-1, H-C-2), 4.19 (m, 4.16 – 4.21, 1H, H-C-4). 13C 
NMR (101 MHz, CDCl3) δ 11.9 (3C, 3 X CHMe2 TIPS), 17.9 (3C, 3 X CH3 TIPS), 18.0 (3C, 3 X 
CH3 TIPS), 63.9 (1C, C-6), 69.0 (C-2), 69.5 (C-1), 69.7 (C-4), 74.6 (C-3), 78.3 (C-5), 116.6 (1C, CQ 
Nitrile); HRMS (NSI-FTMS) m/z found for [M+H]
+: 346.2045; [C16H31NO5Si+H]
+ requires 
346.2044. 
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2S,3S,4R,5S,6R)-3,4,5-tris(benzyloxy)-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-2-carbonitrile (437) 
 
Sodium hydride (0.045 g, 1.86 mmol, 3.7 equiv.) was added in one portion to a stirred solution 
of 436b (0.174 g, 0.50 mmol) in dry DMF (2 ml) at 0 oC. The mixture was then stirred at 0 oC for 
a further 30 minutes. Then benzyl bromide (0.27 ml, 2.27 mmol, 4.5 equiv.), was added 
dropwise to the mixture. The mixture was then stirred for 72 hours at rt, then quenched 
cautiously with methanol. The mixture was then concentrated under reduced pressure. The 
residue was treated with water (ca. 10 ml) and EtOAc (ca. 10 ml), and the layers were separated. 
The aqueous layer was then extracted with EtOAc twice. The combined organic extracts were 
washed with water, brine, and dried over anhydrous MgSO4. After Filtration, the solvent was 
removed under reduced pressure. Purification by flash column chromatography on silica gel 
(petrol:EtOAc, 12:1) afforded the title compound 437 as a pure colourless oil (0.140 g, 
45%);[α]D23 = +21.0 (c 0.99 in CHCl3);IR νmax (film)/cm-1: 3066, 3032, 2942, 2866, 1497, 1455, 
1110; 1H NMR (400 MHz, Chloroform-d) δ 1.01 – 1.06 (m, 18H, 6 X CH3 TIPS), 1.07 – 1.18 (m, 
3H, H-CMe2 TIPS), 3.39 (td, J = 6.7 1.1 Hz, 1H, H-C-5), 3.51 (dd, J = 9.6, 2.8 Hz, 1H, H-C-3), 
3.74- 3.83 (m, 2H, H2-C-6), 3.98 (dd, J = 2.8, 1.1 Hz, 1H, H-C-4), 4.03 (d, J = 9.6 Hz, 1H, H-C-1), 
4.19 (t, J = 9.6 Hz, 1H, H-C-2), 4.66 (d, J = 11.3 Hz, 1H, 1H of CH2Ph Bn), 4.73 (d, J = 11.9 Hz, 
1H, 1H of CH2Ph Bn), 4.77 (d, J = 11.9 Hz, 1H, 1H of CH2Ph Bn), 4.98 – 5.00 (m, 3H, 3H of 
CH2Ph Bn), 7.27 – 7.41 (m, 15H, 15 X H-CAr). 13C NMR (101 MHz, CDCl3) δ 12.0 (3C, 3 X CH-
Me2 TIPS), 18.1 (3C, 3 X CH3 TIPS), 18.1 (3C, 3 X CH3 TIPS), 61.5 (1C, C-6), 68.1 (1C, C-1), 72.9 
(1C, CH2 Bn), 73.4 (1C, C-4), 75.1 (1C, CH2 Bn), 76.1 (1C, CH2 Bn), 76.5 (1C, C-2), 80.1 (1C, C-5), 
83.2 (1C, C-3), 117.0 (1C, Cq Nitrile), 127.8 (2C, 2 X CAR), 127.8 (1C, CAR), 128.0 (1C, CAR), 
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128.1 (1C, CAR), 128.3 (1C, CAR), 128.5 (2C, 2 X CAR), 128.6 (2C, 2 X CAR), 128.7 (2C, 2 X 
CAR), 128.7 (2C, 2 X CAR), 137.4 (1C, Cq AR), 138.0 (1C, Cq AR), 138.5 (1C, Cq AR); HRMS (NSI-
FTMS) m/z found for [M+H]+: 616.3446; [C37H49NO5Si+H]
+ requires 616.3453. 
Further elution (petrol:EtOAc, 7:1) gave compound 438 as a pure colourless oil (0.017 g, 6%); 
[α]D23 = +29.5 (c 0.84 in CHCl3); IR νmax (film)/cm-1: 3501, 3096, 3073, 3033, 2943, 2866, 1497, 
1456, 1210, 1108; 1H NMR (400 MHz, CDCl3) δ 1.03 – 1.08 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.17 
(m, 3H, H-CMe2 TIPS), 3.45 – 3.51 (m, 1H, H-C-5), 3.60 (dd, J = 9.1, 3.0 Hz, 1H), 3.81 – 3.90 (m, 
3H, H2-C-6, H-C-2), 3.96 – 4.01 (m, 2H, H-C-1, H-C-4), 4.73 (d, J = 11.5 Hz, 1H, 1H of CH2Ph 
Bn), 4.81 (d, J = 11.5 Hz, 1H, 1H of CH2Ph Bn), 4.84 (d, J = 10.8 Hz, 1H, 1H of CH2Ph Bn), 4.92 
(d, J = 10.8 Hz, 1H, 1H of CH2Ph Bn), 7.43 – 7.29 (m, 10H, 10 X H-CAR). 13C NMR (101 MHz, 
CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 18.1 (3C, 3 X CH3 TIPS), 18.1 (3C, 3 X CH3 TIPS), 61.2 (1C, 
C-6), 67.7 (1C, C-1 or C-4), 74.9 (1C, C-3), 75.6 (1C, CH2 Bn), 75.6 (1C, CH2 Bn), 75.79 (1C, C-4 or 
C-1), 77.5 (1C, C-2) 79.9 (1C, C-5), 117.0 (1C, Cq Nitrile), 128.1 (2C, 2 X CAR), 128.3 (1C, CAR), 
128.5 (1C, CAR), 128.7 (2C, 2 X CAR), 128.8, 128.8 (2C, 2 X CAR), 137.3 (1C, Cq AR), 138.2 (1C, 
Cq AR); HRMS (ASAP-TOF) m/z found for [M+H]
+: 526.2990; [C30H43NO5Si+H]
+ requires 
526.2989. 
439 was also isolated as a pure colourless oil (0.009 g, 3%); [α]D23 = +7.5 (c 1.01 in CHCl3);IR 
νmax (film)/cm-1: 3480, 3090, 3065, 3032, 2943, 2866, 1463, 1455, 1211, 1105; 1H NMR (500 
MHz, Chloroform-d) δ 1.02 – 1.08 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.16 (m, 3H, H-CMe2 TIPS), 
2.97 (br, 1H, OH), 3.37 (ddd, J = 6.0, 4.7, 1.1 Hz, 1H, H-C-5), 3.47 (dd, J = 8.9, 3.0 Hz, 1H, H-C-
3), 3.91 (dd, J = 10.3, 4.7 Hz, 1H, H-C-6), 3.99 (dd, J = 10.4, 6.0, 1H, H’-C-6),  4.02 (d, J = 10.1 
Hz, 1H, H-C-1), 4.10 (dd, J = 10.1, 8.9 Hz, 1H, H-C-2), 4.13 – 4.15 (m, 1H, H-C-4), 4.75 (s, 2H, 
CH2Ph Bn), 4.90 (s, 2H, CH2Ph Bn), 7.29 – 7.41 (m, 10H, 10 X H-C-AR).13C NMR (126 MHz, 
CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 18.0 (3C, 3 X CH3 TIPS), 18.0 (3C, 3 X CH3 TIPS), 62.9 (1C, 
C-6), 66.8 (1C, C-4), 68.0 (1C, C-1) , 72.3 (1C, CH2 Bn), 75.9 (1C, C-2), 76.2 (1C, CH2 Bn), 78.8 
(1C, C-5), 81.6 (1C, C-3), 116.9 (1C, Cq Nitrile), 128.0 (2C, 2 X CAR), 128.3 (1C, CAR), 128.3 (1C, 
CAR), 128.7 (4C, 4 X CAR), 128.8 (2C, 2 X CAR), 137.3 (1C, Cq AR), 137.6 (1C, Cq AR); HRMS 
(ASAP-TOF) m/z found for [M+H]+: 526.2991; [C30H43NO5Si+H]
+ requires 526.2989. 
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Further elution (petrol:EtOAc, 3:1) gave compound 440 as a pure colourless solid (0.005 g, 2%); 
[α]D23 = +18.6 (c 0.99 in CHCl3); IR νmax (film)/cm-1: 3432, 3065, 3033, 2943, 2890, 2867, 1498, 
1463, 1367, 1212, 1108; 1H NMR (500 MHz, Chloroform-d) δ 1.04 – 1.09 (m, 18H, 6 X CH3 
TIPS), 1.09 – 1.17 (m, 3H, H-CMe2 TIPS), 3.40 – 3.43 (m, 1H, H-C-5), 3.53 (br, 1H, OH), 3.57 (dd, 
J = 8.8, 3.2 Hz, 1H, H-C-3), 3.91 – 3.95 (m, 1H, H-C-2), 3.99 (dd, J = 10.8, 4.3 Hz, 1H, H-C-6), 
4.01 (d, J = 10.0 Hz, 1H, H-C-1), 4.05 (dd, J = 10.8, 5.1 Hz, 1H, H’-C-6), 4.15 (dd, J = 3.2, 1.0 
Hz, 1H, H-C-4), 4.88 (d, J = 10.9 Hz, 1H, 1H of CH2Ph Bn), 4.95 (d, J = 10.9 Hz, 1H, 1H of 
CH2Ph Bn), 7.31 – 7.35 (m, 1H, H-CAR), 7.36 – 7.40 (m, 2H, 2 X H-CAR), 7.41 – 7.44 (m, 2H, 2 
X H-C-AR). 
13C NMR (101 MHz, CDCl3) δ 11.9 (3C, 3 X CHMe2 TIPS), 18.0 (3C, 3 X CH3 TIPS), 
18.0 (3C, 3 X CH3 TIPS), 63.9 (1C, C-6), 67.6 (1C, C-1), 69.8 (1C, C-4), 74.7 (1C, C-3), 75.7 (1C, 
CH2 Bn), 77.1 (1C, C-2), 78.1 (1C, C-5), 117.0 (1C, Cq Nitrile), 128.5 (1C, CAR) 128.6 (2C, 2 X 
CAR), 128.8 (2C, 2 X CAR), 137.4 (1C, Cq AR); HRMS (ASAP-TOF) m/z found for [M+H]
+: 
436.2518; [C23H37NO5Si+H]
+ requires 436.2519. 
441 was also isolated as a pure colourless solid (0.009 g, 4%); [α]D23 = +13.9 (c 0.66 in CHCl3); 
IR νmax (film)/cm-1: 3450, 3070, 3032, 2943, 2895, 2866, 1497, 1463, 1367, 1100; 1H NMR (400 
MHz, CDCl3) δ 1.01 –  1.08 (m, 18H, 6 X CH3 TIPS), 1.09 – 1.15 (m, 3H, H-CMe2 TIPS) 2.65 (br, 
1H, OH), 2.90 (br, 1H, OH), 3.34 (dd, J = 9.0, 3.0 Hz, 1H, H-C-3), 3.39 – 3.43 (m, 1H, H-C-5), 
3.91 (dd, J = 10.3, 4.7 Hz, 1H, H-C-6), 3.96 – 4.04 (m, 2H, H’-C-6, H-C-1), 4.14 – 4.21 (m, 2H, 
H-C-4, H-C-2), 4.69 (d, J = 11.9 Hz, 1H, 1H of CH2Ph Bn), 4.78 (d, J = 11.9 Hz, 1H, , 1H of 
CH2Ph Bn), 7.30 – 7.41(m, 5H, 5 X H-C-AR). 13C NMR (101 MHz, CDCl3) δ12.0 (3C, 3 X CH-
Me2 TIPS). 18.0 (3C, 3 X CH3 TIPS), 18.0 (3C, 3 X CH3 TIPS), 62.9 (1C, C-6), 66.3 (1C, C-4), 68.3 
(1C, C-2), 69.1 (1C, C-1), 72.2 (1C, CH2 Bn), 79.0 (1C, C-5), 81.4 (1C, C-3), 116.4 (1C, Cq Nitrile), 
128.1 (2C, 2 X CAR), 128.5 (1C, CAR), 128.9 (2C, 2 X CAR), 137.5 (1C, Cq AR); HRMS (ASAP-
TOF) m/z found for [M+H]+: 436.2521; [C23H37NO5Si+H]
+ requires 436.2519. 
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(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-
2-carbonitrile (437) 
 
Sodium hydride (0.377 g, 15.69 mmol, 4.95 equiv.) in one portion was added to a stirred solution 
of 436b (1.096 g, 3.17 mmol) in dry THF (12.7 ml) at 0 oC. The mixture was then stirred at 0 oC 
for a further 30 minutes. Then, after the dropwise addition of benzyl bromide (1.7 ml,14.30 
mmol, 4.5 equiv.), TBAI (0.094 g, 0.25 mmol, 0.08 equiv.) was added. The mixture was then 
stirred for 72 hours at rt, then quenched cautiously with methanol. The mixture was then 
concentrated in vacuo. The residue was treated with water (ca. 50 ml) and EtOAc (ca. 50 ml). 
The layers were separated. The aqueous layer was then extracted with EtOAc twice.  The 
combined organic extracts were washed with water, brine, and dried over anhydrous MgSO4.  
After Filtration, the solvent was removed under reduced pressure. The crude product was 
purified by flash column chromatography on silica gel (petrol:EtOAc, 12:1) to furnish 437 as a 
pure colourless oil (1.358 g, 70%). 
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Sodium (2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-
carboxylate (448)14 
 
A solution of methanolic sodium methoxide (7.3 ml, 0.73 mmol, 0.1 M in methanol, 0.18 equiv.) 
was added dropwise to a stirred solution of 64 (1.449 g, 4.06 mmol) in dry methanol (3.1 ml). 
The mixture was stirred at rt for 2 h. The mixture was then concentrated in vacuo affording crude 
435 (0.764 g), which was then used directly in the next step without any purification.   
Crude 435 (0.764 g) was then dissolved in 12.5% aqueous NaOH (18 ml). The stirred solution 
was refluxed for 3 hours. After the brown reaction mixture was cooled to rt, water (60 ml) was 
added. The solution was then acidified with Amberlite IR-120 (H+-form) and filtered. The filtrate 
was evaporated under reduced pressure to furnish 448 as a colourless solid (0.969 g, 60% over 
two steps ); [α]D22 = +75.8 (c 0.95 in H2O) [lit. [α]D25 = +51.8 (c 1.03 in H2O)]14; IR νmax 
(film)/cm-1: 3391, 2918, 1725, 1091; 1H NMR (500 MHz, D2O) δ 3.64 – 3.84 (m, 6H, H-C-1, H-
C-2, H-C3, H-C5, H-C-6, H’-C-6), 3.95 (bd, J = 3.3 Hz, H-C-4). 13C NMR (126 MHz, D2O; internal 
standard, methanol) δ 61.9 (1C, C-6), 69.7 (1C, C-2), 69.7 (1C, C-4), 74.5 (1C, C-3), 79.0 (1C, C-5), 
80.1 (1C, C-1), 177.0 (1C, Cq carboxylate); HRMS (NSI-FTMS) m/z found for [M-Na]
-: 207.0510; 
[C7H12O7-Na]
- requires 207.0510. 
Data is in agreement with the literature reference.14 
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(2R,3R,4S,5R,6R)-methyl 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-
carboxylate (446)15,16 
 
Acetyl chloride (1.24 ml, 17.4 mmol, 7.15 equiv.) was added dropwise over 10 minutes to dry 
methanol (7.5 ml) in a 3-neck round bottom flask fitted with a condenser at 0 oC and was stirred 
for 5 minutes. Compound 448 (0.969 g, 2.43 mmol) was added in one portion to the stirred 
solution. The solution was then heated under reflux for 72 hours. The mixture was then 
concentrated in vacuo furnishing a crude brown solid. The crude residue was purified by 
trituration with EtOAc affording the title compound as a pure brown solid (0.537 g, quant.); mp 
121 – 122 oC [lit. 121 – 123 oC]15; [α]D22 = -33.8 (c 1.30 in H2O) [lit. [α]D20 = -32 (c 0.12 in 
H2O)]
15; IR νmax (film)/cm-1: 3347, 2924, 2854, 1722, 1251, 1089; 1H NMR (400 MHz, 
Deuterium Oxide) δ 3.70 – 3.86 (m, 5H, H-C-3, H-C-4, H-C-5, H-C-6, H’-C-6), 3.87 (s, 3H, CH3 
Ester), 3.97 – 4.05 (m, 2H, H-C-2, H-C-1); 13C NMR (101 MHz, D2O; internal standard, methanol) 
δ 53.6 (1C, CH3 Ester), 61.7 (1C, C-6), 69.0 (1C, C-2), 69.3 (1C, C-4), 74.1 (1C, C-3), 79.1 (1C, C-1), 
79.6 (1C, C-5), 172.1 (1C, Cq Ester); HRMS (NSI-FTMS) m/z found for [M+H]
+: 223.0814; 
[C8H14O7+H]
+ requires 223.0812. 
Data is in agreement with the literature references.15,16 
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2R,3R,4S,5R,6R)-methyl 3,4,5-trihydroxy-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-2-carboxylate (449) 
 
To a solution of 446 (0.338 g, 1.52 mmol) in dry DMF (5.6 ml) at 0 oC, was added imidazole 
(0.414 g, 6.08 mmol, 4 equiv.), then TIPSCl (0.65 ml, 3.04 mmol, 2 equiv.) dropwise. The 
mixture was stirred for 72 hours at rt and then concentrated in vacuo. The residue was then 
treated with water and DCM, and the layers were then separated. The aqueous layer was then 
extracted with DCM twice. The combined organic extracts were washed with water, brine, and 
dried over anhydrous MgSO4. Filtration and removal of the solvent in vacuo furnished a 
colourless crude residue. The crude residue was purified by flash column chromatography on 
silica gel (petrol:EtOAc, 1:2) to yield 449 as a pure colourless oil ( 0.141 g, 24%); [α]D23 = +16.3 
(c 0.81 in CHCl3);IR νmax (film)/cm-1: 3390, 2944, 2891, 2867, 1739, 1244, 1105, 1071; 1H NMR 
(400 MHz, CDCl3) δ 1.07 – 1.03 (m, 18H, 6 X CH3 TIPS), 1.16 – 1.08 (m, 3H, H-CMe2 TIPS), 3.16 
(br, 2H, 2 X OH), 3.41 (br, 1H, OH), 3.54 (ddd, J = 6.6, 4.8, 1.2 Hz, 1H, H-C-5), 3.61 (dd, J = 
9.2, 3.3 Hz, 1H, H-C-3), 3.78 – 3.82  (m, 4H, CH3 Ester, H-C-1), 3.95 (dd, J = 10.2, 4.8 Hz, 1H, H-
C-6), 4.05 – 3.98 (m, 2H, H-C-6, H-C-2), 4.16 (dd, J = 3.3, 1.2 Hz, 1H, H-C-4). 13C NMR (101 
MHz, CDCl3) δ12.0 (3C, 3 X CHMe2 TIPS), 18.0 (3C, 3 X CH3 TIPS), 18.0 (3C, 3 X CH3 TIPS), 52.8 
(1C, CH3 Ester), 62.9 (1C, C-6), 68.8 (1C, C-4), 69.6 (1C, C-2), 74.8 (1C, C-3), 78.1 (1C, C-1), 78.4 
(1C, C-5), 170.7 (1C, Cq Ester); HRMS (NSI-FTMS) m/z found for [M+H]
+: 379.2150; 
[C17H34O7Si+H]
+ requires 371.2147. 
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((2R,3R,4R)-methyl 3,4-bis(benzyloxy)-2-(((triisopropylsilyl)oxy)methyl)-3,4-dihydro-2H-
pyran-6-carboxylate) (451) 
 
Methyl ester 449 (0.190 g, 0.50 mmol) was dissolved in dry DMF (2 ml). After cooling the 
stirred solution to 0 oC, sodium hydride (0.060 g, 2.48 mmol, 4.95 equiv.) was added in one 
portion. The mixture was stirred at 0 oC for a further 30 minutes. Then, after the dropwise 
addition of benzyl bromide (1.7 ml,14.30 mmol, 4.5 equiv.), TBAI (0.094 g, 0.25 mmol, 0.08 
equiv.) was added. The mixture was then stirred for 72 hours at rt, then quenched cautiously with 
methanol. The mixture was then concentrated under reduced pressure. The residue was treated 
with water (ca. 20 ml) and EtOAc (ca. 20 ml), and the layers were separated. The aqueous layer 
was then extracted with EtOAc twice.  The combined organic extracts were washed with water, 
brine, and dried over anhydrous MgSO4.  After Filtration, the solvent was removed under 
reduced pressure. The crude product was purified by flash column chromatography on silica gel 
(petrol:EtOAc, 10:1) to furnish glycal 451 as a pure colourless oil (0.160 g, 59%); [α]D23 = +46.8 
(c 0.88 in CHCl3); IR νmax (film)/cm-1: 3089, 3064, 3031, 2943, 2890, 2866, 1737, 1651, 1497, 
1455, 1285, 1103, 1063; 1H NMR (400 MHz, Chloroform-d) δ 1.04 – 1.10 (m, 18H, 6 X CH3 
TIPS), 1.11 – 1.19 (m, 3H, H-CMe2 TIPS), 3.81 (s, 3H, CH3 Ester), 4.00 – 4.12 (m, 3H, H-C-6, H’-C-6, 
H-C-5), 4.13 – 4.18 (m, 1H, H-C-3), 4.38 – 4.42 (m, 1H, H-C-4), 4.67 (d, J = 12.1 Hz, 1H, 1H of 
CH2Ph Bn), 4.74 (d, J = 12.1 Hz, 1H, 1H of CH2Ph Bn), 4.76 (d, J = 11.6 Hz, 1H, 1H of CH2Ph 
Bn), 5.01 (d, J = 11.6 Hz, 1H, 1H of CH2Ph Bn), 6.15 (t, J = 2.1 Hz, 1H, H-C-2), 7.25 – 7.43 (m, 
10H, 10 X H-CAR). 
13C NMR (101 MHz, CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 18.1 (3C, 3 X 
CH3 TIPS), 18.1 (3C, 3 X CH3 TIPS), 52.4 (1C, CH3 Ester), 61.1 (1C, C-6), 69.3 (1C, C-3), 71.1 (1C, 
CH2 Bn), 72.9 (1C, C-4), 74.6 (1C, CH2 Bn), 78.5 (1C, C-5), 109.7 (1C, C-2), 127.6 (2C, 2 X CAR), 
127.6(1C, CAR), 127.9 (1C CAR), 128.0 (2C, 2 X CAR), 128.3 (2C, 2 X CAR), 128.6 (2C, 2 X 
CAR), 138.1 (1C, Cq AR), 138.7 (1C, Cq AR), 143.9 (1C, C-1), 162.8 (1C, Cq Ester); HRMS (NSI-
FTMS) m/z found for [M+NH4]
+: 558.3242; [C31H44O6Si+NH4]
+ requires 558.3245. 
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(((2S,3S,4R,5S,6R)-3,4,5-tris(benzyloxy)-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-
pyran-2-yl)methanamine) (458) and (((2R,3S,4R,5S,6S)-6-(aminomethyl)-3,4,5-
tris(benzyloxy)tetrahydro-2H-pyran-2-yl)methanol) (457) 
 
Red-Al® (52 μl, 3.5 M in toluene, 0.18 mmol, 1 equiv.) was added dropwise to a stirred solution 
of 437 (0.111 g, 0.18 mmol) in dry toluene (1.8 ml) at -78 oC. The stirred reaction mixture was 
then warmed slowly to 0 oC over 30 minutes. After 90 minutes at 0 oC, 1M aqueous tartaric acid 
(ca. 1 ml) was added. After warming to rt, the suspension was poured into Et2O (ca. 10 ml) and 
the layers were then separated. The aqueous layer was extracted with Et2O (2 X 10 ml). The 
combined organic layers were washed with water, brine, and dried over anhydrous MgSO4. 
Filtration and the removal of the solvent under reduced pressure furnished a crude residue.  The 
crude residue was purified by flash column chromatography on silica gel (DCM:methanol, 20:1) 
to afford 458 as a pure colourless oil (0.005 g, 4%); [α]D23 = +34.5 (c 0.73 in CHCl3); IR νmax 
(film)/cm-1: 3088, 3064, 3031, 2942, 2865, 1497, 1454, 1364, 1108, 1069; 1H NMR (400 MHz, 
Chloroform-d) δ 1.05 – 1.11 (m, 18H, 6 X CH3 TIPS), 1.11 – 1.20 (m, 3H, H-CMe2 TIPS), 1.95 – 
2.19 (br, 2H, 2 X OH), 2.81 (br, 1H, 1H of CH2NH2), 3.07 (s, 1H br, 1H, 1H of CH2NH2), 3.20 – 
3.31 (m, 1H, H-C-1), 3.42 – 3.48 (m, 1H, H-C-5 ), 3.67 (dd, J = 9.4, 2.8 Hz, 1H, H-C--3), 3.73 – 
3.87 (m, 3H, H-C-6, H’-C-6, H-C-2), 4.04 – 4.09 (m, 1H, H-C-4), 4.63 – 4.83 (m, 5H, 5 X CH2Ph 
Bn), 4.98 (d, J = 11.6 Hz, 1H , 1H of CH2Ph Bn), 5.01 (d, J = 11.6 Hz, 1H , 1H of CH2Ph Bn), 7.45 
– 7.27 (m, 15H, 15 X H-CAR). 13C NMR (101 MHz, CDCl3) δ12.0 (3C, 3 X CHMe2 TIPS), 18.1 
(3C, 3 X CH3 TIPS), 18.2 (3C, 3 X CH3 TIPS), 43.1 (1C, CH2NH2), 62.1 (1C, C-6), 72.4 (1C, CH2 
Bn), 73.9 (1C, C-4), 74.8 (1C, CH2 Bn), 75.3 (1C, CH2 Bn), 76.5 (1C, C-2), 78.9 (1C, C-5), 80.9 (1C, 
C-1), 85.1 (1C, C-3), 127.6 (1C, CAR), 127.7 (2C, 2 X CAR), 127.8 (1C, CAR), 127.9 (1C, CAR), 
128.1 (2C, 2 X CAR), 128.3 (2C, 2 X CAR), 128.4 (2C, 2 X CAR), 128.6 (4C, 4 X CAR), 138.4 (1C, 
Cq AR), 138.5 (1C, Cq AR), 139.1 (1C, Cq AR); HRMS (ESI-TOF) m/z found for [M+H]
+: 
620.3776; [C37H53NO5Si+H]
+ requires 620.3771. 
288 
 
Further elution (DCM:methanol, 10:1) gave compound 457 as a pure colourless solid (0.065 g, 
78%); mp 122 – 144 oC; [α]D23 = +60.3 (c 0.69 in CHCl3); IR νmax (film)/cm-1: 3367, 3309, 3088, 
3063, 3030, 2917, 2863, 1469, 1454, 1102, 1027; 1H NMR (400 MHz, Chloroform-d) δ 2.44 (br, 
2H, 2 X OH), 2.78 (d, J = 12.7 Hz, 1H, 1H of CH2NH2), 3.06 (d, J = 13.7 Hz, 1H, 1H of 
CH2NH2), 3.20 – 3.29 (m, 1H, H-C-1), 3.38 – 3.49 (m, 2H, H-C-5, H-C-6), 3.64 (dd, J = 9.4, 2.7 
Hz, 1H, H-C-3), 3.68 – 3.81 (m, 2H, H-C-2, H’-C-6), 3.85 – 3.90 (m, 1H, H-C-4), 4.64 (d, J = 10.6 
Hz, 1H, 1H of CH2Ph Bn), 4.67 (d, J = 11.3 Hz, 1H, 1H of CH2Ph Bn), 4.73 (d, J = 11.7 Hz, 1H, 
1H of CH2Ph Bn), 4.79 (d, J = 11.7 Hz, 1H, 1H of CH2Ph Bn), 4.82 (d, J = 10.6 Hz, 1H, 1H of 
CH2Ph Bn), 4.83 (d, J = 11.3 Hz, 1H, 1H of CH2Ph Bn), 7.24 – 7.43 (m, 15H, 15 X H-CAR). 13C 
NMR (101 MHz, CDCl3) δ 43.1 (1C, CH2NH2), 62.5 (1C, C-6), 72.6 (1C, CH2 Bn), 73.8 (1C, C-4), 
74.4 (1C, CH2 Bn), 75.4 (1C, CH2 Bn), 76.4 (1C, C-2), 79.1 (1C, C-5), 80.6 (1C, C-1), 85.1 (1C, C-
3), 127.7 (2C, 2 X CAR), 127.9 (1C, CAR), 128.0 (1C, CAR), 128.0 (1C, CAR), 128.3 (2C, 2 X CAR), 
128.5 (2C, 2 X CAR), 128.6 (2C, 2 X CAR), 128.6 (2C, 2 X CAR), 128.7 (2C, 2 X CAR), 138.28 
(1C, Cq AR), 138.29 (1C, Cq AR), 138.42 (1C, Cq AR); HRMS (ESI-TOF) m/z found for [M+H]
+: 
464.2438; [C28H33NO5Si+H]
+ requires 464.2438.  
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(2R,3S,4R,5S,6S)-2-(acetoxymethyl)-6-((E)-(2-tosylhydrazono)methyl)tetrahydro-2H-
pyran-3,4,5-triyl triacetate (465)17
 
Raney nickel grade 2800 (ca. 12.6 g from an aqueous suspension) was added to a stirred solution 
of pyridine (47.8 ml), acetic acid (28.6 ml) and water (28.6 ml). To the heterogenous mixture 
was then added sodium hypophosphite monohydrate (7.48 g, 70.5 mmol, 8.4 equiv.), 
tosylhydrazide (2.64 g, 14.3 mmol, 1.7 equiv.) and compound 64 (3.0 g, 8.40 mmol). After 
leaving the reaction for 24 hours, the mixture was filtered through a pad of celite and washed 
with DCM. The layers of the filtrate were then separated. The aqueous layer was extracted with 
DCM twice. The combined organic layers were washed with 10% aqueous HCl (ca. 2 X 30 ml), 
saturated aqueous NaHCO3 solution (ca. 2 X 30 ml), water (ca. 30 ml), brine (ca. 30 ml), and 
dried over anhydrous MgSO4. Filtration and removal of the solvent in vacuo gave a crude 
residue. The crude residue was purified by flash column chromatography on silica gel 
(hexane:EtOAc, 3:2) to furnish 465 as a pure colourless solid (3.682 g, 83%); mp 68-70 oC; 
[α]D26 = +10.1 (c 1.27 in CHCl3) [lit. [α]D = +6 (c 0.97 in CHCl3)]17; IR νmax (film)/cm-1: 3620, 
3198, 2970, 1751, 1371, 1225, 1166, 1056; 1H NMR (500 MHz, DMSO-d6) δ 1.66 (s, 3H, CH3 
Acetate), 1.90 (s, 3H, CH3 Acetate), 1.98 (s, 3H, CH3 Acetate), 2.10 (s, 3H, CH3 Acetate), 2.37 (s, 3H, CH3 
Tosylate), 3.94 (dd, J = 11.5, 7.2 Hz, 1H, H-C-6), 3.98 – 4.01 (m, 1H, H’-C-6), 4.14 (dd, J = 10.0, 
6.7 Hz, 1H, H-C-1), 4.22 (ddd, J = 7.2, 5.2, 1.3 Hz, 1H, H-C-5), 4.95 (t, J = 10.0 Hz, 1H, H-C-2), 
5.22 (dd, J = 10.0, 3.5 Hz, 1H, H-C-3), 5.29 (dd, J = 3.5, 1.3 Hz, 1H, H-C-4), 7.00 (d, J = 6.7 Hz, 
1H, HC=N hydrazone), 7.39 – 7.43 (m, 2H, 2 X H-CAR Tosylate), 7.65 – 7.69 (m, 2H, 2 X H-CAR Tosylate 
), 11.61 (s, 1H, NH). 13C NMR (126 MHz, CDCl3) δ 20.4 (1C, CH3 Acetate), 20.7 (1C, CH3 Acetate), 
20.8 (1C, CH3 Acetate), 20.8 (1C, CH3 Acetate), 21.7 (1C, CH3 Tosylate), 61.8 (1C, C-6), 67.0 (1C, C-2), 
67.6 (1C, C-4), 71.0 (1C, C-3), 74.6 (1C, C-5), 78.4 (1C, C-1), 128.3 (2C, 2 X CAR), 129.9 (2C, 2 X 
CAR), 135.4 (1C, Cq AR), 144.3 (1C, Cq AR), 144.5 (1C, C-1), 170.1 (1C, Cq Acetate), 170.2 (1C, Cq 
Acetate), 170.6 (1C, Cq Acetate), 170.7 (1C, Cq Acetate).  
Data is in agreement with the literature references.17 
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(2R,3S,4S,5R)-2-(acetoxymethyl)-6-methylenetetrahydro-2H-pyran-3,4,5-triyl triacetate 
(466)17 
 
A stirred suspension of sodium hydride (0.582 g, 24.3 mmol, 10 equiv.) in dry 1,4-dioxane (61 
ml) was heated under reflux. A solution of compound 465 (1.282 g, 2.43 mmol) in dry 1,4-
dioxane (61 ml) was added to this mixture. The suspension was then refluxed for 30 minutes and 
then cooled to rt. The mixture was then filtered through a pad of celite and washed with DCM. 
The filtrate was evaporated under reduce pressure to give a crude residue. The crude residue was 
purified by flash column chromatography on silica gel (hexane:EtOAc, 3:1) to furnish 466 as a 
pure colourless solid (0.605 g, 72%); [α]D26 = +67.6 (c 0.84 in CHCl3) [lit. [α]D = +74 (c 1.45 in 
CHCl3)]
1; IR νmax (film)/cm-1: 2942, 1751, 1666, 1374, 1219, 1085; 1H NMR (500 MHz, 
Chloroform-d) δ 2.00 (s, 3H, CH3 Acetate), 2.06 (s, 3H, CH3 Acetate), 2.13 (s, 3H, CH3 Acetate), 2.16 (s, 
3H, CH3 Acetate), 4.01 (td, J = 6.5, 1.5 Hz, 1H, H-C5), 4.11 – 4.23 (m, 2H, H-C-6, H’-C6), 4.50 (t, J 
= 1.9 Hz, 1H, H-C=C Alkene), 4.81 (t, J = 1.9 Hz, 1H, H’-C=C Alkene), 5.05 (dd, J = 10.4, 3.1 Hz, 
1H, H-C-3), 5.51 (dd, J = 3.1, 1.5 Hz, 1H, H-C-4), 5.68 (dt, J = 10.4, 1.9 Hz, 1H H-C-2). 
13C NMR 
(126 MHz, CDCl3) δ 20.8 (2C, 2 X CH3 Acetate), 20.8 (1C, CH3 Acetate), 20.9 (1C, CH3 Acetate), 61.7 
(1C, C-6), 67.0 (1C, C-2), 67.7 (1C, C-4), 71.4 (1C, C-3), 75.7 (1C, C-5), 96.1 (1C, H2C=C Alkene), 
154.1 (1C, C-1), 169.6 (1C, Cq Acetate), 170.1 (1C, Cq Acetate), 170.2 (1C, Cq Acetate), 170.5 (1C, Cq 
Acetate).  
Data is in agreement with the literature references.17 
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(2R,3R,4S,5R)-2-(hydroxymethyl)-6-methylenetetrahydro-2H-pyran-3,4,5-triol (467) 
 
A solution of methanolic sodium methoxide (9.7 ml, 0.1 M in methanol, 0.97 mmol, 0.18 equiv.) 
was added dropwise to a stirred solution of 466 (1.850 g, 5.37 mmol) in dry methanol (4 ml). 
The mixture was stirred at rt and monitored by TLC until full consumption of 466 was observed. 
The mixture was then concentrated in vacuo affording 467 as a colourless solid (0.945 g, quant.); 
[α]D25 = +86.4 (c 1.06 in H2O); IR νmax (film)/cm-1: 3480, 3291, 3185, 2910, 1653, 1069; 1H 
NMR (500 MHz, DMSO-d6) δ 3.27 (dd, J = 9.6, 3.3 Hz, 1H, H-C-3), 3.42 (td, J = 6.0, 1.3 Hz, 
1H, H-C-5), 3.54 (d, J = 6.0 Hz, 2H, H-C-6, H’-C-6), 3.78 (dd, J = 3.3, 1.3 Hz, 1H, H-C-4), 3.97 
(dt, J = 9.6, 2.0 Hz, 1H, H-C-2), 4.38 (d, J = 2.0 Hz, 1H, H-C=C Alkene), 4.49 (d, J = 2.0 Hz, 1H, 
H’-C=C Alkene), 4.69 (br, 1H, OH). 13C NMR (126 MHz, DMSO) δ 60.9 (1C, C-6), 68.3 (1C, C-2), 
68.8 (1C, C-4), 74.1 (1C, C-3), 80.4 (1C, C-5), 90.9 (1C, H2C=C Alkene), 162.4 (1C, C-1); HRMS 
(NSI-FTMS) m/z found for [M+H]+: 177.0756; [C7H12O5+H]
+ requires 177.0757. 
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(2S,3R,4S,5S,6R)-2-(1H-imidazol-1-yl)-2-methyl-4-((triisopropylsilyl)oxy)-6-
(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-3,5-diol (469) and (2R,3R,4S,5S,6R)-2-
(1H-imidazol-1-yl)-2-methyl-4-((triisopropylsilyl)oxy)-6-
(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-3,5-diol (470) and (2S,3R,4S,5R,6R)-2-
(1H-imidazol-1-yl)-2-methyl-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-
triol (471) 
  
Compound 467 (0.424 g, 2.41 mmol) was dissolved in dry DMF (8.8 ml) and the solution was 
then cooled to 0 oC. To this stirred solution was added imidazole (0.656 g, 9.63 mmol, 4 equiv.), 
then TIPSCl (1.03 ml, 4.82 mmol, 2 equiv.) dropwise. The reaction mixture was stirred at rt for 
48 hours. The mixture was then concentrated in vacuo. The residue was treated with water (ca. 
20 ml) and EtOAc (ca. 20 ml), and the layers were then separated. The aqueous layer was 
extracted with EtOAc (2 X 20 ml). The combined organic extracts were then washed with water, 
brine, and dried over anhydrous MgSO4. Filtration and removal of the solvent under reduced 
pressure gave a crude residue. The crude residue was purified by flash column chromatography 
(petrol:EtOAc, 1:2) to afford 469 as a pure colourless oil (0.571 g, 43%); mp 118-119 oC; [α]D26 
= +40.0 (c 0.96 in CHCl3); IR νmax (film)/cm-1: 3155, 2943, 2867, 1464, 1101, 1073; 1H NMR 
(500 MHz, Chloroform-d) δ 1.03 – 1.17 (m, 42H, 6 X H-CMe2 TIPS, 12 X CH3 TIPS,), 1.73 (s, 3H, 
CH3), 2.64 (br, 1H, OH), 3.23 (br, 1H, OH), 3.45 (td, J = 5.9, 1.3 Hz, 1H, H-C-5), 3.88 – 4.00 (m, 
4H, H-C-6, H’-C-6, H-C-3, H-C-4), 4.18 (d, J = 9.8 Hz, 1H, H-C-2), 7.06 (br, 1H, H-CAR), 7.35 (br, 
1H, H-CAR), 8.12 (br, 1H, H-CAR). 
13C NMR (126 MHz, CDCl3) δ 12.0 (3C, 3 X CHMe2 TIPS), 
12.5 (3C, 3 X CHMe2 TIPS), 18.0 (6C, 6 X CH3 TIPS), 18.1 (3C, 3 X CH3 TIPS), 18.1 (3C, 3 X CH3 
TIPS), 29.4 (1C, CH3), 62.9 (1C, C-6), 69.7 (1C, C-4), 72.1 (1C, C-3), 73.1 (1C, C-5), 74.4 (1C, C-2), 
89.8 (1C, C-1), 117.4 (1C, CAR), 128.4 (1C, CAR), 136.2 (1C, CAR); HRMS (NSI-FTMS) m/z 
found for [M+H]+: 557.3795; [C28H56N2O5 Si2+H]
+ requires 557.3811. 
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Further elution (petrol:EtOAc, 1:3) gave compound 470 as a pure colourless solid (0.249 g, 
19%); [α]D26 = +4.2 (c 1.04 in CHCl3); IR νmax (film)/cm-1: 3569, 3141, 2943, 2892, 2867, 1464, 
1383, 1235, 1103, 1071; 1H NMR (500 MHz, Chloroform-d) δ 1.03 – 1.07 (m, 18H, 6 X CH3 
TIPS), 1.07 – 1.22 (m, 24H, 6 X CH3 TIPS, 6 X H-CMe2 TIPS), 1.72 (s, 3H, CH3), 3.78 (d, J = 9.4 
Hz, H-C-2), 3.80 – 3.83 (m, 1H, H-C-5), 3.87 – 3.92 (m, 2H, H-C-6, H-C-3), 4.04 – 4.09 (m, 2H, 
H’-C-6, H-C-4), 6.77 (br, 1H, H-CAR), 7.15 (br, 1H, H-CAR), 7.57 (br, 1H, H-CAR). 13C NMR (126 
MHz, CDCl3) δ 12.1 (3C, 3 X CHMe2 TIPS), 12.6 (3C, 3 X CHMe2 TIPS), 18.0 (6C, 3 X CH3 TIPS), 
18.1 (6C, 3 X CH3 TIPS), 18.2 (6C, 6 X CH3 TIPS), 62.5 (1C, C-6), 69.2 (C-4), 73.6 (C-5), 73.6 (C-3), 
74.2 (C-2), 90.6 (1C, C-1), 116.3 (1C, CAR), 127.8 (1C, CAR), 134.5 (1C, CAR); HRMS (ASAP-
TOF) m/z found for [M+H]+: 557.3806; [C28H56N2O5 Si2+H]
+ requires 557.3811. 
Further elution (DCM:Methanol, 10:1) gave compound 471 as a pure colourless solid (0.110 g, 
11%); mp 144-145 oC; [α]D26 = +42.4 (c 1.00 in MeOH); IR νmax (film)/cm-1: 3376, 2942, 2866, 
1464, 1376, 1219, 10921235, 1103, 1071;  1H NMR (500 MHz, DMSO-d6) δ 0.99 – 1.11 (m, 
21H, 6 X CH3 TIPS, 3 X H-CMe2 TIPS), 1.56 (s, 3H, CH3), 3.18 – 3.22 (m, 1H, H-C-5), 3.44 – 3.51 
(m, 1H, H-C-3), 3.68 (ddd, J = 4.4, 3.2, 1.2 Hz, 1H, H-C-4), 3.71 – 3.79 (m, 2H, H-C-6, H’-C-6), 
3.87 (dd, J = 10.4, 5.5 Hz, 1H, H-C-2), 4.69 (d, J = 4.4 Hz, 1H, OH), 5.03 (d, J = 5.1 Hz, 1H, 
OH, OH), 6.02 (d, J = 5.5 Hz, 1H, OH), 6.87 (t, J = 1.1 Hz, 1H, H-CAR), 7.34 (t, J = 1.1 Hz, 1H, 
H-CAR), 7.98 (t, J = 1.1 Hz, 1H, H-CAR). 
13C NMR (126 MHz, DMSO) δ 11.4 (3C, 3 X CHMe2 
TIPS), 17.8 (3C, 3 X CH3 TIPS), 17.8 (3C, 3 X CH3 TIPS), 29.2 (1C, CH3), 63.1 (1C, C-6), 68.5 (1C, 
C-4), 69.4 (1C, C-3), 72.6 (1C, C-2), 74.1 (1C, C-5), 89.6 (1C, C-1), 117.3 (1C, CAR), 127.4 (1C, 
CAR), 135.9 (1C, AR); HRMS (NSI-FTMS) m/z found for [M+H]
+: 401.2465; [C19H36N2O5 
Si+H]+ requires 401.2472. 
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(3R,4S,5R,6R)-2-methylene-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-
triol (468) 
  
To a solution of compound 467 (0.304 g, 1.73 mmol) in dry DMF (6.3 ml) at 0 oC was added 
imidazole (0.258 g, 3.80 mmol, 2.2 equiv.) then TIPSCl (0.41 ml, 1.90 mmol, 1.1 equiv.) 
dropwise. After 48 hours at rt, the mixture was then concentrated in vacuo. The residue was 
treated with water (ca. 15 ml) and EtOAc (ca. 15 ml), and the layers were then separated. The 
aqueous layer was extracted with EtOAc (2 X 15 ml). The combined organic extracts were then 
washed with water, brine, and dried over anhydrous MgSO4. Filtration and evaporation of the 
solvent under reduced pressure gave a crude residue. The crude residue was purified by flash 
column chromatography (DCM:Methanol, 12:1) to furnish 471 as a pure colourless solid (0.439 
g, 64%). 
The title compound 468 was also isolated as pure colourless gum (0.114 g, 11%); [α]D26 = +49.9 
(c 0.77 in MeOH); IR νmax (film)/cm-1: 3369, 2942, 2866, 1660, 1463, 1092, 681; 1H NMR (500 
MHz, DMSO-d6) δ 1.00 – 1.05 (m, 18H, 6 X CH3 TIPS), 1.06 – 1.12 (m, 3H, 3 X H-CMe2 TIPS), 
3.28– 3.33 (m, 1H, H-C-3), 3.47 – 3.51 (m, 1H, H-C-5), 3.74 – 3.86 (m, 3H, H-C-6, H’-C-6, H-C-4), 
4.00 (ddt, J = 9.7, 5.7, 2.2 Hz, 1H, H-C-2), 4.39 (d, J = 2.2 Hz, 1H, H-C=C Alkene), 4.52 (d, J = 2.2 
Hz, 1H, H’-C=C Alkene), 4.67 (d, J = 4.6, 1H, OH), 4.95 (d, J = 5.2 Hz, 1H, OH), 5.15 (d, J = 5.7 
Hz, 1H, OH). 13C NMR (126 MHz, DMSO) δ 11.4 (3C, 3 X CHMe2 TIPS), 17.8 (6C, 6 X CH3 
TIPS), 62.9 (1C, C-6), 68.1 (1C, C-2), 68.6 (1C, C-4), 73.9 (1C, C-3), 80.4 (1C, C-5), 91.3 (1C, 
H2C=C Alkene), 162.2 (1C, C-1); HRMS (ASAP-TOF) m/z found for [M+H]
+: 333.2090; 
[C16H32O5 Si+H]
+ requires 333.2097. 
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 (2S,3R,4S,5R,6R)-2-methyl-6-(((triisopropylsilyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-
tetraol (472) 
  
To a stirred solution of compound 467 (0.349 g, 1.98 mmol) in dry DMF (26 ml) at 0 oC was 
added 2,6-lutidine (0.46 ml, 3.96 mmol, 2 equiv.) followed by the dropwise addition of TIPSOTf 
(0.59 ml, 2.18 mmol, 1.1 equiv.). The reaction mixture was stirred at 0 oC for 15 minutes then at 
rt for 24 hours. The reaction mixture was then quenched with water (10 ml) and saturated 
aqueous NaHCO3 solution (10 ml). The solvents were evaporated under reduced pressure. The 
residue was treated with EtOAc and water, and the layers were then separated. The aqueous layer 
was then extracted with EtOAc twice.  The combined organic extracts were washed with water, 
brine, and dried over anhydrous MgSO4. Filtration and removal of the solvent in vacuo gave a 
crude residue. The crude residue was purified by flash column chromatography on silica gel 
(petrol:EtOAc, 2:1) to yield 472 as a pure colourless oil (0.021 g, 3%); [α]D22 = +14.4 (c 0.73 in 
CHCl3); IR νmax (film)/cm-1: 3385, 2942, 2867, 2973, 1749, 1382, 1247, 1089; 1H NMR (500 
MHz, DMSO-d6) δ 0.99 – 1.11 (m, 21H, 6 X CH3 TIPS, 3 X H-CMe2 TIPS), 1.37 (s, 3H, CH3), 3.40 
– 3.41 (m, 1H, H-C-6), 3.42 – 3.43 (m, 1H, H-C-2), 3.46 – 3.51 (m, 2H, H’-C-6, H-C-4), 3.60 – 
3.64 (m, 1H, H-C-3), 4.16 (m, 1H, H-C-5), 4.97 (d, J = 7.8 Hz, 1H, OH), 5.26 (d, J = 4.4 Hz, 1H, 
OH); 13C NMR (126 MHz, DMSO) δ 11.3 (3C, 3 X CHMe2 TIPS), 15.9 (1C, CH3), 17.8 (6C, 6 X 
CH3 TIPS), 63.5 (1C, C-6), 76.1 (1C, C-3), 78.0 (1C, C-4), 83.2 (1C, C-5), 85.2 (1C, C-2), 107.1 (1C, 
C-1); HRMS (NSI-FTMS) m/z found for [M+Na]
+: 373.2018; [C16H34O6Si+Na]
+ requires 
373.2017. 
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(3S,5R,6S,7S,8R)-5-(acetoxymethyl)-1,4-dioxaspiro[2.5]octane-6,7,8-triyl triacetate (-473) 
 
An aqueous solution of NaHCO3 (0.62 ml, 0.6 M, 1.03 mmol, 3.62 equiv.) was added to a 
solution of 466 (0.099g, 0.29 mmol) in DCM (4.3 ml). mCPBA (0.059 g, 0.34 mmol, 1.3 equiv.) 
was added to the mixture at 0 oC. The reaction mixture was stirred at rt overnight. A saturated 
aqueous solution of NaHCO3 was added and the layers were separated. The aqueous layer was 
extracted with DCM twice. The combined organic extracts were washed with a saturated 
aqueous solution of NaHCO3, water, brine, and dried over anhydrous MgSO4. Filtration and 
removal of the solvent under reduced pressure at ambient temperature gave a pure colourless 
solid (0.103 g, 98%); mp 93-95 oC; [α]D22 = +53.3 (c 0.96 in CHCl3); IR νmax (film)/cm-1: 2973, 
1749, 1373, 1215, 1079; 1H NMR (500 MHz, Chloroform-d) δ 2.00 (s, 3H, CH3 Acetate), 2.04 (s, 
3H, CH3 Acetate), 2.05 (s, 3H, CH3 Acetate), 2.18 (s, 3H, CH3 Acetate), 2.74 (d, J = 4.0 Hz, 1H of CH2 
Epoxide), 3.07 (d, J = 4.0 Hz, 1H of CH2 Epoxide), 4.07 (dd, J = 11.4, 6.6 Hz, 1H, H-C-6), 4.13 (dd, J 
= 11.4, 6.6 Hz, 1H, H’-C-6), 4.29 (td, J = 6.6, 1.3 Hz, 1H, H-C-5), 5.31 (dd, J = 10.8, 3.3 Hz, 1H, 
H-C-3), 5.57 (dd, J = 3.3, 1.3 Hz, 1H, H-C-4), 5.76 (d, J = 10.8 Hz, 1H, H-C-2). 
13C NMR (126 
MHz, CDCl3) δ 20.7 (2C, 2 X CH3 Acetate), 20.8 (1C, CH3 Acetate), 20.8 (1C, CH3 Acetate), 50.4 (1C, 
CH2 Epoxide), 61.3 (1C, C-6), 64.0 (1C, C-2), 68.0 (1C, C-4), 70.0 (1C, C-3), 72.0 (1C, C-5), 82.0 (1C, 
C-1), 170.0 (1C, Cq Acetate), 170.1 (1C, Cq Acetate), 170.2 (1C, Cq Acetate), 170.5 (1C, Cq Acetate); 
HRMS (ASAP-TOF) m/z found for [M+H]+: 361.1133; [C15H20O10+H]
+ requires 361.1135. 
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(2R,3R,4S,5S,6R)-6-(acetoxymethyl)-2-cyano-2-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-
pyran-3,4,5-triyl triacetate 
 (479) 
 
To a stirred solution of epoxide -473 (0.201 g, 0.56 mmol) in toluene (6 ml) and hexane (3 ml) 
at 0 oC, was added iodine (0.283 g, 1.12 mmol, 2 equiv.) then TMSCN (0.35 ml, 2.79 mmol, 5 
equiv.) dropwise. The mixture was stirred at 0 oC until TLC showed complete consumption of 
starting material. Once complete, a saturated aqueous solution of Na2SO3 (ca. 10 ml) was added, 
and the layers were separated. The aqueous layer was extracted with EtOAc (3 X 10 ml). The 
combined organic extracts were washed with water (ca. 30 ml), brine (ca. 30 ml), and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. The 
crude product was purified by flash column chromatography on silica gel (hexane:EtOAc, 3:1) to 
furnish 479 as a pure colourless oil (0.0094 g, 4%); [α]D22 = -71.0 (c 0.49 in CHCl3); IR νmax 
(film)/cm-1: 2960, 1755, 1371, 1215, 1060; 1H NMR (500 MHz, Chloroform-d) δ0.21 (s, 9H, 3 X 
CH3 TMS), 1.99 (s, 3H, CH3 Acetate), 2.06 (s, 3H, CH3 Acetate), 2.12 (s, 3H, CH3 Acetate), 2.19 (s, 3H, 
CH3 Acetate), 4.08 (d, J = 11.5 Hz, 1H of CH2OTMS), 4.12 (d, J = 6.5 Hz, 2H, H-C-6, H’-C-6), 4.19 
(d, J = 11.5 Hz, 1H, 1H of CH2OTMS), 4.59 (td, J = 6.5, 1.7 Hz, 1H, H-C-5), 5.41 (dd, J = 3.5, 
1.7 Hz, 1H, H-C-4), 5.58 (dd, J = 10.3, 3.5 Hz, 1H, H-C-3), 5.79 (d, J = 10.3 Hz, 1H, H-C-2). 
13C 
NMR (126 MHz, CDCl3) δ -0.7 (3C, 3 X CH3 TMS), 20.7 (1C, CH3 Acetate), 20.7 (1C, CH3 Acetate), 
20.8 (1C, CH3 Acetate), 20.8 (1C, CH3 Acetate), 61.9 (1C, CH2 of CH2OTMS), 64.5 (1C, C-6), 67.4 
(1C, C-4), 67.6 (1C, C-2), 68.4 (1C, C-3), 71.8 (1C, C-5), 75.7 (1C, C-1), 116.8 (1C, Cq Nitrile), 168.8 
(1C, Cq Acetate), 170.0 (1C, Cq Acetate), 170.3 (1C, Cq Acetate), 170.5 (1C, Cq Acetate); HRMS (ASAP-
TOF) m/z found for [M+H]+: 460.1639; [C19H29NO10 Si+H]
+ requires 460.1639. 
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(2R,3S,4R,5S,6S)-2-(acetoxymethyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-
triyl triacetate (481) 
 
A solution of 9-BBN in THF (0.63 ml, 0.5 M in THF, 0.32 mmol, 1 equiv.) was added dropwise 
to a stirred solution of compound 466 (0.109 g, 0.32 mmol) in dry THF (2.5 ml) at 0 oC. The 
mixture was gradually warmed to rt and stirred until the starting material was fully consumed 
(monitored by TLC). Once complete, the reaction mixture was cooled to 0 oC and treated with 
1:1 EtOH-THF (0.6 ml), pH 7 0.1 M potassium phosphate buffer (0.6 ml) and 30% aqueous 
H2O2 (0.97 ml). After being left for 5 hours stirring at rt, the reaction mixture was poured into a 
mixture of EtOAc (10 ml) and 30% aqueous NaHSO3 (10 ml), and the layers were then 
separated. The aqueous layer was extracted with EtOAc twice. The combined organic extracts 
were washed with saturated aqueous Na2SO3, saturated aqueous NaHCO3, water, brine, and dried 
over anhydrous MgSO4. Filtration and removal of the solvent in vacuo gave a crude oil. 
Purification by flash column chromatography on silica gel (hexane:EtOAc 2:1 → 1:1) furnished 
an inseparable mixture (481:unknown compound, 7:1) of  481 and an unknown compound 
(0.013 g, 11%)*; IR νmax (film)/cm-1: 3482, 2926, 2857, 1745, 1228, 1050; 1H NMR (400 MHz, 
Chloroform-d) δ 1.99 (s, 3H, CH3 Acetate), 2.05 s, 3H, CH3 Acetate), 2.07 (s, 3H, CH3 Acetate), 2.15 (s, 
3H, CH3 Acetate), 3.48 (ddd, J = 10.0, 4.8, 2.3 Hz, 1H, H-C-1), 3.61 (dd, J = 12.6, 4.8 Hz, 1H, 1H 
of CH2OH), 3.73 (dd, J = 12.6, 2.3 Hz, 1H, 1H of CH2OH), 3.90 – 3.95 (m, 1H, H-C-5), 4.07- 
4.17 (m, 2H, H-C-6, H’-C-6), 5.10 (dd, J = 10.0, 3.5 Hz, 1H, H-C-3), 5.21 (t, J = 10.0 Hz, 1H, H-
C-2), 5.44 (dd, J = 3.5, 1.1 Hz, 1H, H-C-4); 
13C NMR (101 MHz, CDCl3) δ 20.8 (1C, CH3 Acetate), 
20.8 (1C, CH3 Acetate), 20.9 (1C, CH3 Acetate), 20.9 (1C, CH3 Acetate), 61.7 (1C, CH2OH), 61.9 (1C, 
C-6), 66.4 (1C, C-2), 67.8 (1C, C-4), 72.0 (1C, C-3), 74.5 (1C, C-5), 78.7(1C, C-1), 170.3 (1C, Cq 
Acetate), 170.4 (1C, Cq Acetate), 170.6 (1C, Cq Acetate), 170.7 (1C, Cq Acetate); HRMS (NSI-FTMS) m/z 
found for [M+Na]+: 385.1099; [C15H22O10+Na]
+ requires 385.1105. 
*Assuming the unknown compound is an isomer of the title compound 481, the number of moles 
of the title compound 481 in the inseparable mixture were calculated from molar ratios seen in 
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the 1H NMR spectrum. Since the yield of 481 is based on the number of moles of 481 in the 
inseparable mixture, the yield of the 481 derives from the aforementioned molar ratios seen in 
the 1H NMR spectrum of the inseparable mixture. 
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